
<html lang="en"     class="pb-page"  data-request-id="57907a95-f275-4230-94cf-011cdc5ae947"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2010.53.issue-22;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm100571n;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="4-(Pyrazol-4-yl)-pyrimidines as Selective Inhibitors of Cyclin-Dependent Kinase 4/6" /></meta><meta name="dc.Creator" content="Young Shin  Cho" /></meta><meta name="dc.Creator" content="Maria  Borland" /></meta><meta name="dc.Creator" content="Christopher  Brain" /></meta><meta name="dc.Creator" content="Christine H.-T.  Chen" /></meta><meta name="dc.Creator" content="Hong  Cheng" /></meta><meta name="dc.Creator" content="Rajiv  Chopra" /></meta><meta name="dc.Creator" content="Kristy  Chung" /></meta><meta name="dc.Creator" content="James  Groarke" /></meta><meta name="dc.Creator" content="Guo  He" /></meta><meta name="dc.Creator" content="Ying  Hou" /></meta><meta name="dc.Creator" content="Sunkyu  Kim" /></meta><meta name="dc.Creator" content="Steven  Kovats" /></meta><meta name="dc.Creator" content="Yipin  Lu" /></meta><meta name="dc.Creator" content="Marc  O’Reilly" /></meta><meta name="dc.Creator" content="Junqing  Shen" /></meta><meta name="dc.Creator" content="Troy  Smith" /></meta><meta name="dc.Creator" content="Gary  Trakshel" /></meta><meta name="dc.Creator" content="Markus  Vögtle" /></meta><meta name="dc.Creator" content="Mei  Xu" /></meta><meta name="dc.Creator" content="Ming  Xu" /></meta><meta name="dc.Creator" content="Moo Je  Sung" /></meta><meta name="dc.Description" content="Identification and structure-guided optimization of a series of 4-(pyrazol-4-yl)-pyrimidines as selective CDK4/6 inhibitors is reported herein. Several potency and selectivity determinants were est..." /></meta><meta name="Description" content="Identification and structure-guided optimization of a series of 4-(pyrazol-4-yl)-pyrimidines as selective CDK4/6 inhibitors is reported herein. Several potency and selectivity determinants were est..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 1, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100571n" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100571n" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100571n" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100571n" /></link>
        
    
    

<title>4-(Pyrazol-4-yl)-pyrimidines as Selective Inhibitors of Cyclin-Dependent Kinase 4/6 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100571n" /></meta><meta property="og:title" content="4-(Pyrazol-4-yl)-pyrimidines as Selective Inhibitors of Cyclin-Dependent Kinase 4/6" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0013.jpeg" /></meta><meta property="og:description" content="Identification and structure-guided optimization of a series of 4-(pyrazol-4-yl)-pyrimidines as selective CDK4/6 inhibitors is reported herein. Several potency and selectivity determinants were established based on the X-ray crystallographic analysis of representative compounds bound to monomeric CDK6. Significant selectivity for CDK4/6 over CDK1 and CDK2 was demonstrated with several compounds in both enzymatic and cellular assays." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100571n"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100571n">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100571n&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100571n&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100571n&amp;href=/doi/10.1021/jm100571n" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 7938-7957</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100491v" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm100593s" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">4-(Pyrazol-4-yl)-pyrimidines as Selective Inhibitors of Cyclin-Dependent Kinase 4/6</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Young+Shin++Cho">Young Shin Cho</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Borland">Maria Borland</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Brain">Christopher Brain</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine+H.-T.++Chen">Christine H.-T. Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Cheng">Hong Cheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rajiv++Chopra">Rajiv Chopra</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kristy++Chung">Kristy Chung</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James++Groarke">James Groarke</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guo++He">Guo He</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ying++Hou">Ying Hou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sunkyu++Kim">Sunkyu Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Kovats">Steven Kovats</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yipin++Lu">Yipin Lu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marc++O%E2%80%99Reilly">Marc O’Reilly</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Junqing++Shen">Junqing Shen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Troy++Smith">Troy Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Trakshel">Gary Trakshel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Markus++V%C3%B6gtle">Markus Vögtle</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mei++Xu">Mei Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ming++Xu">Ming Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Moo+Je++Sung">Moo Je Sung</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Astex Therapeutics, 436 Cambridge Science Park, Milton Road, Cambridge, CB4 0QA, United Kingdom</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. For Y.S.C.: phone, 617-871-3495; fax, 617-871-4081; E-mail, <a href="/cdn-cgi/l/email-protection#7c051309121b0f141512521f14133c12130a1d0e08150f"><span class="__cf_email__" data-cfemail="b8c1d7cdd6dfcbd0d1d696dbd0d7f8d6d7ced9caccd1cb">[email protected]</span></a>. For M.J.S.: phone, 617-871-7522; fax, 617-871-4081; E-mail, <a href="/cdn-cgi/l/email-protection#066b69696c632875736861466869706774726f75"><span class="__cf_email__" data-cfemail="3b565454515e15484e555c7b55544d5a494f5248">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100571n&amp;href=/doi/10.1021%2Fjm100571n" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 7938–7957</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 1, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 May 2010</li><li><span class="item_label"><b>Published</b> online</span>1 November 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 November 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100571n" title="DOI URL">https://doi.org/10.1021/jm100571n</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7938%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYoung%2BShin%2BCho%252C%2BMaria%2BBorland%252C%2BChristopher%2BBrain%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D22%26contentID%3Djm100571n%26title%3D4-%2528Pyrazol-4-yl%2529-pyrimidines%2Bas%2BSelective%2BInhibitors%2Bof%2BCyclin-Dependent%2BKinase%2B4%252F6%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7957%26publicationDate%3DNovember%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100571n"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5486</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">55</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100571n" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;4-(Pyrazol-4-yl)-pyrimidines as Selective Inhibitors of Cyclin-Dependent Kinase 4/6&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Young&quot;,&quot;last_name&quot;:&quot;Shin Cho&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Borland&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Brain&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;H.-T. Chen&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Cheng&quot;},{&quot;first_name&quot;:&quot;Rajiv&quot;,&quot;last_name&quot;:&quot;Chopra&quot;},{&quot;first_name&quot;:&quot;Kristy&quot;,&quot;last_name&quot;:&quot;Chung&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Groarke&quot;},{&quot;first_name&quot;:&quot;Guo&quot;,&quot;last_name&quot;:&quot;He&quot;},{&quot;first_name&quot;:&quot;Ying&quot;,&quot;last_name&quot;:&quot;Hou&quot;},{&quot;first_name&quot;:&quot;Sunkyu&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Kovats&quot;},{&quot;first_name&quot;:&quot;Yipin&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;O’Reilly&quot;},{&quot;first_name&quot;:&quot;Junqing&quot;,&quot;last_name&quot;:&quot;Shen&quot;},{&quot;first_name&quot;:&quot;Troy&quot;,&quot;last_name&quot;:&quot;Smith&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Trakshel&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Vögtle&quot;},{&quot;first_name&quot;:&quot;Mei&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Ming&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Moo&quot;,&quot;last_name&quot;:&quot;Je Sung&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;7938-7957&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100571n&quot;},&quot;abstract&quot;:&quot;Identification and structure-guided optimization of a series of 4-(pyrazol-4-yl)-pyrimidines as selective CDK4/6 inhibitors is reported herein. Several potency and selectivity determinants were established based on the X-ray crystallographic analysis of representative compounds bound to monomeric CDK6. Significant selectivity for CDK4/6 over CDK1 and CDK2 was demonstrated with several compounds in both enzymatic and cellular assays.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100571n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100571n" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100571n&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100571n" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100571n&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100571n" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100571n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100571n&amp;href=/doi/10.1021/jm100571n" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100571n" /></input><a href="/doi/pdf/10.1021/jm100571n" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100571n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100571n%26sid%3Dliteratum%253Aachs%26pmid%3D21038853%26genre%3Darticle%26aulast%3DCho%26date%3D2010%26atitle%3D4-%2528Pyrazol-4-yl%2529-pyrimidines%2Bas%2BSelective%2BInhibitors%2Bof%2BCyclin-Dependent%2BKinase%2B4%252F6%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D22%26spage%3D7938%26epage%3D7957%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291917" title="Pyrimidine">Pyrimidine</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jmcmar.2010.53.issue-22/production/jmcmar.2010.53.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Identification and structure-guided optimization of a series of 4-(pyrazol-4-yl)-pyrimidines as selective CDK4/6 inhibitors is reported herein. Several potency and selectivity determinants were established based on the X-ray crystallographic analysis of representative compounds bound to monomeric CDK6. Significant selectivity for CDK4/6 over CDK1 and CDK2 was demonstrated with several compounds in both enzymatic and cellular assays.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00422" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00422" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cyclin-dependent kinases (CDKs<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: CDK, cyclin-dependent kinase; pRb, retinoblastoma protein; S<sub>N</sub>Ar, nucleophilic aromatic substitution; dba, dibenzylideneacetone; BINAP, 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl; XANTPHOS, 4,5-bis(diphenylphosphino)-9,9′-dimethylzanthene; SEM, 2-(trimethylsilyl)ethoxymethyl; LDA, lithium diisopropylamide; LHMDS, lithium bis(trimethylsilyl)amide; mCPBA, <i>meta</i>-chloroperbenzoic acid; NCS, <i>N</i>-chlorosuccinimide; DMF, dimethylformamide; NBS, <i>N</i>-bromosuccinimide; DDQ, 2,3-dichloro-5,6-dicyanobenzoquinone; TBAI, tetrabutylammonium iodide; Boc, <i>t</i>-butoxycarbonyl; THF, tetrahydrofuran; TFAA, trifluoroacetic anhydride; AIBN, 2,2′-azo bisisobutyronitrile; ATP, adenosine-5′-triphosphate; PSA, polar surface area; SAR, structure−activity relationship; ELISA, enzyme-linked immunosorbent assay; FACS, fluorescence-activated cell sorting; ALK, anaplastic lymphoma kinase; ERK2, extracellular signal-related kinase 2; FGFR-4, fibroblast growth factor receptor-4; GSK 3β, glycogen synthase kinase 3β; JAK1, janus kinase 1; MAPK2, mitogen-activated protein kinase 2; MAPK 5, mitogen-activated protein kinase 5; PDGFRα, platelet-derived growth factor receptor α; PDK1, 3-phosphoinositide dependent kinase 1; PKA, protein kinase A; PKB α, protein kinase B α; SYK, spleen tyrosine kinase; cMET, mesenchymal-epithelial transition factor.</p></div>) 4 and 6 are highly homologous proline-dependent serine/threonine kinases that belong to the CDK enzyme family.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> CDK family members such as CDK1, 2, and 4/6 function as regulators of cell cycle progression and check points, whereas CDK8 and 9 are involved in transcriptional regulation.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Each CDK enzyme is activated by binding to a specific cyclin, whose expression is often tied to a particular phase of the cell cycle. The CDK4/6|D-cyclin enzyme complex is responsible for the deactivation of retinoblastoma protein (pRb) via phosphorylation of pRb. This in turn leads to the release of the E2F transcription factor and activation of genes required for G1 phase to S phase transition.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Alteration of the pRb pathway to favor cell proliferation is one of the hallmarks of a transformed cell phenotype and is universally observed in cancers. Loss of pRb function that results in unchecked E2F activity can be achieved either by loss of pRb itself or by aberrations in other parts of the pRb pathway that lead to deactivation of the protein (80% of cancers maintain a functional pRb protein but display genetic alterations elsewhere).<a onclick="showRef(event, 'cit2a'); return false;" href="javascript:void(0);" class="ref cit2a">(2a)</a> Some examples of the latter include: translocation of D-cyclins in mantle-cell lymphoma and multiple myeloma, amplification of cyclin D1 in squamous cell esophageal cancer and breast cancer, amplifications of CDK4 in liposarcoma, and suppression of p16 in melanoma, nonsmall-cell lung cancer, and pancreatic cancer.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In addition to these direct genetic defects, CDK4/6 kinase activity can also be hyperactivated by mitogen pathways with activating mutations of their own.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> These mutations are expected to increase cell cycle progression via increasing D-cyclin expression. Taken together, many different cancers spanning various tissue origins appear to contain activating aberrations of the CDK4/6 pathway.</div><div class="NLM_p">On the basis of clear evidence that numerous cancers hyperactivate CDK4/6 kinase activity to achieve unchecked proliferation, suppression of CDK4/6 kinase activity has been proposed as an effective way to treat human neoplasia. Indeed, inhibition of CDK4/6 kinase activity stops the progression of tumors in various in vivo and in vitro models.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Furthermore, genetic knockout experiments involving CDK4/6 have demonstrated that the inhibition of these kinases in fibroblast cells was well tolerated due to compensation by CDK1, while CDK1 inhibition led to lethality in all cell systems investigated.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> This indicates that selective CDK4/6 inhibitors may have a larger therapeutic window as compared to pan-CDK inhibitors.</div><div class="NLM_p">While there are several pan-CDK inhibitors in clinical trials,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> a variety of CDK4/6-selective inhibitors are emerging in the literature.<a onclick="showRef(event, 'cit2d ref9'); return false;" href="javascript:void(0);" class="ref cit2d ref9">(2d, 9)</a> Among those, <b>1</b> (PD-0332991, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>)<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> is noteworthy, with selectivity achieved over a broad panel of protein kinases including CDK1 and 2, oral efficacy in several xenograft models, and advancement into clinical trials.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Recently, we embarked on efforts toward identification of CDK4/6-selective and potent inhibitors. Herein, we describe our structure-based optimization of 4-(pyrazol-4-yl)-pyrimidines (<b>A</b>),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> a hit series identified via high-throughput screening.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0014.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selective CDK4/6 inhibitor <b>1</b> and general structure of 4-(pyrazol-4-yl)-pyrimidines (<b>A</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23700" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23700" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The compounds described in this report were prepared via two different coupling reactions: (1) displacement of a sulfone at the <i>C</i>2 position of the pyrimidine core with an amine side chain,(2) palladium-mediated amination reaction of the 2-chloro-pyrimidine (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). These reactions were followed by removal of protecting groups where necessary.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0015.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (I) R<sub>1</sub>NH<sub>2</sub>, heating; (II) R<sub>1</sub>NH<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, BINAP or XANTPHOS, NaO<i>t</i>Bu or Cs<sub>2</sub>CO<sub>3</sub>, dioxane, heating.</p></p></figure><div class="NLM_p">The general synthetic routes to <b>B</b> and <b>C</b> are described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Acylation of 4-methyl-2-(methylthio)pyrimidine <b>2</b> with various esters afforded the ketones <b>3a</b>−<b>f</b>. The ketones were then treated with dimethylformamide dimethyl acetal, and the resulting product was condensed with hydrazine to provide the pyrazoles <b>4a</b>−<b>f</b>. Subsequent oxidation of <b>4a</b>−<b>f</b> gave the sulfones <b>5a</b>−<b>f</b>. <b>5b</b> was further converted to 2-chloro-pyrimidine <b>6</b> upon treatment with sulfuryl chloride in acetic acid at 60 °C. Protection of the pyrazole <b>6</b> with a 2-(trimethylsilyl)ethoxymethyl (SEM) group followed by chlorination with <i>N</i>-chlorosuccinimide afforded bischloro 4-(pyrazol-4-yl)-pyrimidine <b>7</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0016.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LDA or LHMDS, THF, 0 °C; R<sub>1</sub>CO<sub>2</sub>Me, 0 °C to room temperature; (b) (i) dimethylformamide dimethyl acetal, (ii) H<sub>2</sub>NNH<sub>2</sub>·H<sub>2</sub>O, MeOH; (c) <i>m</i>CPBA, CH<sub>2</sub>Cl<sub>2</sub> or oxone, DMF, 90 °C; (d) SO<sub>2</sub>Cl<sub>2</sub>, AcOH, 60 °C, 43%; (e) (i) Cs<sub>2</sub>CO<sub>3</sub>, SEMCl, DMF, 73%, (ii) NCS, DMF, 40 °C, 62%.</p></p></figure><div class="NLM_p">Exploration of other substitutions on the pyrazole is summarized in Schemes <a class="ref internalNav" href="#sch3" aria-label="3">3</a> and <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Regioselective bromination of <b>4b</b> and <b>5b</b> to yield <b>8</b> and <b>9</b>, respectively, was disclosed previously.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Oxidation of <b>8</b> with <i>m</i>-chloroperbenzoic acid provided <b>10</b>, which was converted to <b>11</b> via subsequent Stille reaction. The same Stille reaction conditions were applied to <b>9</b> to obtain <b>12</b> in 69% yield. 3-Trifluoromethylpyrazole <b>13</b><a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> was protected with a <i>N</i>,<i>N</i>-dimethylsulfamoyl group and installed on the pyrimidine ring following the procedure developed by Strekowski et al.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> to give <b>14</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0017.jpeg" id="gr6" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0018.jpeg" id="gr7" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a> describes a general synthetic route to pyridin-2-ylamines.<a onclick="showRef(event, 'cit10a ref16'); return false;" href="javascript:void(0);" class="ref cit10a ref16">(10a, 16)</a> Displacement of bromine with various piperazine derivatives or 4-(dimethylamino)piperidine was followed by reduction of the nitro group to afford <b>16</b>−<b>22</b>. Insertion of a methylene between the pyridine and the piperazine was achieved by following the reaction steps described in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. Conversion of 5-methyl-pyridin-2-ylamine <b>23</b> to its 2,2,2-trifluoroacetamide and subsequent bromination of the methyl group<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> provided <i>N</i>-(5-bromomethyl-pyridin-2-yl)-2,2,2-trifluoro-acetamide, which was then reacted with substituted piperazine derivatives. Methanolysis of the resulting products gave <b>24</b> and <b>25</b>. A Boc-protected piperidine was installed via Suzuki reaction of <b>26</b> and <b>27</b>,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> followed by hydrogenation to give <b>28</b> in 42% yield over two steps (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>). 6-Chloro-pyridazine <b>29</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and 5-bromo-pyrazine <b>30</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> were subjected to palladium-catalyzed cross-coupling with benzophenone imine, an ammonia synthon,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and subsequently deprotected to yield <b>31</b> and <b>32</b> (Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>).</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0019.jpeg" id="gr8" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0020.jpeg" id="gr9" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0021.jpeg" id="gr10" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0001.jpeg" id="gr11" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12427" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12427" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">High-throughput screening of the Novartis compound collection against the CDK4 enzyme identified a pyrazolyl-pyrimidine derivative <b>33</b> as a promising hit for optimization (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Competition binding experiments confirmed that <b>33</b> binds competitively and reversibly to the ATP binding site of CDK4 (data not shown). This compound also demonstrated selectivity against other non-CDK kinases despite the fact that it contains an aminopyrimidine moiety, a common element in many ATP-competitive kinase inhibitors. However, similar activity against CDK1 and 2 alerted us a potential hurdle of achieving selectivity within the CDK family. The low molecular weight (MW 243) and calculated properties (cLogP 2.36, polar surface area (PSA) 66) made compound <b>33</b> attractive as a starting point for a medicinal chemistry campaign.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> Values for Compounds in the CDK Enzyme Assays<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0002.gif" alt="" id="fx2" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0003.gif" alt="" id="fx3" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for detailed descriptions of each assay.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Results are expressed as the mean ± standard deviation of one to two IC<sub>50</sub> determinations. For each determination, concentration−inhibition curves were obtained in duplicate and then averaged to afford a single IC<sub>50</sub> curve with a ≥95% confidence interval.</p></div></div></div><div class="NLM_p">During the early hit-to-lead optimization, the rapid synthesis of the core allowed us to quickly explore the structure−activity relationship (SAR) at the <i>C</i>2 position of the pyrimidine as well as substitution on the pyrazole moiety. Substitution on the pyrazole with an isopropyl group (<b>35</b>) led to an improvement in the overall potency against CDKs as compared to methyl derivative <b>34</b>. Subsequent incorporation of a basic amine into the cyclohexyl ring at the <i>C</i>2 side chain, as exemplified by compounds <b>36</b> and <b>37</b>, resulted in the enhancement in selectivity for CDK4 over CDK1 and CDK2. In addition to slight improvement in CDK4 binding affinity, <i>N</i>-methylation of the piperidine also improved the cellular potency (vide infra) of <b>37</b> (non-normalized IC<sub>50</sub> 0.300 μM, normalized IC<sub>50</sub> 0.640 μM) relative to <b>36</b> (non-normalized IC<sub>50</sub> 0.944 μM, normalized IC<sub>50</sub> 1.615 μM).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">With a potent and modestly selective compound <b>37</b> in hand, we next probed the binding mode of 4-(pyrazol-4-yl)-pyrimidines to the enzyme. To this end, an X-ray crystal structure of <b>37</b> bound to inactive monomeric CDK6 was obtained (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> CDK6 shares approximately 70% homology with CDK4 and demonstrates a comparable SAR profile with reduced potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The X-ray structure reveals that <b>37</b> binds to the CDK6 ATP binding pocket in a compact conformation in which the pyrimidine and the pyrazole are coplanar and the piperazine moiety packs against the isopropyl group of the pyrazole. Two hydrogen-bonding interactions are indicated in the CDK6 hinge region, one between the pyrimidine <i>N</i>1 and the backbone NH of Val101 and the other between the 2-amino NH and the Val101 backbone carbonyl. The pyrazole N and NH form additional polar interactions with the side chains of Lys43 and Asp163, respectively. An edge-to-face aromatic−aromatic contact is observed between the pyrazole and the kinase gatekeeper residue, Phe80. The isopropyl substituent has complementary packing and hydrophobic interactions with Val27, Gly20, Leu152, Ala162, and the hydrophobic residue of the Asn150 side chain. The piperidinyl group sits in a solvent exposed cleft which is mainly hydrophobic but lined with several polar residues at the edge (Thr107, Asp104, Asp102, Gln/Glu149).</div><figure id="fig2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray structure of compound <b>37</b> bound to CDK6.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Values for Compounds in the CDK Enzyme Assays<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0007.gif" alt="" id="fx4" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" colspan="4" align="left" char="±">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left">compd</th><th class="colsep0 rowsep0" align="left">R1</th><th class="colsep0 rowsep0" align="left">R2</th><th class="colsep0 rowsep0" align="left" char="±">CDK4/cyclin D1</th><th class="colsep0 rowsep0" align="left" char="±">CDK6/cyclin D3</th><th class="colsep0 rowsep0" align="left" char="±">CDK1/cyclin B</th><th class="colsep0 rowsep0" align="left" char="±">CDK2/cyclin A</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.130 ± 0.020</td><td class="colsep0 rowsep0" align="char" char="±">NA<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">3.028 ± 0.035</td><td class="colsep0 rowsep0" align="char" char="±">4.187 ± 0.251</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char="±">1.979 ± 0.549</td><td class="colsep0 rowsep0" align="char" char="±">7.769 ± 0.910</td><td class="colsep0 rowsep0" align="char" char="±">>15</td><td class="colsep0 rowsep0" align="char" char="±">>15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.540 ± 0.018</td><td class="colsep0 rowsep0" align="char" char="±">0.737 ± 0.058</td><td class="colsep0 rowsep0" align="char" char="±">2.507 ± 0.364</td><td class="colsep0 rowsep0" align="char" char="±">1.965 ± 0.135</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="char" char="±">0.076 ± 0.009</td><td class="colsep0 rowsep0" align="char" char="±">0.231 ± 0.018</td><td class="colsep0 rowsep0" align="char" char="±">1.722 ± 0.214</td><td class="colsep0 rowsep0" align="char" char="±">1.037 ± 0.124</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for detailed descriptions of each assay.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Results are expressed as the mean ± standard deviation of one to two IC<sub>50</sub> determinations. For each determination, concentration−inhibition curves were obtained in duplicate and then averaged to afford a single IC<sub>50</sub> curve with a ≥95% confidence interval.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">NA: not available</p></div></div></div><div class="NLM_p">The overlay of X-ray structures of compounds <b>37</b> and <b>1</b> bound to CDK6 suggests space available for substitution on the pyrimidine and the pyrazole for a tighter binding in the gatekeeper area defined by Phe98 (data not shown). Indeed, exploiting substitutions at <i>C</i>5 and <i>C</i>6 of the pyridopyrimidine series resulted in a potent and selective compound (<b>1</b>).<a onclick="showRef(event, 'cit9f cit10a'); return false;" href="javascript:void(0);" class="ref cit9f cit10a">(9f, 10a)</a> To probe this region with the 4-(pyrazol-4-yl)-pyrimidines, we prepared compounds which contain methyl or bromine at the <i>C</i>5 of the pyrimidine or the <i>C</i>3 of the pyrazole. This exercise resulted in reduced potency compared to <b>37</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_p">Next, we turned our attention to the <i>C</i>2 side chain of the pyrimidine to further improve enzyme potency and selectivity. Analysis of reported SAR around <b>1</b><a onclick="showRef(event, 'cit9f ref10'); return false;" href="javascript:void(0);" class="ref cit9f ref10">(9f, 10)</a> and X-ray structure of compound <b>37</b> bound to CDK6, as well as molecular modeling studies, suggested that additional selectivity could be obtained by replacing the piperidinylamine with a piperazine-substituted pyridinylamine. Introduction of the pyridine could enhance selectivity over other kinases via interactions with the side-chain of hinge residue His 100. An analysis of the sequence alignment of over 400 kinases (data not shown) indicates that this His residue is conserved in only a few kinases. The distal amine of the piperazine could reach into a more polar and solvent exposed region of CDK4/6, composed of residues Asp96(CDK4)/Asp104(CDK6) and Thr99(CDK4)/Thr107(CDK6). As previously noted,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> this “selectivity” pocket has a divergent charge profile due, in part, to the residues Thr99/107 in CDK4/6 and Lys89 in CDK1/2. A basic substituent approaching this space could introduce unfavorable electrostatic repulsion in CDK1/2, thereby boosting selectivity over these closely related kinases.</div><div class="NLM_p">Compound <b>42</b> indeed demonstrated improved selectivity profile over <b>37</b>, although CDK4 enzyme potency remained similar (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The aniline counterpart of <b>42</b> proved to be a less selective CDK inhibitor, as shown with compound <b>43</b>.<a onclick="showRef(event, 'cit10a'); return false;" href="javascript:void(0);" class="ref cit10a">(10a)</a> Removal of the piperazine (<b>44</b>) resulted in reduction in potency, selectivity, and solubility (<b>42</b> 0.9105 mM at pH 6.8, <b>44</b> 0.0851 mM at pH 6.8). The piperazine moiety proved to be not only a solubilizing group but also an important selectivity determinant by reason of deleterious interactions unique to CDK1/2. A crystal structure of CDK6 in complex with compound <b>42</b> confirmed that the key hydrogen-bonding interactions with the hinge region are maintained, and the core of the pyrazole-pyrimidine scaffold is essentially identical in its interactions (data not shown).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. IC<sub>50</sub> Values for Compounds in the CDK Enzyme Assays<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0008.gif" alt="" id="fx5" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for detailed descriptions of each assay.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Results are expressed as the mean ± standard deviation of one to two IC<sub>50</sub> determinations. For each determination, concentration−inhibition curves were obtained in duplicate and then averaged to afford a single IC<sub>50</sub> curve with a ≥95% confidence interval.</p></div></div></div><div class="NLM_p">To explore pyrazole substituents, we prepared a small set of closely related analogues (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Although the selectivity for CDK4 appeared to be retained, any change in size of the substituent R<sub>1</sub> (R<sub>2</sub> = H) diminished the potency for CDK4. This pattern of substitution was also observed in a series of imidazole pyrimidine amides where isopropyl was found to be optimal for hydrophobic interactions with CDKs.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Introduction of chloride atom at R<sub>2</sub> (<b>50</b>) led to a modest improvement in the CDK4 inhibitory activity. A crystal structure of compound <b>50</b> bound to CDK6 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) revealed that the planes of the pyrimidine and the pyrazole are tilted relative to each other, with an interplanar angle of ca 25°. The chlorine substituent of the pyrazole is projected toward the aromatic plane of Phe80, possibly forming a favorable Cl−π interaction.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Chlorination of the pyrazole also resulted in improved metabolic stability in rat liver microsomes (hepatic extraction ratio 67% for <b>42</b> and 36% for <b>50</b>). As seen earlier, 3-isopropyl-5-methyl-pyrazole of <b>51</b> led to a reduction in potency in CDK4, suggesting that replacement of a hydrogen with a methyl may interrupt a favorable edge-to-face aromatic−aromatic interaction observed in the compound <b>42</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. IC<sub>50</sub> Values for Compounds in the CDK Enzyme Assays<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0009.gif" alt="" id="fx6" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" colspan="3" align="left" char="±">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left">compd</th><th class="colsep0 rowsep0" align="left">R1</th><th class="colsep0 rowsep0" align="left">R2</th><th class="colsep0 rowsep0" align="left" char="±">CDK4/cyclin D1</th><th class="colsep0 rowsep0" align="left" char="±">CDK1/cyclin B</th><th class="colsep0 rowsep0" align="left" char="±">CDK2/cyclin A</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.532 ± 0.001</td><td class="colsep0 rowsep0" align="char" char="±">>15</td><td class="colsep0 rowsep0" align="char" char="±">>15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.037 ± 0.008</td><td class="colsep0 rowsep0" align="char" char="±">5.422 ± 0.175</td><td class="colsep0 rowsep0" align="char" char="±">10.065 ± 1.134</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left"><i>c</i>Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.089 ± 0.003</td><td class="colsep0 rowsep0" align="char" char="±">15.031 ± 3.621</td><td class="colsep0 rowsep0" align="char" char="±">15.634 ± 4.455</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left"><i>t</i>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.187 ± 0.012</td><td class="colsep0 rowsep0" align="char" char="±">>15</td><td class="colsep0 rowsep0" align="char" char="±">>15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left"><i>p</i>-F-Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.742 ± 0.019</td><td class="colsep0 rowsep0" align="char" char="±">>15</td><td class="colsep0 rowsep0" align="char" char="±">>15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>Pr</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">0.011 ± 0.000</td><td class="colsep0 rowsep0" align="char" char="±">6.325 ± 0.549</td><td class="colsep0 rowsep0" align="char" char="±">1.435 ± 0.036</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>Pr</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char="±">0.274 ± 0.034</td><td class="colsep0 rowsep0" align="char" char="±">>15</td><td class="colsep0 rowsep0" align="char" char="±">>15</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for detailed descriptions of each assay.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Results are expressed as the mean ± standard deviation of one to two IC<sub>50</sub> determinations. For each determination, concentration−inhibition curves were obtained in duplicate and then averaged to afford a single IC<sub>50</sub> curve with a ≥95% confidence interval.</p></div></div></div><figure id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overlay of compounds <b>50</b> (carbon atoms, cyan; chlorine, green) and <b>37</b> (carbon atoms, purple) bound to the active site of CDK6 (carbon atoms, yellow).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With the pyrazole substituents fixed as R<sub>1</sub> = isopropyl and R<sub>2</sub> = chloride, different heteroaromatic rings and various basic solubilizing groups were applied to the pyrimidine <i>C</i>2 side chain in an attempt to further improve selectivity over CDK1 and 2 (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Pyridazine (<b>52</b>) and pyrazine (<b>53</b>) were not equivalent to pyridine in terms of CDK4 potency and selectivity. Replacement of a piperazine with a piperidine (<b>54</b>) and substitution on the terminal amine of the piperazine (<b>55</b> and <b>56</b>) was well tolerated; however, no impact on selectivity was seen. Compounds in which steric bulk was introduced around the terminal amine (<b>57</b>−<b>60</b>) demonstrated only a slight loss in CDK1/2 activity. When the piperazine moiety was further extended into the solvent-exposed region, overall loss of CDK activities was observed, as shown with compounds <b>61</b> and <b>62</b>. The best potency and selectivity profile was demonstrated with compound <b>63</b>, wherein the 4-(dimethylamino)piperidine moiety is speculated to make a favorable polar interaction with Thr107 of CDK4/6 and an unfavorable electrostatic repulsion with Lys89 in CDK1/2. Finally, we tested whether a trifluoromethyl group could act as a surrogate for Cl on the pyrazole ring. Compound <b>64</b> showed an 8-fold decrease of CDK4 potency as compared to <b>63</b>; however, this decrease was less dramatic than that observed in the case of compounds <b>51</b> vs <b>50</b>, which suggests that the CF<sub>3</sub>-substituted pyrazole holds some advantage relative to the methyl-substituted in terms of its interaction with CDK4.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. IC<sub>50</sub> Values for Compounds in the CDK Enzyme Assays<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0004.gif" alt="" id="fx7" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0005.gif" alt="" id="fx8" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for detailed descriptions of each assay.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Results are expressed as the mean ± standard deviation of one to two IC<sub>50</sub> determinations. For each determination, concentration−inhibition curves were obtained in duplicate and then averaged to afford a single IC<sub>50</sub> curve with a ≥95% confidence interval.</p></div></div></div><div class="NLM_p">Five representive compounds with a range of potency and selectivity for CDK4/6, as well as structural diversity, were chosen for evaluation in a cell-based assay measuring phosphorylation levels of pRb at the Ser780 site using an enzyme-linked immunosorbent assay (ELISA) method (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Jeko-1, a mantle-cell lymphoma cell line, was selected for use in this assay due to its known translocation and subsequent overexpression of cyclin D1.<a onclick="showRef(event, 'cit4a'); return false;" href="javascript:void(0);" class="ref cit4a">(4a)</a> Percent inhibition was calculated at each compound concentration by comparing phosphorylation levels against the level seen in the vehicle control, and these inhibitions were used to determine non-normalized IC<sub>50</sub>s. A separate ELISA assay was conducted to quantitate total pRb levels at each compound concentration and to compensate for the reduced signal due to the loss of total pRb protein. The numbers incorporating the results from this second ELISA are reported as normalized IC<sub>50</sub>s.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. IC<sub>50</sub> Values for Compounds in the CDK4 Cellular Assays<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" colspan="2" align="char" char="±">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left">compd</th><th class="colsep0 rowsep0" align="char" char="±">non-normalized</th><th class="colsep0 rowsep0" align="char" char="±">normalized</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="char" char="±">0.451 ± 0.052</td><td class="colsep0 rowsep0" align="char" char="±">0.591 ± 0.068</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="char" char="±">0.223 ± 0.016</td><td class="colsep0 rowsep0" align="char" char="±">0.467 ± 0.033</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="char" char="±">0.134 ± 0.024</td><td class="colsep0 rowsep0" align="char" char="±">0.383 ± 0.069</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="char" char="±">0.324 ± 0.061</td><td class="colsep0 rowsep0" align="char" char="±">0.365 ± 0.068</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="char" char="±">0.468 ± 0.107</td><td class="colsep0 rowsep0" align="char" char="±">0.557 ± 0.127</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for detailed descriptions of each assay.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Results are expressed as the mean ± standard deviation of single IC<sub>50</sub> determinations. For each determination, concentration−inhibition curves were obtained in triplicate and then averaged to afford a single IC<sub>50</sub> curve with a ≥95% confidence interval.</p></div></div></div><div class="NLM_p">The same set of compounds was then tested for their ability to affect individual phases of the cell cycle. To this end, a flow cytometry analysis was performed, where it was expected that selective CDK4 inhibitors would afford an exclusive G1 arrest by inhibition of pRb phosphorylation and subsequent blocking of S phase transition (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Jeko-1 cells were treated with compound and then sorted based on their DNA content using fluorescence-activated cell sorting (FACS). In each case, a dose-related increase in G1 arrest was observed with increasing concentrations of compound. Compound <b>42</b> demonstrated a clean G1 block at 1 μM. However, at 3.3 μM, we started to see blocks in non-G1 phases of the cell cycle, suggesting that the ca 200-fold CDK4 vs CDK1/2 selectivity seen in enzymatic assays with <b>42</b> is insufficient for achieving a comparable cellular selectivity to that of compound <b>1</b>.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Compounds <b>50</b>, <b>54</b>, and <b>63</b> imposed a G1 block on cells at 0.37 μM, a lower concentration than achieved with <b>42</b>, thereby corroborating the data from the pRb phosphorylation studies, which showed lower IC<sub>50</sub>s for these compounds. Exclusive G1 arrest was maintained over a wider range of concentrations with these compounds as compared to <b>42</b>, which we attribute to their improved enzyme selectivity for CDK4. A shift of the clean G1 arrest concentration window to higher concentrations with compound <b>64</b> was in agreement with its less potent enzymatic and cellular IC<sub>50</sub>s. Compounds <b>63</b> and <b>64</b> exhibited the most sustained G1 arrest among five compounds and were tested further against a selection of serine−threonine and tyrosine kinases and proved to be selective for CDK4/6 over 35 other kinases. Several representative data are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>.</div><figure id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0011.jpeg" id="_i10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cell cycle flow cytometry analyses.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Selected Inhibitory Activity of Compounds <b>63</b> and <b>64</b> against a Panel of Kinases<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" colspan="2" align="char" char=".">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left">protein kinase</th><th class="colsep0 rowsep0" align="char" char="."><b>63</b></th><th class="colsep0 rowsep0" align="char" char="."><b>64</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">anaplastic lymphoma kinase (ALK)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">extracellular signal-related kinase 2 (ERK2)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">fibroblast growth factor receptor-4 (FGFR-4)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">glycogen synthase kinase (GSK3β)</td><td class="colsep0 rowsep0" align="char" char=".">9.6</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">janus kinase 1 (JAK1)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mitogen-activated protein kinase 2 (MAPK2)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mitogen-activated protein kinase 5 (MAPK5)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">platelet-derived growth factor receptor α (PDGFRα)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3-phosphoinositide dependent kinase 1 (PDK1)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">protein kinase A (PKA)</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">protein kinase B (PKBα)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spleen tyrosine kinase (SYK)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mesenchymal-epithelial transition factor (cMET)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Results are from single IC<sub>50</sub> determinations. For each determination, concentration−inhibition curves were obtained in triplicate and then averaged to afford a single IC<sub>50</sub> curve with a ≥95% confidence interval.</p></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50174" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50174" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A series of substituted 4-(pyrazol-4-yl)-pyrimidines were identified as selective inhibitors of CDK4/6. X-ray crystallographic studies demonstrated a general binding mode of the compounds bound to CDK6 and guided further optimization efforts in the series. Our SAR agreed with that of previously reported CDK inhibitors,<a onclick="showRef(event, 'ref10 ref25'); return false;" href="javascript:void(0);" class="ref ref10 ref25">(10, 25)</a> wherein a substituted pyridinylamine side-chain off of the pyrimidine <i>C</i>2 position introduced both potency and selectivity and an isopropyl-substituted pyrazole at <i>C</i>3 afforded further improvements in potency. Additional substitution of the pyrazole with chlorine was found to enhance potency and selectivity in both enzymatic and cellular settings. A robust G1 cell cycle block of Jeko-1 cells was demonstrated with several compounds, suggesting that the enzymatic selectivity of CDK4 over CDK1/2 could be translated to a specific cellular phenotype that mirrored the genetic inhibition of CDK4/6. Selective compounds in the cell cycle flow cytometry analyses, <b>63</b> and <b>64</b>, were evaluated against a panel of protein kinases and exhibited broad selectivity. Further studies on these compounds will be reported in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10267" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10267" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> CDK Enzyme Assays</h3><div class="NLM_p">Human CDK4/cyclin D1 was expressed in Sf21 cells via baculovirus infection. An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format and was used for IC<sub>50</sub> determination and kinetic analysis. The reaction was carried out in a 30 μL volume containing 0.25 nM CDK4/cyclin D1, 150 nM biotin-pRb (773−924), 3 μM ATP, and 1.3% DMSO (or compound in DMSO) in the assay buffer (50 mM HEPES-Na, pH 7.5; 5 mM MgCl<sub>2</sub>, 1 mM DTT, 0.02% Tween-20, and 0.05% BSA). Three μM ATP was added last to initiate the reaction. The reaction was quenched with 10 μL of 240 mM EDTA-Na (pH 8.0) after 60 min incubation at 22 °C. The signal was developed by the addition of 40 μL of detection solution containing 40 nM SA-APC, 143 ng/mL antiphospho-pRb (S780) antibody, and 2 nM Eu-W1024 antirabbit IgG antibody in the detection buffer (50 mM HEPES-Na, pH 7.5, 60 mM EDTA-Na, pH 8.0, 0.05% BSA, and 0.1% Triton X-100). After 60 min incubation in the dark, the plate was read on Envision (Perkin-Elmer 2102−0010).</div><div class="NLM_p">Human CDK6/cyclin D3 was purchased from Carna Biosciences Inc. (catalog no. 04-107). An assay for monitoring CDK6/cyclin D3-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format and was used for IC<sub>50</sub> determination and kinetic analysis. The reaction was carried out in a 30 μL volume containing 0.20 nM CDK6/cyclin D3, 200 nM biotin-pRb (773−924), 3 μM ATP, and 1.3% DMSO (or compound in DMSO) in the assay buffer (50 mM HEPES-Na, pH 7.5; 5 mM MgCl<sub>2</sub>, 1 mM DTT, 0.02% Tween-20, and 0.05% BSA). Three μM ATP was added last to initiate the reaction. The reaction was quenched with 10 μL of 120 mM EDTA-Na (pH 8.0) after 120 min incubation at 22 °C. The signal was developed by the addition of 40 μL of detection solution containing 40 nM SA-APC, 143 ng/mL antiphospho-pRb (S780) antibody, and 2 nM Eu-W1024 antirabbit IgG antibody in the detection buffer (50 mM HEPES-Na, pH 7.5, 60 mM EDTA-Na, pH 8.0, 0.05% BSA, and 0.1% Triton X-100). After 60 min incubation in the dark, the plate was read on Envision (Perkin-Elmer 2102−0010).</div><div class="NLM_p last">The inhibition of human CDK1/cyclin B and human CDK2/cyclin A (catalog no. 14-450 and 14-448, respectively, Millipore) was monitored using IMAP-FP assays (Molecular Devices, CA) by following the phosphorylation of Tamra-Histone H1-derived peptide (catalog no. R7385, Molecular Devices). The final reaction volume was 20 μL and contained 0.25 nM CDK1/cyclin B or 0.3 nM CDK2/cyclin A, 100 nM Tamra-H1, and 20 μM ATP in 1× reaction buffer (R8139, Molecular Devices). The reactions were run for 2 h at 22 °C. Quenching and detection was carried out following the protocols for the peptide substrate provided by the vendor.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> CDK4 Cellular Assays</h3><div class="NLM_p">The pRb expressing Jeko-1 mantle cell lymphoma cell line was grown in complete media consisting of RPMI1640 (Gibco catalog no. 22400-071), 20% FBS (Gibco catalog no. 10082-131), 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Gibco catalog no. 25030-081), and 1% penicillin/streptomycin (Gibco catalog no. 15140-133). Jeko-1 cells were seeded in Biocoat Cell Environment poly-<span class="smallcaps smallerCapital">d</span>-lysine 96-well tissue culture plates (Becton Dickinson catalog no. 356461) at 20000 cells/well in 100 μL final volume of complete media. Cells were allowed to adhere overnight. Compounds were prepared as 10 mM stock solution in DMSO and diluted to a concentration of 110 μM in complete media in a 96-well tissue culture plate and then serially diluted 4-fold, allowing a titration curve of 7 points with a final concentration of 26 nM. Ten μL of the dilution were then transferred to the cell culture plate, resulting in a final concentration range of 10 μM to 2 nM. The incubation was carried out at 37 °C with 5% CO<sub>2</sub>. All compounds were tested in triplicates at each concentration. Following compound incubation, the media was removed and the cells were lysed in 35 μL of lysis buffer, consisting of 50 mM Tris.Cl, pH 7.2, 120 mM NaCl, 1 mM EDTA, 6 mM EGTA, 1% NP-40, complete protease inhibitor cocktail (Roche, catalog no. 11836170001) and a protease inhibitor cocktail from Calbiochem (catalog no. 524525). The plates were placed at 4 °C with vigorous shaking for 5 min to lyse the cells. The resulting lysates contained approximately 1 μg/μL of protein.</div><div class="NLM_p">The 4H1 total pRb antibody from Cell Signaling Technology (catalog no. 9309) was added to clear MaxiSorp plates (Nunc catalog no. 442404) at a concentration of 50 ng per well in 50 μL of Dulbecco’s phosphate buffered saline (DPBS) (Gibco catalog no. 14190-144). Plates were incubated overnight at 4 °C with rocking. After a 250 μL wash with TBST (Teknova catalog no. T9501) and blot-drying, 250 μL Superblock (Pierce catalog no. 37535) was added to each well. After shaking for 10 min, the Superblock solution was replaced with fresh Superblock and plates were incubated on a shaker for an additional 50 min. After blocking, 30 μL of Jeko-1 cell lysate, containing approximately 10 μg of total protein, were added to wells in triplicate. Twenty μL of PBS (Gibco catalog no. 10010-023) containing 10% Superblock (Pierce catalog no. 37535) were added to each well for a final reaction volume of 50 μL. Plates were then sealed with Uniseal plate sealers (Whatman catalog no. 7704-0007) and incubated for 2 h at room temperature on a shaker. Plates were washed with 3 × 250 μL TBST. Fifty μL of a 1:1000 dilution of antiphospho Rb Ser<sup>780</sup> from Cell Signaling (catalog no. 9307) in PBS/10% Superblock were added, and the plate was incubated on a shaker for 1 h at room temperature. For all incubation steps, plates were covered with Uniseal plate sealers. Following incubation, plates were washed with 3 × 250 μL TBST. Next, 50 μL of a 1:2500 dilution of donkey-antirabbit HRP (Promega catalog no. W401B) in PBS/10% Superblock were added, and plates were incubated for 30 min at room temperature on a shaker. Plates were again washed as described above. Finally, 50 μL of Ultra TMB ELISA (Pierce catalog no. 34028) were added and plates incubated, unsealed, 5−15 min in the dark, until blue color developed. After incubation, 50 μL of 2 M sulfuric acid were added to plates to top the reaction, and absorbance was determined on a SpectraMax (Molecular Devices, Sunnydale, CA) within 15 min at 450 nm. All washes were performed using a Bio-Tek plate washer.</div><div class="NLM_p">The Total Rb ELISA kit (Invitrogen catalog no. KHO0011) was used to determine the levels of total pRb. This kit uses wells precoated with a proprietary total pRb antibody for capture. All reagents listed, with the exception of cell lysate, were included in the kit. The nature of the antibodies used for capture and detection was labeled as proprietary and not disclosed. Ten μg of cell lysate was loaded into the wells and volume adjusted to 50 μL with standard dilution buffer. Plates were sealed with film included in the kit and incubated for 2 h at room temperature on a shaker. Plates are then manually washed three times with 250 μL wash buffer. Fifty μL of proprietary primary antibody (preconjugated to biotin) was added to wells and incubated for 1 h at room temperature on a shaker. Then plates were again washed as noted above. The secondary antibody (HRP preconjugated to Streptavidin) was diluted 1:100 in streptavidin-HRP diluent buffer, and 50 μL was added to each well. Plates were then incubated for 30 min. Afterward, plates were washed four times with buffer as outlined above. Finally, 50 μL of stabilized Chromogen was added per well and plates were incubated for 15 min, at which point, 50 μL of stop solution was added. Plates were then read on a Spectramax at 450 nm.</div><div class="NLM_p last">Upon quantitation of the pRb phosphorylation (p-pRb) levels, % inhibition values were derived for each concentration tested and used to determine 50% inhibitory concentrations (IC<sub>50</sub>) for a particular compound (non-normalized). The total pRb levels were then used to adjust the p-pRb % inhibition values to account for any loss of signal due to the absence of the pRb protein itself, and the IC<sub>50</sub> values obtained from the adjusted % inhibitions represent normalized cellular p-pRb IC<sub>50</sub>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Fluorescence Activated Cell Sorting (FACS)</h3><div class="NLM_p last">Analysis of cellular DNA content by propidium iodide (PI) staining was used to determine cells that were in G<sub>0</sub>/G<sub>1</sub>, S, or G<sub>2</sub>/M phase. The media containing Jeko-1 cells was transferred to a fresh V-bottom 96-well polypropylene plate (Nunc catalog no. 249944). Next, cells were spun at 1000<i>g</i> for 10 min and the media was gently removed using pipet. Then 100 μL of a hypotonic lysis buffer (0.1% sodium citrate (Sigma catalog no. S-4641), 0.1% Triton X-100 (MP Biomedicals catalog no. 807423), 25 μg/mL PI (MP Biomedicals catalog no. 195458), and 10 μg/mL RNase (Roche catalog no. 1 579 681) were added to the cells, and the whole cocktail was incubated at room temperature in the dark for 1 h. If necessary, cells were stored at this step overnight at 4 °C. Finally, the cells were subjected to DNA content analysis using the BD LSR II System and FACSDiva, version 5.0.1 (BD biosciences, Franklin Lakes, NJ, USA). The data was analyzed using the ModFit LT 3.1.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Crystallography</h3><div class="NLM_p last">An equimolar complex of a compound and CDK6 at 5 mg/mL in buffer (25 mM Tris, 300 mM NaCl, 1 mM TCEP, pH 7.5, 20% glycerol) was crystallized using the hanging-drop vapor diffusion method. The well contained 100 mM MES pH 6.0, 25−50 mM NH<sub>4</sub>NO<sub>3</sub>, and 6−16% PEG3350. Crystals were frozen using glycerol as a cryoprotectant, and data were collected at beamline 17ID of the Argonne Photo Source (Chicago, IL) using an ADSC-Q210 detector. Data were processed using the HKL200 package.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Using CDK2 as the start model, structures were solved employing the software suites from CCP4<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and CNX<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and deposited to the PDB (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NUP">3NUP</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NUX">3NUX</a>).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div class="NLM_p">All solvents employed were commercially available “anhydrous” grade, and reagents were used as received unless otherwise noted. A Biotage Initiator Sixty system was used for microwave heating. Flash column chromatography was performed on either an Analogix Intelliflash 280 using Si 50 columns (32−63 μm, 230−400 mesh, 60 Å) or on a Biotage SP1 system (32−63 μm particle size, KP-Sil, 60 Å pore size). Preparative high pressure liquid chromatography (HPLC) was performed using a Waters 2525 pump with 2487 dual wavelength detector and 2767 Sample manager. Columns were Waters C18 OBD 5 μm, either 50 mm × 100 mm Xbridge or 30 mm × 100 mm Sunfire. Systems were run with either a 5−95% or 10−90% ACN/H<sub>2</sub>O gradient with either a 0.1% TFA or 0.1% NH<sub>4</sub>OH modifier. NMR spectra were recorded on Bruker AV400 (Avance 400 MHz) or AV500 (Avance 500 MHz) instruments. Analytical LC−MS was conducted using an Agilent 1100 series with UV detection at 214 and 254 nm and an electrospray mode (ESI) coupled with a Waters ZQ single quad mass detector. One of two methods was used: method A, 5−95% ACN/H<sub>2</sub>O with 5 mM ammonium formate with a 2 min run, 3 μL injection through an Inertisil C8 3 cm × 5 mm × 3 μm; method B, 20−95% ACN/H<sub>2</sub>O with 10 mM ammonium formate with a 2 min run, 3 μL injection through an Inertisil C8 3 cm × 5 mm × 3 μm.</div><div class="NLM_p last">All tested compounds were ≥95% purity as determined by an Agilent 1100 HPLC system and one of the following methods, unless explicitly noted. Method 1 (at both 214 and 254 nm): used an Inertisil ODS3 3 μm 3.0 mm × 100 mm C18 column at the flow rate of 1.0 mL/min, with a gradient of 5−95% acetonitrile/water 5 mM ammonia formate over 7.75 min. Method 2 (at both 214 and 254 nm): used an Inertisil ODS3 3 μm 3.0 mm × 100 mm C18 column at the flow rate of 1.0 mL/min, with a gradient of 5−95% acetonitrile/water with 0.1% TFA over 7.75 min. Method 3 (at 214 nm): used an Inertsil ODS3 3 μm 3.0 mmm × 100 mm C18 column at the flow rate of 1.5 mL/min, with a gradient of 10−95% acetonitrile/water with 0.1% TFA over 15 min. Method 4 (at both 215 and 254 nm): used a Nova-Pak 4 μm 3.9 mm × 150 mm C18 column at the flow rate of 2.0 mL/min, with a gradient of 10−90% acetonitrile/water with 0.1% TFA over 5.0 min. Method 5 (at both 214 and 254 nm): used an Inertisil ODS3 100 mm × 3 mm C18 column at the flow rate of 1.0 mL/min, with a gradient of 5−95% acetonitrile/water with 0.1% formic acid over 7.75 min. LC/ESI-MS data were recorded using a Waters LCT Premier mass spectrometer with dual electrospray ionization source and Agilent 1100 liquid chromatograph. The resolution of the MS system was approximately 12000 (fwhm definition). HPLC separation was performed at 1.0 mL/min flow rate with the gradient from 10% to 95% in 2.5 min. Ammonia formate (10 mM) was used as the modifier additive in the Aqueous phase. Sulfadimethoxine (Sigma; protonated molecule <i>m</i>/<i>z</i> 311.0814) was used as a reference and acquired through the LockSpray channel every third scan.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 3-Methyl-1-(2-methylsulfanyl-pyrimidin-4-yl)-butan-2-one (<b>3b</b>)</h3><div class="NLM_p last">To a cooled (−20 °C) solution of diisopropylamine (1746 g, 2.0 equiv) in THF (10 L) was added a solution of <i>n</i>BuLi in THF (1.6 M, 8 L, 1.5 equiv) dropwise over 3 h. The reaction mixture was warmed to 0 °C and treated with a solution of 4-methyl-2-methylsulfanyl-pyrimidine (<b>2</b>, 1211 g, 8.63 mol) in THF (1 L) dropwise. The resulting solution was stirred for 15 min and treated with a solution of isobutyric acid methyl ester (1038 mL, 1.05 equiv) in DMF-THF (5 L, 4:1 = v/v) dropwise. The resulting mixture was warmed to room temperature and stirred overnight. The reaction mixture was treated with 1 N aqueous solution of HCl (17 L) and extracted with <i>tert</i>-butyl methyl ether (TBME) (3 × 10 L). The combined organics were washed with water (3 × 5 L), brine (5 L), dried over MgSO<sub>4</sub>, filtered, and concentrated. Column chromatography (18 kg silica) with hexane/ethylacetate 12:1 gave 993 g (4.66 mol, 54%) of 3-methyl-1-(2-methylsulfanyl-pyrimidin-4-yl)-butan-2-one (<b>3b</b>). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>, a 4:1 mixture of keto- and enol form) δ ppm 13.84 (br s, 0.2 H), 8.54 (d, <i>J</i> = 5.06 Hz, 1.6 H), 8.38 (d, <i>J</i> = 5.10 Hz, 0.2 H), 7.08 (d, <i>J</i> = 5.06 Hz, 1.6 H), 6.85 (d, <i>J</i> = 5.10 Hz, 0.2 H), 5.49 (s, 0.2 H), 3.99 (s, 1.6 H), 2.58−2.80 (m, 0.8 H), 2.31−2.56 (m, 3.2 H), 1.13 (d, <i>J</i> = 7.00 Hz, 1.6 H), 1.05 (d, <i>J</i> = 7.00 Hz, 4.8 H). MS <i>m</i>/<i>z</i> 211.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 1-Cyclopropyl-2-(2-methylsulfanyl-pyrimidin-4-yl)-ethanone (<b>3c</b>)</h3><div class="NLM_p last">To a cooled (0 °C) solution of lithium hexamethyldisilazane (1 M, 14.2 mL, 2 equiv) was added neat 4-methyl-2-methylsulfanyl-pyrimidine (<b>2</b>, 1 mL, 7.1 mmol), and the resulting mixture was stirred for 5 min and then treated with cyclopropylcarboxylate methyl ester (0.72 mL, 3 equiv). The reaction mixture was stirred at room temperature for 30 min, treated with water (25 mL) and extracted into CH<sub>2</sub>Cl<sub>2</sub> (3 × 50 mL). Combined organics were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Column chromatography (EtOAc/heptanes 10 to 60%) gave 1-cyclopropyl-2-(2-methylsulfanyl-pyrimidin-4-yl)-ethanone (<b>3c</b>, 1.47 g) in quantitative yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.56 (d, <i>J</i> = 5.05 Hz, 1 H), 7.13 (d, <i>J</i> = 5.05 Hz, 1 H), 4.05 (s, 2 H), 2.49 (s, 3 H), 2.43 (m, 1 H), 0.92 (m, 4 H). MS <i>m</i>/<i>z</i> 209.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 1,1,1-Trifluoro-3-(2-methylsulfanyl-pyrimidin-4-yl)-propan-2-one (<b>3d</b>)</h3><div class="NLM_p last">Prepared from 4-methyl-2-methylsulfanyl-pyrimidine (<b>2</b>) and methyltrifluoroacetate following the procedure described for <b>3c</b> in 60% yield. MS <i>m</i>/<i>z</i> 237.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 3,3-Dimethyl-1-(2-methylsulfanyl-pyrimidin-4-yl)-butan-2-one (<b>3e</b>)</h3><div class="NLM_p last">Prepared from 4-methyl-2-methylsulfanyl-pyrimidine (<b>2</b>) and trimethylacetylchloride following the procedure described for <b>3c</b> in quantitative yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.54 (d, <i>J</i> = 5.05 Hz, 1 H), 7.07 (d, <i>J</i> = 5.05 Hz, 1 H), 4.05 (s, 2H), 2.48 (s, 3H), 1.16 (s, 9H). MS <i>m</i>/<i>z</i> 225.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 1-(4-Fluoro-phenyl)-2-(2-methylsulfanyl-pyrimidin-4-yl)-ethanone (<b>3f</b>)</h3><div class="NLM_p last">Prepared from 4-methyl-2-methylsulfanyl-pyrimidine (<b>2</b>) and methyl 4-fluorobenzoate following the procedure described for <b>3c</b> and used as a crude mixture for the next reaction. MS <i>m</i>/<i>z</i> 263.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 4-(3-Methyl-1<i>H</i>-pyrazol-4-yl)-2-methylsulfanyl-pyrimidine (<b>4a</b>)</h3><div class="NLM_p last">To a cooled (0 °C) solution of lithium hexamethyldisilazane (1 M, 14.2 mL, 2 euiv) was added neat 4-methyl-2-methylsulfanyl-pyrimidine (1 mL, 7.1 mmol), and the resulting mixture was stirred for 5 min and then treated with anhydrous ethyl acetate (10 mL). The reaction mixture was stirred for 30 min at room temperature and concentrated in vacuo. The residue was dissolved in methanol (2 mL) and treated with dimethylformamide dimethylacetal (10 mL). The resulting mixture was heated at 100 °C for 1 h and cooled to room temperature. The mixture was then treated with 55% hydrazine hydrate (2 mL) and stirred for 18 h. The reaction mixture was concentrated in vacuo, and the residue was redissolved in CH<sub>2</sub>Cl<sub>2</sub> (50 mL), washed with saturated aqueous sodium bicarbonate (2 × 20 mL), water (2 × 20 mL), and brine (30 mL). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Column chromatography (EtOAc/heptanes 10 to 60%) gave 4-(3-methyl-1<i>H</i>-pyrazol-4-yl)-2-methylsulfanyl-pyrimidine (<b>4a</b>, 126 mg) in 19% yield over three steps. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13 (broad doublet tautomers, 1 H), 8.47 (d, <i>J</i> = 5.43 Hz, 1 H), 7.39 (d, <i>J</i> = 5.43 Hz, 1 H), 3.31 (s, 3 H), 2.53 (s, 3 H). MS <i>m</i>/<i>z</i> 207.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 4-(3-Isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methylsulfanyl-pyrimidine (<b>4b</b>)</h3><div class="NLM_p">A mixture of dimethylformamide dimethylacetal (1.15 L, 2.0 equiv) and 3-methyl-1-(2-methylsulfanyl-pyrimidin-4-yl)-butan-2-one (<b>3b</b>, 890 g, 4.23 mol) in DMF (1 L) was heated at 90 °C for 2 h. The reaction mixture was then concentrated in vacuo and dried under high vacuum overnight. The residue was triturated with 100 mL of hexane. The solid was collected and dried under high-vacuum to provide 1-dimethylamino-4-methyl-2-(2-methylsulfanyl-pyrimidin-4-yl)-pent-1-en-3-one (583 g) in 52% yield as red crystals. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.38 (d, <i>J</i> = 5.23 Hz, 1 H), 7.66 (s, 1 H), 6.99 (d, <i>J</i> = 5.23 Hz, 1 H), 2.92−3.12 (sept, <i>J</i> = 6.80 Hz 1 H), 2.55−2.95 (br s, 6H), 2.42 (s, 3 H), 0.95 (d, <i>J</i> = 6.80 Hz, 6 H). MS <i>m</i>/<i>z</i> 266.2 (M + H)<sup>+</sup>.</div><div class="NLM_p last">To 1-dimethylamino-4-methyl-2-(2-methylsulfanyl-pyrimidin-4-yl)-pent-1-en-3-one (580 g, 2.18 mol) in a 10 L reactor was added aqueous hydrazine hydrate (24%, 2.5 L, 5.5 equiv) at 0 °C. The resulting yellow suspension was slowly warmed to room temperature and stirred for 1 h. The reaction mixture was extracted EtOAc (3 × 2.5 L). Organics were washed with water (2 × 1 L), brine (0.5 L), dried over MgSO<sub>4</sub>, filtered, and concentrated to give 4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methylsulfanyl-pyrimidine (<b>4b</b>, 511 g) in quantitative yield as red crystals. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 13.03 (br s, 1H), 8.44 (d, <i>J</i> = 5.47 Hz, 1 H), 7.38 (d, <i>J</i> = 5.47 Hz, 1 H), 3.95 (br s, 1 H), 2.48 (s, 3 H), 1.25 (br s, 6 H). MS <i>m</i>/<i>z</i> 235.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 4-(3-Cyclopropyl-1<i>H</i>-pyrazol-4-yl)-2-methylsulfanyl-pyrimidine (<b>4c</b>)</h3><div class="NLM_p last">A mixture of 1-cyclopropyl-2-(2-methylsulfanyl-pyrimidin-4-yl)-ethanone (<b>3c</b>, 1.47 g, 7.1 mmol) and dimethylformamide dimethylacetal (10 mL) in methanol (2 mL) was heated at 100 °C for 1.5 h. After cooling to room temperature, the reation mixture was treated with 55% hydrazine hydrate (3 mL) and stirred for 18 h. The mixture was concentrated, and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (50 mL), washed with saturated aqueous sodium bicarbonate (2 × 20 mL), water (2 × 20 mL), and brine (30 mL). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Column chromatography (EtOAc/heptanes 10−60%) provided 4-(3-cyclopropyl-1<i>H</i>-pyrazol-4-yl)-2-methylsulfanyl-pyrimidine (<b>4c</b>, 1.2 g) in 73% yield. MS <i>m</i>/<i>z</i> 233.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-Methylsulfanyl-4-(3-trifluoromethyl-1<i>H</i>-pyrazol-4-yl)-pyrimidine (<b>4d</b>)</h3><div class="NLM_p last">A mixture of 1,1,1-trifluoro-3-(2-methylsulfanyl-pyrimidin-4-yl)-propan-2-one (<b>3d</b>, 1.13 g, 4.8 mmol), dimethylformamide dimethylacetal (2.3 mL, 2 equiv), and acetic acid (600 μL, 2 equiv) in THF (15 mL) was stirred at room temperature for 18 h and treated with 55% hydrazine hydrate (40 mL). After stirring additional 4 h, the reaction mixture was concentrated in vacuo. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (50 mL), washed with saturated aqueous sodium bicarbonate (2 × 20 mL), water (2 × 20 mL), and brine (30 mL). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Column chromatography (EtOAc/heptanes 10−60%) gave 2-methylsulfanyl-4-(3-trifluoromethyl-<i>1H</i>-pyrazol-4-yl)-pyrimidine (<b>4d</b>, 450 mg) in 40% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.78 (s, 1 H), 8.61 (d, <i>J</i> = 5.18 Hz, 1 H), 7.47 (d, <i>J</i> = 5.18 Hz, 1 H), 2.53 (s, 3H). MS <i>m</i>/<i>z</i> 261.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 4-(3-<i>tert</i>-Butyl-1<i>H</i>-pyrazol-4-yl)-2-methylsulfanyl-pyrimidine (<b>4e</b>)</h3><div class="NLM_p last">Prepared from 3,3-dimethyl-1-(2-methylsulfanyl-pyrimidin-4-yl)-butan-2-one (<b>3e</b>) following the procedure described for <b>4c</b> in 42% yield. MS <i>m</i>/<i>z</i> 249.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 4-[3-(4-Fluoro-phenyl)-1<i>H</i>-pyrazol-4-yl]-2-methylsulfanyl-pyrimidine (<b>4f</b>)</h3><div class="NLM_p last">Prepared from 1-(4-fluoro-phenyl)-2-(2-methylsulfanyl-pyrimidin-4-yl)-ethanone (<b>3f</b>) following the procedure described for <b>4c</b> in 56% yield over three steps. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.47 (br d tautomers, 1 H), 8.5 (br s tautomer 1, 0.5 H), 8.45 (d, <i>J</i> = 5.31 Hz, 1 H), 8.19 (br s tautomer 2, 0.5 H), 7.56 (br s, 2 H), 7.32 (m, 1 H), 7.25 (m, 1 H), 7.14 (m, 1 H), 2.23 (s, 3 H). MS <i>m</i>/<i>z</i> 287.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-Methanesulfonyl-4-(3-methyl-1<i>H</i>-pyrazol-4-yl)-pyrimidine (<b>5a</b>)</h3><div class="NLM_p last">To a solution of 4-(3-methyl-1<i>H</i>-pyrazol-4-yl)-2-methylsulfanyl-pyrimidine (<b>4a</b>) (110 mg, 0.5 mmol) in DMF (6 mL) was added solid oxone (770 mg, 2.5 equiv), and the resulting mixture was heated at 90 °C for 1 h. After cooling to room temperature, the reaction mixture was treated with water (30 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 30 mL). Combined organics were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated, and used for the next reaction without purification. MS <i>m</i>/<i>z</i> 239.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-(3-Isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>5b</b>)</h3><div class="NLM_p last">To a cooled (0 °C) solution of 4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methylsulfanyl-pyrimidine (<b>4b</b>, 530 g, 2.26 mol) in CH<sub>2</sub>Cl<sub>2</sub> (5 L) was added <i>m</i>CPBA (70%, 1.4 kg, 2.5 equiv) in 100 g portions to keep the internal temperature below 10 °C. The suspension was then slowly warmed to room temperature and stirred for another 2 h. The reaction mixture was treated with saturated aqueous NaHCO<sub>3</sub> solution (1.1 L), and the phases were separated. The aqueous phase was extracted CH<sub>2</sub>Cl<sub>2</sub> (3 × 2 L). The combined organics were washed with water (1 L), brine (0.5 L), dried over MgSO<sub>4</sub>, filtered, and concentrated. Column chromatography (1.5 kg silica) with hexane/ethylacetate 2:3 gave 375 g (1.4 mol, 62%) of 4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>5b</b>) as beige crystals. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.23 (br s, 1H), 8.86 (d, <i>J</i> = 5.41 Hz, 1 H), 7.99 (d, <i>J</i> = 5.41 Hz, 1 H), 3.89 (br s, 1 H), 3.40 (s, 3 H), 1.29 (br s, 6 H). MS <i>m</i>/<i>z</i> 267.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-(3-Cyclopropyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>5c</b>)</h3><div class="NLM_p last">Prepared from 4-(3-cyclopropyl-1<i>H</i>-pyrazol-4-yl)-2-methylsulfanyl-pyrimidine (<b>4c</b>) following the procedure described for <b>5a</b>: MS <i>m</i>/<i>z</i> 265.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-Methanesulfonyl-4-(3-trifluoromethyl-1<i>H</i>-pyrazol-4-yl)-pyrimidine (<b>5d</b>)</h3><div class="NLM_p last">Prepared from 2-methylsulfanyl-4-(3-trifluoromethyl-1<i>H</i>-pyrazol-4-yl)-pyrimidine (<b>4d</b>) following the procedure described for <b>5a</b> in 71% yield: MS <i>m</i>/<i>z</i> 293.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4-(3-<i>tert</i>-Butyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>5e</b>)</h3><div class="NLM_p last">Prepared from 4-(3-<i>tert</i>-butyl-1<i>H</i>-pyrazol-4-yl)-2-methylsulfanyl-pyrimidine (<b>4e</b>) following the procedure described for <b>5a</b>: MS <i>m</i>/<i>z</i> 281.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 4-[3-(4-Fluoro-phenyl)-1<i>H</i>-pyrazol-4-yl]-2-methanesulfonyl-pyrimidine (<b>5f</b>)</h3><div class="NLM_p last">Prepared from 4-[3-(4-fluoro-phenyl)-1<i>H</i>-pyrazol-4-yl]-2-methylsulfanyl-pyrimidine (<b>4f</b>) following the procedure described for <b>5a</b>: MS <i>m</i>/<i>z</i> 319.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-Chloro-4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidine (<b>6</b>)</h3><div class="NLM_p last">To a suspension of 4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>5b</b>, 15.2 g, 56.9 mmol) in acetic acid (15 mL) was added sulfuryl chloride (20 mL, 4.2 equiv), and the resulting mixture was heated at 60 °C for 7 h. After cooling to room temperature, the reaction mixture was concentrated to remove acetic acid. The residue was diluted with EtOAc (300 mL) and washed with water (100 mL), 20% aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (100 mL), and saturated aqueous NaHCO<sub>3</sub> (2 × 100 mL). The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. Column chromatography (EtOAc/heptanes 10−60%) gave 2-chloro-4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidine (<b>6</b>, 5.5 g) in 43% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.36 (d, <i>J</i> = 6.0 Hz, 1 H), 8.04 (s, 1 H), 7.48 (d, <i>J</i> = 6.0 Hz, 1 H), 3.82 (q, <i>J</i> = 7.0 Hz, 1 H), 1.24 (d, <i>J</i> = 7.0 Hz, 6 H). MS <i>m</i>/<i>z</i> 223.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> A Mixture of 2-Chloro-4-[5-chloro-3-isopropyl-1-(2-trimethylsilanyl-ethoxymethyl)-1<i>H</i>-pyrazol-4-yl]-pyrimidine and 2-Chloro-4-[3-chloro-5-isopropyl-1-(2-trimethylsilanyl-ethoxymethyl)-1<i>H</i>-pyrazol-4-yl]-pyrimidine (<b>7</b>)</h3><div class="NLM_p">To a solution of 2-chloro-4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidine (<b>6</b>, 4.3 g, 19 mmol) in DMF (28 mL) was added Cs<sub>2</sub>CO<sub>3</sub> (13.99 g, 2.2 equiv), and the resulting mixture was stirred for 45 min at room temperature. The reaction mixture was treated with SEMCl (8.0 mL, 2.3 equiv) and stirred at room temperature for 90 min. The reaction mixture was diluted with EtOAc (150 mL), washed with 4% aqueous NaCl (150 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. Column chromatography (EtOAc/heptanes 5−30%) gave a mixture of 2-chloro-4-[3-isopropyl-1-(2-trimethylsilanyl-ethoxymethyl)-1<i>H</i>-pyrazol-4-yl]-pyrimidine and 2-chloro-4-[5-isopropyl-1-(2-trimethylsilanyl-ethoxymethyl)-1<i>H</i>-pyrazol-4-yl]-pyrimidine (5.0 g) in 73% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, ∼9:1 mixture of tautomers, only major peaks analyzed) δ 8.51 (d, <i>J</i> = 5.3 Hz, 1 H), 8.13 (s, 1 H), 7.31 (d, <i>J</i> = 5.3 Hz, 1 H), 5.42 (s, 2 H), 3.64 (t, <i>J</i> = 8.3 Hz, 2 H), 3.61 (m, 1H), 1.37 (d, <i>J</i> = 6.8 Hz, 6 H), 0.94 (t, <i>J</i> = 8.2 Hz, 2 H). 0.00 (s, 9 H). MS <i>m</i>/<i>z</i> 353.3 (M + H)<sup>+</sup>.</div><div class="NLM_p last">To a solution of a mixture of 2-chloro-4-[3-isopropyl-1-(2-trimethylsilanyl-ethoxymethyl)-1<i>H</i>-pyrazol-4-yl]-pyrimidine and 2-chloro-4-[5-isopropyl-1-(2-trimethylsilanyl-ethoxymethyl)-1<i>H</i>-pyrazol-4-yl]-pyrimidine (3.1 g, 8.7 mmol) in DMF (15 mL) was added <i>N</i>-chlorosuccinicimide (3.53 g, 3.0 equiv), and the resulting mixture was stirred at 40 °C for 3 h. The reaction mixture was cooled to room temperature, diluted with EtOAc (400 mL), washed with 20% aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (80 mL), saturated aqueous NaHCO<sub>3</sub> (80 mL), and 4% aqueous NaCl (100 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. Column chromatography (EtOAc/heptanes 5−30%) gave a mixture of 2-chloro-4-[5-chloro-3-isopropyl-1-(2-trimethylsilanyl-ethoxymethyl)-1<i>H</i>-pyrazol-4-yl]-pyrimidine and 2-chloro-4-[3-chloro-5-isopropyl-1-(2-trimethylsilanyl-ethoxymethyl)-1<i>H</i>-pyrazol-4-yl]-pyrimidine (<b>7</b>, 2.1 g) in 62% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, ∼19:1 mixture of tautomers, only major peaks analyzed) δ 8.61 (d, <i>J</i> = 5.3 Hz, 1 H), 7.62 (d, <i>J</i> = 5.3 Hz, 1 H), 5.50 (s, 2 H), 3.68 (m, 2 H), 3.64 (m, 1 H), 1.30 (d, <i>J</i> = 6.9 Hz, 6 H), 0.94 (m, 2 H), 0.01 (s, 9 H). MS <i>m</i>/<i>z</i> 387.4 (M + H)<sup>+</sup>.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 5-Bromo-4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methylsulfanyl-pyrimidine (<b>8</b>)</h3><div class="NLM_p last">To a solution of 4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methylsulfanyl-pyrimidine (<b>4b</b>, 0.50 g, 2.1 mmol) in DMF (5 mL) was added <i>N</i>-bromosuccinicimide (0.37 g, 1.0 equiv) at 0 °C. The mixture was stirred at room temperature for 2 h. The reaction mixture was quenched with 20% Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> aqueous solution. The mixture was stirred for several min and then basified with saturated NaHCO<sub>3</sub> aqueous solution. The two phases were separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (EtOAc/pet. ether) to give 5-bromo-4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methylsulfanyl-pyrimidine (<b>8</b>, 0.28 g) as a yellow solid in 42% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.53 (s, 1 H), 8.24 (s, 1 H), 3.59−3.75 (m, 1 H), 2.49 (s, 3 H), 1.29 (d, <i>J</i> = 7.03 Hz, 6 H). MS <i>m</i>/<i>z</i> 315.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 4-(5-Bromo-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>9</b>)</h3><div class="NLM_p last">To a solution of 4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>5b</b>, 3.0 g, 11 mmol) in DMF (90 mL) was added <i>N</i>-bromosuccinimide (2.0 g, 1 equiv) at 0 °C. The mixture was stirred at room temperature for 2 d. The mixture was treated with water and extracted with EtOAc. The organic extracts were washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (32% EtOAc/pet. ether) to give 4-(5-bromo-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>9</b>, 2.4 g) as a white solid in 61% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.81 (d, <i>J</i> = 5.5 Hz, 1 H), 8.09 (d, <i>J</i> = 5.5 Hz, 1 H), 3.81 (m, 1 H), 3.31 (s, 3 H), 1.31 (d, <i>J</i> = 7.0 Hz, 6 H). MS <i>m</i>/<i>z</i> 347.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 5-Bromo-4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>10</b>)</h3><div class="NLM_p last">To a solution of 5-bromo-4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methylsulfanyl-pyrimidine (<b>8</b>, 157 mg, 0.5 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added <i>m</i>CPBA (336 mg, 77%, 0.54 mmol) 0 °C. The mixture was warmed to room temperature and stirred for 2 h. The reaction mixture was quenched with 20% Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> aqueous solution. The mixture was stirred for several minutes and then basified with saturated NaHCO<sub>3</sub> aqueous solution. The two phases were separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (EtOAc:heptane = 10:90 to 100:0) to give 5-bromo-4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>10</b>, 160 mg) as a light-yellow solid in 93% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.89 (s, 1 H), 8.55 (s, 1 H), 3.86 (ddd, <i>J</i> = 13.68, 7.03, 6.90 Hz, 1 H), 3.37 (s, 3 H), 1.42 (d, <i>J</i> = 7.03 Hz, 6 H). MS <i>m</i>/<i>z</i> 346.8 (M + H)<sup>+</sup>.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 4-(3-Isopropyl-1<i>H</i>-pyrazol-4-yl)-5-methyl-2-methylsulfonyl-pyrimidine (<b>11</b>)</h3><div class="NLM_p last">To a degassed solution of 5-bromo-4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methylsulfanyl-pyrimidine (<b>10</b>, 100 mg, 0.29 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (66.9 mg, 0.058 mmol) in DMF (2 mL) was added tetramethyltin (155 mg, 0.87 mmol) by syringe at room temperature. The mixture was heated at 100 °C for 16 h. After cooling to room temperature, the mixture was filtered through a pad of Celite and rinsed with CH<sub>2</sub>Cl<sub>2</sub>. The filtrate was washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (MeOH:CH<sub>2</sub>Cl<sub>2</sub> = 1:99 to 8:92) to give 4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-5-methyl-2-methylsulfonyl-pyrimidine (<b>11</b>, 70 mg) as a white solid in 86% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.66 (s, 1 H), 7.94 (s, 1 H), 3.81 (q, <i>J</i> = 7.07, 1 H), 3.33 (s, 3 H), 2.54 (s, 3 H), 1.37 (d, <i>J</i> = 7.07 Hz, 6 H). MS <i>m</i>/<i>z</i> 281.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4-(3-Isopropyl-1<i>H</i>-pyrazol-4-yl)-5-methyl-2-methylsulfonyl-pyrimidine (<b>12</b>)</h3><div class="NLM_p last">To a degassed solution of 5-bromo-4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methylsulfonyl-pyrimidine (<b>9</b>, 100 mg, 0.29 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (66.9 mg, 0.058 mmol) in DMF (2 mL) was added tetramethyltin (0.11 mL, 0.78 mmol) by syringe at room temperature. The mixture was heated at 100 °C for 16 h. After cooling to room temperature, the mixture was filtered through a pad of Celite and rinsed with EtOAc. The filtrate was washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (EtOAc:heptane = 10:90 to 100:0) to give 4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-5-methyl-2-methylsulfonyl-pyrimidine as a light-yellow solid (<b>12</b>, 56 mg) in 69% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.63 (d, <i>J</i> = 5.05 Hz, 1 H), 7.55 (d, <i>J</i> = 5.05 Hz, 1 H), 3.69 (ddd, <i>J</i> = 13.77, 7.07, 6.96 Hz 1 H), 3.39 (s, 3 H), 2.58 (s, 3 H), 1.39 (d, <i>J</i> = 7.07 Hz, 6 H). MS <i>m</i>/<i>z</i> 281.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 4-(2-Chloro-pyrimidin-4-yl)-5-isopropyl-3-trifluoromethyl-pyrazole-1-sulfonic Acid Dimethylamide (<b>14</b>)</h3><div class="NLM_p">To a cooled (0 °C) solution of 4-bromo-5-isopropyl-3-trifluoromethyl-1<i>H</i>-pyrazole (<b>13</b>, 1.52 g, 5.91 mmol) in THF (40 mL) was added NaH (60%, 0.478 g, 4.0 equiv) and the resulting mixture was stirred at room temperature for 1 h. The reaction mixture was treated with <i>N</i>,<i>N</i>-dimethylsulfamoyl chloride (1.2 mL, 3.9 equiv) and stirred at room temperature for 20 h. The reaction mixture was diluted with EtOAc (150 mL), washed with saturated aqueous NaCl (2 × 50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. Column chromatography (EtOAc/heptanes 0 to 8%) gave a mixture of 4-bromo-5-isopropyl-3-trifluoromethyl-pyrazole-1-sulfonic acid dimethylamide and 4-bromo-3-isopropyl-5-trifluoromethyl-pyrazole-1-sulfonic acid dimethylamide (1.04 g) in 48% yield: MS <i>m</i>/<i>z</i> 366.0 (M + H)<sup>+</sup>.</div><div class="NLM_p">A solution of a mixture of 4-bromo-5-isopropyl-3-trifluoromethyl-pyrazole-1-sulfonic acid dimethylamide and 4-bromo-3-isopropyl-5-trifluoromethyl-pyrazole-1-sulfonic acid dimethylamide (1.04 g, 2.84 mmol) in THF (10 mL) was added to a cooled (−78 °C) solution of <i>n</i>BuLi (2.5 M, 1.5 mL, 1.3 equiv) in THF (5 mL) over 5 min. The resulting mixture was treated with a suspension of 2-chloropyrimidine (0.348 g, 1.07 equiv) in THF (2 mL) quickly and stirred at −30 °C for 40 min and 0 °C for 20 min. The reaction mixture was quenched with a solution of acetic acid (0.17 mL, 1.04 equiv) and water (0.02 mL, 0.39 equiv) in THF (0.5 mL) and treated with DDQ (0.681 g, 1.05 equiv). The resulting mixture was stirred at room temperature for 5 min, cooled to 0 °C, treated with a cold aqueous solution of NaOH (1 N, 3.2 mL, 1.1 equiv), and stirred at 0 °C for 5 min. The reaction mixture was diluted with EtOAc (150 mL), washed with saturated aqueous NaHCO<sub>3</sub> (70 mL) and brine (70 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. Column chromatography (EtOAc/heptanes 3 to 20%) gave 4-(2-chloro-pyrimidin-4-yl)-5-isopropyl-3-trifluoromethyl-pyrazole-1-sulfonic acid dimethylamide (<b>14</b>, 0.686 g) in 57% yield and 4-(2-chloro-pyrimidin-4-yl)-3-isopropyl-5-trifluoromethyl-pyrazole-1-sulfonic acid dimethylamide (0.093 mg) in 8% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, <b>14</b> only) δ 8.78 (d, <i>J =</i> 5.0 Hz, 1 H), 7.50 (d, <i>J =</i> 5.0 Hz, 1 H), 3.78 (m, 1 H), 3.19 (s, 6 H), 1.24 (d, <i>J =</i> 7.2 Hz, 6 H). MS <i>m</i>/<i>z</i> 398.1 (M + H)<sup>+</sup>. The structure was determined by 2D NMR analysis including HSQC and HMBC.</div><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0012.gif" alt="" id="fx1" /></img></div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 5-(4-Methyl-piperazin-1-yl)-pyridin-2-ylamine (<b>17</b>)</h3><div class="NLM_p">To a solution of 5-bromo-2-nitro-pyridine (<b>15</b>, 15.0 g, 73.9 mmol) in DMSO (150 mL) were added 1-methyl-piperazine (12.7 g, 126.1 mmol), tetrabutylammonium iodide (1.6 g, 4.3 mmol), and potassium carbonate (15.3 g, 110.7 mmol). The reaction mixture was heated at 80 °C for 5 h. The reaction mixture was poured into ice−water and then extracted with EtOAc. The combined extracts were washed with water and brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification by column chromatography (1:9 methanol/chloroform) gave 1-methyl-4-(6-nitro-pyridin-3-yl)-piperazine (16.2 g, 98.6%) as a solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.25 (d, <i>J</i> = 4.0 Hz, 1 H), 8.14 (d, <i>J</i> = 8.0 Hz, 1 H), 7.47 (dd, <i>J</i> = 8.0, 4.0 Hz, 1 H), 3.48 (t, <i>J</i> = 4.0 Hz, 4 H), 2.43 (t, <i>J</i> = 4.0 Hz, 4 H), 2.20 (s, 3 H). MS <i>m</i>/<i>z</i> 222.9 (M + H)<sup>+</sup>.</div><div class="NLM_p last">A solution of 1-methyl-4-(6-nitro-pyridin-3-yl)-piperazine (2.0 g, 9.0 mmol) in methanol (100 mL) was hydrogenated in the presence of 10% Pd/C (0.2 g) using an H<sub>2</sub> balloon. After 16 h, the reaction mixture was filtered through a pad of Celite and rinsed with methanol (2 × 15 mL). The filtrate was concentrated and purified by column chromatography (1:9 methanol/chloroform) to afford the title compound (<b>17</b>, 1.5 g, 87%) as a solid. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 7.64 (dd, <i>J</i> = 9.5, 2.8 Hz, 1 H), 7.40 (d, <i>J</i> = 2.8 Hz, 1 H), 6.83 (d, <i>J</i> = 9.5 Hz, 1 H), 3.50 (br s, 4 H), 3.11−3.05 (m, 4 H), 2.82 (s, 3 H). MS <i>m</i>/<i>z</i> 192.9 (M + H)<sup>+</sup>.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (<i>R</i>)-4-(6-Amino-pyridin-3-yl)-2-methyl-piperazine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>18</b>)</h3><div class="NLM_p">To a solution of 5-bromo-2-nitropyridine (<b>15</b>, 4.0 g, 19.7 mmol) in DMSO (40 mL) were added <i>R</i>-(−)-2-methyl-piperazine (3.0 g, 29.8 mmol), tetrabutylammonium iodide (0.42 g, 1.2 mmol), and potassium carbonate (4.1 g, 29.7 mmol). The reaction mixture was heated at 80 °C for 16 h. The reaction mixture was poured into ice−water (150 mL) and then extracted with chloroform. The extracts were washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. Purification by column chromatography (1:9 methanol/chloroform) gave (<i>R</i>)-3-methyl-1-(6-nitro-pyridin-3-yl)-piperazine (4.3 g, 98%) as a solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.18 (d, <i>J</i> = 9.2 Hz, 1 H), 8.13 (d, <i>J</i> = 3.1 Hz, 1 H), 7.20 (dd, <i>J</i> = 9.2, 3.1 Hz, 1 H), 3.78−3.74 (m, 2 H), 3.15 (m, 1 H), 3.04−3.00 (m, 3 H), 2.68 (m, 1 H), 1.19 (d, <i>J</i> = 6.3 Hz, 3 H). MS <i>m</i>/<i>z</i> 222.8 (M + H)<sup>+</sup>.</div><div class="NLM_p">To a solution of (<i>R</i>)-3-methyl-1-(6-nitro-pyridin-3-yl)-piperazine (2.4 g, 10.8 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) were added di-<i>tert</i>-butyl dicarbonate (2.8 g, 12.9 mmol) and triethylamine (3.0 mL, 21.6 mmol). The reaction mixture was heated to reflux for 4 h and concentrated under reduced pressure. The residue was dissolved in EtOAc (50 mL). The solution was washed with water and brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. Purification by column chromatography (1:9 methanol/chloroform) gave (<i>R</i>)-2-methyl-4-(6-nitro-pyridin-3-yl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (2.5 g, 71.8%) as a solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.19 (d, <i>J</i> = 12.4 Hz, 1 H), 8.10 (d, <i>J</i> = 4.0 Hz, 1 H), 7.16 (dd, <i>J</i> = 12.4 Hz, 4.0 Hz, 1 H), 4.40 (br s, 1 H), 3.99 (m, 1 H), 3.75 (m, 1 H), 3.63 (m, 1 H), 3.43−3.34 (m, 2 H), 3.25 (m, 1 H), 1.49 (s, 9 H), 1.25 (d, <i>J</i> = 4.0 Hz, 3 H). MS <i>m</i>/<i>z</i> 323.0 (M + H)<sup>+</sup>.</div><div class="NLM_p last">A solution of (<i>R</i>)-2-methyl-4-(6-nitro-pyridin-3-yl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (2.5 g, 7.7 mmol) in methanol (100 mL) was hydrogenated in the presence of 10% Pd/C (0.2 g) using an H<sub>2</sub> balloon. After 16 h, the reaction mixture was filtered through a pad of Celite and rinsed with methanol (2 × 15 mL). The filtrate was concentrated and purified by column chromatography (1:9 methanol/chloroform) to afford the title compound (<b>18</b>, 1.86 g, 82%) as a solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.59 (d, <i>J</i> = 2.8 Hz, 1 H), 7.14 (dd, <i>J</i> = 8.8, 2.9 Hz, 1 H), 6.39 (d, <i>J</i> = 8.8 Hz, 1 H), 4.16 (br s, 1 H), 3.76 (m, 1 H), 3.23 (m, 1 H), 3.13−3.06 (m, 2 H), 2.60 (m, 1 H), 2.42 (m, 1 H); 1.40 (s, 9 H) 1.21 (d, <i>J</i> = 6.7 Hz, 3 H). MS <i>m</i>/<i>z</i> 293.5(M + H)<sup>+</sup>.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (<i>S</i>)-4-(6-Amino-pyridin-3-yl)-2-methyl-piperazine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>19</b>)</h3><div class="NLM_p last">Prepared from <i>S</i>-(+)-2-methyl-piperazine following the procedure for <b>18</b> in 50% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.59 (d, <i>J</i> = 2.8 Hz, 1 H), 7.14 (dd, <i>J</i> = 8.8, 2.9 Hz, 1 H), 6.39 (d, <i>J</i> = 8.8 Hz, 1 H), 4.16 (br s, 1 H), 3.76 (m, 1 H), 3.23 (m, 1 H), 3.13−3.06 (m, 2 H), 2.60 (m, 1 H), 2.42 (m, 1 H); 1.40 (s, 9 H) 1.21 (d, <i>J</i> = 6.7 Hz, 3 H). MS <i>m</i>/<i>z</i> 293.0 (M + H)<sup>+</sup>.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 4-(6-Amino-pyridin-3-yl)-2,2-dimethyl-piperazine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>20</b>)</h3><div class="NLM_p last">Prepared from 2,2-dimethyl-piperazine following the procedure for <b>18</b> in 51% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.54 (d, <i>J</i> = 3.0 Hz, 1 H), 7.09 (dd, <i>J</i> = 8.8, 3.0 Hz, 1 H), 6.39 (d, <i>J</i> = 8.8 Hz, 1 H), 5.32 (br s, 2 H), 3.52−3.49 (m, 2 H), 3.01−2.98 (m, 2 H), 2.89 (s, 2 H), 1.40 (s, 9 H), 1.34 (s, 6 H). MS <i>m</i>/<i>z</i> 307.0 (M + H)<sup>+</sup>.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 4-(6-Amino-pyridin-3-yl)-2,6-dimethyl-piperazine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>21</b>)</h3><div class="NLM_p last">Prepared from 2,6-dimethyl-piperazine following the procedure for <b>18</b> in 54% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.78 (d, <i>J</i> = 2.7 Hz, 1 H), 7.17 (dd, <i>J</i> = 8.7, 2.7 Hz, 1 H), 6.50 (d, <i>J</i> = 8.7 Hz, 1 H), 4.24−4.21 (m, 4 H), 3.10 (d, <i>J</i> = 11.6 Hz, 2 H), 2.81 (dd, <i>J</i> = 11.6, 4.2 Hz, 2 H), 1.50 (s, 9 H), 1.37 (d, <i>J</i> = 6.8 Hz, 6 H). MS <i>m</i>/<i>z</i> 307.0 (M + H)<sup>+</sup>.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N</i>*4*,<i>N</i>*4*-Dimethyl-3,4,5,6-tetrahydro-2<i>H</i>-[1,3′]bipyridinyl-4,6′-diamine (<b>22</b>)</h3><div class="NLM_p">To a solution of 5-bromo-2-nitropyridine (<b>15</b>, 5.10 g, 24.9 mmol) in MeCN (60 mL) were added 4-dimethylamino piperidine (3.64 g, 1.14 equiv) and <i>i</i>Pr<sub>2</sub>NEt (4.75 mL, 1.09 equiv), and the resulting mixture was heated to reflux for 20 h. The reaction mixture was cooled to room temparature and concentrated. Dimethyl-(6′-nitro-3,4,5,6-tetrahydro-2<i>H</i>-[1,3′]bipyridinyl-4-yl)-amine (4.89 g) was obtained by trituration in MeCN in 79% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.23 (d, <i>J</i> = 6.0 Hz, 1 H), 8.21 (s, 1 H), 7.56 (dd, <i>J</i> = 9.3, 3.0 Hz, 1 H), 4.29 (dd, <i>J</i> = 16, 2.5 Hz, 2 H), 3.51 (m, 1 H), 3.12 (m, 2 H), 2.91 (s, 6 H), 2.13−2.37 (m, 2 H), 1.82 (dd, <i>J</i> = 12, 4.1 Hz, 2 H). MS <i>m</i>/<i>z</i> 251.2 (M + H)<sup>+</sup>.</div><div class="NLM_p last">A mixture of dimethyl-(6′-nitro-3,4,5,6-tetrahydro-2<i>H</i>-[1,3′]bipyridinyl-4-yl)-amine (3.44 g, 13.6 mmol) and 10% Pd/C (333 mg) in MeOH−H<sub>2</sub>O (80 mL, v/v = 1:1) was stirred under H<sub>2</sub> (1 atm) for 24 h. The reaction mixture was filtered through a pad of Celite (rinsed with MeOH) and concentrated in vacuo. Trituration of the residue in MeCN gave <i>N</i>*4*,<i>N</i>*4*-dimethyl-3,4,5,6-tetrahydro-2<i>H</i>-[1,3′]bipyridinyl-4,6′-diamine (<b>22</b>, 2.554 g) in 85% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.61 (d, <i>J</i> = 2.8 Hz, 1 H), 7.40 (dd, <i>J</i> = 9.1, 2.9 Hz, 1 H), 6.64 (d, <i>J</i> = 9.0 Hz, 1 H), 3.56 (dd, <i>J</i> = 10.3, 2.1 Hz, 2 H), 3.23 (m, 1 H), 2.87 (s, 6 H), 2.74 (m, 2 H), 2.17 (m, 2 H), 1.86 (m, 2 H). MS <i>m</i>/<i>z</i> 221.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>S</i>)-4-(6-Amino-pyridin-3-ylmethyl)-2-methyl-piperazine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>24</b>)</h3><div class="NLM_p last">Prepared following the procedure described for <b>25</b> (see below), substituting (<i>R</i>)-2-methyl-piperazine-1-carboxylic acid <i>tert</i>-butyl ester for (<i>S</i>)-2-methyl-piperazine-1-carboxylic acid <i>tert</i>-butyl ester in 28% yield. <sup>1</sup>H NMR (400 MHz, DMSO) δ 7.75 (s, 1 H), 7.27 (d, <i>J</i> = 8.4 Hz, 1 H), 6.39 (d, <i>J</i> = 8.4 Hz, 1 H), 5.80 (s, 2 H), 4.04 (br s, 1 H), 3.65 (m, 1 H), 3.29 (d, <i>J</i> = 13.0 Hz, 1 H), 3.18 (d, <i>J</i> = 13.0 Hz, 1 H), 2.93 (m, 1 H), 2.71 (m, 1 H), 2.51 (m, 1 H), 1.94 (m, 1 H), 1.81 (m, 1 H), 1.38 (s, 9 H), 1.17 (d, <i>J</i> = 7.3 Hz, 3 H). MS <i>m</i>/<i>z</i> 307.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (<i>R</i>)-4-(6-Amino-pyridin-3-ylmethyl)-2-methyl-piperazine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>25</b>)</h3><div class="NLM_p">To a cooled (0 °C) solution of 2-amino-5-methylpyridine (<b>23</b>, 25.0 g, 231.4 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (250 mL) were added pyridine (181.0 mL) and trifluoroacetic anhydride (35.7 mL, 254.6 mmol). The reaction mixture was stirred for 2 h, quenched with water, and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The extract was washed with citric acid solution, water, and brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification by column chromatography (3:7 EtOAc/pet. ether) gave 2,2,2-trifluoro-<i>N</i>-(5-methyl-pyridin-2-yl)-acetamide (37.0 g, 78%) as a solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.32 (br s, 1 H), 8.17 (s, 1 H), 8.08 (d, <i>J</i> = 8.4 Hz, 1 H), 7.62 (dd, <i>J</i> = 8.4 Hz, 1 H), 2.53 (s, 3 H). MS <i>m</i>/<i>z</i> 204.7 (M + H)<sup>+</sup>.</div><div class="NLM_p">To a solution of 2,2,2-trifluoro-<i>N</i>-(5-methyl-pyridin-2-yl)-acetamide (37.0 g, 181.2 mmol) in carbon tetrachloride (500 mL) were added <i>N</i>-bromosuccinicimide (31.9 g, 179.4 mmol) and AIBN (3.27 g, 19.9 mmol). The reaction mixture was heated to reflux for 4 h. After cooling to room temperature, the mixture was filtered through a pad of Celite and the filtrate was concentrated under reduced pressure to give the crude bromide (50.0 g, ca 98%), which was used for the next step without further purification.</div><div class="NLM_p">To a solution of the crude bromide (2.0 g, 10 mmol) in dimethylformamide (40 mL) were added (<i>R</i>)-2-methyl-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (4.7 g, 16.7 mmol) and triethylamine (1.4 mL, 10 mmol) at 0 °C. The reaction mixture was stirred for 36 h. The mixture was diluted with water (150 mL) and extracted with EtOAc (50 mL × 3). The combined extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by column chromatography (1:10 EtOAc/petroleum ether) to provide (<i>R</i>)-2-methyl-4-[6-(2,2,2-trifluoroacetylamino)-pyridin-3-ylmethyl]-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (1.6 g, 40%) as a solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.80 (br s, 1 H), 8.29 (d, <i>J</i> = 1.8 Hz, 1 H), 8.16 (d, <i>J</i> = 8.5 Hz, 1 H), 7.81 (dd, <i>J</i> = 8.5, 1.8 Hz, 1 H), 4.21 (br s, 1 H), 3.83 (m, 1 H), 3.55 (d, <i>J</i> = 13.6 Hz, 1 H), 3.42 (d, <i>J</i> = 13.6 Hz, 1 H), 3.11 (m, 1 H), 2.74 (d, <i>J</i> = 10.6 Hz, 1 H), 2.55 (d, <i>J</i> = 11.1 Hz, 1 H), 2.18 (dd, <i>J</i> = 11.1, 3.9 Hz, 1 H), 2.06 (m, 1 H), 1.48 (s, 9 H), 1.19 (d, <i>J</i> = 8.0 Hz, 3 H). MS <i>m</i>/<i>z</i> 403.2 (M + H)<sup>+</sup>.</div><div class="NLM_p last">To a solution of ammonia in MeOH (ca 7 N, 150 mL) was added (<i>R</i>)-2-methyl-4-[6-(2,2,2-trifluoroacetylamino)-pyridin-3-ylmethyl]-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (1.6 g, 4.0 mmol). The mixture was stirred for 24 h and concentrated under reduced pressure. The residue was purified by column chromatography (1:100 MeOH/chloroform) to give (<i>R</i>)-4-(6-amino-pyridin-3-ylmethyl)-2-methyl-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>25</b>, 0.72 g, 56%) as a solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.75 (s, 1 H), 7.27 (d, <i>J</i> = 8.4 Hz, 1 H), 6.39 (d, <i>J</i> = 8.4 Hz, 1 H), 5.80 (s, 2 H), 4.04 (br s, 1 H), 3.65 (m, 1 H), 3.29 (d, <i>J</i> = 13.0 Hz, 1 H), 3.18 (d, <i>J</i> = 13.0 Hz, 1 H), 2.93 (m, 1 H), 2.71 (m, 1 H), 2.51 (m, 1 H), 1.94 (m, 1 H), 1.81 (m, 1 H), 1.38 (s, 9 H), 1.17 (d, <i>J</i> = 7.3 Hz, 3 H). MS <i>m</i>/<i>z</i> 307.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 6-Amino-3′,4′,5′,6′-tetrahydro-2′<i>H</i>-[3,4′]bipyridinyl-1′-carboxylic Acid <i>tert</i>-Butyl Ester (<b>28</b>)</h3><div class="NLM_p">To a mixture of 5-bromo-2-amino-pyridine (<b>26</b>, 0.67 g, 3.9 mmol) and 4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,6-dihydro-2<i>H</i>-pyridine-1-carboxylic acid <i>tert</i>-butyl ester (<b>27</b>, 1.20 g, 3.9 mmol) were added Pd(PPh<sub>3</sub>)<sub>4</sub> (0.45 g, 0.39 mmol) and KF/Al<sub>2</sub>O<sub>3</sub> (3.6 g). The mixture was degassed for 0.5 h and then heated at 100 °C for 2 h. The reaction mixture was diluted with EtOAc (100 mL), filtered through a pad of Celite, and the filter cake was rinsed with EtOAc (2 × 50 mL). The combined filterates were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by column chromatography (1:2 EtOAc/petroleum ether) provided 6-nitro-3′,6′-dihydro-2′<i>H</i>-[3,4′]bipyridinyl-1′-carboxylic acid <i>tert</i>-butyl ester (0.75 g, 70%) as a brownish solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.97 (d, <i>J</i> = 2.4 Hz, 1 H), 7.48 (dd, <i>J</i> = 8.7, 2.4 Hz, 1 H), 6.41 (d, <i>J</i> = 8.7 Hz, 1 H), 5.98 (s, 1 H), 5.93 (br s, 2 H), 3.94 (br s, 2 H), 3.51−3.48 (m, 2 H), 2.37 (br s, 2 H), 1.41 (s, 9 H). MS <i>m</i>/<i>z</i> 276.2 (M + H)<sup>+</sup>.</div><div class="NLM_p last">A solution of 6-nitro-3′,6′-dihydro-2′<i>H</i>-[3,4′]bipyridinyl-1′-carboxylic acid <i>tert</i>-butyl ester (0.75 g, 2.7 mmol) in EtOH (20 mL) was hydrogenated in the presence of 10% Pd/C (0.2 g) using an H<sub>2</sub> balloon. After 16 h, the reaction mixture was filtered through a pad of Celite and rinsed with EtOH (2 × 10 mL). The filtrate was concentrated and purified by column chromatography to give 6-amino-3′,4′,5′,6′-tetrahydro-2′<i>H</i>-[3,4′]bipyridinyl-1′-carboxylic acid <i>tert</i>-butyl ester (<b>28</b>, 0.45 g, 60%) as a solid. <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.76 (d, <i>J</i> = 2.3 Hz, 1 H), 7.38 (dd, <i>J</i> = 8.6, 2.3 Hz, 1 H), 6.56 (d, <i>J</i> = 8.6 Hz, 1 H), 4.21−4.18 (m, 2 H), 2.84 (br s, 2 H), 2.60 (m, 1 H), 1.78−1.75 (m, 2 H), 1.58−1.57(m, 2 H), 1.48 (s, 9 H). MS <i>m</i>/<i>z</i> 278.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 4-(6-Amino-pyridazin-3-yl)-piperazine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>31</b>)</h3><div class="NLM_p">To a solution of 4-(6-chloro-pyridazin-3-yl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>29</b>, 2.0 g, 6.7 mmol) in toluene (30 mL) were added benzophenone imine (1.3 g, 7.3 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (0.18 g, 0.2 mmol), BINAP (0.37 g, 0.6 mmol), and sodium <i>tert</i>-butoxide (0.9 g, 0.9 mmol). The reaction mixture was degassed for 0.5 h and then heated at 115 °C for 14 h. The mixture was cooled to room temperature, diluted with water (200 mL), and extracted with EtOAc (200 mL × 3). The extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by column chromatography (3:7 EtOAc/petroleum ether) to afford 4-[6-(benzhydrylidene-amino)-pyridazin-3-yl]-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (1.5 g, 51%) as a pale-yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.92−7.76 (m, 2 H), 7.36−7.18 (m, 8 H), 6.82 (d, <i>J</i> = 9.5 Hz, 1 H), 6.73 (d, <i>J</i> = 9.5 Hz, 1 H), 3.53 (br s, 8 H), 1.49 (s, 9 H). MS <i>m</i>/<i>z</i> 444.2 (M + H)<sup>+</sup>.</div><div class="NLM_p last">To a solution of 4-[6-(benzhydrylidene-amino)-pyridazin-3-yl]-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (1.5 g, 3.4 mmol) in MeOH (14 mL) were added sodium acetate (0.56 g, 6.8 mmol) and hydroxyamine hydrochloride (0.43 g, 6.1 mmol). The reaction mixture was stirred for 0.5 h and then concentrated in vacuo. The residue was purified by column chromatography (1:9 MeOH/chloroform) to give 4-(6-amino-pyridazin-3-yl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>31</b>, 0.87 g, 92%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.30 (d, <i>J</i> = 9.7 Hz, 1 H), 6.97 (dd, <i>J</i> = 9.7, 2.1 Hz, 1 H), 3.53−3.52 (m, 4 H), 3.37−3.35 (m, 4 H), 1.47 (s, 9 H). MS <i>m</i>/<i>z</i> 280.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 5′-Amino-2,3,5,6-tetrahydro-[1,2′]bipyrazinyl-4-carboxylic Acid <i>tert</i>-Butyl Ester (<b>32</b>)</h3><div class="NLM_p last">Prepared from 5′-bromo-2,3,5,6-tetrahydro-[1,2′]bipyrazinyl-4-carboxylic acid <i>tert</i>-butyl ester (<b>30</b>) following the procedure described for <b>31</b> in 59% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.66 (d, <i>J</i> = 1.4 Hz 1 H), 7.57 (d, <i>J</i> = 1.4 Hz, 1 H), 5.61 (s, 2 H), 3.42−3.40 (m, 4 H), 3.19−3.16 (m, 4 H) 1.41 (s, 9 H). MS <i>m</i>/<i>z</i> 280.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Cyclopentyl-[4-(3-methyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-amine (<b>33</b>)</h3><div class="NLM_p last">Synthesized from 4-(3-methyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>5a</b>) and cyclopentylamine following the procedure described for <b>37</b> (see below) in 46.7% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.95 (br s, 1 H), 8.16 (d, <i>J</i> = 5.56 Hz, 1 H), 7.34 (s, 1 H), 6.88 (d, <i>J</i> = 5.56 Hz, 1 H), 4.21 (br s, 1 H), 2.57 (s, 3 H), 1.93 (d, <i>J</i> = 6.06 Hz, 2 H), 1.78−1.61 (m, 2 H), 1.61−1.44 (m, 4 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 6.20 min (method 2, purity 96.30%/90.40%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 244.1567, calcd 244.1562.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Cyclohexyl-[4-(3-methyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-amine (<b>34</b>)</h3><div class="NLM_p last">Synthesized from 4-(3-methyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>5a</b>) and cyclohexylamine following the procedure described for <b>37</b> (see below) in 32.4% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.84 (br s, 1 H), 8.15 (d, <i>J</i> = 6 Hz, 1 H), 7.96 (s, 1 H), 6.78 (d, <i>J</i> = 6 Hz, 1 H), 6.75 (br s, 1 H), 3.72 (m, 1 H), 2.58 (s, 3 H), 1.94 (m, 2 H), 1.71 (m, 2 H), 1.63 (m, 1 H), 1.30 (m, 5 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 7.25 min (method 2, purity 96.6%/100%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 258.1718, calcd 258.1719.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Cyclohexyl-[4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-amine (<b>35</b>)</h3><div class="NLM_p last">Synthesized from 4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>5b</b>) and cyclohexylamine following the procedure described for <b>37</b> (see below) in 36.3% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.12 (b. s, 1 H), 8.10 (d, <i>J</i> = 5.05 Hz, 1 H), 7.85 (s, 1 H), 6.61 (d, <i>J</i> = 5.05 Hz, 1 H), 5.08 (br s, 1 H), 3.93 (br s, 1 H), 3.77 (ddd, <i>J</i> = 14.40, 10.36, 4.04 Hz, 1 H), 2.00 (dd, <i>J</i> = 12.38, 3.28 Hz, 2 H), 1.71 (ddd, <i>J</i> = 13.26, 3.66, 3.28 Hz, 2 H), 1.58 (dd, <i>J</i> = 9.09, 4.04 Hz, 1 H), 1.30 (d, <i>J</i> = 7.07 Hz, 8 H), 1.24−1.09 (m, 3 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 7.87 min (method 2, purity 100.00%/100.00%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 286.2039, calcd 286.2032.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> [4-(3-Isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-piperidin-4-yl-amine (<b>36</b>)</h3><div class="NLM_p last">Synthesized from 4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>5b)</b> and piperidin-4-ylamine following the procedure described for <b>37</b> (see below) in 38% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.06 (d, <i>J</i> = 5.0 Hz, 1 H), 7.91 (s, 1 H), 6.76, (d, <i>J</i> = 5.0 Hz, 1 H), 3.95 (m, 2 H), 3.29 (ddd, <i>J</i> = 12.8, 3.8, 3.7 Hz, 2 H), 2.93−2.87 (m, 2 H), 2.10 (dd, <i>J</i> = 13.9 Hz, 3.3 Hz, 2 H), 1.65 (q, <i>J</i> = 10.6 Hz, 2 H), 1.26 (d, <i>J</i> = 7.1 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 9.58 min (method 1, purity 100.00%/100.00%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 287.1985, calcd 287.1984.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> [4-(3-Isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-(1-methyl-piperidin-4-yl)-amine (<b>37</b>)</h3><div class="NLM_p last">The mixture of 4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>5b</b>, 30 mg, 0.11 mmol) and 1-methyl-piperidin-4-ylamine (63 mg, 0.55 mmol) in DMSO (0.5 mL) was heated at 130 °C for 1 h. The crude product was purified by prep-HPLC with a gradient of 5−90% acetonitrile/water with 3% <i>n</i>-propanol to give [4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-(1-methyl-piperidin-4-yl)-amine (<b>37</b>, 10.9 mg) in 33% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.13 (d, <i>J</i> = 5.6 Hz, 1 H), 8.01 (s, 1 H), 6.84 (d, <i>J</i> = 5.6 Hz, 1 H), 4.11 (s, 1 H), 3.88, (dd, <i>J</i> = 14.6, 6.6 Hz, 1 H), 2.94 (d, <i>J</i> = 12.1 Hz, 2 H), 2.34 (s, 3 H), 2.22 (t, <i>J</i> = 11.4 Hz, 2 H), 2.06 (d, <i>J</i> = 10.6 Hz, 2 H), 1.66 (q, <i>J</i> = 9.6 Hz, 2 H), 1.37 (d, <i>J</i> = 6.6 Hz, 6 H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 5.16 min (method 1, purity 97.4%/97.8%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 301.2142, calcd 301.2141.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> [4-(3-Isopropyl-1<i>H</i>-pyrazol-4-yl)-5-methyl-pyrimidin-2-yl]-(1-methyl-piperidin-4-yl)-amine (<b>38</b>)</h3><div class="NLM_p last">Synthesized from 4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-5-methyl-2-methylsulfonyl-pyrimidine (<b>11</b>) and 1-methyl-piperidin-4-ylamine following the procedure described for <b>37</b> in 26.4% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.08 (s, 1 H), 7.77 (br s, 1 H), 3.85 (dd, <i>J</i> = 14.9, 6.3 Hz, 1 H), 3.66 (br s, 1 H), 2.95 (d, <i>J</i> = 12.1 Hz, 2 H), 2.36 (s, 3 H), 2.28 (t, <i>J</i> = 11.4 Hz, 2 H), 2.18 (s, 3 H), 2.03 (d, <i>J</i> = 10.6 Hz, 2 H), 1.63 (d, <i>J</i> = 10.6 Hz, 2 H), 1.29 (d, <i>J</i> = 7.1 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 5.72 min (method 1, purity 100.0%/100.0%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 315.2287, calcd 315.2297.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 4-(3-Isopropyl-5-methyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-(1-methyl-piperidin-4-yl)-amine (<b>39</b>)</h3><div class="NLM_p last">Synthesized from 4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-5-methyl-2-methylsulfonyl-pyrimidine (<b>12</b>) and 1-methyl-piperidin-4-ylamine following the procedure described for <b>37</b> in 53.2% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.20 (d, <i>J</i> = 5.0 Hz, 1 H), 6.67 (d, <i>J</i> = 5.0 Hz, 1 H), 3.88 (dd, <i>J</i> = 14.6, 6.6 Hz, 1 H), 3.67 (s, 1 H), 2.90 (d, <i>J</i> = 11.6 Hz, 2 H), 2.42 (s, 3H), 2.31 (s, 3H), 2.19 (t, <i>J</i> = 11.1 Hz, 2 H), 2.04 (d, <i>J</i> = 11.1 Hz, 2 H), 1.64 (d, <i>J</i> = 9.6 Hz, 2 H), 1.31 (d, <i>J</i> = 6.6 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 5.71 min (method 1, purity 98.2%/95.1%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 315.2285, calcd 315.2297.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> [5-Bromo-4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-(1-methyl-piperidin-4-yl)-amine (<b>40</b>)</h3><div class="NLM_p last">Synthesized from 5-bromo-4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>10</b>) and 1-methyl-piperidin-4-ylamine following the procedure described for <b>37</b> in 11.3% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.22 (s, 1 H), 8.00 (s, 1 H), 3.70 (dd, <i>J</i> = 15.4, 6.3 Hz, 1 H), 3.61 (d, <i>J</i> = 6.6 Hz, 1 H), 2.79 (d, <i>J</i> = 11.6 Hz, 2 H), 2.19 (s, 3H), 2.06 (t, <i>J</i> = 12.1 Hz, 2 H), 1.90 (d, <i>J</i> = 11.6 Hz, 2 H), 1.52 (d, <i>J</i> = 9.1 Hz, 2 H), 1.21 (d, <i>J</i> = 7.1 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 5.71 min (method 1, purity 88.8%/93.3%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 379.1250, calcd 379.1246.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> [4-(5-Bromo-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-(1-methyl-piperidin-4-yl)-amine (<b>41</b>)</h3><div class="NLM_p last">Synthesized from 4-(5-bromo-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>9</b>) and 1-methyl-piperidin-4-ylamine following the procedure described for <b>37</b> in 66.7% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.25 (d, <i>J</i> = 5.0 Hz, 1 H), 7.00 (d, <i>J</i> = 5.0 Hz, 1 H), 3.88 (dd, <i>J</i> = 15.2, 6.6 Hz, 1 H), 3.77 (dt, <i>J</i> = 14.2, 7.1 Hz, 1 H), 2.93 (d, <i>J</i> = 12.1 Hz, 2 H), 2.33 (s, 3H), 2.22 (t, <i>J</i> = 11.4 Hz, 2 H), 2.05 (d, <i>J</i> = 10.1 Hz, 2 H), 1.66 (d, <i>J</i> = 9.6 Hz, 2 H), 1.33 (d, <i>J</i> = 7.1 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 5.79 min (Method 1, purity 98%/95.2%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 379.1245, calcd 379.1246.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 4-(3-Isopropyl-1<i>H</i>-pyrazol-4-yl)-<i>N</i>-(5-(piperazin-1-yl)pyridin-2-yl)pyrimidin-2-amine (<b>42</b>)</h3><div class="NLM_p">To a solution of 2-chloro-4-[3-isopropyl-1-(2-trimethylsilanyl-ethoxymethyl)-1<i>H</i>-pyrazol-4-yl]-pyrimidine and 2-chloro-4-[5-isopropyl-1-(2-trimethylsilanyl-ethoxymethyl)-1<i>H</i>-pyrazol-4-yl]-pyrimidine (a mixture of intermediates from <b>6</b> to <b>7</b>, 40 mg, 0.113 mmol) in 1,4-dioxane (3 mL) in a sealed tube were added <i>tert</i>-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate (<b>16</b>, 32.2 mg, 1.02 equiv), BINAP (6.97 mg, 0.1 equiv), NaO<i>t</i>Bu (16.3 mg, 1.5 equiv), and Pd<sub>2</sub>(dba)<sub>2</sub> (5.20 mg, 0.05 equiv). Nitrogen was bubbled into the resulting mixture for 3 min to degas. The mixture was sealed and heated at 110 °C for 3.5 h. After cooling to room temperature, the reaction mixture was filtered through a pad of Celite (rinsed with EtOAc). The filtrate was washed with water (2 × 10 mL) and brine (10 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Column chromatography (EtOAc/heptanes 0 to 50%) and subsequent HPLC purification gave <i>tert</i>-butyl 4-(6-(4-(3-isopropyl-1-((2-silylethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridin-3-yl)piperazine-1-carboxylate (25 mg) in 37% yield. <sup>1</sup>HNMR (400 MHz, CD<sub>3</sub>OD) δ 8.38 (d, <i>J</i> = 5.3 Hz, 1 H), 8.34 (s, 1 H), 8.11 (d, <i>J</i> = 9.1 Hz, 1 H), 8.01 (d, <i>J</i> = 2.9 Hz, 1 H), 7.51 (dd, <i>J</i> = 9.2, 3.0 Hz, 1 H), 7.07 (d, <i>J</i> = 5.3 Hz, 1 H), 5.44 (s, 2 H), 3.86 (q, <i>J</i> = 6.9 Hz, 1 H), 3.71−3.58 (m, 5 H), 3.52 (t, <i>J</i> = 6.7 Hz, 1 H), 3.19−3.01 (m, 4 H), 1.51 (s, 9 H), 1.31 (d, <i>J</i> = 7.0 Hz, 6 H), 0.98−0.86 (m, 2 H), 0.0 (s, 9 H). MS <i>m</i>/<i>z</i> 595.6 (M + H)<sup>+</sup>.</div><div class="NLM_p last">To a solution of <i>tert</i>-butyl 4-(6-(4-(3-isopropyl-1-((2-silylethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridin-3-yl)piperazine-1-carboxylate (25 mg, 0.042 mmol) in 1,4-dioxane (1.0 mL) was added 4 M HCl in dioxane (1.0 mL, 100 equiv). The mixture was stirred at room temperature for 5 h. The yellow solid was collected by filtration, washed with cold dioxane (5 mL) and then ether (10 mL), and dried under high vacuum overnight to give 4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-<i>N</i>-(5-(piperazin-1-yl)pyridin-2-yl)pyrimidin-2-amine as a hydrochloride salt (23 mg) in 91% yield. <sup>1</sup>HNMR (600 MHz, CD<sub>3</sub>OD) δ 8.49 (d, <i>J</i> = 6.0 Hz, 1 H), 8.28 (s, 1 H), 8.04−7.97 (m, 2 H), 7.48 (d, <i>J</i> = 6.0 Hz, 1 H), 7.45 (d, <i>J</i> = 9.9 Hz, 1 H), 4.16 (m, 1 H), 3.51−3.47 (m, 4 H), 3.43−3.40 (m, 4 H), 1.36 (d, <i>J =</i> 6.8 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.30 min (method 5, 100.00%/100%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 364.2238, calcd 364.2250.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> [4-(3-Isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-(4-piperazin-1-yl-phenyl)-amine (<b>43</b>)</h3><div class="NLM_p">To a solution of 2-chloro-4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidine (<b>6</b>, 55 mg, 0.247 mmol) in 1,4-dioxane (3 mL) in a microwave vial were added 4-(4-aminophenyl)piperazine-1-carboxylic acid <i>t</i>-butyl ester (75.4 mg, 1.1 equiv), XANTPHOS (14.3 mg, 0.1 equiv), Cs<sub>2</sub>CO<sub>3</sub> (86.9 mg, 2.0 equiv), and Pd<sub>2</sub>(dba)<sub>2</sub> (11.3 mg, 0.05 equiv). Nitrogen was bubbled into the resulting mixture for 3 min to degas. The mixture was sealed and heated in a microwave reactor at 150 °C for 40 min. After cooling to room temperature, the reaction mixture was filtered through a pad of Celite (rinsed with EtOAc) and washed with water (2 × 10 mL) and brine (10 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Column chromatography (EtOAc/heptanes 0−50%) and subsequent HPLC purification gave <i>tert</i>-butyl 4-(4-(4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)phenyl)piperazine-1-carboxylate (13.2 mg) in 11% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.21 (s, 1 H), 8.15 (d, <i>J =</i> 6.3 Hz, 1 H), 7.42 (d, <i>J =</i> 8.8 Hz, 2 H), 7.18 (d, <i>J =</i> 6.2 Hz, 1 H), 7.10 (d, <i>J =</i> 9.0 Hz, 2 H), 3.97 (m, 1 H), 3.63 (br s, 4 H), 3.13−3.26 (m, 4 H), 1.51 (s, 9 H), 1.24 (d, <i>J =</i> 7.0 Hz, 6H). MS <i>m</i>/<i>z</i> 464.5 (M + H)<sup>+</sup>.</div><div class="NLM_p last">[4-(3-Isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-(4-piperazin-1-yl-phenyl)-amine (<b>43</b>) was prepared from <i>tert</i>-butyl 4-(4-(4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)phenyl)piperazine-1-carboxylate following the procedure descirbed for the deprotection reaction of <b>42</b> as a hydrochloride salt in quantitative yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 8.39 (s, 1 H), 8.05 (br s., 1 H), 7.39−7.21 (m, 3 H), 7.13 (d, <i>J</i> = 8.7 Hz, 2 H), 3.79 (br s, 1 H), 3.50−3.41 (m, 4 H), 3.41−3.30 (m, 4 H), 2.58 (s, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.30 min (method 5, 100%/100%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 364.2238, calcd 364.2250.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 4-(3-Isopropyl-1<i>H</i>-pyrazol-4-yl)-N-(pyridin-2-yl)pyrimidin-2-amine (<b>44</b>)</h3><div class="NLM_p last">To a solution of 2-chloro-4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)pyrimidine (<b>6</b>, 100 mg, 0.45 mmol) and pyridine-2-amine (54.4 mg, 0.49 mmol) in 1,4-dioxane (5 mL) in a sealed tube were added Xantphos (26 mg, 0.1 equiv), LHMDS 1 M solution (670 uL, 1.5 equiv), and Pd<sub>2</sub>(dba)<sub>2</sub> (21 mg, 0.05 equiv). Nitrogen was bubbled into the resulting mixture for 3 min to degas. The mixture was sealed and heated at 110 °C for 3.5 h. After cooling to room temperature, the reaction mixture was filtered through a pad of Celite (rinsed with EtOAc). The filtrate was washed with water (2 × 10 mL) and brine (10 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Column chromatography (EtOAc/heptanes 0−50%) and subsequent HPLC purification gave 4-(3-isopropyl-1<i>H</i>-pyrazol-4-yl)-<i>N</i>-(pyridin-2-yl)pyrimidin-2-amine (<b>44</b>, 15 mg) in 12% yield. <sup>1</sup>HNMR (400 MHz, CD<sub>3</sub>OD) δ 8.50 (d, <i>J</i> = 5.6 Hz, 1 H), 8.33 (d, <i>J</i> = 5.4 Hz,1 H), 8.15 (br s,1 H), 7.99 (br m, 2 H), 7.32 (d, <i>J</i> = 5.4 Hz, 1 H), 7.19 (d, <i>J</i> = 2.4 Hz, 1 H), 1.69−1.45 (m, 2 H), 1.38 (d, <i>J</i> = 7.0 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.70 min (method 5, 100%/100%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 281.1511, calcd 281.1515.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 4-{6-[4-(3-Methyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-ylamino]-pyridin-3-yl}-piperazine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>45</b>)</h3><div class="NLM_p last">A mixture of 2-methanesulfonyl-4-(3-methyl-1<i>H</i>-pyrazol-4-yl)-pyrimidine (<b>5a</b>, 120 mg, 0.5 mmol) and 4-(6-amino-pyridin-3-yl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>16</b>, 211 mg, 1.5 equiv) in toluene (6 mL) was heated at 120 °C for 16 h, allowing the solvent to boil off to yield a melt. After cooling to room temperature, the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and treated with trifluoroacetic acid (2 mL). After 1 h, the reaction mixture was concentrated and purified by HPLC. A trifluoroacetic acid salt was then neutralized using polymer-linked carbonate resin (Stratospheres SPE PL-HCO<sub>3</sub> MP 500 mg cartridges) to yield 5 mg of 4-{6-[4-(3-methyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-ylamino]-pyridin-3-yl}-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>45</b>) in 3% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.94 (br s, 1 H), 9.19 (s, 1 H), 8.37 (d, <i>J</i> = 5.31 Hz, 1 H), 8.08 (d, <i>J</i> = 8.97 Hz, 1 H), 7.96 (d, <i>J</i> = 3.03 Hz, 1 H), 7.41 (dd, <i>J</i> = 8.97, 3.03 Hz, 1 H), 7.06 (d, <i>J</i> = 5.31 Hz, 1 H), 3.01 (m, 4 H), 2.84 (m, 4 H), 2.56 (2.56, 3 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.89 min (method 3, purity 94%/88%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 337.1895, calcd 337.1889.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (5-Piperazin-1-yl-pyridin-2-yl)-[4-(3-trifluoromethyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-amine (<b>46</b>)</h3><div class="NLM_p last">Prepared from 2-methanesulfonyl-4-(3-trifluoromethyl-1<i>H</i>-pyrazol-4-yl)-pyrimidine (<b>5d</b>) and 4-(6-amino-pyridin-3-yl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>16</b>) following the procedure described for <b>45</b> in <1% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.90 (s, 1 H), 8.34 (d, <i>J</i> = 5.31, 1 H), 8.24 (s, 1 H), 8.19 (d, <i>J</i> = 8.97 Hz, 1 H), 7.94 (d, <i>J</i> = 2.78 Hz, 1 H), 7.39 (dd, <i>J</i> = 8.97, 2.78 Hz, 1 H), 6.92 (d, <i>J</i> = 5.31 Hz, 1 H), 3.01 (m, 4 H), 2.84 (m, 4 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.36 min (method 4, 94%, 89%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 391.1618, calcd 391.1607.</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> [4-(3-Cyclopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-(5-piperazin-1-yl-pyridin-2-yl) amine (<b>47</b>)</h3><div class="NLM_p last">Prepared from 4-(3-cyclopropyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>5c</b>) and 4-(6-amino-pyridin-3-yl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>16</b>) following the procedure described for <b>45</b>, except neutralization, in 3% yield as a trifluoroacetic acid salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.89 (br s, 1 H), 8.93 (s, 2 H), 8.50 (d, <i>J</i> = 5.31 Hz, 1 H), 8.30 (s, 1 H), 8.02 (s, 1 H), 7.84 (d, <i>J</i> = 8.72 Hz, 1 H), 7.76 (d, <i>J</i> = 8.72 Hz, 1 H), 7.43 (d, <i>J</i> = 5.31 Hz, 1 H), 3.37 (m, 4 H), 3.29 (m, 4 H), 2.88 (m, 1H), 1.02 (m, 2 H), 0.91 (m, 2 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.10 min (method 5, 87%,87%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 363.2060, calcd 363.2046.</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> [4-(3-<i>tert</i>-Butyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-(5-piperazin-1-yl-pyridin-2-yl)-amine (<b>48</b>)</h3><div class="NLM_p last">Prepared from 4-(3-<i>tert</i>-butyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>5e</b>) and 4-(6-amino-pyridin-3-yl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>16</b>) following the procedure described for <b>45</b>, except neutralization, as a trifluoroacetic acid salt in 7% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.29 (s, 1 H), 8.81 (bs, 1 H), 8.48 (d, <i>J</i> = 5.56 Hz, 1 H), 8.07 (s, 1 H), 8.01 (s, 1 H), 7.85 (d, <i>J</i> = 9.22 Hz, 1 H), 7.78 (d, <i>J</i> = 9.22 Hz, 1 H), 7.24 (d, <i>J</i> = 5.43 Hz, 1 H), 3.36 (m, 4 H), 3.28 (m, 4 H), 1.42 (s, 9 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.36 min (method 5, 91%/90%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 379.2365, calcd 379.2359.</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> {4-[3-(4-Fluoro-phenyl)-1<i>H</i>-pyrazol-4-yl]-pyrimidin-2-yl}-(5-piperazin-1-yl-pyridin-2-yl)-amine (<b>49</b>)</h3><div class="NLM_p last">Prepared from 4-[3-(4-fluoro-phenyl)-1<i>H</i>-pyrazol-4-yl]-2-methanesulfonyl-pyrimidine (<b>5f</b>) and 4-(6-amino-pyridin-3-yl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>16</b>) following the procedure described for <b>45</b> in <1% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.10 (s, 1 H), 8.34 (d, <i>J</i> = 5.18 Hz, 1 H), 8.24 (s, 1 H), 7.91 (d, <i>J</i> = 2.91 Hz, 1 H), 7.59 (dd, <i>J</i> = 8.84, 8.84 Hz, 2 H), 7.57 (d, <i>J</i> = 2.91 Hz, 1 H), 7.25 (dd, <i>J</i> = 8.84, 8.84 Hz, 2 H), 7.02 (dd, <i>J</i> = 8.84, 2.91 Hz, 1 H), 6.81 (d, <i>J</i> = 5.18 Hz, 1 H), 2.97 (m, 4 H); 2.84 (m, 4 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.20 min (method 4, purity 97%/93%. HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 417.1965, calcd 417.1951.</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> [4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-(5-piperazin-1-yl-pyridin-2-yl)-amine (<b>50</b>)</h3><div class="NLM_p"><i>tert</i>-Butyl 4-(6-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridin-3-yl)piperazine-1-carboxylate was prepared from <b>7</b> and 4-(6-amino-pyridin-3-yl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>16</b>) following the procedure described for the coupling reaction of <b>42</b> in 10.4% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.50 (d, <i>J</i> = 5.2 Hz, 1 H), 8.15 (d, <i>J =</i> 9.1 Hz, 1 H), 8.01 (d, <i>J</i> = 2.9 Hz, 1 H), 7.48 (dd, <i>J =</i> 9.2 Hz, 1 H), 7.13 (d, <i>J</i> = 5.2 Hz, 1 H), 5.52 (s, 2 H), 3.71 (m, 2 H), 3.19−3.07 (m, 5 H), 3.13(m, 4 H), 1.50 (s, 9 H), 1.25 (d, <i>J =</i> 6.9 Hz, 6 H), 0.93 (m, 2 H), 0.00 (s, 9 H). MS <i>m</i>/<i>z</i> 629.6 (M + H)<sup>+</sup>.</div><div class="NLM_p last">[4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-(5-piperazin-1-yl-pyridin-2-yl)-amine (<b>50</b>) was prepared from <i>tert</i>-butyl 4-(6-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridin-3-yl)piperazine-1-carboxylate following the procedure described for the deprotection reaction of <b>42</b> as a hydrochloride salt in 65% yield. <sup>1</sup>HNMR (400 MHz, CD<sub>3</sub>OD) δ 8.59 (d, <i>J</i> = 5.7 Hz, 1 H), 8.07 (dd, <i>J</i> = 9.5, 3.0 Hz, 1 H), 7.86 (d, <i>J</i> = 2.6 Hz, 1 H), 7.56 (d, <i>J</i> = 5.7 Hz, 1 H), 7.44 (d, <i>J</i> = 9.5 Hz, 1 H), 3.97−3.73 (m, 1 H), 3.47−3.39 (m, 4 H), 3.38−3.30 (m, 4 H), 1.25 (d, <i>J =</i> 7.1 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.45 min (method 5, purity 93.38%/95.94%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 339.1821, calcd 399.1812.</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> [4-(5-Isopropyl-3-methyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-(5-piperazin-1-yl-pyridin-2-yl)-amine (<b>51</b>)</h3><div class="NLM_p last">Prepared from 4-(5-isopropyl-3-methyl-1<i>H</i>-pyrazol-4-yl)-2-methanesulfonyl-pyrimidine (<b>12</b>) and 4-(6-amino-pyridin-3-yl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>16</b>) following the procedure described for <b>45</b> in 3% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.18 (s, 1 H), 8.40 (d, <i>J</i> = 5.18 Hz, 1 H), 8.02 (d, <i>J</i> = 9.22, 1 H), 7.96 (d, <i>J</i> = 2.78 Hz, 1 H), 7.37 (dd, <i>J</i> = 9.22, 2.78 Hz, 1 H), 6.84 (d, <i>J</i> = 5.18 Hz, 1 H), 3.59 (dd, <i>J</i> = 8.84, 8.84 Hz, 2 H), 7.02 (dd, <i>J</i> = 8.84, 2.91 Hz, 1 H), 6.84 (d, <i>J</i> = 5.18 Hz, 1H), 3.59 (m, 1 H), 3.01 (m, 4 H), 2.84 (m, 4 H), 1.20 (d, <i>J</i> = 6.95, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.27 min (method 2, purity 98%/95%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 379.2371, calcd 379.2359.</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> [4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-(6-piperazin-1-yl-pyridazin-3-yl)-amine (<b>52</b>)</h3><div class="NLM_p"><i>tert</i>-Butyl 4-(6-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridazin-3-yl)piperazine-1-carboxylate was prepared from <b>7</b> and 4-(6-amino-pyridazin-3-yl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>31</b>) following the procedure described for the coupling reaction of <b>42</b> in 16% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.52 (d, <i>J</i> = 5.0 Hz, 1 H), 8.35 (d, <i>J</i> = 9.5 Hz, 1 H), 7.39 (d, <i>J</i> = 10.0 Hz, 1 H), 7.18 (d, <i>J</i> = 5.0 Hz, 1 H), 5.52 (s, 2H), 3.76−3.66 (m, 2 H), 3.66−3.53 (m, 10 H), 1.51 (s, 9 H), 1.24 (d, <i>J</i> = 7.0 Hz, 6 H), 0.93 (t, <i>J</i> = 8.0 Hz, 2H), 0.00 (s, 9 H). MS <i>m</i>/<i>z</i> 630.5 (M + H)<sup>+</sup>.</div><div class="NLM_p last">[4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-(6-piperazin-1-yl-pyridazin-3-yl)-amine (<b>52</b>) was prepared from <i>tert</i>-butyl 4-(6-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridazin-3-yl)piperazine-1-carboxylate following the procedure described for the deprotection reaction of <b>42</b> as a hydrochloride salt in 63% yield. <sup>1</sup>HNMR (400 MHz, CD<sub>3</sub>OD) δ 8.79 (d, <i>J</i> = 5.6 Hz, 1 H), 8.14 (d, <i>J</i> = 10.1 Hz, 1 H), 7.90 (d, <i>J</i> = 10.0 Hz, 1 H), 7.69 (d, <i>J</i> = 5.4 Hz, 1 H), 4.02−3.80 (m, 5 H), 3.47−3.39 (m, 4 H), 1.38 (d, <i>J =</i> 7.1 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.33 min (method 5, purity 100.00%/100.00%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 400.1771, calcd 400.1765.</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> [4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-(3,4,5,6-tetrahydro-2<i>H</i>-[1,2′]bipyrazinyl-5′-yl)-amine (<b>53</b>)</h3><div class="NLM_p"><i>tert</i>-Butyl 4-(5-(4-(5-chloro-3-isopropyl-1-((2-(trimethyl-silyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyrazin-2-yl)piperazine-1-carboxylate was prepared from <b>7</b> and 5′-amino-2,3,5,6-tetrahydro-[1,2′]bipyrazinyl-4-carboxylic acid <i>tert</i>-butyl ester (<b>32</b>) following the procedure described for the coupling reaction of <b>55</b> (see below) in 50% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.22 (d, <i>J</i> = 1.4 Hz, 1 H), 8.47 (d, <i>J</i> = 5.2 Hz, 1 H), 7.86 (d, <i>J</i> = 1.5 Hz, 1 H), 7.58 (s, 1 H), 7.06 (d, <i>J</i> = 5.2 Hz, 1 H), 5.49 (s, 2 H), 3.75−3.64 (m, 2 H), 3.64−3.44 (m, 9 H), 1.50 (s, 9 H), 1.27 (d, <i>J</i> = 7.0 Hz, 6 H), 1.01−0.89 (m, 2 H), 0.00 (s, 9 H). MS <i>m</i>/<i>z</i> 630.5 (M + H)<sup>+</sup>.</div><div class="NLM_p last">[4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-(3,4,5,6-tetrahydro-2<i>H</i>-[1,2′]bipyrazinyl-5′-yl)-amine (<b>53</b>) was prepared from <i>tert</i>-butyl 4-(5-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyrazin-2-yl)piperazine-1-carboxylate following the procedure described for the deprotection reaction of <b>42</b> as a hydrochloride salt in 87% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.52 (d, <i>J</i> = 6.9 Hz, 1 H), 8.37 (d, <i>J</i> = 1.4 Hz, 1 H), 8.23 (d, <i>J</i> = 1.3 Hz, 1 H), 7.87 (d, <i>J</i> = 6.8 Hz, 1 H), 4.16 (dt, <i>J</i> = 14.0, 6.9 Hz, 1 H), 3.98−3.86 (m, 4 H), 3.47−3.34 (m, 4 H), 1.40 (d, <i>J</i> = 7.1 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.54 min (method 5, purity 100.00%/100.00%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 400.1765, calcd 400.1765.</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-<i>N</i>-(5-(piperidin-4-yl)pyridin-2-yl)pyrimidin-2-amine (<b>54</b>)</h3><div class="NLM_p"><i>tert</i>-Butyl 4-(6-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridin-3-yl)piperidine-1-carboxylate was prepared from <b>7</b> and 6-amino-3′,4′,5′,6′-tetrahydro-2′<i>H</i>-[3,4′]bipyridinyl-1′-carboxylic acid <i>tert</i>-butyl ester (<b>28</b>) following the procedure described for the coupling reaction of <b>42</b> in 8% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 9.22 (d, <i>J</i> = 5.3 Hz, 1 H), 8.95 (d, <i>J</i> = 8.6 Hz, 1 H), 8.84 (d, <i>J</i> = 2.3 Hz, 1 H), 8.34 (dd, <i>J</i> = 8.7, 2.4 Hz, 1 H), 7.85 (d, <i>J</i> = 5.2 Hz, 1 H), 6.20 (s, 2 H), 4.91 (d, <i>J</i> = 13.01 Hz, 2 H), 4.46−4.25 (m, 3 H), 3.57 (br s, 2 H), 3.50−3.32 (m, 1 H), 2.51 (br s, 2 H), 2.37−2.21 (m, 2 H), 2.17 (s, 9 H),1.93 (d, <i>J</i> = 6.8 Hz, 6 H), 1.61 (m, 2 H), 0.67 (s, 9 H). MS <i>m</i>/<i>z</i> 629.6 (M + H)<sup>+</sup>.</div><div class="NLM_p last">4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-<i>N</i>-(5-(piperidin-4-yl)pyridin-2-yl)pyrimidin-2-amine (<b>54</b>) was prepared from <i>tert</i>-butyl 4-(6-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridin-3-yl)piperidine-1-carboxylate following the procedure described for the deprotection reaction of <b>42</b> as a hydrochloride salt in quantitative yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.72 (d, <i>J</i> = 5.5 Hz, 1 H), 8.31 (s, 1 H), 8.21 (d, <i>J</i> = 8.5 Hz, 1 H), 7.76 (d, <i>J</i> = 9.03 Hz, 1 H), 7.65 (d, <i>J</i> = 5.5 Hz, 1 H), 3.98 (dt, <i>J</i> = 14.05, 7.03 Hz, 1 H), 3.58 (d, <i>J</i> = 13.0 Hz, 2 H), 3.28−3.09 (m, 3 H), 2.19 (d, <i>J</i> = 14.0 Hz, 2 H), 2.06−1.89 (m, 2 H), 1.37 (d, <i>J</i> = 7.03 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.63 min (method 5, purity 96.73%/98.27%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 398.1842, calcd 398.1860.</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> {4-[5-Chloro-3-isopropyl-1-(2-trimethylsilanyl-ethoxymethyl)-1<i>H</i>-pyrazol-4-yl]-pyrimidin-2-yl}-[5-(4-methyl-piperazin-1-yl)-pyridin-2-yl]-amine (<b>55</b>)</h3><div class="NLM_p">To a solution of <b>7</b> (100 mg, 0.258 mmol) in 1,4-dioxane (4 mL) and water (100 μL) in a microwave vial were added 5-(4-methyl-piperazin-1-yl)-1-pyridin-2-ylamine (<b>17</b>, 49.6 mg, 1.0 equiv), BINAP (16.1 mg, 0.1 equiv), NaO<i>t</i>Bu (37.2 mg, 1.5 equiv), and Pd<sub>2</sub>(dba)<sub>2</sub> (11.8 mg, 0.05 equiv). Nitrogen was bubbled into the resulting mixture for 3 min to degas. The mixture was sealed and heated at 140 °C for 6 h. After cooling to room temperature, the reaction mixture was filtered through a pad of Celite (rinsed with EtOAc). The filtrate was washed with water (2 × 10 mL) and brine (10 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Column chromatography (EtOAc/heptanes 0−100%) yielded a solid, which was triturated with cold MeCN to give {4-[5-chloro-3-isopropyl-1-(2-trimethylsilanyl-ethoxymethyl)-1<i>H</i>-pyrazol-4-yl]-pyrimidin-2-yl}-[5-(4-methyl-piperazin-1-yl)-pyridin-2-yl]-amine (33 mg) in 23.5% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.48 (d, <i>J</i> = 5.0 Hz, 1 H), 8.31 (d, <i>J</i> = 9.0 Hz, 1 H), 8.01 (d, <i>J</i> = 2.5 Hz, 1 H), 7.78 (s, 1 H), 7.32 (dd, <i>J </i>= 9.0, 3.0 Hz, 1 H), 7.05 (d, <i>J</i> = 5.5 Hz, 1 H), 5.50 (s, 2 H), 3.68 (m, 2 H), 3.66−3.55 (m, 1 H), 3.21 (br s, 4 H), 2.66 (br s, 4 H), 2.41 (br s, 3 H), 1.28 (d, <i>J</i> = 7.0 Hz, 6 H), 0.94 (m, 2 H), 0.00 (s, 9 H). MS <i>m</i>/<i>z</i> 543.6 (M + H)<sup>+</sup>.</div><div class="NLM_p last">[4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-[5-(4-methyl-piperazin-1-yl)-pyridin-2-yl]-amine (<b>55</b>) was prepared from {4-[5-chloro-3-isopropyl-1-(2-trimethylsilanyl-ethoxymethyl)-1<i>H</i>-pyrazol-4-yl]-pyrimidin-2-yl}-[5-(4-methyl-piperazin-1-yl)-pyridin-2-yl]-amine following the procedure described for the deprotection reaction of <b>42</b> as a hydrochloride salt in 18.6% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.59 (d, <i>J</i> = 6.0 Hz, 1 H), 8.08 (dd, <i>J</i> = 9.5, 3.0 Hz, 1 H), 7.86 (d, <i>J</i> = 3.0 Hz, 1 H), 7.57 (d, <i>J</i> = 5.5 Hz, 1 H), 7.44 (d, <i>J</i> = 9.5 Hz, 1 H), 3.97−3.75 (m, 3 H), 3.65−3.49 (m, 3 H), 3.30−3.06 (m, 3 H), 2.89 (s, 3 H), 1.25 (d, <i>J</i> = 7.0 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 4.04 min (method 5, purity 100.00%/100.00%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 413.1960, calcd 413.1969.</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 2-(4-{6-[4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-ylamino]-pyridin-3-yl}-piperazin-1-yl)-ethanol (<b>56</b>)</h3><div class="NLM_p last">To a solution of [4-(5-chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-(5-piperazin-1-yl-pyridin-2-yl)-amine hydrochloride (<b>50</b>, 50 mg, 0.125 mmol) in acetonitrile (5 mL) were added di-isopropylethylamine (44 μL, 2.0 equiv) and 2-bromoethanol (9.3 μL, 1.05 equiv). The reaction mixture was stirred at 40 °C for 24 h. The reaction mixture was diluted in EtOAc (10 mL) and washed with water (2 × 20 mL) and then with brine (10 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by HPLC to give 2-(4-{6-[4-(5-chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-ylamino]-pyridin-3-yl}-piperazin-1-yl)-ethanol (<b>56</b>, 9.5 mg) in 17% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.50 (d, <i>J</i> = 5.0 Hz, 1 H), 8.32 (d, <i>J</i> = 9.0 Hz, 1 H), 8.20 (br s, 1 H), 8.08 (d, <i>J</i> = 2.5 Hz, 1 H), 7.34 (dd, <i>J</i> = 9.5, 3.0 Hz, 1 H), 7.22 (d, <i>J</i> = 5.0 Hz, 1 H), 3.97−3.80 (m, 1 H), 3.75 (t, <i>J</i> = 5.3 Hz, 2 H), 3.64 (t, <i>J</i> = 6.8 Hz, 1 H), 3.25−3.13 (m, 4 H), 2.79 (br s, 4 H), 2.71 (t, <i>J</i> = 5.0 Hz, 1 H), 1.81−1.62 (m, 1 H), 1.34 (d, <i>J</i> = 7.0 Hz, 6 H), 0.96 (t, <i>J</i> = 7.3 Hz, 1 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.90 min (method 5, purity 94.44%/95.66%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 443.2079, calcd 443.2075.</div></div><div id="sec5_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> [4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-[5-((<i>S</i>)-3-methyl-piperazin-1-yl)-pyridin-2-yl]-amine (<b>57</b>)</h3><div class="NLM_p">(<i>S</i>)-<i>tert</i>-Butyl 4-(6-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridin-3-yl)-2-methylpiperazine-1-carboxylate was prepared from <b>7</b> and (<i>S</i>)-4-(6-amino-pyridin-3-yl)-2-methyl-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>19</b>) following the procedure described for the coupling reaction of <b>55</b> in 51% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.90 (d, <i>J</i> = 9.7 Hz, 1 H), 8.58 (d, <i>J</i> = 5.3 Hz, 1 H), 7.76 (dd, <i>J</i> = 10.0, 3.0 Hz, 1 H), 7.54 (d, <i>J</i> = 2.8 Hz, 1 H), 7.32 (d, <i>J</i> = 5.3 Hz, 1 H), 5.50 (s, 2 H), 4.43 (br s, 1 H), 4.03 (d, <i>J</i> = 15.0 Hz, 1 H), 3.76−3.54 (m, 3 H), 3.43 (d, <i>J</i> = 12.4 Hz, 1 H), 3.33−3.22 (m, 2 H), 3.05 (d, <i>J</i> = 3.9 Hz, 1 H), 2.84 (br s, 1 H), 1.54−1.46 (m, 9 H), 1.38−1.24 (m, 9 H), 1.20 (d, <i>J</i> = 5.2 Hz, 1 H), 1.00−0.94 (m, 2 H), 0.00 (s, 9 H). MS <i>m</i>/<i>z</i> 643.6 (M + H)<sup>+</sup>.</div><div class="NLM_p last">[4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-[5-((<i>S</i>)-3-methyl-piperazin-1-yl)-pyridin-2-yl]-amine (<b>57</b>) was prepared from (<i>S</i>)-<i>tert</i>-butyl 4-(6-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridin-3-yl)-2-methylpiperazine-1-carboxylate following the procedure described for the deprotection reaction of <b>42</b> as a hydrochloride salt in quantitative yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.68 (d, <i>J</i> = 5.8 Hz, 1 H), 8.17 (dd, <i>J</i> = 9.0, 2.8 Hz, 1 H), 7.96 (d, <i>J</i> = 2.8 Hz, 1 H), 7.65 (d, <i>J</i> = 5.8 Hz, 1 H), 7.53 (d, <i>J</i> = 9.6 Hz, 1 H), 3.96 (quin, <i>J</i> = 7.0 Hz, 1 H), 3.86 (dd, <i>J</i> = 19.9, 12.9 Hz, 2 H), 3.61−3.50 (m, 2 H), 3.40−3.31 (m, 1 H), 3.24−3.13 (m, 1 H), 2.95 (dd, <i>J</i> = 13.1,10.5 Hz, 1 H), 1.43 (d, <i>J</i> = 6.6 Hz, 3 H), 1.34 (d, <i>J </i>= 7.0 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.75 min (method 5, purity 100.00%/100.00%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 413.1970, calcd 413.1969.</div></div><div id="sec5_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> [4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-[5-((<i>R</i>)-3-methyl-piperazin-1-yl)-pyridin-2-yl]-amine (<b>58</b>)</h3><div class="NLM_p">(<i>R</i>)-<i>tert</i>-Butyl 4-(6-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridin-3-yl)-2-methylpiperazine-1-carboxylate was prepared from <b>7</b> and (<i>R</i>)-4-(6-amino-pyridin-3-yl)-2-methyl-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>18</b>) following the procedure described for the coupling reaction of <b>55</b> in 54% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.48 (d, <i>J</i> = 5.2 Hz, 1 H), 8.31 (d, <i>J</i> = 9.1 Hz, 1 H), 7.98 (d, <i>J</i> = 2.8 Hz, 1 H), 7.77 (s, 1 H), 7.29 (d, <i>J</i> = 3.0 Hz, 1 H), 7.05 (d, <i>J</i> = 5.2 Hz, 1 H), 5.49 (s, 2 H), 4.38 (br s, 1 H), 3.98 (d, <i>J</i> = 13.4 Hz, 1 H), 3.72−3.65 (m, 2 H), 3.61 (quin, <i>J</i> = 6.9 Hz, 1 H), 3.49 (q, <i>J</i> = 7.1 Hz, 1 H), 3.41 (d, <i>J</i> = 11.6 Hz, 1 H), 3.29−3.22 (m, 2 H), 2.93 (dd, <i>J</i> = 11.8, 3.8 Hz, 1 H), 2.75 (td, <i>J</i> = 11.7, 3.5 Hz, 1 H), 1.50 (s, 9 H), 1.34 (d, <i>J</i> = 6.8 Hz, 3 H), 1.28 (d, <i>J</i> = 7.0 Hz, 6 H), 1.22 (t, <i>J</i> = 7.0 Hz, 1 H), 0.91−0.98 (m, 2 H), 0.00 (s, 9 H). MS <i>m</i>/<i>z</i> 643.6 (M + H)<sup>+</sup>.</div><div class="NLM_p last">[4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-[5-((<i>R</i>)-3-methyl-piperazin-1-yl)-pyridin-2-yl]-amine (<b>58</b>) was prepared from (<i>R</i>)-<i>tert</i>-butyl 4-(6-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridin-3-yl)-2-methylpiperazine-1-carboxylate following the procedure described for the deprotection reaction of <b>42</b> as a hydrochloride salt in quantitative yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.60 (d, <i>J</i> = 5.5 Hz, 1 H), 8.10 (dd, <i>J</i> = 9.5, 3.0 Hz, 1 H), 7.87 (d, <i>J</i> = 3.0 Hz, 1 H), 7.56 (d, <i>J</i> = 5.5 Hz, 1 H), 7.45 (d, <i>J</i> = 9.5 Hz, 1H), 3.88 (dt, <i>J</i> = 14.0,7.0 Hz, 1 H), 3.84−3.70 (m, 2 H), 3.48 (d, <i>J</i> = 4.5 Hz, 2 H), 3.26 (td, <i>J</i> = 12.3, 3.0 Hz, 1 H), 3.15−3.04 (m, 1 H), 2.86 (dd, <i>J</i> = 13.0, 10.5 Hz, 1 H), 1.34 (d, <i>J</i> = 6.5 Hz, 3 H), 1.25 (d, <i>J</i> = 7.0 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.70 min (method 5, purity 95.28%/97.72%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 413.1956, calcd 413.1969.</div></div><div id="sec5_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> [4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-[5-(3,3-dimethyl-piperazin-1-yl)-pyridin-2-yl]-amine (<b>59</b>)</h3><div class="NLM_p"><i>tert</i>-Butyl 4-(6-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridin-3-yl)-2,2-dimethylpiperazine-1-carboxylate was prepared from <b>7</b> and 4-(6-amino-pyridin-3-yl)-2,2-dimethyl-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>20</b>) following the procedure described for the coupling reaction of <b>55</b> in 42% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.46 (d, <i>J</i> = 5.2 Hz, 1 H), 8.26 (d, <i>J</i> = 9.1 Hz, 1 H), 7.84 (d, <i>J</i> = 2.8 Hz, 1 H), 7.69 (br s, 1 H), 7.13 (dd, <i>J</i> = 9.22, 2.8 Hz, 1 H), 7.03 (d, <i>J</i> = 5.2 Hz, 1 H), 5.49 (s, 2 H), 3.79 (t, <i>J</i> = 5.6 Hz, 2 H), 3.73−3.66 (m, 2 H), 3.61 (quin, <i>J</i> = 6.9 Hz, 1 H), 3.34 (t, <i>J</i> = 5.6 Hz, 2 H), 3.22 (s, 2 H), 1.56 (s, 6 H), 1.50 (s, 3 H), 1.45 (s, 6 H), 1.28 (d, <i>J</i> = 6.9 Hz, 6 H), 0.99−0.91 (m, 2 H), 0.00 (s, 9 H). MS <i>m</i>/<i>z</i> 657.4 (M + H)<sup>+</sup>.</div><div class="NLM_p last">[4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-[5-(3,3-dimethyl-piperazin-1-yl)-pyridin-2-yl]-amine (<b>59</b>) was prepared from <i>tert</i>-butyl 4-(6-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridin-3-yl)-2,2-dimethylpiperazine-1-carboxylate following the procedure described for the deprotection reaction of <b>42</b> as a hydrochloride salt in 65% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.70 (d, <i>J</i> = 5.5 Hz, 1 H), 8.18 (dd, <i>J</i> = 9.8, 2.8 Hz, 1 H), 7.96 (d, <i>J</i> = 3.0 Hz, 1 H), 7.67 (d, <i>J</i> = 5.5 Hz, 1 H), 7.55 (d, <i>J</i> = 9.5 Hz, 1 H), 3.98 (dt, <i>J</i> = 14.0,7.0 Hz, 1 H), 3.49 (br s, 4 H), 3.35 (s, 2 H), 1.54 (s, 6 H), 1.35 (d, <i>J</i> = 7.0 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.88 min (method 5, purity 100.00%/100.00%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 427.2122, calcd 427.2125.</div></div><div id="sec5_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> [4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-[5-(3,5-dimethyl-piperazin-1-yl)-pyridin-2-yl]-amine (<b>60</b>)</h3><div class="NLM_p"><i>tert</i>-Butyl 4-(6-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridin-3-yl)-2,6-dimethylpiperazine-1-carboxylate was prepared from <b>7</b> and 4-(6-amino-pyridin-3-yl)-2,6-dimethyl-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>21</b>) following the procedure described for the coupling reaction of <b>55</b> in 82% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.48 (d, <i>J</i> = 5.2 Hz, 1 H), 8.35 (d, <i>J</i> = 9.1 Hz, 1 H), 7.97 (d, <i>J</i> = 2.5 Hz, 1 H), 7.33 (dd, <i>J</i> = 9.1, 2.5 Hz, 1 H), 7.06 (d, <i>J</i> = 5.2 Hz, 1 H), 5.50 (s, 2H), 4.32−4.21 (m, 2 H), 3.74−3.65 (m, 2 H), 3.61 (dt, <i>J</i> = 13.7, 6.8 Hz, 1 H), 3.26 (d, <i>J</i> = 11.7 Hz, 2 H), 2.9 (dd, <i>J</i> = 11.6, 4.2 Hz, 2 H), 1.50 (s, 10 H), 1.39 (d, <i>J</i> = 6.8 Hz, 6 H), 1.29 (d, <i>J</i> = 7.0 Hz, 6 H), 0.99−0.91 (m, 2 H), 0.00 (s, 9 H). MS <i>m</i>/<i>z</i> 657.4 (M + H)<sup>+</sup>.</div><div class="NLM_p last">[4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-[5-(3,5-dimethyl-piperazin-1-yl)-pyridin-2-yl]-amine (<b>60</b>) was prepared from <i>tert</i>-butyl 4-(6-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridin-3-yl)-2,6-dimethylpiperazine-1-carboxylate following the procedure described for the deprotection reaction of <b>42</b> as a hydrochloride salt in quantitative yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.70 (d, <i>J</i> = 5.4 Hz, 1 H), 8.10 (d, <i>J</i> = 9.2 Hz, 1 H), 8.03 (d, <i>J</i> = 2.8 Hz, 1 H), 7.81 (d, <i>J</i> = 9.5 Hz, 1 H), 7.44 (d, <i>J</i> = 5.4 Hz, 1 H), 3.91−3.83 (m, 3 H), 3.78 (dt, <i>J</i> = 14.0, 6.9 Hz, 2 H), 3.40 (br s, 3 H), 2.88 (t, <i>J</i> = 12.1 Hz, 2 H), 1.35 (s, (d, <i>J</i> = 6.6 Hz, 6 H), 1.29 (d, <i>J</i> = 7.1 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.77 min (method 5, purity 98.58%/100.00%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 427.2109, calcd 427.2125.</div></div><div id="sec5_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> [4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-[5-((<i>S</i>)-3-methyl-piperazin-1-ylmethyl)-pyridin-2-yl]-amine (<b>61</b>)</h3><div class="NLM_p">(<i>S</i>)-<i>tert</i>-Butyl 4-((6-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridin-3-yl)methyl)-2-methylpiperazine-1-carboxylate was prepared from <b>7</b> and (<i>S</i>)-4-(6-amino-pyridin-3-ylmethyl)-2-methyl-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>24</b>) following the procedure described for the coupling reaction of <b>55</b> in 15% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.54 (d., <i>J</i> = 5.0 Hz, 1 H), 8.42 (d., <i>J</i> = 8.5 Hz, 1 H), 8.23 (s,1 H), 8.20 (br s, 1 H), 7.68 (dd, <i>J</i> = 8.5, 2.0 Hz, 1 H), 7.10 (d., <i>J</i> = 5.0 Hz, 1 H), 5.50 (s, 2 H), 4.20 (br s, 1 H), 3.82 (d, <i>J</i> = 12.0 Hz, 1 H), 3.74−3.66 (m, 2 H), 3.66−3.57 (m, 1 H), 3.54−3.46 (m, 1H), 3.41−3.33 (m, 1 H), 3.10 (td, <i>J</i> = 12.5, 3.0 Hz, 1 H), 2.78 (d., <i>J</i> = 11.0 Hz, 1 H), 2.59 (d, <i>J</i> = 11.5 Hz, 1 H), 2.14 (dd, <i>J</i> = 11.3, 3.8 Hz, 1 H), 2.08−1.97 (m, 1 H), 1.46 (s, 9 H), 1.28 (d, <i>J</i> = 6.5 Hz, 6 H), 1.22 (d, <i>J</i> = 6.5 Hz, 3 H), 0.99−0.91 (m, 2 H), 0.00 (s, 9 H). MS <i>m</i>/<i>z</i> 657.3 (M + H)<sup>+</sup>.</div><div class="NLM_p last">[4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-[5-((<i>S</i>)-3-methyl-piperazin-1-ylmethyl)-pyridin-2-yl]-amine (<b>61</b>) was prepared from (<i>S</i>)-<i>tert</i>-butyl 4-((6-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridin-3-yl)methyl)-2-methylpiperazine-1-carboxylate following the procedure described for the deprotection reaction of <b>42</b> as a hydrochloride salt in 81% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.63 (d, <i>J</i> = 6.0 Hz, 1 H), 8.55 (s, 1 H), 8.35 (dd, <i>J</i> = 9.0, 2.0 Hz, 1 H), 7.69 (d, <i>J</i> = 6.0 Hz, 1 H), 7.50 (d, <i>J</i> = 9.0 Hz, 1 H), 4.35 (br s, 2 H), 3.93 (dt, <i>J</i> = 14.0, 7.0 Hz, 1 H), 3.71 (br s, 1 H), 3.28 (br s, 1 H), 3.07 (br s, 1 H), 1.31 (d, <i>J</i> = 7.0 Hz, 3 H), 1.26 (d, <i>J</i> = 7.0 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.84 min (method 5, purity 81.28%/94.42%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 427.2135, calcd 427.2125.</div></div><div id="sec5_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> [4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-[5-((<i>R</i>)-3-methyl-piperazin-1-ylmethyl)-pyridin-2-yl]-amine (<b>62</b>)</h3><div class="NLM_p">(<i>R</i>)-<i>tert</i>-Butyl 4-((6-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridin-3-yl)methyl)-2-methylpiperazine-1-carboxylate was prepared from <b>7</b> and (<i>R</i>)-4-(6-Amino-pyridin-3-ylmethyl)-2-methyl-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>25</b>) following the procedure described for the coupling reaction of <b>55</b> in 32% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.52 (d, <i>J</i> = 5.0 Hz, 1 H), 8.42 (d, <i>J</i> = 8.6 Hz, 1 H), 8.22 (d, <i>J</i> = 1.5 Hz, 1 H), 7.97 (br s, 1 H), 7.70 (br s, 1 H), 7.11 (d., <i>J</i> = 5.0 Hz, 1 H), 5.50 (d, <i>J</i> = 8.6 Hz, 1 H), 4.21 (br s, 1 H), 3.83 (d, <i>J</i> = 12.1 Hz, 1 H), 3.75−3.57 (m, 3 H), 3.52 (d, <i>J</i> = 11.1 Hz, 1 H), 3.38 (d, <i>J</i> = 14.1 Hz, 1 H), 3.12 (br s, 1 H), 2.79 (br s, 1 H), 2.78 (d, <i>J</i> = 11.0 Hz, 1 H), 2.61 (d, <i>J</i> = 10.6 Hz, 1 H), 2.16 (br s, 1 H), 2.05 (br s, 1 H), 1.46 (s, 9 H), 1.29 (d, <i>J</i> = 7.1 Hz, 6 H), 1.24 (d, <i>J</i> = 6.6 Hz, 3 H), 0.99−0.91 (m, 2 H), 0.00 (s, 9 H). MS <i>m</i>/<i>z</i> 657.6 (M + H)<sup>+</sup>.</div><div class="NLM_p last">[4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-[5-((<i>R</i>)-3-methyl-piperazin-1-ylmethyl)-pyridin-2-yl]-amine (<b>62</b>) was prepared from (<i>R</i>)-<i>tert</i>-butyl 4-((6-(4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)pyrimidin-2-ylamino)pyridin-3-yl)methyl)-2-methylpiperazine-1-carboxylate following the procedure described for the deprotection reaction of <b>42</b> as a hydrochloride salt in quantitative yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.63 (d, <i>J</i> = 5.5 Hz, 1 H), 8.53 (br s, 1 H), 8.34 (d, <i>J</i> = 9.0 Hz, 1 H), 7.69 (d, <i>J</i> = 6.0 Hz, 1 H), 7.50 (d, <i>J</i> = 9.0 Hz, 1 H), 4.29 (br s, 3 H), 3.93 (m, 1 H), 3.68 (br s, 1 H), 3.30−3.51 (m, 3 H), 3.02 (br s, 1 H), 1.30 (d, <i>J</i> = 6.5 Hz, 3 H), 1.26 (d, <i>J</i> = 7.0 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.85 min (method 5, purity 89.92%/100.00%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 427.2120, calcd 427.2125.</div></div><div id="sec5_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-<i>N</i>-(5-(4-(dimethylamino)piperidin-1-yl)pyridin-2-yl)pyrimidin-2-amine (<b>63</b>)</h3><div class="NLM_p">4-(5-Chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)-<i>N</i>-(5-(4-(dimethylamino)piperidin-1-yl)pyridin-2-yl)pyrimidin-2-amine was prepared from <b>7</b> and <i>N</i>*4*,<i>N</i>*4*-dimethyl-3,4,5,6-tetrahydro-2<i>H</i>-[1,3′]bipyridinyl-4,6′-diamine (<b>22</b>) following the procedure described for the coupling reaction of <b>55</b> in 25% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.50 (d, <i>J</i> = 5.0 Hz, 1 H), 8.30 (d, <i>J</i> = 9.0 Hz, 1 H), 8.14 (s, 1 H), 8.04 (d, <i>J</i> = 3.0 Hz, 1 H), 7.33 (dd, <i>J</i> = 9.0, 3.0 Hz, 1 H), 7.04 (d, <i>J</i> = 5.0 Hz, 1H), 5.50 (s, 2 H), 3.76−3.55 (m, 5 H), 3.17 (br s, 1 H), 2.74 (td, <i>J</i> = 12.0, 2.0 Hz, 2 H), 2.37 (s, 6 H), 1.99 (d, <i>J</i> = 12.5 Hz, 2 H), 1.78−1.63 (m, 2 H), 1.28 (d, <i>J</i> = 6.5 Hz, 6 H), 0.99−0.90 (m, 2 H), 0.00 (s, 9 H). MS <i>m</i>/<i>z</i> 571.3 (M + H)<sup>+</sup>.</div><div class="NLM_p last">4-(5-Chloro-3-isopropyl-1<i>H</i>-pyrazol-4-yl)-<i>N</i>-(5-(4-(dimethylamino)piperidin-1-yl)pyridin-2-yl)pyrimidin-2-amine (<b>63</b>) was prepared from 4-(5-chloro-3-isopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-yl)-<i>N</i>-(5-(4-(dimethylamino)piperidin-1-yl)pyridin-2-yl)pyrimidin-2-amine following the procedure described for the deprotection reaction of <b>42</b> as a hydrochloride salt in 71.8% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.68 (d, <i>J</i> = 5.7 Hz, 1 H), 8.17 (dd, <i>J</i> = 9.7, 3.0 Hz, 1 H), 7.90 (d, <i>J</i> = 2.8 Hz, 1 H), 7.63 (d, <i>J</i> = 5.7 Hz, 1 H), 7.51 (d, <i>J</i> = 9.7 Hz, 1 H), 3.84−4.05 (m, 3 H), 3.53−3.36 (m, 1 H), 2.98−2.95 (m, 2 H), 2.91 (s, 7 H), 2.25 (d, <i>J</i> = 13.0 Hz, 2 H), 1.91 (m, 2 H), 1.34 (d, <i>J</i> = 7.0 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.84 min (method 5, purity 100.00%/100.00%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 441.2282, calcd 441.2282.</div></div><div id="sec5_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> <i>N</i>*6′*-[4-(5-Isopropyl-3-trifluoromethyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-<i>N</i>*4*,<i>N</i>*4*-dimethyl-3,4,5,6-tetrahydro-2<i>H</i>-[1,3′]bipyridinyl-4,6′-diamine (<b>64</b>)</h3><div class="NLM_p">4-[2-(4-Dimethylamino-3,4,5,6-tetrahydro-<i>2H</i>-[1,3′]bipyridinyl-6′-ylamino)-pyrimidin-4-yl]-5-isopropyl-3-trifluoromethyl-pyrazole-1-sulfonic acid dimethylamide was prepared from 4-(2-chloro-pyrimidin-4-yl)-5-isopropyl-3-trifluoromethyl-pyrazole-1-sulfonic acid dimethylamide (<b>14</b>) and <i>N</i>*4*,<i>N</i>*4*-dimethyl-3,4,5,6-tetrahydro-2<i>H</i>-[1,3′]bipyridinyl-4,6′-diamine (<b>22</b>) following the procedure described for the coupling reaction of <b>55</b> in 56% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.75 (s, 1 H), 8.58 (d, <i>J</i> = 5.0 Hz, 1 H), 8.00 (d, <i>J</i> = 3.0 Hz, 1 H), 7.96, (d, <i>J</i> = 9.0 Hz, 1 H), 7.40 (dd, <i>J</i> = 9.0, 3.0 Hz, 1 H), 6.97 (d, <i>J</i> = 5.0 Hz, 1 H), 3.71−3.57 (m, 3 H), 3.14 (s, 6 H), 2.74−2.56 (m, 2 H), 2.18 (s, 6 H), 1.82 (d, <i>J</i> = 12 Hz, 2 H), 1.45 (m, 2 H), 1.18 (d, <i>J</i> = 7.0 Hz, 6 H). MS <i>m</i>/<i>z</i> 582.4 (M + H)<sup>+</sup>.</div><div class="NLM_p last">To a suspension of 4-[2-(4-dimethylamino-3,4,5,6-tetrahydro-2<i>H</i>-[1,3′]bipyridinyl-6′-ylamino)-pyrimidin-4-yl]-5-isopropyl-3-trifluoromethyl-pyrazole-1-sulfonic acid dimethylamide (140 mg, 0.241 mmol) in MeOH (12 mL) was added a few drops of 37% HCl and the resulting solution was stirred at 40 °C for 16 h. The reaction mixture was concentrated and dissolved in MeOH (2 mL). The solution was filtered through PL-HCO<sub>3</sub> MP-Resin (StratoSpheres SPE, <a href="http://www.polymerlabs.com" class="extLink">www.polymerlabs.com</a>) and concentrated to give <i>N</i>*6′*-[4-(5-Isopropyl-3-trifluoromethyl-1<i>H</i>-pyrazol-4-yl)-pyrimidin-2-yl]-<i>N</i>*4*,<i>N</i>*4*-dimethyl-3,4,5,6-tetrahydro-2<i>H</i>-[1,3′]bipyridinyl-4,6′-diamine (<b>64</b>, 84.7 mg) in 74% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.75 (br s, 1 H), 9.52 (s, 1 H), 8.51 (d, <i>J</i> = 5.0 Hz, 1 H), 8.16−7.92 (m, 2 H), 7.37 (dd, <i>J</i> = 9.3, 2.8 Hz, 1 H), 6.84 (d, <i>J</i> = 5.0 Hz, 1 H), 3.63 (d, <i>J</i> = 12 Hz, 2 H), 3.41 (m, 1 H), 2.63 (t, <i>J</i> = 11 Hz, 2 H), 2.19 (s, 6 H), 1.83 (d, <i>J</i> = 12 Hz, 2 H), 1.48 (m, 2 H), 1.24 (d, <i>J</i> = 7.0 Hz, 6 H). Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.91 min (method 1, purity 100.00%/100.00%). HR-MS <i>m</i>/<i>z</i> (M + H)<sup>+</sup>: measured 475.2543, calcd 475.2546.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43537" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43537" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Young Shin Cho</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d9a0b6acb7beaab1b0b7f7bab1b699b7b6afb8abadb0aaf9b4b6b6b3bcf7aaacb7be99b7b6afb8abadb0aa"><span class="__cf_email__" data-cfemail="b3cadcc6ddd4c0dbdadd9dd0dbdcf3dddcc5d2c1c7dac0">[email protected]</span> <span class="__cf_email__" data-cfemail="9af7f5f5f0ffb4e9eff4fddaf4f5ecfbe8eef3e9">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Moo Je Sung</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6d140218030a1e050403430e05022d03021b0c1f19041e4d0002020708431e18030a2d03021b0c1f19041e"><span class="__cf_email__" data-cfemail="d6afb9a3b8b1a5bebfb8f8b5beb996b8b9a0b7a4a2bfa5">[email protected]</span> <span class="__cf_email__" data-cfemail="1f727070757a316c6a71785f7170697e6d6b766c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Borland</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Brain</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine H.-T. Chen</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Cheng</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajiv Chopra</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristy Chung</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Groarke</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guo He</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying Hou</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sunkyu Kim</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Kovats</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yipin Lu</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc O’Reilly</span> - <span class="hlFld-Affiliation affiliation">Astex Therapeutics, 436 Cambridge Science Park, Milton Road, Cambridge, CB4 0QA, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Junqing Shen</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Troy Smith</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Trakshel</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Vögtle</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mei Xu</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ming Xu</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm100571n" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88736" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88736" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Karen Miller-Moslin for helpful suggestions in the preparation of the manuscript.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14634" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14634" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 29 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ortega, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cyclin D-dependent kinases, INK4 inhibitors and cancer</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1602</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1016%2FS0304-419X%2802%2900037-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=11960696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD38XktVKgu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1602&publication_year=2002&pages=73-87&author=S.+Ortegaauthor=M.+Malumbresauthor=M.+Barbacid&title=Cyclin+D-dependent+kinases%2C+INK4+inhibitors+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin D-dependent kinases, INK4 inhibitors and cancer</span></div><div class="casAuthors">Ortega, Sagrario; Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1602</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-87</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Cyclin D-Cdk4,6/INK4/Rb/E2F pathway plays a key role in controlling cell growth by integrating multiple mitogenic and antimitogenic stimuli.  The components of this pathway are gene families with a high level of structural and functional redundancy and are expressed in an overlapping fashion in most tissues and cell types.  Using classical transgenic technol. as well as gene-targeting in ES cells, a series of mouse models have been developed to study the in vivo function of individual components of this pathway in both normal homeostasis and tumor development.  These models have proven to be useful to define specific as well as redundant roles among members of these cell cycle regulatory gene families.  This pathway is deregulated in the vast majority of human tumors by genetic and epigenetic alterations that target at least some of its key members such as Cyclin D1, Cdk4, INK4a and INK4b, pRb etc.  As a consequence, some of these mols. are currently being considered as targets for cancer therapy, and several novel mols., such as Cdk inhibitors, are under development as potential anti-cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpizIeKkGlMJLVg90H21EOLACvtfcHk0lhrZVTgmJ8WOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktVKgu7o%253D&md5=8f5ab2839d58abcb3a7df53269af2913</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FS0304-419X%2802%2900037-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-419X%252802%252900037-9%26sid%3Dliteratum%253Aachs%26aulast%3DOrtega%26aufirst%3DS.%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCyclin%2520D-dependent%2520kinases%252C%2520INK4%2520inhibitors%2520and%2520cancer%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2002%26volume%3D1602%26spage%3D73%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sherr, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. M.</span><span> </span><span class="NLM_article-title">CDK inhibitors: positive and negative regulators of G1-phase progression</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1501</span><span class="NLM_x">–</span> <span class="NLM_lpage">1512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1101%2Fgad.13.12.1501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=10385618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADyaK1MXktlOhsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=1501-1512&author=C.+J.+Sherrauthor=J.+M.+Roberts&title=CDK+inhibitors%3A+positive+and+negative+regulators+of+G1-phase+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">CDK inhibitors: positive and negative regulators of G1-phase progression</span></div><div class="casAuthors">Sherr, Charles J.; Roberts, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1501-1512</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review with over 100 refs.  Topics include: collaboration between cyclin D- and E-dependent kinases during G1 phase, catalytically active cyclin D-dependent holoenzymes contain Cip/Kip subunits, cyclinD-CDK assembly requires CKIs, INK4 proteins depend on Cip/Kip proteins to induce G1-phase arrest, is cyclin D-dependent kinase activity essential for cell cycle, and role for Cip/Kip proteins in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwaa1ctpF0IrVg90H21EOLACvtfcHk0ljQOzQlEZv4rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktlOhsLs%253D&md5=ea4e91c8d0e79a17148b4abec162c8cb</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1101%2Fgad.13.12.1501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.13.12.1501%26sid%3Dliteratum%253Aachs%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26atitle%3DCDK%2520inhibitors%253A%2520positive%2520and%2520negative%2520regulators%2520of%2520G1-phase%2520progression%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26spage%3D1501%26epage%3D1512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Benson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bono, J.</span><span> </span><span class="NLM_article-title">Clinical anticancer drug development: targeting the cyclin-dependent kinases</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1038%2Fsj.bjc.6602229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=15558073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2qu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2005&pages=7-12&author=C.+Bensonauthor=S.+Kayeauthor=P.+Workmanauthor=M.+Garrettauthor=M.+Waltonauthor=J.+de+Bono&title=Clinical+anticancer+drug+development%3A+targeting+the+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical anticancer drug development: targeting the cyclin-dependent kinases</span></div><div class="casAuthors">Benson, C.; Kaye, S.; Workman, P.; Garrett, M.; Walton, M.; de Bono, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-12</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cell division involves a cyclical biochem. process composed of several step-wise reactions that have to occur once per cell cycle.  Dysregulation of cell division is a hallmark of all cancers.  Genetic and epigenetic mechanisms frequently result in deranged expression and/or activity of cell-cycle proteins including the cyclins, cyclin-dependent kinases (Cdks), Cdk inhibitors and checkpoint control proteins.  The crit. nature of these proteins in cell cycling raises hope that targeting them may result in selective cytotoxicity and valuable anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQY1tBrrikrVg90H21EOLACvtfcHk0ljQOzQlEZv4rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2qu7k%253D&md5=82191c598697434e2f8f80a5171f99dc</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6602229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6602229%26sid%3Dliteratum%253Aachs%26aulast%3DBenson%26aufirst%3DC.%26aulast%3DKaye%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DGarrett%26aufirst%3DM.%26aulast%3DWalton%26aufirst%3DM.%26aulast%3Dde%2BBono%26aufirst%3DJ.%26atitle%3DClinical%2520anticancer%2520drug%2520development%253A%2520targeting%2520the%2520cyclin-dependent%2520kinases%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2005%26volume%3D92%26spage%3D7%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Blagosklonny, M. V.</span><span> </span><span class="NLM_article-title">Flavopiridol, an inhibitor of transcription: implications, problems and solutions</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1537</span><span class="NLM_x">–</span> <span class="NLM_lpage">1542</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1537-1542&author=M.+V.+Blagosklonny&title=Flavopiridol%2C+an+inhibitor+of+transcription%3A+implications%2C+problems+and+solutions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlagosklonny%26aufirst%3DM.%2BV.%26atitle%3DFlavopiridol%252C%2520an%2520inhibitor%2520of%2520transcription%253A%2520implications%252C%2520problems%2520and%2520solutions%26jtitle%3DCell%2520Cycle%26date%3D2004%26volume%3D3%26spage%3D1537%26epage%3D1542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Deshpande, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinds, P. W.</span><span> </span><span class="NLM_article-title">Cyclins and cdks in development and cancer: a perspective</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2909</span><span class="NLM_x">–</span> <span class="NLM_lpage">2915</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=2909-2915&author=A.+Deshpandeauthor=P.+Sicinskiauthor=P.+W.+Hinds&title=Cyclins+and+cdks+in+development+and+cancer%3A+a+perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeshpande%26aufirst%3DA.%26aulast%3DSicinski%26aufirst%3DP.%26aulast%3DHinds%26aufirst%3DP.%2BW.%26atitle%3DCyclins%2520and%2520cdks%2520in%2520development%2520and%2520cancer%253A%2520a%2520perspective%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D2909%26epage%3D2915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span> </span><span class="NLM_article-title">Recent advances in the development of selective small molecule inhibitors for cyclin-dependent kinases</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.2174%2F1568026053507688" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=15853645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFyksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=167-179&author=H.+Hiraiauthor=N.+Kawanishiauthor=Y.+Iwasawa&title=Recent+advances+in+the+development+of+selective+small+molecule+inhibitors+for+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of selective small molecule inhibitors for Cyclin-dependent kinases</span></div><div class="casAuthors">Hirai, Hiroshi; Kawanishi, Nobuhiko; Iwasawa, Yoshikazu</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-179</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Loss of normal cell cycle regulation is the hallmark of human cancers, and alteration of the components involved in cell cycle regulation occurs in most human tumors.  This suggests that Cyclin dependent kinases (CDKs) are an attractive target for the development of pharmacol. agents for the treatment of cancer.  Recently, CDK family members that are not directly involved in cell cycle regulation were identified.  This includes CDK7, CDK8, and CDK9, which participate in transcription regulation, and CDK5, which plays a role in neuronal and secretory functions.  Given the involvement of CDKs in multiple cellular processes, development of selective small mol. inhibitors for specific CDKs is expected to help clarify whether improved specificity of cell cycle CDK inhibitors will enhance their therapeutic potential in cancer treatment.  Selective inhibitors are also needed as tools to explore the biol. of diseases in which CDKs may participate and to help develop therapeutics to treat them.  Intensive screening and drug design based on CDK/inhibitor co-crystal structure and SAR studies have led to the identification of a large variety of chem. inhibitors of CDKs.  Although they are competitive with ATP at the catalytic site, their kinase selectivity varies greatly, and inhibitors selective for certain CDKs have begun to be identified.  There are currently 2 categories of selective CDK inhibitors: those that are selective for CDK2 and CDK1 and those that are selective for CDK4/6.  These 2 types of inhibitors have different effects on tumor cells and are expected to be useful in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooiAF6UAza_7Vg90H21EOLACvtfcHk0ljQOzQlEZv4rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFyksbw%253D&md5=2fceab02ebbaaca45061a80884571ef7</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.2174%2F1568026053507688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053507688%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DKawanishi%26aufirst%3DN.%26aulast%3DIwasawa%26aufirst%3DY.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520selective%2520small%2520molecule%2520inhibitors%2520for%2520cyclin-dependent%2520kinases%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D167%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kamb, A.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase inhibitors and human cancer</span> <span class="citation_source-journal">Curr. Top. Microbiol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">227</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=1998&pages=139-148&author=A.+Kamb&title=Cyclin-dependent+kinase+inhibitors+and+human+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKamb%26aufirst%3DA.%26atitle%3DCyclin-dependent%2520kinase%2520inhibitors%2520and%2520human%2520cancer%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D1998%26volume%3D227%26spage%3D139%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Malumbres, M.</span><span> </span><span class="NLM_article-title">Revisiting the “Cdk-centric” view of the mammalian cell cycle</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">206</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=206-210&author=M.+Malumbres&title=Revisiting+the+%E2%80%9CCdk-centric%E2%80%9D+view+of+the+mammalian+cell+cycle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26atitle%3DRevisiting%2520the%2520%25E2%2580%259CCdk-centric%25E2%2580%259D%2520view%2520of%2520the%2520mammalian%2520cell%2520cycle%26jtitle%3DCell%2520Cycle%26date%3D2005%26volume%3D4%26spage%3D206%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Murray, A. W.; Hunt, T.</span> <span class="citation_source-book">The Cell Cycle</span><span> </span><span class="NLM_article-title"></span>; <span class="NLM_publisher-name">Oxford Univeristy Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1993</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&author=A.+W.+Murray&author=T.+Hunt&title=The+Cell+Cycle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DA.%2BW.%26btitle%3DThe%2520Cell%2520Cycle%26pub%3DOxford%2520Univeristy%2520Press%26date%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaharevitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gussio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louarn-Leost, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunick, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahusen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headlee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbuck, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senderowicz, A.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinases: initial approaches to exploit a novel therapeutic target</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2h&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1016%2FS0163-7258%2898%2900062-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2h&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=10454206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2h&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFOhtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1999&pages=285-292&author=E.+A.+Sausvilleauthor=D.+Zaharevitzauthor=R.+Gussioauthor=L.+Meijerauthor=M.+Louarn-Leostauthor=C.+Kunickauthor=R.+Schultzauthor=T.+Lahusenauthor=D.+Headleeauthor=S.+Stinsonauthor=S.+G.+Arbuckauthor=A.+Senderowicz&title=Cyclin-dependent+kinases%3A+initial+approaches+to+exploit+a+novel+therapeutic+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2hR"><div class="casContent"><span class="casTitleNuber">2h</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinases: initial approaches to exploit a novel therapeutic target</span></div><div class="casAuthors">Sausville, Edward A.; Zaharevitz, Daniel; Gussio, Robert; Meijer, Laurent; Louarn-Leost, Maryse; Kunick, Conrad; Schultz, Robert; Lahusen, Tyler; Headlee, Donna; Stinson, Sherman; Arbuck, Susan G.; Senderowicz, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">285-292</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (CDKs) have been recognized as key regulators of cell cycle progression.  Alteration and deregulation of CDK activity are pathogenic hallmarks of neoplasia.  Therefore, inhibitors or modulators would be of interest to explore as novel therapeutic agents in cancer, as well as other hyperproliferative disorders.  Flavopiridol is a semisynthetic flavonoid that emerged from an empirical screening program as a potent antiproliferative agent that mechanistic studies demonstrated to directly inhibit CDKs 1, 2, and 4 as a competitive ATP site antagonist.  Initial clin. trials have shown that concns. that inhibit cell proliferation and CDK activity in vitro can be safely achieved in humans, and addnl. clin. trials will establish its clin. potential.  To address the need for addnl. chemotypes that may serve as lead structures for drugs that would not have the toxicities assocd. with flavopiridol, compds. with a similar pattern of cell growth inhibitory activity in the National Cancer Institute's in vitro anticancer drug screen have been recognized by the computer-assisted pattern recognition algorithm COMPARE and then screened for anti-CDK activity in a biochem. screen.  The benzodiazepine deriv. NSC 664704 (7,12-dihydro-indolo[3,2-d][1]benzazepin-6(5H)-one) was revealed by that approach as a moderately potent (IC50 0.4 μM) inhibitor of CDK2, which in initial expts. shows evidence of causing cell cycle redistribution in living cells.  NSC 664704 is, therefore, a candidate for further structural optimization, guided in part by understanding of the ATP-binding site in CDK2.  This approach represents one way of combining empirical screening information with structure-based design to derive novel candidate therapeutic agents directed against an important cellular target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlhbRCp8hA6rVg90H21EOLACvtfcHk0lgmvpeczcT3aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFOhtLk%253D&md5=de21027b523d6fad892d4afd19fa6514</span></div><a href="/servlet/linkout?suffix=cit2h&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2898%2900062-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252898%252900062-X%26sid%3Dliteratum%253Aachs%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DZaharevitz%26aufirst%3DD.%26aulast%3DGussio%26aufirst%3DR.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DLouarn-Leost%26aufirst%3DM.%26aulast%3DKunick%26aufirst%3DC.%26aulast%3DSchultz%26aufirst%3DR.%26aulast%3DLahusen%26aufirst%3DT.%26aulast%3DHeadlee%26aufirst%3DD.%26aulast%3DStinson%26aufirst%3DS.%26aulast%3DArbuck%26aufirst%3DS.%2BG.%26aulast%3DSenderowicz%26aufirst%3DA.%26atitle%3DCyclin-dependent%2520kinases%253A%2520initial%2520approaches%2520to%2520exploit%2520a%2520novel%2520therapeutic%2520target%26jtitle%3DPharmacol.%2520Ther.%26date%3D1999%26volume%3D82%26spage%3D285%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ely, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Liberto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niesvizky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baughn, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatada, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knowles, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen-Kiang, S.</span><span> </span><span class="NLM_article-title">Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">11345</span><span class="NLM_x">–</span> <span class="NLM_lpage">11353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=11345-11353&author=S.+Elyauthor=M.+Di+Libertoauthor=R.+Niesvizkyauthor=L.+B.+Baughnauthor=H.+J.+Choauthor=E.+N.+Hatadaauthor=D.+M.+Knowlesauthor=J.+Laneauthor=S.+Chen-Kiang&title=Mutually+exclusive+cyclin-dependent+kinase+4%2Fcyclin+D1+and+cyclin-dependent+kinase+6%2Fcyclin+D2+pairing+inactivates+retinoblastoma+protein+and+promotes+cell+cycle+dysregulation+in+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEly%26aufirst%3DS.%26aulast%3DDi%2BLiberto%26aufirst%3DM.%26aulast%3DNiesvizky%26aufirst%3DR.%26aulast%3DBaughn%26aufirst%3DL.%2BB.%26aulast%3DCho%26aufirst%3DH.%2BJ.%26aulast%3DHatada%26aufirst%3DE.%2BN.%26aulast%3DKnowles%26aufirst%3DD.%2BM.%26aulast%3DLane%26aufirst%3DJ.%26aulast%3DChen-Kiang%26aufirst%3DS.%26atitle%3DMutually%2520exclusive%2520cyclin-dependent%2520kinase%25204%252Fcyclin%2520D1%2520and%2520cyclin-dependent%2520kinase%25206%252Fcyclin%2520D2%2520pairing%2520inactivates%2520retinoblastoma%2520protein%2520and%2520promotes%2520cell%2520cycle%2520dysregulation%2520in%2520multiple%2520myeloma%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D11345%26epage%3D11353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kitagawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">SuzukiTakahashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taya, Y.</span><span> </span><span class="NLM_article-title">The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">7060</span><span class="NLM_x">–</span> <span class="NLM_lpage">7069</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1002%2Fj.1460-2075.1996.tb01097.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=9003781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADyaK2sXosFKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1996&pages=7060-7069&author=M.+Kitagawaauthor=H.+Higashiauthor=H.+K.+Jungauthor=I.+SuzukiTakahashiauthor=M.+Ikedaauthor=K.+Tamaiauthor=J.+Katoauthor=K.+Segawaauthor=E.+Yoshidaauthor=S.+Nishimuraauthor=Y.+Taya&title=The+consensus+motif+for+phosphorylation+by+cyclin+D1-Cdk4+is+different+from+that+for+phosphorylation+by+cyclin+A%2FE-Cdk2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2</span></div><div class="casAuthors">Kitagawa, Masatoshi; Higashi, Hideaki; Jung, Hai-Kwan; Suzuki-Takahashi, Ikuko; Ikeda, Masako; Tamai, Katsuyuki; Kato, Jun-ya; Segawa, Kaoru; Yoshida, Eisaku; Nishimura, Susumu; Taya, Yoichi</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7060-7069</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Cyclin D-Cdk4/6 and cyclin A/E-Cdk2 are suggested to be involved in phosphorylation of the retinoblastoma protein (pRB) during the G1/S transition of the cell cycle.  However, it is unclear why several Cdks are needed and how they are different from one another.  We found that the consensus amino acid sequence for phosphorylation by cyclin D1-Cdk4 is different from S/T-P-X-K/R, which is the consensus sequence for phosphorylation by cyclin A/E-Cdk2 using various synthetic peptides as substrates.  Cyclin D1-Cdk4 efficiently phosphorylated the G1 peptide, RPPTLS780PIPhipr that contained a part of the sequence of pRB, while cyclins E-Cdk2 and A-Cdk2 did not.  To det. the phosphorylation state of pRB in vitro and in vivo, we raised the specific antibody against phospho-Ser780 in pRB.  We confirmed that cyclin D1-Cdk4, but not cyclin E-Cdk2, phosphorylated Ser780 in recombinant pRB.  The Ser780 in pRB was phosphorylated in the G1 phase in a cell cycle-dependent manner.  Furthermore, we found that pRB phosphorylated at Ser780 cannot bind to E2F-1 in vivo.  Our data show that cyclin D1-Cdk4 and cyclin A/E Cdk2 phosphorylate different sites of pRB in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogbhxXMzHcPrVg90H21EOLACvtfcHk0lh5-PKUGESDbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXosFKlsQ%253D%253D&md5=a0bb66af6ded3baa26d56771f0fd5d67</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1002%2Fj.1460-2075.1996.tb01097.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fj.1460-2075.1996.tb01097.x%26sid%3Dliteratum%253Aachs%26aulast%3DKitagawa%26aufirst%3DM.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DJung%26aufirst%3DH.%2BK.%26aulast%3DSuzukiTakahashi%26aufirst%3DI.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DTamai%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DJ.%26aulast%3DSegawa%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DE.%26aulast%3DNishimura%26aufirst%3DS.%26aulast%3DTaya%26aufirst%3DY.%26atitle%3DThe%2520consensus%2520motif%2520for%2520phosphorylation%2520by%2520cyclin%2520D1-Cdk4%2520is%2520different%2520from%2520that%2520for%2520phosphorylation%2520by%2520cyclin%2520A%252FE-Cdk2%26jtitle%3DEMBO%2520J.%26date%3D1996%26volume%3D15%26spage%3D7060%26epage%3D7069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Amin, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medeiros, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassidakis, G. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leventaki, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, R.</span><span> </span><span class="NLM_article-title">Characterization of 4 mantle cell lymphoma cell lines: Establishment of an in vitro study model</span> <span class="citation_source-journal">Arch. Pathol. Lab. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">424</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=12683869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A280%3ADC%252BD3s7ms1Cjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2003&pages=424-431&author=H.+M.+Aminauthor=T.+J.+McDonnellauthor=L.+J.+Medeirosauthor=G.+Z.+Rassidakisauthor=V.+Leventakiauthor=S.+L.+O%E2%80%99Connorauthor=M.+J.+Keatingauthor=R.+Lai&title=Characterization+of+4+mantle+cell+lymphoma+cell+lines%3A+Establishment+of+an+in+vitro+study+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of 4 mantle cell lymphoma cell lines</span></div><div class="casAuthors">Amin Hesham M; McDonnell Timothy J; Medeiros L Jeffrey; Rassidakis Georgios Z; Leventaki Vasiliki; O'Connor Sean L; Keating Michael J; Lai Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Archives of pathology & laboratory medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">424-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">CONTEXT:  Mantle cell lymphoma (MCL) is a distinct type of B-cell non-Hodgkin lymphoma characterized by t(11;14)(q13;q32) and cyclin D1 overexpression.  The pathogenesis of MCL has not been comprehensively studied, which can be attributed in part to the paucity of well-characterized MCL cell lines.  OBJECTIVES:  We collected 4 previously developed MCL cell lines and performed extensive characterization, including the susceptibly of these cell lines to transduction by adenovirus vectors.  Our aim was to facilitate the establishment of an in vitro model that can be reliably used to study the pathogenesis of MCL.  METHODS:  Standard techniques were used to compare the morphologic, immunophenotypic, and cytogenetic features of the 4 cell lines.  In addition, Western blotting was used to investigate the presence of several cell cycle- and apoptosis-related proteins.  TP53 DNA sequencing was also performed on the cell lines.  The adenoviral transduction efficiency was assessed using an adenoviral vector carrying the gene encoding for the green fluorescence protein (Ad-GFP).  RESULTS:  All cell lines demonstrated evidence of t(11;14)(q13;q32) and overexpression of cyclin D1.  Cyclin D2 was not detectable in all cell lines, whereas cyclin D3 was weakly expressed in JeKo-1 and SP-53.  Other abnormalities of the cell cycle G1 phase regulatory pathway were detected, including loss of expression of p53 (JeKo-1) and p16(INK4a) (SP-53 and Granta 519), as well as TP53 mutation (Mino).  All cell lines express high levels of cyclin E, c-Myc, Bcl-2, Bax, Bcl-x(L), and Mcl-1.  Retinoblastoma protein is hyperphosphorylated in all cell lines.  With the exception of Mino, MCL cell lines are highly transducible with adenoviral vectors.  CONCLUSION:  These cell lines are representative of MCL and can be used as an in vitro model to further explore the pathogenesis of this disease.  The susceptibility of these cell lines to gene transfer provides opportunities to evaluate the importance of various oncogenes and tumor suppressor genes that may have an impact on developing effective therapeutic regimens for MCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRZqla8AANb9RBrI9DTGjC0fW6udTcc2eb3WR2ORKIJBbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7ms1Cjsg%253D%253D&md5=2f8cea1c7a9eaca2e40dbbd4f9e2be62</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmin%26aufirst%3DH.%2BM.%26aulast%3DMcDonnell%26aufirst%3DT.%2BJ.%26aulast%3DMedeiros%26aufirst%3DL.%2BJ.%26aulast%3DRassidakis%26aufirst%3DG.%2BZ.%26aulast%3DLeventaki%26aufirst%3DV.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DS.%2BL.%26aulast%3DKeating%26aufirst%3DM.%2BJ.%26aulast%3DLai%26aufirst%3DR.%26atitle%3DCharacterization%2520of%25204%2520mantle%2520cell%2520lymphoma%2520cell%2520lines%253A%2520Establishment%2520of%2520an%2520in%2520vitro%2520study%2520model%26jtitle%3DArch.%2520Pathol.%2520Lab.%2520Med.%26date%3D2003%26volume%3D127%26spage%3D424%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bergsagel, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehl, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlogie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaughnessy, J.</span><span> </span><span class="NLM_article-title">Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">296</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=296-303&author=P.+L.+Bergsagelauthor=W.+M.+Kuehlauthor=F.+H.+Zhanauthor=J.+Sawyerauthor=B.+Barlogieauthor=J.+Shaughnessy&title=Cyclin+D+dysregulation%3A+an+early+and+unifying+pathogenic+event+in+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26aulast%3DKuehl%26aufirst%3DW.%2BM.%26aulast%3DZhan%26aufirst%3DF.%2BH.%26aulast%3DSawyer%26aufirst%3DJ.%26aulast%3DBarlogie%26aufirst%3DB.%26aulast%3DShaughnessy%26aufirst%3DJ.%26atitle%3DCyclin%2520D%2520dysregulation%253A%2520an%2520early%2520and%2520unifying%2520pathogenic%2520event%2520in%2520multiple%2520myeloma%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D296%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bergsagel, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehl, W. M.</span><span> </span><span class="NLM_article-title">Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">194</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1034%2Fj.1600-065X.2003.00052.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=12846810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsV2ms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2003&pages=96-104&author=P.+L.+Bergsagelauthor=W.+M.+Kuehl&title=Critical+roles+for+immunoglobulin+translocations+and+cyclin+D+dysregulation+in+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma</span></div><div class="casAuthors">Bergsagel, P. Leif; Kuehl, W. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">194</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">96-104</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">A review.  Multiple myeloma (MM) is a tumor of long-lived bone marrow plasma cells (PCs).  Nearly 40% of MM tumors have Ig H (IgH) translocations involving four recurrent chromosomal loci (oncogenes): 11q13 (cyclin D1), 6p21 (cyclin D3), 4p16 (MMSET and FGFR3), and 16q23 (c-maf).  Other MM tumors have Ig translocations involving different loci, none of which is involved in more than 1% of tumors.  At least 25% of MM tumors have no Ig translocation.  Unlike normal PCs, MM tumors usually express one of the three cyclin D genes at a high level.  Translocations involving 4p16 and 16q23 do not directly target a cyclin D gene, but they are assocd. with a high level of cyclin D2 expression.  Although cyclin D1 is not expressed in normal hematopoietic cells, one-third of MM tumors ectopically express cyclin D1 in the absence of t(11;14).  Despite a low proliferation index in MM dysregulation of a cyclin D gene seems to be a unifying oncogenic event.  Anal. of 34 MM cell lines indicates that tumors having an IgH translocation are significantly over-represented, whereas tumors that ectopically express cyclin D1 are not represented.  We speculate that ectopic cyclin D1 expression without t(11;14) is dependent on tumor-specific interaction with bone marrow stromal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYEua-3MWjkbVg90H21EOLACvtfcHk0lh5-PKUGESDbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsV2ms7w%253D&md5=904c6abc53606495daa7a9b748248096</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1034%2Fj.1600-065X.2003.00052.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1600-065X.2003.00052.x%26sid%3Dliteratum%253Aachs%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26aulast%3DKuehl%26aufirst%3DW.%2BM.%26atitle%3DCritical%2520roles%2520for%2520immunoglobulin%2520translocations%2520and%2520cyclin%2520D%2520dysregulation%2520in%2520multiple%2520myeloma%26jtitle%3DImmunol.%2520Rev.%26date%3D2003%26volume%3D194%26spage%3D96%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, T. S.</span><span> </span><span class="NLM_article-title">Detection of CCND1 amplification using laser capture microdissection coupled with real-time polymerase chain reaction in human esophageal squamous cell carcinoma</span> <span class="citation_source-journal">Cancer Genet. Cytogenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">175</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1016%2Fj.cancergencyto.2007.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=17498553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A280%3ADC%252BD2szksVOgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2007&pages=19-25&author=C.+Huangauthor=L.+Yangauthor=Z.+F.+Liauthor=J.+Yangauthor=J.+J.+Zhaoauthor=D.+H.+Xuauthor=L.+Y.+Liuauthor=Q.+L.+Wangauthor=T.+S.+Song&title=Detection+of+CCND1+amplification+using+laser+capture+microdissection+coupled+with+real-time+polymerase+chain+reaction+in+human+esophageal+squamous+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4d</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of CCND1 amplification using laser capture microdissection coupled with real-time polymerase chain reaction in human esophageal squamous cell carcinoma</span></div><div class="casAuthors">Huang Chen; Yang Lin; Li Zhongfang; Yang Jun; Zhao Junjie; Dehui Xu; Liu Liying; Wang Quanli; Song Tusheng</div><div class="citationInfo"><span class="NLM_cas:title">Cancer genetics and cytogenetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-25</span>
        ISSN:<span class="NLM_cas:issn">0165-4608</span>.
    </div><div class="casAbstract">Several methods have been used to detect CCND1 amplification or overexpression in esophageal squamous cell carcinoma (ESCC), but problems remain, associated with heterogeneity of tumor tissue and quantification of gene copies.  Laser capture microdissection coupled with real-time polymerase chain reaction (PCR) is a reliable method for the molecular analysis of gene profiles in specific tissues.  All 35 specimens of ESCC studied were paraffin-embedded, cut into tissue slides, and stained by hematoxylin-eosin.  The pure ESCC cell and normal squamous epithelia populations were separated by LCM and then genomic DNA was extracted from the dissected cells.  CCND1 amplification was detected with real-time FQ-PCR and with PCR.  Amplification was calculated by the formula X = 2(-DeltaDeltaCt) and R = (CCND1/ACTB) CANCER/(CCND1/ACTB) NORMAL.  Twenty (57%) of primary ESCC cancer cell groups had a detectable CCND1 amplification (range, 2.06-fold to 25.9-fold) with real-time FQ-PCR, but only 2 of 15 primary ESCC cancer cell groups had detectable CCND1 amplification by PCR.  CCND1 amplification was not correlated with age, sex, size of tumor, histological grade, and lymph node metastasis.  In conclusion, LCM coupled with real-time fluorescence quantitative-PCR technique is more precise than PCR for the identifying amplified oncogenes; The role of CCND1 amplification in ESCC development and progression needs more extensive study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRI_he2LCM0b1f1XRtfYM0dfW6udTcc2eaLro5pCj_0a7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szksVOgsw%253D%253D&md5=b392255cb6de61cccacd50f8ce1cd4f4</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1016%2Fj.cancergencyto.2007.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cancergencyto.2007.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DZ.%2BF.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26aulast%3DXu%26aufirst%3DD.%2BH.%26aulast%3DLiu%26aufirst%3DL.%2BY.%26aulast%3DWang%26aufirst%3DQ.%2BL.%26aulast%3DSong%26aufirst%3DT.%2BS.%26atitle%3DDetection%2520of%2520CCND1%2520amplification%2520using%2520laser%2520capture%2520microdissection%2520coupled%2520with%2520real-time%2520polymerase%2520chain%2520reaction%2520in%2520human%2520esophageal%2520squamous%2520cell%2520carcinoma%26jtitle%3DCancer%2520Genet.%2520Cytogenet.%26date%3D2007%26volume%3D175%26spage%3D19%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, I. B.</span><span> </span><span class="NLM_article-title">Amplification and Expression of the Human Cyclin-D Gene in Esophageal Cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2980</span><span class="NLM_x">–</span> <span class="NLM_lpage">2983</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1992&pages=2980-2983&author=W.+Jiangauthor=S.+M.+Kahnauthor=N.+Tomitaauthor=Y.+J.+Zhangauthor=S.+H.+Luauthor=I.+B.+Weinstein&title=Amplification+and+Expression+of+the+Human+Cyclin-D+Gene+in+Esophageal+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DKahn%26aufirst%3DS.%2BM.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DY.%2BJ.%26aulast%3DLu%26aufirst%3DS.%2BH.%26aulast%3DWeinstein%26aufirst%3DI.%2BB.%26atitle%3DAmplification%2520and%2520Expression%2520of%2520the%2520Human%2520Cyclin-D%2520Gene%2520in%2520Esophageal%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D1992%26volume%3D52%26spage%3D2980%26epage%3D2983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Steeg, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span> </span><span class="NLM_article-title">Cyclins and breast cancer</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1023%2FA%3A1006102916060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=10066069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A280%3ADyaK1M7mtl2msA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1998&pages=17-28&author=P.+S.+Steegauthor=Q.+Zhou&title=Cyclins+and+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4fR"><div class="casContent"><span class="casTitleNuber">4f</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclins and breast cancer</span></div><div class="casAuthors">Steeg P S; Zhou Q</div><div class="citationInfo"><span class="NLM_cas:title">Breast cancer research and treatment</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">17-28</span>
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    </div><div class="casAbstract">Cyclins are regulatory subunits for cyclin dependent kinases in the coordination of the cell cycle.  Cyclins can also serve non-cell cycle functions, such as the transactivation of estrogen receptor by cyclin D.  Evidence for the participation of the G1 cyclins D and E in breast cancer is summarized, including transgenic and knockout mice, transfections, and expression patterns in cohort studies.  Overexpression of cyclin D has been reported in ductal carcinoma in situ (DCIS), and similar overexpression of cyclin E is suggested.  Strategies to reduce cyclin expression are discussed as potential prevention efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkUNrTIA9hgmx8TEN9K18QfW6udTcc2eaExXeQ6wjV07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7mtl2msA%253D%253D&md5=dd96bd4b146d25341030f011417f23ff</span></div><a href="/servlet/linkout?suffix=cit4f&amp;dbid=16384&amp;doi=10.1023%2FA%3A1006102916060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1006102916060%26sid%3Dliteratum%253Aachs%26aulast%3DSteeg%26aufirst%3DP.%2BS.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DCyclins%2520and%2520breast%2520cancer%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D1998%26volume%3D52%26spage%3D17%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase pathways as targets for cancer treatment</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1770</span><span class="NLM_x">–</span> <span class="NLM_lpage">1783</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4g&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1200%2FJCO.2005.03.7689" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=1770-1783&author=G.+I.+Shapiro&title=Cyclin-dependent+kinase+pathways+as+targets+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4g&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.03.7689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.03.7689%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DCyclin-dependent%2520kinase%2520pathways%2520as%2520targets%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D24%26spage%3D1770%26epage%3D1783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dailey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrosetti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansukhani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basilico, C.</span><span> </span><span class="NLM_article-title">Mechanisms underlying differential responses to FGF signaling</span> <span class="citation_source-journal">Cytokine Growth Factor Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1016%2Fj.cytogfr.2005.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=15863038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=233-247&author=L.+Daileyauthor=D.+Ambrosettiauthor=A.+Mansukhaniauthor=C.+Basilico&title=Mechanisms+underlying+differential+responses+to+FGF+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms underlying differential responses to FGF signaling</span></div><div class="casAuthors">Dailey, Lisa; Ambrosetti, Davide; Mansukhani, Alka; Basilico, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine & Growth Factor Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-247</span>CODEN:
                <span class="NLM_cas:coden">CGFRFB</span>;
        ISSN:<span class="NLM_cas:issn">1359-6101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Fibroblast growth factors (FGFs) are key regulators of several developmental processes in which cell fate and differentiation to various tissue lineages are detd.  The importance of the proper spatial and temporal regulation of FGF signals is evident from human and mouse genetic studies which show that mutations leading to the dysregulation of FGF signals cause a variety of developmental disorders including dominant skeletal diseases and cancer.  The FGF ligands signal via a family of receptor tyrosine kinases and, depending on the cell type or stage of maturation, produce diverse biol. responses that include proliferation, growth arrest, differentiation or apoptosis.  A central issue in FGF biol. is to understand how these diverse cellular responses are detd. and how similar signaling inputs can generate distinct patterns of gene expression that govern the specificity of the cellular response.  In this review the authors draw upon studies from the past fifteen years and attempt to construct a mol. picture of the different levels of regulation by which such specific cellular responses could be achieved by FGF signals.  The authors discuss whether specificity could lie in the nature of the ligand, the particular receptor, the signal transduction pathways utilized, or the transcriptional regulation of specific genes.  Finally, the authors also discuss how the interplay of FGF signals with other signaling systems could contribute to the cellular response.  In particular the authors focus on the interaction with the Wnt pathway since FGF/Wnt cross-talk is emerging as an important nexus in regulating a variety of biol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOsKybSoaLlLVg90H21EOLACvtfcHk0lgEA_-2XfX25A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOnsLs%253D&md5=d58f7df4baa2ab2fa348a9b443e95782</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2Fj.cytogfr.2005.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cytogfr.2005.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DDailey%26aufirst%3DL.%26aulast%3DAmbrosetti%26aufirst%3DD.%26aulast%3DMansukhani%26aufirst%3DA.%26aulast%3DBasilico%26aufirst%3DC.%26atitle%3DMechanisms%2520underlying%2520differential%2520responses%2520to%2520FGF%2520signaling%26jtitle%3DCytokine%2520Growth%2520Factor%2520Rev.%26date%3D2005%26volume%3D16%26spage%3D233%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Protein and lipid kinase inhibitors as targeted anticancer agents of the Ras/Raf/MEK and PI3K/PKB pathways</span> <span class="citation_source-journal">Purinergic Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=117-125&author=C.+Garcia-Echeverria&title=Protein+and+lipid+kinase+inhibitors+as+targeted+anticancer+agents+of+the+Ras%2FRaf%2FMEK+and+PI3K%2FPKB+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DProtein%2520and%2520lipid%2520kinase%2520inhibitors%2520as%2520targeted%2520anticancer%2520agents%2520of%2520the%2520Ras%252FRaf%252FMEK%2520and%2520PI3K%252FPKB%2520pathways%26jtitle%3DPurinergic%2520Signalling%26date%3D2009%26volume%3D5%26spage%3D117%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">John, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, M. S.</span><span> </span><span class="NLM_article-title">Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">S14</span><span class="NLM_x">–</span> <span class="NLM_lpage">S23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=S14-S23&author=T.+Johnauthor=G.+Liuauthor=M.+S.+Tsao&title=Overview+of+molecular+testing+in+non-small-cell+lung+cancer%3A+mutational+analysis%2C+gene+copy+number%2C+protein+expression+and+other+biomarkers+of+EGFR+for+the+prediction+of+response+to+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohn%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DTsao%26aufirst%3DM.%2BS.%26atitle%3DOverview%2520of%2520molecular%2520testing%2520in%2520non-small-cell%2520lung%2520cancer%253A%2520mutational%2520analysis%252C%2520gene%2520copy%2520number%252C%2520protein%2520expression%2520and%2520other%2520biomarkers%2520of%2520EGFR%2520for%2520the%2520prediction%2520of%2520response%2520to%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DOncogene%26date%3D2009%26volume%3D28%26spage%3DS14%26epage%3DS23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Landis, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlyk, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinds, P. W.</span><span> </span><span class="NLM_article-title">Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=13-22&author=M.+W.+Landisauthor=B.+S.+Pawlykauthor=T.+Liauthor=P.+Sicinskiauthor=P.+W.+Hinds&title=Cyclin+D1-dependent+kinase+activity+in+murine+development+and+mammary+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLandis%26aufirst%3DM.%2BW.%26aulast%3DPawlyk%26aufirst%3DB.%2BS.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DSicinski%26aufirst%3DP.%26aulast%3DHinds%26aufirst%3DP.%2BW.%26atitle%3DCyclin%2520D1-dependent%2520kinase%2520activity%2520in%2520murine%2520development%2520and%2520mammary%2520tumorigenesis%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D13%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yu, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span> </span><span class="NLM_article-title">Specific protection against breast cancers by cyclin D1 ablation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">411</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1021</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=1017-1021&author=Q.+Y.+Yuauthor=Y.+Gengauthor=P.+Sicinski&title=Specific+protection+against+breast+cancers+by+cyclin+D1+ablation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DQ.%2BY.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DSicinski%26aufirst%3DP.%26atitle%3DSpecific%2520protection%2520against%2520breast%2520cancers%2520by%2520cyclin%2520D1%2520ablation%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D1017%26epage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yu, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagozdzon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stal, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span> </span><span class="NLM_article-title">Requirement for CDK4 kinase function in breast cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1016%2Fj.ccr.2005.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=16413469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD28XosFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=23-32&author=Q.+Y.+Yuauthor=E.+Sicinskaauthor=Y.+Gengauthor=M.+Ahnstromauthor=A.+Zagozdzonauthor=Y.+Kongauthor=H.+Gardnerauthor=H.+Kiyokawaauthor=L.+N.+Harrisauthor=Q.+Stalauthor=P.+Sicinski&title=Requirement+for+CDK4+kinase+function+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement for CDK4 kinase function in breast cancer</span></div><div class="casAuthors">Yu, Qunyan; Sicinska, Ewa; Geng, Yan; Ahnstrom, Marie; Zagozdzon, Agnieszka; Kong, Yinxin; Gardner, Humphrey; Kiyokawa, Hiroaki; Harris, Lyndsay N.; Stal, Olle; Sicinski, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-32</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cyclin D1 is overexpressed in the majority of human breast cancers.  The authors previously found that mice lacking cyclin D1 are resistant to mammary carcinomas triggered by the ErbB-2 oncogene.  In this study, the authors investigated which function of cyclin D1 is required for ErbB-2-driven mammary oncogenesis.  The authors report that the ability of cyclin D1 to activate cyclin-dependent kinase CDK4 underlies the crit. role for cyclin D1 in breast cancer formation.  The authors also found that the continued presence of CDK4-assocd. kinase activity is required to maintain breast tumorigenesis.  The authors analyzed primary human breast cancers and found high cyclin D1 levels in a subset (∼25%) of ErbB-2-overexpressing tumors.  The authors propose that this subset of breast cancer patients might benefit from inhibiting CDK4 kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7XtIoi9OqULVg90H21EOLACvtfcHk0lhJE39_ryOubQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosFersw%253D%253D&md5=de0dbbf7f2463d60b126c201ac6bb7f6</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2005.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2005.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DQ.%2BY.%26aulast%3DSicinska%26aufirst%3DE.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DAhnstrom%26aufirst%3DM.%26aulast%3DZagozdzon%26aufirst%3DA.%26aulast%3DKong%26aufirst%3DY.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DKiyokawa%26aufirst%3DH.%26aulast%3DHarris%26aufirst%3DL.%2BN.%26aulast%3DStal%26aufirst%3DQ.%26aulast%3DSicinski%26aufirst%3DP.%26atitle%3DRequirement%2520for%2520CDK4%2520kinase%2520function%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D23%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamaria, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerezo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Mammalian cells cycle without the D-type cyclin-elependent kinases Cdk4 and Cdk6</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2004&pages=493-504&author=M.+Malumbresauthor=R.+Sotilloauthor=D.+Santamariaauthor=J.+Galanauthor=A.+Cerezoauthor=S.+Ortegaauthor=P.+Dubusauthor=M.+Barbacid&title=Mammalian+cells+cycle+without+the+D-type+cyclin-elependent+kinases+Cdk4+and+Cdk6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DSotillo%26aufirst%3DR.%26aulast%3DSantamaria%26aufirst%3DD.%26aulast%3DGalan%26aufirst%3DJ.%26aulast%3DCerezo%26aufirst%3DA.%26aulast%3DOrtega%26aufirst%3DS.%26aulast%3DDubus%26aufirst%3DP.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DMammalian%2520cells%2520cycle%2520without%2520the%2520D-type%2520cyclin-elependent%2520kinases%2520Cdk4%2520and%2520Cdk6%26jtitle%3DCell%26date%3D2004%26volume%3D118%26spage%3D493%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rane, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boden, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mettus, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Loss of cyclin-dependent kinase 4 (Cdk4) causes insulin-deficient diabetes while its activation results in pancreatic islet hyperplasia</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">A34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1999&pages=A34&author=S.+G.+Raneauthor=G.+Bodenauthor=R.+V.+Mettusauthor=E.+P.+Reddyauthor=M.+Barbacid&title=Loss+of+cyclin-dependent+kinase+4+%28Cdk4%29+causes+insulin-deficient+diabetes+while+its+activation+results+in+pancreatic+islet+hyperplasia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRane%26aufirst%3DS.%2BG.%26aulast%3DBoden%26aufirst%3DG.%26aulast%3DMettus%26aufirst%3DR.%2BV.%26aulast%3DReddy%26aufirst%3DE.%2BP.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DLoss%2520of%2520cyclin-dependent%2520kinase%25204%2520%2528Cdk4%2529%2520causes%2520insulin-deficient%2520diabetes%2520while%2520its%2520activation%2520results%2520in%2520pancreatic%2520islet%2520hyperplasia%26jtitle%3DDiabetes%26date%3D1999%26volume%3D48%26spage%3DA34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Santamaria, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barriere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerqueira, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caceres, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cdk1 is sufficient to drive the mammalian cell cycle</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">448</span><span class="NLM_x">, </span> <span class="NLM_fpage">811</span><span class="NLM_x">–</span> <span class="NLM_lpage">U8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2007&pages=811-U8&author=D.+Santamariaauthor=C.+Barriereauthor=A.+Cerqueiraauthor=S.+Huntauthor=C.+Tardyauthor=K.+Newtonauthor=J.+F.+Caceresauthor=P.+Dubusauthor=M.+Malumbresauthor=M.+Barbacid&title=Cdk1+is+sufficient+to+drive+the+mammalian+cell+cycle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSantamaria%26aufirst%3DD.%26aulast%3DBarriere%26aufirst%3DC.%26aulast%3DCerqueira%26aufirst%3DA.%26aulast%3DHunt%26aufirst%3DS.%26aulast%3DTardy%26aufirst%3DC.%26aulast%3DNewton%26aufirst%3DK.%26aulast%3DCaceres%26aufirst%3DJ.%2BF.%26aulast%3DDubus%26aufirst%3DP.%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCdk1%2520is%2520sufficient%2520to%2520drive%2520the%2520mammalian%2520cell%2520cycle%26jtitle%3DNature%26date%3D2007%26volume%3D448%26spage%3D811%26epage%3DU8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sherr, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. M.</span><span> </span><span class="NLM_article-title">Living with or without cyclins and cyclin-dependent kinases</span> <span class="citation_source-journal">Gene. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2699</span><span class="NLM_x">–</span> <span class="NLM_lpage">2711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=2699-2711&author=C.+J.+Sherrauthor=J.+M.+Roberts&title=Living+with+or+without+cyclins+and+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26atitle%3DLiving%2520with%2520or%2520without%2520cyclins%2520and%2520cyclin-dependent%2520kinases%26jtitle%3DGene.%2520Dev.%26date%3D2004%26volume%3D18%26spage%3D2699%26epage%3D2711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cell cycle, CDKs and cancer: a changing paradigm</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1038%2Fnrc2602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=19238148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=153-166&author=M.+Malumbresauthor=M.+Barbacid&title=Cell+cycle%2C+CDKs+and+cancer%3A+a+changing+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle, CDKs and cancer: a changing paradigm</span></div><div class="casAuthors">Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-166</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. cell cycle defects are often mediated by alterations in cyclin-dependent kinase (CDK) activity.  Misregulated CDKs induce unscheduled proliferation as well as genomic and chromosomal instability.  According to current models, mammalian CDKs are essential for driving each cell cycle phase, so therapeutic strategies that block CDK activity are unlikely to selectively target tumor cells.  However, recent genetic evidence has revealed that, whereas CDK1 is required for the cell cycle, interphase CDKs are only essential for proliferation of specialized cells.  Emerging evidence suggests that tumor cells may also require specific interphase CDKs for proliferation.  Thus, selective CDK inhibition may provide therapeutic benefit against certain human neoplasias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzlIKlbCPWnLVg90H21EOLACvtfcHk0lhJE39_ryOubQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D&md5=2a7eb34b2381e288b3f43ec1bffc0aec</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1038%2Fnrc2602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2602%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCell%2520cycle%252C%2520CDKs%2520and%2520cancer%253A%2520a%2520changing%2520paradigm%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D153%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, J. R.</span><span> </span><span class="NLM_article-title">CDK inhibitors in cancer therapy: what is next?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2007&pages=16-21&author=M.+Malumbresauthor=P.+Pevarelloauthor=M.+Barbacidauthor=J.+R.+Bischoff&title=CDK+inhibitors+in+cancer+therapy%3A+what+is+next%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DBarbacid%26aufirst%3DM.%26aulast%3DBischoff%26aufirst%3DJ.%2BR.%26atitle%3DCDK%2520inhibitors%2520in%2520cancer%2520therapy%253A%2520what%2520is%2520next%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D29%26spage%3D16%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Horiuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahane, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uoto, K.</span><span> </span><span class="NLM_article-title">Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: Synthesis, biological evaluation and structure−activity relationships. Part 2</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">7850</span><span class="NLM_x">–</span> <span class="NLM_lpage">7860</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=7850-7860&author=T.+Horiuchiauthor=M.+Nagataauthor=M.+Kitagawaauthor=K.+Akahaneauthor=K.+Uoto&title=Discovery+of+novel+thieno%5B2%2C3-d%5Dpyrimidin-4-yl+hydrazone-based+inhibitors+of+Cyclin+D1-CDK4%3A+Synthesis%2C+biological+evaluation+and+structure%E2%88%92activity+relationships.+Part+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoriuchi%26aufirst%3DT.%26aulast%3DNagata%26aufirst%3DM.%26aulast%3DKitagawa%26aufirst%3DM.%26aulast%3DAkahane%26aufirst%3DK.%26aulast%3DUoto%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520novel%2520thieno%255B2%252C3-d%255Dpyrimidin-4-yl%2520hydrazone-based%2520inhibitors%2520of%2520Cyclin%2520D1-CDK4%253A%2520Synthesis%252C%2520biological%2520evaluation%2520and%2520structure%25E2%2588%2592activity%2520relationships.%2520Part%25202%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D7850%26epage%3D7860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Aubry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmerson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickens, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span> </span><span class="NLM_article-title">Fascaplysin-inspired diindolyls as selective inhibitors of CDK4 /cyclin D1</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6073</span><span class="NLM_x">–</span> <span class="NLM_lpage">6084</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6073-6084&author=C.+Aubryauthor=A.+J.+Wilsonauthor=D.+Emmersonauthor=E.+Murphyauthor=Y.+Y.+Chanauthor=M.+P.+Dickensauthor=M.+D.+Garciaauthor=P.+R.+Jenkinsauthor=S.+Mahaleauthor=B.+Chaudhuri&title=Fascaplysin-inspired+diindolyls+as+selective+inhibitors+of+CDK4+%2Fcyclin+D1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAubry%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26aulast%3DEmmerson%26aufirst%3DD.%26aulast%3DMurphy%26aufirst%3DE.%26aulast%3DChan%26aufirst%3DY.%2BY.%26aulast%3DDickens%26aufirst%3DM.%2BP.%26aulast%3DGarcia%26aufirst%3DM.%2BD.%26aulast%3DJenkins%26aufirst%3DP.%2BR.%26aulast%3DMahale%26aufirst%3DS.%26aulast%3DChaudhuri%26aufirst%3DB.%26atitle%3DFascaplysin-inspired%2520diindolyls%2520as%2520selective%2520inhibitors%2520of%2520CDK4%2520%252Fcyclin%2520D1%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D6073%26epage%3D6084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Tsou, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otteng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutterer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suayan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnis, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-diones and 4-[(pyridylmethyl)aminomethylene]-isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2289</span><span class="NLM_x">–</span> <span class="NLM_lpage">2310</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801026e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2289-2310&author=H.-R.+Tsouauthor=X.+Liuauthor=G.+Birnbergauthor=J.+Kaplanauthor=M.+Ottengauthor=T.+Tranauthor=K.+Kuttererauthor=Z.+Tangauthor=R.+Suayanauthor=A.+Zaskauthor=M.+Raviauthor=A.+Bretzauthor=M.+Grilloauthor=J.+P.+McGinnisauthor=S.+K.+Rabindranauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansour&title=Discovery+of+4-%28benzylaminomethylene%29isoquinoline-1%2C3-%282H%2C4H%29-diones+and+4-%5B%28pyridylmethyl%29aminomethylene%5D-isoquinoline-1%2C3-%282H%2C4H%29-diones+as+potent+and+selective+inhibitors+of+the+cyclin-dependent+kinase+4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1021%2Fjm801026e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801026e%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.-R.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBirnberg%26aufirst%3DG.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DOtteng%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DKutterer%26aufirst%3DK.%26aulast%3DTang%26aufirst%3DZ.%26aulast%3DSuayan%26aufirst%3DR.%26aulast%3DZask%26aufirst%3DA.%26aulast%3DRavi%26aufirst%3DM.%26aulast%3DBretz%26aufirst%3DA.%26aulast%3DGrillo%26aufirst%3DM.%26aulast%3DMcGinnis%26aufirst%3DJ.%2BP.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DDiscovery%2520of%25204-%2528benzylaminomethylene%2529isoquinoline-1%252C3-%25282H%252C4H%2529-diones%2520and%25204-%255B%2528pyridylmethyl%2529aminomethylene%255D-isoquinoline-1%252C3-%25282H%252C4H%2529-diones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520cyclin-dependent%2520kinase%25204%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2289%26epage%3D2310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Liu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span> </span><span class="NLM_article-title">Recent research in selective cyclin-dependent kinase 4 inhibitors for anti-cancer treatment</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4869</span><span class="NLM_x">–</span> <span class="NLM_lpage">4888</span><div class="note"><p class="first last">and references therein.</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.2174%2F092986709789909611" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=19929781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=4869-4888&author=N.+Liuauthor=H.+Fangauthor=Y.+Liauthor=W.+Xu&title=Recent+research+in+selective+cyclin-dependent+kinase+4+inhibitors+for+anti-cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">Recent research in selective cyclin-dependent kinase 4 inhibitors for anti-cancer treatment</span></div><div class="casAuthors">Liu, Ning; Fang, Hao; Li, Yanling; Xu, Wenfang</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">4869-4888</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  It is well known that cyclins and cyclin-dependent kinases (CDKs) play essential roles in regulation of the cell cycle.  In past two decades, the scientific researches suggest that the cyclin D1/ CDK4 complex is a key regulator of the transition through the G1 phase of the cell cycle.  Moreover, deregulation of the cyclin D /CDK4 pathway has been identified in multiple tumor types.  Thus, CDK4 is a genetically validated therapeutic target; hence, there has been a surge of interests in finding selective CDK4 inhibitors as anti-cancer agents.  This review will give the recent progress in the studies of structure, functions of CDK4 and highly selective and potent CDK4 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXMr9IPS1YKLVg90H21EOLACvtfcHk0liycKEdcfDC-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSmtro%253D&md5=b56fa129cbd008b0a9c8d043ff81e2b4</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.2174%2F092986709789909611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986709789909611%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DW.%26atitle%3DRecent%2520research%2520in%2520selective%2520cyclin-dependent%2520kinase%25204%2520inhibitors%2520for%2520anti-cancer%2520treatment%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2009%26volume%3D16%26spage%3D4869%26epage%3D4888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Jenkins, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmerson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britton, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of new tryptamine and tetrahydro-β-carboline-based selective inhibitors of CDK4</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">7728</span><span class="NLM_x">–</span> <span class="NLM_lpage">7739</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=7728-7739&author=P.+R.+Jenkinsauthor=J.+Wilsonauthor=D.+Emmersonauthor=M.+D.+Garciaauthor=M.+R.+Smithauthor=S.+J.+Grayauthor=R.+G.+Brittonauthor=S.+Mahaleauthor=B.+Chaudhuri&title=Design%2C+synthesis+and+biological+evaluation+of+new+tryptamine+and+tetrahydro-%CE%B2-carboline-based+selective+inhibitors+of+CDK4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJenkins%26aufirst%3DP.%2BR.%26aulast%3DWilson%26aufirst%3DJ.%26aulast%3DEmmerson%26aufirst%3DD.%26aulast%3DGarcia%26aufirst%3DM.%2BD.%26aulast%3DSmith%26aufirst%3DM.%2BR.%26aulast%3DGray%26aufirst%3DS.%2BJ.%26aulast%3DBritton%26aufirst%3DR.%2BG.%26aulast%3DMahale%26aufirst%3DS.%26aulast%3DChaudhuri%26aufirst%3DB.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520new%2520tryptamine%2520and%2520tetrahydro-%25CE%25B2-carboline-based%2520selective%2520inhibitors%2520of%2520CDK4%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D7728%26epage%3D7739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">VanderWel, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repine, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quin, J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrusin, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toogood, P. L.</span><span> </span><span class="NLM_article-title">Pyrido[2,3-<i>d</i>]pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2371</span><span class="NLM_x">–</span> <span class="NLM_lpage">2387</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049355%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2371-2387&author=S.+N.+VanderWelauthor=P.+J.+Harveyauthor=D.+J.+McNamaraauthor=J.+T.+Repineauthor=P.+R.+Kellerauthor=J.+Quinauthor=R.+J.+Boothauthor=W.+L.+Elliottauthor=E.+M.+Dobrusinauthor=D.+W.+Fryauthor=P.+L.+Toogood&title=Pyrido%5B2%2C3-d%5Dpyrimidin-7-ones+as+specific+inhibitors+of+cyclin-dependent+kinase+4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9f&amp;dbid=16384&amp;doi=10.1021%2Fjm049355%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049355%252B%26sid%3Dliteratum%253Aachs%26aulast%3DVanderWel%26aufirst%3DS.%2BN.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26aulast%3DRepine%26aufirst%3DJ.%2BT.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DQuin%26aufirst%3DJ.%26aulast%3DBooth%26aufirst%3DR.%2BJ.%26aulast%3DElliott%26aufirst%3DW.%2BL.%26aulast%3DDobrusin%26aufirst%3DE.%2BM.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DToogood%26aufirst%3DP.%2BL.%26atitle%3DPyrido%255B2%252C3-d%255Dpyrimidin-7-ones%2520as%2520specific%2520inhibitors%2520of%2520cyclin-dependent%2520kinase%25204%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2371%26epage%3D2387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Toogood, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repine, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanderWel, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodfuehrer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barvian, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span> </span><span class="NLM_article-title">Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2388</span><span class="NLM_x">–</span> <span class="NLM_lpage">2406</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049354h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2388-2406&author=P.+L.+Toogoodauthor=P.+J.+Harveyauthor=J.+T.+Repineauthor=D.+J.+Sheehanauthor=S.+N.+VanderWelauthor=H.+Zhouauthor=P.+R.+Kellerauthor=D.+J.+McNamaraauthor=D.+Sherryauthor=T.+Zhuauthor=J.+Brodfuehrerauthor=C.+Choiauthor=M.+R.+Barvianauthor=D.+W.+Fry&title=Discovery+of+a+potent+and+selective+inhibitor+of+cyclin-dependent+kinase+4%2F6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6</span></div><div class="casAuthors">Toogood, Peter L.; Harvey, Patricia J.; Repine, Joseph T.; Sheehan, Derek J.; VanderWel, Scott N.; Zhou, Hairong; Keller, Paul R.; McNamara, Dennis J.; Sherry, Debra; Zhu, Tong; Brodfuehrer, Joanne; Choi, Chung; Barvian, Mark R.; Fry, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2388-2406</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A pharmacol. approach to inhibition of cyclin-dependent kinases 4 and 6 (Cdk4/6) using highly selective small mol. inhibitors has the potential to provide novel cancer therapies for clin. use.  Achieving high levels of selectivity for Cdk4/6, vs. other ATP-dependent kinases, presents a significant challenge.  The pyrido[2,3-d]pyrimidin-7-one template provides an effective platform for the inhibition of a broad cross-section of kinases, including Cdks.  It is now demonstrated that the modification of pyrido[2,3-d]pyrimidin-7-ones to include a 2-aminopyridine side chain at the C2-position provides inhibitors with exquisite selectivity for Cdk4/6 in vitro.  This selectivity profile is recapitulated in cells where the most selective inhibitors create a G1 block at concns. up to 100-fold the IC50 for cell proliferation.  On the basis of its selectivity profile and pharmacokinetic profile, compd. I (PD 0332991) was identified as a drug candidate for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX577J5U0r97Vg90H21EOLACvtfcHk0liycKEdcfDC-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D&md5=23cbe58426ff1975695712db7c1b128a</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Fjm049354h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049354h%26sid%3Dliteratum%253Aachs%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DRepine%26aufirst%3DJ.%2BT.%26aulast%3DSheehan%26aufirst%3DD.%2BJ.%26aulast%3DVanderWel%26aufirst%3DS.%2BN.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26aulast%3DSherry%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DBarvian%26aufirst%3DM.%2BR.%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520cyclin-dependent%2520kinase%25204%252F6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2388%26epage%3D2406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trachet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albassam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopold, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryer, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toogood, P. L.</span><span> </span><span class="NLM_article-title">Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1427</span><span class="NLM_x">–</span> <span class="NLM_lpage">1438</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=15542782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpslCkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1427-1438&author=D.+W.+Fryauthor=P.+J.+Harveyauthor=P.+R.+Kellerauthor=W.+L.+Elliottauthor=M.+Meadeauthor=E.+Trachetauthor=M.+Albassamauthor=X.+Zhengauthor=W.+R.+Leopoldauthor=N.+K.+Pryerauthor=P.+L.+Toogood&title=Specific+inhibition+of+cyclin-dependent+kinase+4%2F6+by+PD+0332991+and+associated+antitumor+activity+in+human+tumor+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts</span></div><div class="casAuthors">Fry, David W.; Harvey, Patricia J.; Keller, Paul R.; Elliott, William L.; Meade, MaryAnne; Trachet, Erin; Albassam, Mudher; Zheng, XianXian; Leopold, Wilbur R.; Pryer, Nancy K.; Toogood, Peter L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1427-1438</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PD 0332991 is a highly specific inhibitor of cyclin-dependent kinase 4 (Cdk4) (IC50, 0.011 μmol/L) and Cdk6 (IC50, 0.016 μmol/L), having no activity against a panel of 36 addnl. protein kinases.  It is a potent antiproliferative agent against retinoblastoma (Rb)-pos. tumor cells in vitro, inducing an exclusive G1 arrest, with a concomitant redn. of phospho-Ser780/Ser795 on the Rb protein.  Oral administration of PD 0332991 to mice bearing the Colo-205 human colon carcinoma produces marked tumor regression.  Therapeutic doses of PD 0332991 cause elimination of phospho-Rb and the proliferative marker Ki-67 in tumor tissue and down-regulation of genes under the transcriptional control of E2F.  The results indicate that inhibition of Cdk4/6 alone is sufficient to cause tumor regression and a net redn. in tumor burden in some tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9TOgbe4wrBLVg90H21EOLACvtfcHk0li-CLfi0rCrKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpslCkt7c%253D&md5=70931ebc6abd1c59bf1cc29748b7945f</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DElliott%26aufirst%3DW.%2BL.%26aulast%3DMeade%26aufirst%3DM.%26aulast%3DTrachet%26aufirst%3DE.%26aulast%3DAlbassam%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DLeopold%26aufirst%3DW.%2BR.%26aulast%3DPryer%26aufirst%3DN.%2BK.%26aulast%3DToogood%26aufirst%3DP.%2BL.%26atitle%3DSpecific%2520inhibition%2520of%2520cyclin-dependent%2520kinase%25204%252F6%2520by%2520PD%25200332991%2520and%2520associated%2520antitumor%2520activity%2520in%2520human%2520tumor%2520xenografts%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D1427%26epage%3D1438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">McInnes, C.</span><span> </span><span class="NLM_article-title">Progress in the evaluation of CDK inhibitors as anti-tumor agents</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">875</span><span class="NLM_x">–</span> <span class="NLM_lpage">881</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=875-881&author=C.+McInnes&title=Progress+in+the+evaluation+of+CDK+inhibitors+as+anti-tumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcInnes%26aufirst%3DC.%26atitle%3DProgress%2520in%2520the%2520evaluation%2520of%2520CDK%2520inhibitors%2520as%2520anti-tumor%2520agents%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D13%26spage%3D875%26epage%3D881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="note"><p class="first last">4-(Pyrazol-4-yl)-pyrimidines have been applied as a platform to generate inhibitors of various kinases. For example,</p></div><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Humphries, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafontaine, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agree, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, Q.-Q. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunney, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajapakse, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhite, D. M.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of 4-substituted-2-aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2099</span><span class="NLM_x">–</span> <span class="NLM_lpage">2102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2099-2102&author=P.+S.+Humphriesauthor=J.+A.+Lafontaineauthor=C.+S.+Agreeauthor=D.+Alexanderauthor=P.+Chenauthor=Q.-Q.+T.+Doauthor=L.+Y.+Liauthor=E.+A.+Lunneyauthor=R.+J.+Rajapakseauthor=K.+Siegelauthor=S.+L.+Timofeevskiauthor=T.+Wangauthor=D.+M.+Wilhite&title=Synthesis+and+SAR+of+4-substituted-2-aminopyrimidines+as+novel+c-Jun+N-terminal+kinase+%28JNK%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHumphries%26aufirst%3DP.%2BS.%26aulast%3DLafontaine%26aufirst%3DJ.%2BA.%26aulast%3DAgree%26aufirst%3DC.%2BS.%26aulast%3DAlexander%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DDo%26aufirst%3DQ.-Q.%2BT.%26aulast%3DLi%26aufirst%3DL.%2BY.%26aulast%3DLunney%26aufirst%3DE.%2BA.%26aulast%3DRajapakse%26aufirst%3DR.%2BJ.%26aulast%3DSiegel%26aufirst%3DK.%26aulast%3DTimofeevski%26aufirst%3DS.%2BL.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWilhite%26aufirst%3DD.%2BM.%26atitle%3DSynthesis%2520and%2520SAR%2520of%25204-substituted-2-aminopyrimidines%2520as%2520novel%2520c-Jun%2520N-terminal%2520kinase%2520%2528JNK%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2099%26epage%3D2102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ioannidis, S.; Lamb, M.</span><span> </span><span class="NLM_article-title">Preparation of <i>N</i>-(pyrazol-3-yl)-<i>N</i>′-(1-pyridin-2-ylethyl)pyrimidine-2,4-diamine derivatives as JAK inhibitors for the treatment of cancer</span>. Int. Patent WO 2009027736,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Ioannidis&author=M.+Lamb&title=Preparation+of+N-%28pyrazol-3-yl%29-N%E2%80%B2-%281-pyridin-2-ylethyl%29pyrimidine-2%2C4-diamine+derivatives+as+JAK+inhibitors+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DIoannidis%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520N-%2528pyrazol-3-yl%2529-N%25E2%2580%25B2-%25281-pyridin-2-ylethyl%2529pyrimidine-2%252C4-diamine%2520derivatives%2520as%2520JAK%2520inhibitors%2520for%2520the%2520treatment%2520of%2520cancer%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cui, J. J.; Deal, J. G.; Gu, D.; Guo, C.; Johnson, M. C.; Kania, R. S.; Kephart, S. E.; Linton, M. A.; McApline, I. J.; Pairish, M. A.; Palmer, C. L.</span><span> </span><span class="NLM_article-title">Preparation of pyrazole compounds as Raf inhibitors</span>. Int. Patent WO 2009016460,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+J.+Cui&author=J.+G.+Deal&author=D.+Gu&author=C.+Guo&author=M.+C.+Johnson&author=R.+S.+Kania&author=S.+E.+Kephart&author=M.+A.+Linton&author=I.+J.+McApline&author=M.+A.+Pairish&author=C.+L.+Palmer&title=Preparation+of+pyrazole+compounds+as+Raf+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26atitle%3DPreparation%2520of%2520pyrazole%2520compounds%2520as%2520Raf%2520inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Fu, H.; Liotta, D. C.; Thomas, S. L.; Snyder, J. P.</span><span> </span><span class="NLM_article-title">NF-κB inhibitor-p38 MAP kinase inhibitor combination for the treatment of cancer and inflammatory diseases</span>. Int. Patent WO 2008150899,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=H.+Fu&author=D.+C.+Liotta&author=S.+L.+Thomas&author=J.+P.+Snyder&title=NF-%CE%BAB+inhibitor-p38+MAP+kinase+inhibitor+combination+for+the+treatment+of+cancer+and+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DH.%26atitle%3DNF-%25CE%25BAB%2520inhibitor-p38%2520MAP%2520kinase%2520inhibitor%2520combination%2520for%2520the%2520treatment%2520of%2520cancer%2520and%2520inflammatory%2520diseases%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Chen, P.; Hong, Y.; Humphries, P. S.; Johnson, T. O.,  Jr.; Lafontaine, J. A.; Liu, S.; Lunney, E. A.</span><span> </span><span class="NLM_article-title">4-Pyrimidine-5-aminopyrazole compounds as JNK modulators and their preparation, pharmaceutical compositions and use in the treatment of diseases</span>. Int. Patent WO 2007129195,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=P.+Chen&author=Y.+Hong&author=P.+S.+Humphries&author=T.+O.+Johnson&author=J.+A.+Lafontaine&author=S.+Liu&author=E.+A.+Lunney&title=4-Pyrimidine-5-aminopyrazole+compounds+as+JNK+modulators+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26atitle%3D4-Pyrimidine-5-aminopyrazole%2520compounds%2520as%2520JNK%2520modulators%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Bennett, M. J.; Cho-Schultz, S.; Deal, J. G.; King, S. J.; Marrone, T. J.; Palmer, C. L.; Romines, W. H.,  III; Rui, E. Y.; Sutton, S. C.; Zhender, L. R.</span><span> </span><span class="NLM_article-title">Pyrazole compounds as Raf inhibitors and their preparation, pharmaceutical compositions and use in the treatment of abnormal cell growth</span>. Int. Patent WO 2007105058,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+J.+Bennett&author=S.+Cho-Schultz&author=J.+G.+Deal&author=S.+J.+King&author=T.+J.+Marrone&author=C.+L.+Palmer&author=W.+H.+Romines&author=E.+Y.+Rui&author=S.+C.+Sutton&author=L.+R.+Zhender&title=Pyrazole+compounds+as+Raf+inhibitors+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+abnormal+cell+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DM.%2BJ.%26atitle%3DPyrazole%2520compounds%2520as%2520Raf%2520inhibitors%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520abnormal%2520cell%2520growth%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Adams, J. L.; Faitg, T. H.; Ralph, J. M.; Silva, D. J.</span><span> </span><span class="NLM_article-title">Pyrimidinyl-pyrazole inhibitors of Aurora kinases and their preparation, pharmaceutical compositions and use in the treatment of cell proliferative diseases</span>. Int. Patent WO 2007024843,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+L.+Adams&author=T.+H.+Faitg&author=J.+M.+Ralph&author=D.+J.+Silva&title=Pyrimidinyl-pyrazole+inhibitors+of+Aurora+kinases+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+cell+proliferative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26atitle%3DPyrimidinyl-pyrazole%2520inhibitors%2520of%2520Aurora%2520kinases%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520cell%2520proliferative%2520diseases%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Garcia-Echeverria, G.</span><span> </span><span class="NLM_article-title">Preparation of pyrazolyl-pyrimidinyl-amine derivatives as IGF-1R inhibitors</span>. Int. Patent WO 2005068452,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=G.+Garcia-Echeverria&title=Preparation+of+pyrazolyl-pyrimidinyl-amine+derivatives+as+IGF-1R+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Echeverria%26aufirst%3DG.%26atitle%3DPreparation%2520of%2520pyrazolyl-pyrimidinyl-amine%2520derivatives%2520as%2520IGF-1R%2520inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Moon, Y.-C.</span><span> </span><span class="NLM_article-title">Preparation of pyrazolyl pyridinamines and pyrimidinamines as inhibitors of Src and other protein kinases</span>. Int. Patent WO 02092573,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=Y.-C.+Moon&title=Preparation+of+pyrazolyl+pyridinamines+and+pyrimidinamines+as+inhibitors+of+Src+and+other+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DY.-C.%26atitle%3DPreparation%2520of%2520pyrazolyl%2520pyridinamines%2520and%2520pyrimidinamines%2520as%2520inhibitors%2520of%2520Src%2520and%2520other%2520protein%2520kinases%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Cho, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, M. J.</span><span> </span><span class="NLM_article-title">Chemo- and regioselective halogenation of 4-(pyrazol-4-yl)-pyrimidines</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5762</span><span class="NLM_x">–</span> <span class="NLM_lpage">5764</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=5762-5764&author=Y.+S.+Choauthor=Y.+Houauthor=C.+H.-T.+Chenauthor=M.+J.+Sung&title=Chemo-+and+regioselective+halogenation+of+4-%28pyrazol-4-yl%29-pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DC.%2BH.-T.%26aulast%3DSung%26aufirst%3DM.%2BJ.%26atitle%3DChemo-%2520and%2520regioselective%2520halogenation%2520of%25204-%2528pyrazol-4-yl%2529-pyrimidines%26jtitle%3DTetrahedron%2520Lett.%26date%3D2009%26volume%3D50%26spage%3D5762%26epage%3D5764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Jeon, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, I. H.</span><span> </span><span class="NLM_article-title">Synthesis of novel 1,4,5-trisubstituted 3-trifluoromethylpyrazoles via microwave-assisted Stille coupling reactions</span> <span class="citation_source-journal">J. Fluorine Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">1191</span><span class="NLM_x">–</span> <span class="NLM_lpage">1197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1016%2Fj.jfluchem.2007.04.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFShs73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2007&pages=1191-1197&author=S.+L.+Jeonauthor=J.+H.+Choiauthor=B.+T.+Kimauthor=I.+H.+Jeong&title=Synthesis+of+novel+1%2C4%2C5-trisubstituted+3-trifluoromethylpyrazoles+via+microwave-assisted+Stille+coupling+reactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of novel 1,4,5-trisubstituted 3-trifluoromethylpyrazoles via microwave-assisted Stille coupling reactions</span></div><div class="casAuthors">Jeon, Sung Lan; Choi, Ji Hoon; Kim, Bum Tae; Jeong, In Howa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1191-1197</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">1,5-Disubstituted 3-trifluoromethylpyrazoles were reacted with N-bromosuccinimide in DMF at room temp. or 70-80° for 1-2 h to afford the corresponding 4-bromopyrazoles in 95-99% yields.  Subsequent microwave-assisted Stille coupling reactions with arylstannanes having a substituent on the benzene ring and allylstannane in refluxing MeCN in the presence of Pd(PPh3)4 provided the corresponding 1,4,5-trisubstituted 3-(trifluoromethyl)pyrazoles in 75-98% yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-410FPMlccrVg90H21EOLACvtfcHk0liu7WyUUhUeVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFShs73J&md5=6bb9460dca9917ba5777970d12dc0127</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.jfluchem.2007.04.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jfluchem.2007.04.029%26sid%3Dliteratum%253Aachs%26aulast%3DJeon%26aufirst%3DS.%2BL.%26aulast%3DChoi%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DB.%2BT.%26aulast%3DJeong%26aufirst%3DI.%2BH.%26atitle%3DSynthesis%2520of%2520novel%25201%252C4%252C5-trisubstituted%25203-trifluoromethylpyrazoles%2520via%2520microwave-assisted%2520Stille%2520coupling%2520reactions%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D2007%26volume%3D128%26spage%3D1191%26epage%3D1197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Harden, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokrosz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strekowski, L.</span><span> </span><span class="NLM_article-title">Addition and substitution reactions of chloropyrimidines with lithium reagents</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4137</span><span class="NLM_x">–</span> <span class="NLM_lpage">4140</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00252a057" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=4137-4140&author=D.+B.+Hardenauthor=M.+J.+Mokroszauthor=L.+Strekowski&title=Addition+and+substitution+reactions+of+chloropyrimidines+with+lithium+reagents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjo00252a057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00252a057%26sid%3Dliteratum%253Aachs%26aulast%3DHarden%26aufirst%3DD.%2BB.%26aulast%3DMokrosz%26aufirst%3DM.%2BJ.%26aulast%3DStrekowski%26aufirst%3DL.%26atitle%3DAddition%2520and%2520substitution%2520reactions%2520of%2520chloropyrimidines%2520with%2520lithium%2520reagents%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1988%26volume%3D53%26spage%3D4137%26epage%3D4140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Brain, C. T.; Thoma, G.; Sung, M. J.</span><span> </span><span class="NLM_article-title">Preparation of pyrrolopyrimidine compounds as protein kinase inhibitors</span>. PCT Int. Appl. WO 2007140222 A2 20071206,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=C.+T.+Brain&author=G.+Thoma&author=M.+J.+Sung&title=Preparation+of+pyrrolopyrimidine+compounds+as+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrain%26aufirst%3DC.%2BT.%26atitle%3DPreparation%2520of%2520pyrrolopyrimidine%2520compounds%2520as%2520protein%2520kinase%2520inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Santora, V.; Askew, B.; Ghose, A.; Hague, A.; Kim, T. S.; Laber, E.; Li, A.; Lian, B.; Liu, G.; Norman, M. H.; Smith, L.; Tasker, A.; Tegley, C.; Yang, K.</span><span> </span><span class="NLM_article-title">Preparation of diheteroaryl ureas as antitumor agents</span>. PCT Int. Appl. WO 2002014311 A2 20020221,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=V.+Santora&author=B.+Askew&author=A.+Ghose&author=A.+Hague&author=T.+S.+Kim&author=E.+Laber&author=A.+Li&author=B.+Lian&author=G.+Liu&author=M.+H.+Norman&author=L.+Smith&author=A.+Tasker&author=C.+Tegley&author=K.+Yang&title=Preparation+of+diheteroaryl+ureas+as+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSantora%26aufirst%3DV.%26atitle%3DPreparation%2520of%2520diheteroaryl%2520ureas%2520as%2520antitumor%2520agents%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Kim, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, B.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. H.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of novel aryl-tetrahydropyridine PPARα/γ dual agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4993</span><span class="NLM_x">–</span> <span class="NLM_lpage">4996</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4993-4996&author=E.+Kimauthor=C.+S.+Parkauthor=T.+Hanauthor=M.-H.+Baeauthor=W.+Chongauthor=C.+H.+Leeauthor=Y.+A.+Shinauthor=B.-N.+Ahnauthor=M.+K.+Kimauthor=C.+Y.+Shinauthor=M.+Sonauthor=J.+K.+Kimauthor=H.+S.+Moonauthor=H.+J.+Shimauthor=E.+J.+Kimauthor=S.+H.+Kimauthor=J.+I.+Limauthor=C.+H.+Lee&title=Design%2C+synthesis%2C+and+evaluation+of+novel+aryl-tetrahydropyridine+PPAR%CE%B1%2F%CE%B3+dual+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DE.%26aulast%3DPark%26aufirst%3DC.%2BS.%26aulast%3DHan%26aufirst%3DT.%26aulast%3DBae%26aufirst%3DM.-H.%26aulast%3DChong%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DShin%26aufirst%3DY.%2BA.%26aulast%3DAhn%26aufirst%3DB.-N.%26aulast%3DKim%26aufirst%3DM.%2BK.%26aulast%3DShin%26aufirst%3DC.%2BY.%26aulast%3DSon%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%2BK.%26aulast%3DMoon%26aufirst%3DH.%2BS.%26aulast%3DShim%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DE.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DLim%26aufirst%3DJ.%2BI.%26aulast%3DLee%26aufirst%3DC.%2BH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520novel%2520aryl-tetrahydropyridine%2520PPAR%25CE%25B1%252F%25CE%25B3%2520dual%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4993%26epage%3D4996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Allerton, C. M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, K. K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMurray, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, L.</span><span> </span><span class="NLM_article-title">Design and synthesis of pyridazinone-based 5-HT2C agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5791</span><span class="NLM_x">–</span> <span class="NLM_lpage">5795</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5791-5795&author=C.+M.+N.+Allertonauthor=M.+D.+Andrewsauthor=J.+Blaggauthor=D.+Ellisauthor=E.+Evrardauthor=M.+P.+Greenauthor=K.+K.-C.+Liuauthor=G.+McMurrayauthor=M.+Ralphauthor=V.+Sandersonauthor=R.+Wardauthor=L.+Watson&title=Design+and+synthesis+of+pyridazinone-based+5-HT2C+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllerton%26aufirst%3DC.%2BM.%2BN.%26aulast%3DAndrews%26aufirst%3DM.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DEvrard%26aufirst%3DE.%26aulast%3DGreen%26aufirst%3DM.%2BP.%26aulast%3DLiu%26aufirst%3DK.%2BK.-C.%26aulast%3DMcMurray%26aufirst%3DG.%26aulast%3DRalph%26aufirst%3DM.%26aulast%3DSanderson%26aufirst%3DV.%26aulast%3DWard%26aufirst%3DR.%26aulast%3DWatson%26aufirst%3DL.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520pyridazinone-based%25205-HT2C%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5791%26epage%3D5795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Brown, D. L.; Grapperhaus, M. L.; Kassab, D. J.; Massa, M. A.; Mcdonald, J. J.; Mullins, P. B.; Rico, J. G.; Schmidt, M. A.</span><span> </span><span class="NLM_article-title">Preparation of piperidinyl- and piperazinylsulfonylmethyl hydroxamic acids and their use as protease inhibitors</span>. PCT Int. Appl. WO 2005042521 A2 20050512,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=D.+L.+Brown&author=M.+L.+Grapperhaus&author=D.+J.+Kassab&author=M.+A.+Massa&author=J.+J.+Mcdonald&author=P.+B.+Mullins&author=J.+G.+Rico&author=M.+A.+Schmidt&title=Preparation+of+piperidinyl-+and+piperazinylsulfonylmethyl+hydroxamic+acids+and+their+use+as+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BL.%26atitle%3DPreparation%2520of%2520piperidinyl-%2520and%2520piperazinylsulfonylmethyl%2520hydroxamic%2520acids%2520and%2520their%2520use%2520as%2520protease%2520inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Cioffi, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlin, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, R. J.</span><span> </span><span class="NLM_article-title">Convenient palladium-catalyzed preparation of primary anilines using a fluorous benzophenone imine reagent</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">845</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=841-845&author=C.+L.+Cioffiauthor=M.+L.+Berlinauthor=R.+J.+Herr&title=Convenient+palladium-catalyzed+preparation+of+primary+anilines+using+a+fluorous+benzophenone+imine+reagent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCioffi%26aufirst%3DC.%2BL.%26aulast%3DBerlin%26aufirst%3DM.%2BL.%26aulast%3DHerr%26aufirst%3DR.%2BJ.%26atitle%3DConvenient%2520palladium-catalyzed%2520preparation%2520of%2520primary%2520anilines%2520using%2520a%2520fluorous%2520benzophenone%2520imine%2520reagent%26jtitle%3DSynlett%26date%3D2004%26spage%3D841%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="note"><p class="first last">See <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for a detailed description of the cellular assay.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Day, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tickle, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holding, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhoti, H.</span><span> </span><span class="NLM_article-title">Crystal structure of human CDK4 in complex with a D-type cyclin</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">4166</span><span class="NLM_x">–</span> <span class="NLM_lpage">4170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=4166-4170&author=P.+J.+Dayauthor=A.+Cleasbyauthor=I.+J.+Tickleauthor=M.+O%E2%80%99Reillyauthor=J.+E.+Coyleauthor=F.+P.+Holdingauthor=R.+L.+McMenaminauthor=J.+Yonauthor=R.+Chopraauthor=C.+Lengauerauthor=H.+Jhoti&title=Crystal+structure+of+human+CDK4+in+complex+with+a+D-type+cyclin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DTickle%26aufirst%3DI.%2BJ.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DHolding%26aufirst%3DF.%2BP.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DYon%26aufirst%3DJ.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DCrystal%2520structure%2520of%2520human%2520CDK4%2520in%2520complex%2520with%2520a%2520D-type%2520cyclin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D4166%26epage%3D4170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Gahmen, U.</span><span> </span><span class="NLM_article-title">Toward understanding the structural basis of cyclin-dependent kinase 6 specific inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3826</span><span class="NLM_x">–</span> <span class="NLM_lpage">3831</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0600388" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVKgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3826-3831&author=H.+Luauthor=U.+Schulze-Gahmen&title=Toward+understanding+the+structural+basis+of+cyclin-dependent+kinase+6+specific+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">Toward Understanding the Structural Basis of Cyclin-Dependent Kinase 6 Specific Inhibition</span></div><div class="casAuthors">Lu, Heshu; Schulze-Gahmen, Ursula</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3826-3831</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (CDKs) are key players in cell cycle control, and genetic alterations of CDKs and their regulators have been linked to a variety of cancers.  Hence, CDKs are obvious targets for therapeutic intervention in various proliferative diseases, including cancer.  To date, drug design efforts have mostly focused on CDK2 because methods for crystn. of its inhibitor complexes have been well established.  CDK4 and CDK6, however, may be at least as important as enzymes for cell cycle regulation and could provide alternative treatment options.  We describe here two complex structures of human CDK6 with a very specific kinase inhibitor, PD0332991, which is based on a pyrido[2,3-d]pyrimidin-7-one scaffold, and with the less specific aminopurvalanol inhibitor.  Anal. of the structures suggests that relatively small conformational differences between CDK2 and CDK6 in the hinge region are contributing to the inhibitor specificity by inducing changes in the inhibitor orientation that lead to sterical clashes in CDK2 but not CDK6.  These complex structures provide valuable insights for the future development of CDK-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt5qOCDA_blLVg90H21EOLACvtfcHk0ljr-X0LrrbISg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVKgtbk%253D&md5=218bcdfeac3e7371e3ae16ab0a5799db</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1021%2Fjm0600388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0600388%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DH.%26aulast%3DSchulze-Gahmen%26aufirst%3DU.%26atitle%3DToward%2520understanding%2520the%2520structural%2520basis%2520of%2520cyclin-dependent%2520kinase%25206%2520specific%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3826%26epage%3D3831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baratte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Gahmen, U.</span><span> </span><span class="NLM_article-title">Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">743</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049353p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFSqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=737-743&author=H.+Luauthor=D.+J.+Changauthor=B.+Baratteauthor=L.+Meijerauthor=U.+Schulze-Gahmen&title=Crystal+structure+of+a+human+cyclin-dependent+kinase+6+complex+with+a+flavonol+inhibitor%2C+fisetin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23cR"><div class="casContent"><span class="casTitleNuber">23c</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of a Human Cyclin-Dependent Kinase 6 Complex with a Flavonol Inhibitor, Fisetin</span></div><div class="casAuthors">Lu, Heshu; Chang, Debbie J.; Baratte, Blandine; Meijer, Laurent; Schulze-Gahmen, Ursula</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">737-743</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (CDKs) play a central role in cell cycle control, apoptosis, transcription, and neuronal functions.  They are important targets for the design of drugs with antimitotic or antineurodegenerative effects.  CDK4 and CDK6 form a subfamily among the CDKs in mammalian cells, as defined by sequence similarities.  Compared to CDK2 and CDK5, structural information on CDK4 and CDK6 is sparse.  We describe here the crystal structure of human CDK6 in complex with a viral cyclin and a flavonol inhibitor, fisetin.  Fisetin binds to the active form of CDK6, forming hydrogen bonds with the side chains of residues in the binding pocket that undergo large conformational changes during CDK activation by cyclin binding.  The 4-keto group and the 3-hydroxyl group of fisetin are hydrogen bonded with the backbone in the hinge region between the N-terminal and C-terminal kinase domain, as has been obsd. for many CDK inhibitors.  However, CDK2 and HCK kinase in complex with other flavone inhibitors such as quercetin and flavopiridol showed a different binding mode with the inhibitor rotated by about 180°.  The structural information of the CDK6-fisetin complex is correlated with the binding affinities of different flavone inhibitors for CDK6.  This complex structure is the first description of an inhibitor complex with a kinase from the CDK4/6 subfamily and can provide a basis for selecting and designing inhibitor compds. with higher affinities and specificities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeJrMaE-wOqrVg90H21EOLACvtfcHk0ljr-X0LrrbISg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFSqsQ%253D%253D&md5=0c3910ed0310038be241230a633ba840</span></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.1021%2Fjm049353p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049353p%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DD.%2BJ.%26aulast%3DBaratte%26aufirst%3DB.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DSchulze-Gahmen%26aufirst%3DU.%26atitle%3DCrystal%2520structure%2520of%2520a%2520human%2520cyclin-dependent%2520kinase%25206%2520complex%2520with%2520a%2520flavonol%2520inhibitor%252C%2520fisetin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D737%26epage%3D743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Honma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukasawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeura, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikuta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki-Takahashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima, H.</span><span> </span><span class="NLM_article-title">A novel approach for the development of selective Cdk4 inhibitors: library design based on locations of Cdk4 specific amino acid residues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4628</span><span class="NLM_x">–</span> <span class="NLM_lpage">4640</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010326y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4628-4640&author=T.+Honmaauthor=T.+Yoshizumiauthor=N.+Hashimotoauthor=K.+Hayashiauthor=N.+Kawanishiauthor=K.+Fukasawaauthor=T.+Takakiauthor=C.+Ikeuraauthor=M.+Ikutaauthor=I.+Suzuki-Takahashiauthor=T.+Hayamaauthor=S.+Nishimuraauthor=H.+Morishima&title=A+novel+approach+for+the+development+of+selective+Cdk4+inhibitors%3A+library+design+based+on+locations+of+Cdk4+specific+amino+acid+residues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Fjm010326y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010326y%26sid%3Dliteratum%253Aachs%26aulast%3DHonma%26aufirst%3DT.%26aulast%3DYoshizumi%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DN.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DKawanishi%26aufirst%3DN.%26aulast%3DFukasawa%26aufirst%3DK.%26aulast%3DTakaki%26aufirst%3DT.%26aulast%3DIkeura%26aufirst%3DC.%26aulast%3DIkuta%26aufirst%3DM.%26aulast%3DSuzuki-Takahashi%26aufirst%3DI.%26aulast%3DHayama%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DS.%26aulast%3DMorishima%26aufirst%3DH.%26atitle%3DA%2520novel%2520approach%2520for%2520the%2520development%2520of%2520selective%2520Cdk4%2520inhibitors%253A%2520library%2520design%2520based%2520on%2520locations%2520of%2520Cdk4%2520specific%2520amino%2520acid%2520residues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D4628%26epage%3D4640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pratt, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E. M.</span><span> </span><span class="NLM_article-title">Dissecting the determinants of cyclin-dependent kinase 2 and dyclin-cependent kinase 4 inhibitor selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5470</span><span class="NLM_x">–</span> <span class="NLM_lpage">5477</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060216x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5470-5477&author=D.+J.+Prattauthor=J.+Bentleyauthor=P.+Jewsburyauthor=F.+T.+Boyleauthor=J.+A.+Endicottauthor=M.+E.+M.+Noble&title=Dissecting+the+determinants+of+cyclin-dependent+kinase+2+and+dyclin-cependent+kinase+4+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1021%2Fjm060216x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060216x%26sid%3Dliteratum%253Aachs%26aulast%3DPratt%26aufirst%3DD.%2BJ.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DNoble%26aufirst%3DM.%2BE.%2BM.%26atitle%3DDissecting%2520the%2520determinants%2520of%2520cyclin-dependent%2520kinase%25202%2520and%2520dyclin-cependent%2520kinase%25204%2520inhibitor%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5470%26epage%3D5477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jones, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blades, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byth, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, M. R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, H. M.</span><span> </span><span class="NLM_article-title">Imidazole pyrimidine amides as potent, orally bioavailable cyclin-dependent kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6486</span><span class="NLM_x">–</span> <span class="NLM_lpage">6489</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6486-6489&author=C.+D.+Jonesauthor=D.+M.+Andrewsauthor=A.+J.+Barkerauthor=K.+Bladesauthor=K.+F.+Bythauthor=M.+R.+V.+Finlayauthor=C.+Gehauthor=C.+P.+Greenauthor=M.+Johannsenauthor=M.+Walkerauthor=H.+M.+Weir&title=Imidazole+pyrimidine+amides+as+potent%2C+orally+bioavailable+cyclin-dependent+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BD.%26aulast%3DAndrews%26aufirst%3DD.%2BM.%26aulast%3DBarker%26aufirst%3DA.%2BJ.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DByth%26aufirst%3DK.%2BF.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%2BV.%26aulast%3DGeh%26aufirst%3DC.%26aulast%3DGreen%26aufirst%3DC.%2BP.%26aulast%3DJohannsen%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DM.%26aulast%3DWeir%26aufirst%3DH.%2BM.%26atitle%3DImidazole%2520pyrimidine%2520amides%2520as%2520potent%252C%2520orally%2520bioavailable%2520cyclin-dependent%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6486%26epage%3D6489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jones, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blades, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daunt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">East, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loddick, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarland, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGregor, A.a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudge, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swain, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M.</span><span> </span><span class="NLM_article-title">The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosing</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6369</span><span class="NLM_x">–</span> <span class="NLM_lpage">6373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1016%2Fj.bmcl.2008.10.102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=18996007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWjs7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6369-6373&author=C.+D.+Jonesauthor=D.+M.+Andrewsauthor=A.+J.+Barkerauthor=K.+Bladesauthor=P.+Dauntauthor=S.+Eastauthor=C.+Gehauthor=M.+A.+Grahamauthor=K.+M.+Johnsonauthor=S.+A.+Loddickauthor=H.+M.+McFarlandauthor=A.a+McGregorauthor=L.+Mossauthor=D.+A.+Rudgeauthor=P.+B.+Simpsonauthor=M.+L.+Swainauthor=K.+Y.+Tamauthor=J.+A.+Tuckerauthor=M.+Walker&title=The+discovery+of+AZD5597%2C+a+potent+imidazole+pyrimidine+amide+CDK+inhibitor+suitable+for+intravenous+dosing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosing</span></div><div class="casAuthors">Jones, Clifford D.; Andrews, David M.; Barker, Andrew J.; Blades, Kevin; Daunt, Paula; East, Simon; Geh, Catherine; Graham, Mark A.; Johnson, Keith M.; Loddick, Sarah A.; McFarland, Heather M.; McGregor, Alexandra; Moss, Louise; Rudge, David A.; Simpson, Peter B.; Swain, Michael L.; Tam, Kin Y.; Tucker, Julie A.; Walker, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6369-6373</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The development of a novel series of imidazole pyrimidine amides as cyclin-dependent kinase (CDK) inhibitors is described.  Optimization of inhibitory potency against multiple CDK's (1, 2 and 9) resulted in imidazole pyrimidine amides with potent in vitro anti-proliferative effects against a range of cancer cell lines.  Excellent physiochem. properties and large margins against inhibition of CYP isoforms and the hERG ion channel were achieved by modification of lipophilicity and amine basicity.  A candidate with disease model activity in human cancer cell line xenografts and with suitable physiochem. and pharmacokinetic profiles for i.v. (iv) dosing was selected for further development as AZD5597 (I).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnX9-GP03dzbVg90H21EOLACvtfcHk0liBMghBbvvXIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWjs7bP&md5=084ed54076134c7173953ebbdb23fd86</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.10.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.10.102%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BD.%26aulast%3DAndrews%26aufirst%3DD.%2BM.%26aulast%3DBarker%26aufirst%3DA.%2BJ.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DDaunt%26aufirst%3DP.%26aulast%3DEast%26aufirst%3DS.%26aulast%3DGeh%26aufirst%3DC.%26aulast%3DGraham%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DK.%2BM.%26aulast%3DLoddick%26aufirst%3DS.%2BA.%26aulast%3DMcFarland%26aufirst%3DH.%2BM.%26aulast%3DMcGregor%26aufirst%3DA.a%26aulast%3DMoss%26aufirst%3DL.%26aulast%3DRudge%26aufirst%3DD.%2BA.%26aulast%3DSimpson%26aufirst%3DP.%2BB.%26aulast%3DSwain%26aufirst%3DM.%2BL.%26aulast%3DTam%26aufirst%3DK.%2BY.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DWalker%26aufirst%3DM.%26atitle%3DThe%2520discovery%2520of%2520AZD5597%252C%2520a%2520potent%2520imidazole%2520pyrimidine%2520amide%2520CDK%2520inhibitor%2520suitable%2520for%2520intravenous%2520dosing%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6369%26epage%3D6373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Anderson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brassington, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byth, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culshaw, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, M. R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMiken, H. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcombe, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakes, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauptit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanway, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, H. M.</span><span> </span><span class="NLM_article-title">Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5487</span><span class="NLM_x">–</span> <span class="NLM_lpage">5492</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5487-5492&author=M.+Andersonauthor=D.+M.+Andrewsauthor=A.+J.+Barkerauthor=C.+A.+Brassingtonauthor=J.+Breedauthor=K.+F.+Bythauthor=J.+D.+Culshawauthor=M.+R.+V.+Finlayauthor=E.+Fisherauthor=H.+H.+J.+McMikenauthor=C.+P.+Greenauthor=D.+W.+Heatonauthor=I.+A.+Nashauthor=N.+J.+Newcombeauthor=S.+E.+Oakesauthor=R.+A.+Pauptitauthor=A.+Robertsauthor=J.+J.+Stanwayauthor=A.+P.+Thomasauthor=J.+A.+Tuckerauthor=M.+Walkerauthor=H.+M.+Weir&title=Imidazoles%3A+SAR+and+development+of+a+potent+class+of+cyclin-dependent+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DAndrews%26aufirst%3DD.%2BM.%26aulast%3DBarker%26aufirst%3DA.%2BJ.%26aulast%3DBrassington%26aufirst%3DC.%2BA.%26aulast%3DBreed%26aufirst%3DJ.%26aulast%3DByth%26aufirst%3DK.%2BF.%26aulast%3DCulshaw%26aufirst%3DJ.%2BD.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%2BV.%26aulast%3DFisher%26aufirst%3DE.%26aulast%3DMcMiken%26aufirst%3DH.%2BH.%2BJ.%26aulast%3DGreen%26aufirst%3DC.%2BP.%26aulast%3DHeaton%26aufirst%3DD.%2BW.%26aulast%3DNash%26aufirst%3DI.%2BA.%26aulast%3DNewcombe%26aufirst%3DN.%2BJ.%26aulast%3DOakes%26aufirst%3DS.%2BE.%26aulast%3DPauptit%26aufirst%3DR.%2BA.%26aulast%3DRoberts%26aufirst%3DA.%26aulast%3DStanway%26aufirst%3DJ.%2BJ.%26aulast%3DThomas%26aufirst%3DA.%2BP.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DWalker%26aufirst%3DM.%26aulast%3DWeir%26aufirst%3DH.%2BM.%26atitle%3DImidazoles%253A%2520SAR%2520and%2520development%2520of%2520a%2520potent%2520class%2520of%2520cyclin-dependent%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5487%26epage%3D5492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Matter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazare, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guessregen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreuder, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehner, V.</span><span> </span><span class="NLM_article-title">Evidence for C-Cl/C-Br···π interactions as an important contribution to protein−ligand binding affinity</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2911</span><span class="NLM_x">–</span> <span class="NLM_lpage">2916</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=2911-2916&author=H.+Matterauthor=M.+Nazareauthor=S.+Guessregenauthor=D.+W.+Willauthor=H.+Schreuderauthor=A.+Bauerauthor=M.+Urmannauthor=K.+Ritterauthor=M.+Wagnerauthor=V.+Wehner&title=Evidence+for+C-Cl%2FC-Br%C2%B7%C2%B7%C2%B7%CF%80+interactions+as+an+important+contribution+to+protein%E2%88%92ligand+binding+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatter%26aufirst%3DH.%26aulast%3DNazare%26aufirst%3DM.%26aulast%3DGuessregen%26aufirst%3DS.%26aulast%3DWill%26aufirst%3DD.%2BW.%26aulast%3DSchreuder%26aufirst%3DH.%26aulast%3DBauer%26aufirst%3DA.%26aulast%3DUrmann%26aufirst%3DM.%26aulast%3DRitter%26aufirst%3DK.%26aulast%3DWagner%26aufirst%3DM.%26aulast%3DWehner%26aufirst%3DV.%26atitle%3DEvidence%2520for%2520C-Cl%252FC-Br%25C2%25B7%25C2%25B7%25C2%25B7%25CF%2580%2520interactions%2520as%2520an%2520important%2520contribution%2520to%2520protein%25E2%2588%2592ligand%2520binding%2520affinity%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2009%26volume%3D48%26spage%3D2911%26epage%3D2916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Otwinowski, Z; Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray diffraction data collected in oscillation mode</span>.  <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span>− <span class="NLM_lpage">326</span> (Macromolecular Crystallography, Part A).</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z+Otwinowski&author=W.+Minor&title=Processing+of+X-ray+diffraction+data+collected+in+oscillation+mode"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0lh93pXXiDAwgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ%26atitle%3DProcessing%2520of%2520X-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Bailey, S.</span><span> </span><span class="NLM_article-title">The CCP4 suite: programs for protein crystallography</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=15299374" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=760-763&author=S.+Bailey&title=The+CCP4+suite%3A+programs+for+protein+crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DS.%26atitle%3DThe%2520CCP4%2520suite%253A%2520programs%2520for%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3D50%26spage%3D760%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Brunger, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clore, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLano, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gros, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuszewski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilges, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, G. L.</span><span> </span><span class="NLM_article-title">Crystallography & NMR system: a new software suite for macromolecular structure determination</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">921</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1107%2FS0907444998003254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=9757107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADyaK1cXmsVKgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=905-921&author=A.+T.+Brungerauthor=P.+D.+Adamsauthor=G.+M.+Cloreauthor=W.+L.+DeLanoauthor=P.+Grosauthor=R.+W.+Grosse-Kunstleveauthor=J.+S.+Jiangauthor=J.+Kuszewskiauthor=M.+Nilgesauthor=N.+S.+Pannuauthor=R.+J.+Readauthor=L.+M.+Riceauthor=T.+Simonsonauthor=G.+L.+Warren&title=Crystallography+%26+NMR+system%3A+a+new+software+suite+for+macromolecular+structure+determination"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallography & NMR System: a new software suite for macromolecular structure determination</span></div><div class="casAuthors">Brunger, Axel T.; Adams, Paul D.; Clore, G. Marius; DeLano, Warren L.; Gros, Piet; Grosse-Kunstleve, Ralf W.; Jiang, Jian-Sheng; Kuszewski, John; Nilges, Michael; Pannu, Navraj S.; Read, Randy J.; Rice, Luke M.; Simonson, Thomas; Warren, Gregory L.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">D54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">905-921</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">A new software suite, called Crystallog. & NMR System (CNS), has been developed for macromol. structure detn. by x-ray crystallog. or soln. NMR (NMR) spectroscopy.  In contrast to existing structure-detn. programs the architecture of CNS is highly flexible, allowing for extension to other structure-detn. methods, such as electron microscopy and solid-state NMR spectroscopy.  CNS has a hierarchical structure: a high-level hypertext markup language (HTML) user interface, task-oriented user input files, module files, a symbolic structure-detn. language (CNS language), and low-level source code.  Each layer is accessible to the user.  The novice user may just use the HTML interface, while the more advanced user may use any of the other layers.  The source code will be distributed, thus source-code modification is possible.  The CNS language is sufficiently powerful and flexible that many new algorithms can be easily implemented in the CNS language without changes to the source code.  The CNS language allows the user to perform operations on data structures, such as structure factors, electron-d. maps, and at. properties.  The power of the CNS language has been demonstrated by the implementation of a comprehensive set of crystallog. procedures for phasing, d. modification and refinement.  User-friendly task-oriented input files are available for nearly all aspects of macromol. structure detn. by x-ray crystallog. and soln. NMR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrffnnqTlxIurVg90H21EOLACvtfcHk0lh93pXXiDAwgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsVKgsbo%253D&md5=1ff3025ab69077f4086a6e3d8ef99bf8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0907444998003254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444998003254%26sid%3Dliteratum%253Aachs%26aulast%3DBrunger%26aufirst%3DA.%2BT.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DClore%26aufirst%3DG.%2BM.%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26aulast%3DGros%26aufirst%3DP.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DJiang%26aufirst%3DJ.%2BS.%26aulast%3DKuszewski%26aufirst%3DJ.%26aulast%3DNilges%26aufirst%3DM.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRice%26aufirst%3DL.%2BM.%26aulast%3DSimonson%26aufirst%3DT.%26aulast%3DWarren%26aufirst%3DG.%2BL.%26atitle%3DCrystallography%2520%2526%2520NMR%2520system%253A%2520a%2520new%2520software%2520suite%2520for%2520macromolecular%2520structure%2520determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1998%26volume%3D54%26spage%3D905%26epage%3D921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b','cit2c','cit2d','cit2e','cit2f','cit2g','cit2h'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b','cit4c','cit4d','cit4e','cit4f','cit4g'],'ref5':['cit5a','cit5b','cit5c'],'ref6':['cit6a','cit6b','cit6c'],'ref7':['cit7a','cit7b','cit7c','cit7d'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b','cit9c','cit9d','cit9e','cit9f'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12a','cit12b','cit12c','cit12d','cit12e','cit12f','cit12g','cit12h','cit12i'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':[],'ref23':['cit23a','cit23b','cit23c'],'ref24':['cit24a','cit24b'],'ref25':['cit25a','cit25b','cit25c'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 55 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Mohd Yousuf, Parvez Khan, Anas Shamsi, Mohd Shahbaaz, Gulam Mustafa Hasan, Qazi Mohd Rizwanul Haque, Alan Christoffels, Asimul Islam, <span class="NLM_string-name hlFld-ContribAuthor">Md. Imtaiyaz Hassan</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibiting CDK6 Activity by Quercetin Is an Attractive Strategy for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (42)
                                     , 27480-27491. <a href="https://doi.org/10.1021/acsomega.0c03975" title="DOI URL">https://doi.org/10.1021/acsomega.0c03975</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c03975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c03975%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DInhibiting%252BCDK6%252BActivity%252Bby%252BQuercetin%252BIs%252Ban%252BAttractive%252BStrategy%252Bfor%252BCancer%252BTherapy%26aulast%3DYousuf%26aufirst%3DMohd%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D18082020%26date%3D30092020%26date%3D14102020%26volume%3D5%26issue%3D42%26spage%3D27480%26epage%3D27491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Cheng</span>, <span class="hlFld-ContribAuthor ">Jian  Wei</span>, <span class="hlFld-ContribAuthor ">Bing  Zu</span>, <span class="hlFld-ContribAuthor ">Jianfei  Zhao</span>, <span class="hlFld-ContribAuthor ">Taimin  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Duan</span>, <span class="hlFld-ContribAuthor ">Renqi  Wang</span>, <span class="hlFld-ContribAuthor ">Yun  Li</span>, and <span class="hlFld-ContribAuthor ">Hongbin  Zhai</span>  . </span><span class="cited-content_cbyCitation_article-title">A Chemoselective N-Arylation Reaction of 2-Aminopyridine Derivatives with Arynes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (18)
                                     , 9410-9417. <a href="https://doi.org/10.1021/acs.joc.7b01405" title="DOI URL">https://doi.org/10.1021/acs.joc.7b01405</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b01405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b01405%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252BChemoselective%252BN-Arylation%252BReaction%252Bof%252B2-Aminopyridine%252BDerivatives%252Bwith%252BArynes%26aulast%3DCheng%26aufirst%3DBin%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D07062017%26date%3D30082017%26date%3D15092017%26date%3D15082017%26volume%3D82%26issue%3D18%26spage%3D9410%26epage%3D9417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priya  Mahajan</span>, <span class="hlFld-ContribAuthor ">Gousia  Chashoo</span>, <span class="hlFld-ContribAuthor ">Monika  Gupta</span>, <span class="hlFld-ContribAuthor ">Amit  Kumar</span>, <span class="hlFld-ContribAuthor ">Parvinder Pal  Singh</span>, and <span class="hlFld-ContribAuthor ">Amit  Nargotra</span>  . </span><span class="cited-content_cbyCitation_article-title">Fusion of Structure and Ligand Based Methods for Identification of Novel CDK2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (8)
                                     , 1957-1969. <a href="https://doi.org/10.1021/acs.jcim.7b00293" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00293</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00293%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DFusion%252Bof%252BStructure%252Band%252BLigand%252BBased%252BMethods%252Bfor%252BIdentification%252Bof%252BNovel%252BCDK2%252BInhibitors%26aulast%3DMahajan%26aufirst%3DPriya%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D22052017%26date%3D03082017%26date%3D28082017%26date%3D19072017%26volume%3D57%26issue%3D8%26spage%3D1957%26epage%3D1969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Kruszyk</span>, <span class="hlFld-ContribAuthor ">Mikkel  Jessing</span>, <span class="hlFld-ContribAuthor ">Jesper Langgaard  Kristensen</span>, and <span class="hlFld-ContribAuthor ">Morten  Jørgensen</span>  . </span><span class="cited-content_cbyCitation_article-title">Computational Methods to Predict the Regioselectivity of Electrophilic Aromatic Substitution Reactions of Heteroaromatic Systems. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (12)
                                     , 5128-5134. <a href="https://doi.org/10.1021/acs.joc.6b00584" title="DOI URL">https://doi.org/10.1021/acs.joc.6b00584</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b00584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b00584%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DComputational%252BMethods%252Bto%252BPredict%252Bthe%252BRegioselectivity%252Bof%252BElectrophilic%252BAromatic%252BSubstitution%252BReactions%252Bof%252BHeteroaromatic%252BSystems%26aulast%3DKruszyk%26aufirst%3DMonika%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D31032016%26date%3D31052016%26date%3D17062016%26date%3D13052016%26volume%3D81%26issue%3D12%26spage%3D5128%26epage%3D5134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Boris A.  Trofimov</span>, <span class="hlFld-ContribAuthor ">Ludmila V.  Andriyankova</span>, <span class="hlFld-ContribAuthor ">Lina P.  Nikitina</span>, <span class="hlFld-ContribAuthor ">Kseniya V.  Belyaeva</span>, <span class="hlFld-ContribAuthor ">Anastasia G.  Mal’kina</span>, <span class="hlFld-ContribAuthor ">Lubov N.  Sobenina</span>, <span class="hlFld-ContribAuthor ">Andrei V.  Afonin</span>, and <span class="hlFld-ContribAuthor ">Igor A.  Ushakov</span>  . </span><span class="cited-content_cbyCitation_article-title">Stereoselective Tandem Ring Opening of Imidazoles with Electron-Deficient Acetylenes and Water: Synthesis of Functionalized (Z,Z)-1,4-Diaza-2,5-dienes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2013,</strong> <em>15 </em>
                                    (9)
                                     , 2322-2324. <a href="https://doi.org/10.1021/ol400844x" title="DOI URL">https://doi.org/10.1021/ol400844x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol400844x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol400844x%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DStereoselective%252BTandem%252BRing%252BOpening%252Bof%252BImidazoles%252Bwith%252BElectron-Deficient%252BAcetylenes%252Band%252BWater%25253A%252BSynthesis%252Bof%252BFunctionalized%252B%252528Z%25252CZ%252529-1%25252C4-Diaza-2%25252C5-dienes%26aulast%3DTrofimov%26aufirst%3DBoris%2BA.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D27032013%26date%3D25042013%26date%3D03052013%26volume%3D15%26issue%3D9%26spage%3D2322%26epage%3D2324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anette  Witt</span>, <span class="hlFld-ContribAuthor ">Peter  Teodorovic</span>, <span class="hlFld-ContribAuthor ">Mats  Linderberg</span>, <span class="hlFld-ContribAuthor ">Peter  Johansson</span>, and <span class="hlFld-ContribAuthor ">Anna  Minidis</span>  . </span><span class="cited-content_cbyCitation_article-title">A Novel Scalable Process to the GSK3β Inhibitor AZD8926 Based on a Heterocyclic Ziegler Coupling. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2013,</strong> <em>17 </em>
                                    (4)
                                     , 672-678. <a href="https://doi.org/10.1021/op300365e" title="DOI URL">https://doi.org/10.1021/op300365e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op300365e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop300365e%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DA%252BNovel%252BScalable%252BProcess%252Bto%252Bthe%252BGSK3%2525CE%2525B2%252BInhibitor%252BAZD8926%252BBased%252Bon%252Ba%252BHeterocyclic%252BZiegler%252BCoupling%26aulast%3DWitt%26aufirst%3DAnette%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D20122012%26date%3D08042013%26date%3D19042013%26date%3D22032013%26volume%3D17%26issue%3D4%26spage%3D672%26epage%3D678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H. Billur  Engin</span>, <span class="hlFld-ContribAuthor ">Ozlem  Keskin</span>, <span class="hlFld-ContribAuthor ">Ruth  Nussinov</span>, and <span class="hlFld-ContribAuthor ">Attila  Gursoy</span>  . </span><span class="cited-content_cbyCitation_article-title">A Strategy Based on Protein–Protein Interface Motifs May Help in Identifying Drug Off-Targets. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2012,</strong> <em>52 </em>
                                    (8)
                                     , 2273-2286. <a href="https://doi.org/10.1021/ci300072q" title="DOI URL">https://doi.org/10.1021/ci300072q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci300072q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci300072q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DA%252BStrategy%252BBased%252Bon%252BProtein%2525E2%252580%252593Protein%252BInterface%252BMotifs%252BMay%252BHelp%252Bin%252BIdentifying%252BDrug%252BOff-Targets%26aulast%3DEngin%26aufirst%3DH.%2BBillur%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D06022012%26date%3D31072012%26date%3D27082012%26date%3D20072012%26volume%3D52%26issue%3D8%26spage%3D2273%26epage%3D2286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young Shin  Cho</span>, <span class="hlFld-ContribAuthor ">Hayley  Angove</span>, <span class="hlFld-ContribAuthor ">Christopher  Brain</span>, <span class="hlFld-ContribAuthor ">Christine Hiu-Tung  Chen</span>, <span class="hlFld-ContribAuthor ">Hong  Cheng</span>, <span class="hlFld-ContribAuthor ">Robert  Cheng</span>, <span class="hlFld-ContribAuthor ">Rajiv  Chopra</span>, <span class="hlFld-ContribAuthor ">Kristy  Chung</span>, <span class="hlFld-ContribAuthor ">Miles  Congreve</span>, <span class="hlFld-ContribAuthor ">Claudio  Dagostin</span>, <span class="hlFld-ContribAuthor ">Deborah J.  Davis</span>, <span class="hlFld-ContribAuthor ">Ruth  Feltell</span>, <span class="hlFld-ContribAuthor ">John  Giraldes</span>, <span class="hlFld-ContribAuthor ">Steven D.  Hiscock</span>, <span class="hlFld-ContribAuthor ">Sunkyu  Kim</span>, <span class="hlFld-ContribAuthor ">Steven  Kovats</span>, <span class="hlFld-ContribAuthor ">Bharat  Lagu</span>, <span class="hlFld-ContribAuthor ">Kim  Lewry</span>, <span class="hlFld-ContribAuthor ">Alice  Loo</span>, <span class="hlFld-ContribAuthor ">Yipin  Lu</span>, <span class="hlFld-ContribAuthor ">Michael  Luzzio</span>, <span class="hlFld-ContribAuthor ">Wiesia  Maniara</span>, <span class="hlFld-ContribAuthor ">Rachel  McMenamin</span>, <span class="hlFld-ContribAuthor ">Paul N.  Mortenson</span>, <span class="hlFld-ContribAuthor ">Rajdeep  Benning</span>, <span class="hlFld-ContribAuthor ">Marc  O'Reilly</span>, <span class="hlFld-ContribAuthor ">David C.  Rees</span>, <span class="hlFld-ContribAuthor ">Junqing  Shen</span>, <span class="hlFld-ContribAuthor ">Troy  Smith</span>, <span class="hlFld-ContribAuthor ">Yaping  Wang</span>, <span class="hlFld-ContribAuthor ">Glyn  Williams</span>, <span class="hlFld-ContribAuthor ">Alison J.-A.  Woolford</span>, <span class="hlFld-ContribAuthor ">Wojciech  Wrona</span>, <span class="hlFld-ContribAuthor ">Mei  Xu</span>, <span class="hlFld-ContribAuthor ">Fan  Yang</span>, and <span class="hlFld-ContribAuthor ">Steven  Howard</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>3 </em>
                                    (6)
                                     , 445-449. <a href="https://doi.org/10.1021/ml200241a" title="DOI URL">https://doi.org/10.1021/ml200241a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml200241a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml200241a%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFragment-Based%252BDiscovery%252Bof%252B7-Azabenzimidazoles%252Bas%252BPotent%25252C%252BHighly%252BSelective%25252C%252Band%252BOrally%252BActive%252BCDK4%25252F6%252BInhibitors%26aulast%3DCho%26aufirst%3DYoung%2BShin%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D02122011%26date%3D16042012%26date%3D17052012%26date%3D14062012%26volume%3D3%26issue%3D6%26spage%3D445%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Belem  Avila</span>, <span class="hlFld-ContribAuthor ">Danielle M.  Solano</span>, <span class="hlFld-ContribAuthor ">Makhluf J.  Haddadin</span>, and <span class="hlFld-ContribAuthor ">Mark J.  Kurth</span>  . </span><span class="cited-content_cbyCitation_article-title">Facile Syntheses of Novel Benzo- 1,3-dioxolo-, Benzothiazolo-, Pyrido-, and Quinolino-fused 5H-Benzo[d]-pyrazolo[5,1-b][1,3]-oxazines and 1H-Pyrazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2011,</strong> <em>13 </em>
                                    (5)
                                     , 1060-1063. <a href="https://doi.org/10.1021/ol103108z" title="DOI URL">https://doi.org/10.1021/ol103108z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol103108z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol103108z%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DFacile%252BSyntheses%252Bof%252BNovel%252BBenzo-%252B1%25252C3-dioxolo-%25252C%252BBenzothiazolo-%25252C%252BPyrido-%25252C%252Band%252BQuinolino-fused%252B5H-Benzo%25255Bd%25255D-pyrazolo%25255B5%25252C1-b%25255D%25255B1%25252C3%25255D-oxazines%252Band%252B1H-Pyrazoles%26aulast%3DAvila%26aufirst%3DBelem%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D22122010%26date%3D04022011%26date%3D04032011%26volume%3D13%26issue%3D5%26spage%3D1060%26epage%3D1063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohd  Yousuf</span>, <span class="hlFld-ContribAuthor ">Anas  Shamsi</span>, <span class="hlFld-ContribAuthor ">Aarfa  Queen</span>, <span class="hlFld-ContribAuthor ">Mohd  Shahbaaz</span>, <span class="hlFld-ContribAuthor ">Parvez  Khan</span>, <span class="hlFld-ContribAuthor ">Afzal  Hussain</span>, <span class="hlFld-ContribAuthor ">Mohamed F.  Alajmi</span>, <span class="hlFld-ContribAuthor ">Qazi M.  Rizwanul Haque</span>, <span class="hlFld-ContribAuthor ">Md.  Imtaiyaz Hassan</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting cyclin‐dependent kinase 6 by vanillin inhibits proliferation of breast and lung cancer cells: Combined computational and biochemical studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Biochemistry</span><span> <strong>2021,</strong> <em>122 </em>
                                    (8)
                                     , 897-910. <a href="https://doi.org/10.1002/jcb.29921" title="DOI URL">https://doi.org/10.1002/jcb.29921</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcb.29921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcb.29921%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Biochemistry%26atitle%3DTargeting%252Bcyclin%2525E2%252580%252590dependent%252Bkinase%252B6%252Bby%252Bvanillin%252Binhibits%252Bproliferation%252Bof%252Bbreast%252Band%252Blung%252Bcancer%252Bcells%25253A%252BCombined%252Bcomputational%252Band%252Bbiochemical%252Bstudies%26aulast%3DYousuf%26aufirst%3DMohd%26date%3D2021%26date%3D2021%26volume%3D122%26issue%3D8%26spage%3D897%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eclair Venturini  Filho</span>, <span class="hlFld-ContribAuthor ">Erick M.C.  Pinheiro</span>, <span class="hlFld-ContribAuthor ">Sergio  Pinheiro</span>, <span class="hlFld-ContribAuthor ">Sandro J.  Greco</span>. </span><span class="cited-content_cbyCitation_article-title">Aminopyrimidines: Recent synthetic procedures and anticancer activities. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2021,</strong> <em>92 </em>, 132256. <a href="https://doi.org/10.1016/j.tet.2021.132256" title="DOI URL">https://doi.org/10.1016/j.tet.2021.132256</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2021.132256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2021.132256%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DAminopyrimidines%25253A%252BRecent%252Bsynthetic%252Bprocedures%252Band%252Banticancer%252Bactivities%26aulast%3DFilho%26aufirst%3DEclair%2BVenturini%26date%3D2021%26volume%3D92%26spage%3D132256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prosper Obed  Chukwuemeka</span>, <span class="hlFld-ContribAuthor ">Haruna Isiyaku  Umar</span>, <span class="hlFld-ContribAuthor ">Opeyemi  Iwaloye</span>, <span class="hlFld-ContribAuthor ">Oluwaseyi Matthew  Oretade</span>, <span class="hlFld-ContribAuthor ">Christopher Busayo  Olowosoke</span>, <span class="hlFld-ContribAuthor ">Oyeyemi Janet  Oretade</span>, <span class="hlFld-ContribAuthor ">Michael Omoniyi  Elabiyi</span>. </span><span class="cited-content_cbyCitation_article-title">Predictive hybrid paradigm for cytotoxic activity of 1,3,4-thiadiazole derivatives as CDK6 inhibitors against human (MCF-7) breast cancer cell line and its structural modifications: rational for novel cancer therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>5 </em>, 1-20. <a href="https://doi.org/10.1080/07391102.2021.1913231" title="DOI URL">https://doi.org/10.1080/07391102.2021.1913231</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1913231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1913231%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DPredictive%252Bhybrid%252Bparadigm%252Bfor%252Bcytotoxic%252Bactivity%252Bof%252B1%25252C3%25252C4-thiadiazole%252Bderivatives%252Bas%252BCDK6%252Binhibitors%252Bagainst%252Bhuman%252B%252528MCF-7%252529%252Bbreast%252Bcancer%252Bcell%252Bline%252Band%252Bits%252Bstructural%252Bmodifications%25253A%252Brational%252Bfor%252Bnovel%252Bcancer%252Btherapeutics%26aulast%3DChukwuemeka%26aufirst%3DProsper%2BObed%26date%3D2021%26date%3D2021%26volume%3D5%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher T.  Brain</span>, <span class="hlFld-ContribAuthor ">Rajiv  Chopra</span>, <span class="hlFld-ContribAuthor ">Sunkyu  Kim</span>, <span class="hlFld-ContribAuthor ">Steven  Howard</span>, <span class="hlFld-ContribAuthor ">Moo Je  Sung</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of Kisqali
              ®
              (Ribociclib): A
              CDK
              4/6 Inhibitor for the Treatment of
              HR
              +/
              HER
              2− Advanced Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 273-289. <a href="https://doi.org/10.1002/9783527826872.ch9" title="DOI URL">https://doi.org/10.1002/9783527826872.ch9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527826872.ch9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527826872.ch9%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Bof%252BKisqali%252B%2525C2%2525AE%252B%252528Ribociclib%252529%25253A%252BA%252BCDK%252B4%25252F6%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BHR%252B%25252B%25252F%252BHER%252B2%2525E2%252588%252592%252BAdvanced%252BBreast%252BCancer%26aulast%3DBrain%26aufirst%3DChristopher%2BT.%26date%3D2021%26date%3D2021%26spage%3D273%26epage%3D289%26pub%3DWiley%26atitle%3DSuccessful%252BDrug%252BDiscovery%26aulast%3DFischer%26aufirst%3DJ%25C3%25A1nos%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arpita  Roy</span>, <span class="hlFld-ContribAuthor ">Karanpreet Singh  Bhatia</span>. </span><span class="cited-content_cbyCitation_article-title">In silico analysis of plumbagin against cyclin-dependent kinases receptor. </span><span class="cited-content_cbyCitation_journal-name">Vegetos</span><span> <strong>2021,</strong> <em>34 </em>
                                    (1)
                                     , 50-56. <a href="https://doi.org/10.1007/s42535-020-00169-8" title="DOI URL">https://doi.org/10.1007/s42535-020-00169-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s42535-020-00169-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs42535-020-00169-8%26sid%3Dliteratum%253Aachs%26jtitle%3DVegetos%26atitle%3DIn%252Bsilico%252Banalysis%252Bof%252Bplumbagin%252Bagainst%252Bcyclin-dependent%252Bkinases%252Breceptor%26aulast%3DRoy%26aufirst%3DArpita%26date%3D2021%26date%3D2021%26volume%3D34%26issue%3D1%26spage%3D50%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Doaa A.  Abdelrheem</span>, <span class="hlFld-ContribAuthor ">Aziz A.  Rahman</span>, <span class="hlFld-ContribAuthor ">Khaled N.M.  Elsayed</span>, <span class="hlFld-ContribAuthor ">H.R.  Abd El-Mageed</span>, <span class="hlFld-ContribAuthor ">Hussein S.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Sayed A.  Ahmed</span>. </span><span class="cited-content_cbyCitation_article-title">Isolation, characterization, in vitro anticancer activity, dft calculations, molecular docking, bioactivity score, drug-likeness and admet studies of eight phytoconstituents from brown alga sargassum platycarpum. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1225 </em>, 129245. <a href="https://doi.org/10.1016/j.molstruc.2020.129245" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.129245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.129245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.129245%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DIsolation%25252C%252Bcharacterization%25252C%252Bin%252Bvitro%252Banticancer%252Bactivity%25252C%252Bdft%252Bcalculations%25252C%252Bmolecular%252Bdocking%25252C%252Bbioactivity%252Bscore%25252C%252Bdrug-likeness%252Band%252Badmet%252Bstudies%252Bof%252Beight%252Bphytoconstituents%252Bfrom%252Bbrown%252Balga%252Bsargassum%252Bplatycarpum%26aulast%3DAbdelrheem%26aufirst%3DDoaa%2BA.%26date%3D2021%26volume%3D1225%26spage%3D129245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Yuan</span>, <span class="hlFld-ContribAuthor ">Xiao  Wang</span>, <span class="hlFld-ContribAuthor ">Haojie  Dong</span>, <span class="hlFld-ContribAuthor ">Wenjian  Min</span>, <span class="hlFld-ContribAuthor ">Haiping  Hao</span>, <span class="hlFld-ContribAuthor ">Peng  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Selective inhibition of CDK4/6: A safe and effective strategy for developing anticancer drugs. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     , 30-54. <a href="https://doi.org/10.1016/j.apsb.2020.05.001" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DSelective%252Binhibition%252Bof%252BCDK4%25252F6%25253A%252BA%252Bsafe%252Band%252Beffective%252Bstrategy%252Bfor%252Bdeveloping%252Banticancer%252Bdrugs%26aulast%3DYuan%26aufirst%3DKai%26date%3D2021%26volume%3D11%26issue%3D1%26spage%3D30%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gary  Chinigo</span>, <span class="hlFld-ContribAuthor ">Yiqing  Feng</span>, <span class="hlFld-ContribAuthor ">Susan  Hoy</span>, <span class="hlFld-ContribAuthor ">Ricardo  Lira</span>, <span class="hlFld-ContribAuthor ">Matthew  Perry</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridazines and Their Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00082-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00082-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00082-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00082-2%26sid%3Dliteratum%253Aachs%26atitle%3DPyridazines%252Band%252BTheir%252BBenzo%252BDerivatives%26aulast%3DChinigo%26aufirst%3DGary%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brilliant N.  Marak</span>, <span class="hlFld-ContribAuthor ">Jayanta  Dowarah</span>, <span class="hlFld-ContribAuthor ">Laldingluaia  Khiangte</span>, <span class="hlFld-ContribAuthor ">Ved Prakash  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">A comprehensive insight on the recent development of Cyclic Dependent Kinase inhibitors as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>203 </em>, 112571. <a href="https://doi.org/10.1016/j.ejmech.2020.112571" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112571</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112571%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bcomprehensive%252Binsight%252Bon%252Bthe%252Brecent%252Bdevelopment%252Bof%252BCyclic%252BDependent%252BKinase%252Binhibitors%252Bas%252Banticancer%252Bagents%26aulast%3DMarak%26aufirst%3DBrilliant%2BN.%26date%3D2020%26volume%3D203%26spage%3D112571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohd  Yousuf</span>, <span class="hlFld-ContribAuthor ">Anas  Shamsi</span>, <span class="hlFld-ContribAuthor ">Parvez  Khan</span>, <span class="hlFld-ContribAuthor ">Mohd  Shahbaaz</span>, <span class="hlFld-ContribAuthor ">Mohamed F.  AlAjmi</span>, <span class="hlFld-ContribAuthor ">Afzal  Hussain</span>, <span class="hlFld-ContribAuthor ">Gulam Mustafa  Hassan</span>, <span class="hlFld-ContribAuthor ">Asimul  Islam</span>, <span class="hlFld-ContribAuthor ">Qazi Mohd  Rizwanul Haque</span>, <span class="hlFld-ContribAuthor ">Md. Imtaiyaz  Hassan</span>. </span><span class="cited-content_cbyCitation_article-title">Ellagic Acid Controls Cell Proliferation and Induces Apoptosis in Breast Cancer Cells via Inhibition of Cyclin-Dependent Kinase 6. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (10)
                                     , 3526. <a href="https://doi.org/10.3390/ijms21103526" title="DOI URL">https://doi.org/10.3390/ijms21103526</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21103526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21103526%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DEllagic%252BAcid%252BControls%252BCell%252BProliferation%252Band%252BInduces%252BApoptosis%252Bin%252BBreast%252BCancer%252BCells%252Bvia%252BInhibition%252Bof%252BCyclin-Dependent%252BKinase%252B6%26aulast%3DYousuf%26aufirst%3DMohd%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D10%26spage%3D3526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pingping  Chen</span>, <span class="hlFld-ContribAuthor ">Yinqiu  Xu</span>, <span class="hlFld-ContribAuthor ">Xuanyi  Li</span>, <span class="hlFld-ContribAuthor ">Hequan  Yao</span>, <span class="hlFld-ContribAuthor ">Kejiang  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Development and strategies of CDK4/6 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2020,</strong> <em>12 </em>
                                    (2)
                                     , 127-145. <a href="https://doi.org/10.4155/fmc-2019-0062" title="DOI URL">https://doi.org/10.4155/fmc-2019-0062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2019-0062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2019-0062%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Band%252Bstrategies%252Bof%252BCDK4%25252F6%252Binhibitors%26aulast%3DChen%26aufirst%3DPingping%26date%3D2020%26volume%3D12%26issue%3D2%26spage%3D127%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. P. Shyam  Shankar</span>, <span class="hlFld-ContribAuthor ">Damodaran  Bahulayan</span>. </span><span class="cited-content_cbyCitation_article-title">Chemistry, chemical biology and photophysics of certain new chromene–triazole–coumarin triads as fluorescent inhibitors of CDK2 and CDK4 induced cancers. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2019,</strong> <em>43 </em>
                                    (35)
                                     , 13863-13872. <a href="https://doi.org/10.1039/C9NJ02924A" title="DOI URL">https://doi.org/10.1039/C9NJ02924A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NJ02924A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NJ02924A%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DChemistry%25252C%252Bchemical%252Bbiology%252Band%252Bphotophysics%252Bof%252Bcertain%252Bnew%252Bchromene%2525E2%252580%252593triazole%2525E2%252580%252593coumarin%252Btriads%252Bas%252Bfluorescent%252Binhibitors%252Bof%252BCDK2%252Band%252BCDK4%252Binduced%252Bcancers%26aulast%3DShankar%26aufirst%3DE.%2BP.%2BShyam%26date%3D2019%26date%3D2019%26volume%3D43%26issue%3D35%26spage%3D13863%26epage%3D13872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah M.  Bronner</span>, <span class="hlFld-ContribAuthor ">Karl A.  Merrick</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Laurent  Salphati</span>, <span class="hlFld-ContribAuthor ">John G.  Moffat</span>, <span class="hlFld-ContribAuthor ">Jodie  Pang</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Sneeringer</span>, <span class="hlFld-ContribAuthor ">Nicholas  Dompe</span>, <span class="hlFld-ContribAuthor ">Patrick  Cyr</span>, <span class="hlFld-ContribAuthor ">Hans  Purkey</span>, <span class="hlFld-ContribAuthor ">Gladys de Leon  Boenig</span>, <span class="hlFld-ContribAuthor ">Jun  Li</span>, <span class="hlFld-ContribAuthor ">Aleksandr  Kolesnikov</span>, <span class="hlFld-ContribAuthor ">Robin  Larouche-Gauthier</span>, <span class="hlFld-ContribAuthor ">Kwong Wah  Lai</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Shen</span>, <span class="hlFld-ContribAuthor ">Samuel  Aubert-Nicol</span>, <span class="hlFld-ContribAuthor ">Yi-Chen  Chen</span>, <span class="hlFld-ContribAuthor ">Jonathan  Cheong</span>, <span class="hlFld-ContribAuthor ">James J.  Crawford</span>, <span class="hlFld-ContribAuthor ">Marc  Hafner</span>, <span class="hlFld-ContribAuthor ">Pouyan  Haghshenas</span>, <span class="hlFld-ContribAuthor ">Araz  Jakalian</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Leclerc</span>, <span class="hlFld-ContribAuthor ">Ngiap-Kie  Lim</span>, <span class="hlFld-ContribAuthor ">Tom  O'Brien</span>, <span class="hlFld-ContribAuthor ">Emile G.  Plise</span>, <span class="hlFld-ContribAuthor ">Hadil  Shalan</span>, <span class="hlFld-ContribAuthor ">Claudio  Sturino</span>, <span class="hlFld-ContribAuthor ">John  Wai</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Jianping  Yin</span>, <span class="hlFld-ContribAuthor ">Liang  Zhao</span>, <span class="hlFld-ContribAuthor ">Stephen  Gould</span>, <span class="hlFld-ContribAuthor ">Alan  Olivero</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>. </span><span class="cited-content_cbyCitation_article-title">Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (16)
                                     , 2294-2301. <a href="https://doi.org/10.1016/j.bmcl.2019.06.021" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.06.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.06.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Bof%252Ba%252Bbrain-penetrant%252BCDK4%25252F6%252Binhibitor%252Bfor%252Bglioblastoma%26aulast%3DBronner%26aufirst%3DSarah%2BM.%26date%3D2019%26volume%3D29%26issue%3D16%26spage%3D2294%26epage%3D2301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melania  Poratti</span>, <span class="hlFld-ContribAuthor ">Giovanni  Marzaro</span>. </span><span class="cited-content_cbyCitation_article-title">Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>172 </em>, 143-153. <a href="https://doi.org/10.1016/j.ejmech.2019.03.064" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.064%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThird-generation%252BCDK%252Binhibitors%25253A%252BA%252Breview%252Bon%252Bthe%252Bsynthesis%252Band%252Bbinding%252Bmodes%252Bof%252BPalbociclib%25252C%252BRibociclib%252Band%252BAbemaciclib%26aulast%3DPoratti%26aufirst%3DMelania%26date%3D2019%26volume%3D172%26spage%3D143%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hamid-Reza  Mohammadi-Motlagh</span>, <span class="hlFld-ContribAuthor ">Reza  Yarani</span>, <span class="hlFld-ContribAuthor ">Mona  Sadeghalvad</span>, <span class="hlFld-ContribAuthor ">Elham  Adham</span>, <span class="hlFld-ContribAuthor ">Hassan  Rasouli</span>, <span class="hlFld-ContribAuthor ">Ali  Mostafaie</span>. </span><span class="cited-content_cbyCitation_article-title">2-Methylpyridine-1-ium-1-sulfonate as an Inducer of Apoptosis and Cell Cycle Arrest: A comparative in vitro and Computational Study. </span><span class="cited-content_cbyCitation_journal-name">Nutrition and Cancer</span><span> <strong>2019,</strong> <em>71 </em>
                                    (4)
                                     , 643-656. <a href="https://doi.org/10.1080/01635581.2018.1506495" title="DOI URL">https://doi.org/10.1080/01635581.2018.1506495</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/01635581.2018.1506495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F01635581.2018.1506495%26sid%3Dliteratum%253Aachs%26jtitle%3DNutrition%2520and%2520Cancer%26atitle%3D2-Methylpyridine-1-ium-1-sulfonate%252Bas%252Ban%252BInducer%252Bof%252BApoptosis%252Band%252BCell%252BCycle%252BArrest%25253A%252BA%252Bcomparative%252Bin%252Bvitro%252Band%252BComputational%252BStudy%26aulast%3DMohammadi-Motlagh%26aufirst%3DHamid-Reza%26date%3D2019%26date%3D2018%26volume%3D71%26issue%3D4%26spage%3D643%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shyam Shankar Eramangalam  Puthumana</span>, <span class="hlFld-ContribAuthor ">Bahulayan  Damodaran</span>. </span><span class="cited-content_cbyCitation_article-title">ICT‐Based Blue‐Emitting Dual‐Functional Probe (Ugi EML BLUE) for Bio‐Imaging and Cytotoxic Activities on HeLa Cells. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (18)
                                     , 5366-5374. <a href="https://doi.org/10.1002/slct.201900474" title="DOI URL">https://doi.org/10.1002/slct.201900474</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201900474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201900474%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DICT%2525E2%252580%252590Based%252BBlue%2525E2%252580%252590Emitting%252BDual%2525E2%252580%252590Functional%252BProbe%252B%252528Ugi%252BEML%252BBLUE%252529%252Bfor%252BBio%2525E2%252580%252590Imaging%252Band%252BCytotoxic%252BActivities%252Bon%252BHeLa%252BCells%26aulast%3DPuthumana%26aufirst%3DShyam%2BShankar%2BEramangalam%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D18%26spage%3D5366%26epage%3D5374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katsuhiko  Sekimata</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Sato</span>, <span class="hlFld-ContribAuthor ">Naoki  Sakai</span>, <span class="hlFld-ContribAuthor ">Hisami  Watanabe</span>, <span class="hlFld-ContribAuthor ">Chiemi  Mishima-Tsumagari</span>, <span class="hlFld-ContribAuthor ">Tomonori  Taguri</span>, <span class="hlFld-ContribAuthor ">Takehisa  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Yoshifumi  Fujii</span>, <span class="hlFld-ContribAuthor ">Noriko  Handa</span>, <span class="hlFld-ContribAuthor ">Teruki  Honma</span>, <span class="hlFld-ContribAuthor ">Akiko  Tanaka</span>, <span class="hlFld-ContribAuthor ">Mikako  Shirouzu</span>, <span class="hlFld-ContribAuthor ">Shigeyuki  Yokoyama</span>, <span class="hlFld-ContribAuthor ">Kohei  Miyazono</span>, <span class="hlFld-ContribAuthor ">Yoshinobu  Hashizume</span>, <span class="hlFld-ContribAuthor ">Hiroo  Koyama</span>. </span><span class="cited-content_cbyCitation_article-title">Bis-Heteroaryl Pyrazoles: Identification of Orally Bioavailable Inhibitors of Activin Receptor-Like Kinase-2 (R206H). </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2019,</strong> <em>67 </em>
                                    (3)
                                     , 224-235. <a href="https://doi.org/10.1248/cpb.c18-00598" title="DOI URL">https://doi.org/10.1248/cpb.c18-00598</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c18-00598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c18-00598%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DBis-Heteroaryl%252BPyrazoles%25253A%252BIdentification%252Bof%252BOrally%252BBioavailable%252BInhibitors%252Bof%252BActivin%252BReceptor-Like%252BKinase-2%252B%252528R206H%252529%26aulast%3DSekimata%26aufirst%3DKatsuhiko%26date%3D2019%26volume%3D67%26issue%3D3%26spage%3D224%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisa J.  Keefe</span>, <span class="hlFld-ContribAuthor ">Vincent S.  Stoll</span>. </span><span class="cited-content_cbyCitation_article-title">Accelerating pharmaceutical structure-guided drug design: a successful model. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2019,</strong> <em>24 </em>
                                    (2)
                                     , 377-381. <a href="https://doi.org/10.1016/j.drudis.2018.11.008" title="DOI URL">https://doi.org/10.1016/j.drudis.2018.11.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2018.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2018.11.008%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DAccelerating%252Bpharmaceutical%252Bstructure-guided%252Bdrug%252Bdesign%25253A%252Ba%252Bsuccessful%252Bmodel%26aulast%3DKeefe%26aufirst%3DLisa%2BJ.%26date%3D2019%26volume%3D24%26issue%3D2%26spage%3D377%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. Sila  Ozdemir</span>, <span class="hlFld-ContribAuthor ">Farideh  Halakou</span>, <span class="hlFld-ContribAuthor ">Ruth  Nussinov</span>, <span class="hlFld-ContribAuthor ">Attila  Gursoy</span>, <span class="hlFld-ContribAuthor ">Ozlem  Keskin</span>. </span><span class="cited-content_cbyCitation_article-title">Methods for Discovering and Targeting Druggable Protein-Protein Interfaces and Their Application to Repurposing. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 1-21. <a href="https://doi.org/10.1007/978-1-4939-8955-3_1" title="DOI URL">https://doi.org/10.1007/978-1-4939-8955-3_1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-8955-3_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-8955-3_1%26sid%3Dliteratum%253Aachs%26atitle%3DMethods%252Bfor%252BDiscovering%252Band%252BTargeting%252BDruggable%252BProtein-Protein%252BInterfaces%252Band%252BTheir%252BApplication%252Bto%252BRepurposing%26aulast%3DOzdemir%26aufirst%3DE.%2BSila%26date%3D2019%26date%3D2018%26spage%3D1%26epage%3D21%26pub%3DSpringer%2520New%2520York%26atitle%3DComputational%252BMethods%252Bfor%252BDrug%252BRepurposing%26aulast%3DVanhaelen%26aufirst%3DQuentin%26date%3D2019%26volume%3D1903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irina A.  Tolmacheva</span>, <span class="hlFld-ContribAuthor ">Alexey V.  Nazarov</span>, <span class="hlFld-ContribAuthor ">Daria V.  Eroshenko</span>, <span class="hlFld-ContribAuthor ">Victoria V.  Grishko</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, cytotoxic evaluation, and molecular docking studies of the semi-synthetic “triterpenoid-steroid” hybrids. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2018,</strong> <em>140 </em>, 131-143. <a href="https://doi.org/10.1016/j.steroids.2018.10.005" title="DOI URL">https://doi.org/10.1016/j.steroids.2018.10.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2018.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2018.10.005%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DSynthesis%25252C%252Bcytotoxic%252Bevaluation%25252C%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bof%252Bthe%252Bsemi-synthetic%252B%2525E2%252580%25259Ctriterpenoid-steroid%2525E2%252580%25259D%252Bhybrids%26aulast%3DTolmacheva%26aufirst%3DIrina%2BA.%26date%3D2018%26volume%3D140%26spage%3D131%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V.  Jakubkiene</span>, <span class="hlFld-ContribAuthor ">E.  Vaiciunaite</span>, <span class="hlFld-ContribAuthor ">K.  Kriukaite</span>, <span class="hlFld-ContribAuthor ">J.  Didzgalvis</span>, <span class="hlFld-ContribAuthor ">S.  Tumkevicius</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis of novel 6-substituted 2-(4-aryl-1,2,3-triazol-1-yl)pyrimidines and 7-deazapurines. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2018,</strong> <em>48 </em>
                                    (15)
                                     , 1974-1985. <a href="https://doi.org/10.1080/00397911.2018.1474229" title="DOI URL">https://doi.org/10.1080/00397911.2018.1474229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2018.1474229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2018.1474229%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DEfficient%252Bsynthesis%252Bof%252Bnovel%252B6-substituted%252B2-%2525284-aryl-1%25252C2%25252C3-triazol-1-yl%252529pyrimidines%252Band%252B7-deazapurines%26aulast%3DJakubkiene%26aufirst%3DV.%26date%3D2018%26date%3D2018%26volume%3D48%26issue%3D15%26spage%3D1974%26epage%3D1985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Yin</span>, <span class="hlFld-ContribAuthor ">Heng  Li</span>, <span class="hlFld-ContribAuthor ">Wenjian  Liu</span>, <span class="hlFld-ContribAuthor ">Zhenglin  Yao</span>, <span class="hlFld-ContribAuthor ">Zhenzhen  Cheng</span>, <span class="hlFld-ContribAuthor ">Huabei  Zhang</span>, <span class="hlFld-ContribAuthor ">Hui  Zou</span>. </span><span class="cited-content_cbyCitation_article-title">A highly potent CDK4/6 inhibitor was rationally designed to overcome blood brain barrier in gliobastoma therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>144 </em>, 1-28. <a href="https://doi.org/10.1016/j.ejmech.2017.12.003" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.12.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.12.003%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bhighly%252Bpotent%252BCDK4%25252F6%252Binhibitor%252Bwas%252Brationally%252Bdesigned%252Bto%252Bovercome%252Bblood%252Bbrain%252Bbarrier%252Bin%252Bgliobastoma%252Btherapy%26aulast%3DYin%26aufirst%3DLei%26date%3D2018%26volume%3D144%26spage%3D1%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">, , <span class="hlFld-ContribAuthor ">Mathew P.  Martin</span>, <span class="hlFld-ContribAuthor ">Jane A.  Endicott</span>, <span class="hlFld-ContribAuthor ">Martin E.M.  Noble</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based discovery of cyclin-dependent protein kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Essays in Biochemistry</span><span> <strong>2017,</strong> <em>61 </em>
                                    (5)
                                     , 439-452. <a href="https://doi.org/10.1042/EBC20170040" title="DOI URL">https://doi.org/10.1042/EBC20170040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/EBC20170040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FEBC20170040%26sid%3Dliteratum%253Aachs%26jtitle%3DEssays%2520in%2520Biochemistry%26atitle%3DStructure-based%252Bdiscovery%252Bof%252Bcyclin-dependent%252Bprotein%252Bkinase%252Binhibitors%26aulast%3Dvan%2BMontfort%26aufirst%3DRob%2BL.M.%26date%3D2017%26date%3D2017%26volume%3D61%26issue%3D5%26spage%3D439%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keke  Dong</span>, <span class="hlFld-ContribAuthor ">Xueyu  Yang</span>, <span class="hlFld-ContribAuthor ">Tengteng  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaolei  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">An insight into the inhibitory selectivity of 4-(Pyrazol- 4-yl)-pyrimidines to CDK4 over CDK2. </span><span class="cited-content_cbyCitation_journal-name">Molecular Simulation</span><span> <strong>2017,</strong> <em>43 </em>
                                    (8)
                                     , 599-609. <a href="https://doi.org/10.1080/08927022.2017.1279283" title="DOI URL">https://doi.org/10.1080/08927022.2017.1279283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/08927022.2017.1279283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F08927022.2017.1279283%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Simulation%26atitle%3DAn%252Binsight%252Binto%252Bthe%252Binhibitory%252Bselectivity%252Bof%252B4-%252528Pyrazol-%252B4-yl%252529-pyrimidines%252Bto%252BCDK4%252Bover%252BCDK2%26aulast%3DDong%26aufirst%3DKeke%26date%3D2017%26date%3D2017%26volume%3D43%26issue%3D8%26spage%3D599%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stella  Hernandez Maganhi</span>, <span class="hlFld-ContribAuthor ">Patrizia  Jensen</span>, <span class="hlFld-ContribAuthor ">Ignez  Caracelli</span>, <span class="hlFld-ContribAuthor ">Julio  Zukerman Schpector</span>, <span class="hlFld-ContribAuthor ">Stefan  Fröhling</span>, <span class="hlFld-ContribAuthor ">Ran  Friedman</span>. </span><span class="cited-content_cbyCitation_article-title">Palbociclib can overcome mutations in cyclin dependent kinase 6 that break hydrogen bonds between the drug and the protein. </span><span class="cited-content_cbyCitation_journal-name">Protein Science</span><span> <strong>2017,</strong> <em>26 </em>
                                    (4)
                                     , 870-879. <a href="https://doi.org/10.1002/pro.3135" title="DOI URL">https://doi.org/10.1002/pro.3135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pro.3135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpro.3135%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Science%26atitle%3DPalbociclib%252Bcan%252Bovercome%252Bmutations%252Bin%252Bcyclin%252Bdependent%252Bkinase%252B6%252Bthat%252Bbreak%252Bhydrogen%252Bbonds%252Bbetween%252Bthe%252Bdrug%252Band%252Bthe%252Bprotein%26aulast%3DHernandez%2BMaganhi%26aufirst%3DStella%26date%3D2017%26date%3D2017%26volume%3D26%26issue%3D4%26spage%3D870%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tinghan  Li</span>, <span class="hlFld-ContribAuthor ">Tianwei  Weng</span>, <span class="hlFld-ContribAuthor ">Minzan  Zuo</span>, <span class="hlFld-ContribAuthor ">Zhihui  Wei</span>, <span class="hlFld-ContribAuthor ">Ming  Chen</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress of cyclin-dependent kinase inhibitors as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2016,</strong> <em>8 </em>
                                    (17)
                                     , 2047-2076. <a href="https://doi.org/10.4155/fmc-2016-0129" title="DOI URL">https://doi.org/10.4155/fmc-2016-0129</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2016-0129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2016-0129%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bof%252Bcyclin-dependent%252Bkinase%252Binhibitors%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DLi%26aufirst%3DTinghan%26date%3D2016%26volume%3D8%26issue%3D17%26spage%3D2047%26epage%3D2076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Nathan V.  Lee</span>, <span class="hlFld-ContribAuthor ">Wenyue  Hu</span>, <span class="hlFld-ContribAuthor ">Meirong  Xu</span>, <span class="hlFld-ContribAuthor ">Rose Ann  Ferre</span>, <span class="hlFld-ContribAuthor ">Hieu  Lam</span>, <span class="hlFld-ContribAuthor ">Simon  Bergqvist</span>, <span class="hlFld-ContribAuthor ">James  Solowiej</span>, <span class="hlFld-ContribAuthor ">Wade  Diehl</span>, <span class="hlFld-ContribAuthor ">You-Ai  He</span>, <span class="hlFld-ContribAuthor ">Xiu  Yu</span>, <span class="hlFld-ContribAuthor ">Asako  Nagata</span>, <span class="hlFld-ContribAuthor ">Todd  VanArsdale</span>, <span class="hlFld-ContribAuthor ">Brion W.  Murray</span>. </span><span class="cited-content_cbyCitation_article-title">Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2016,</strong> <em>15 </em>
                                    (10)
                                     , 2273-2281. <a href="https://doi.org/10.1158/1535-7163.MCT-16-0300" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-16-0300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-16-0300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-16-0300%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DSpectrum%252Band%252BDegree%252Bof%252BCDK%252BDrug%252BInteractions%252BPredicts%252BClinical%252BPerformance%26aulast%3DChen%26aufirst%3DPing%26date%3D2016%26date%3D2016%26volume%3D15%26issue%3D10%26spage%3D2273%26epage%3D2281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carl S.  Rye</span>, <span class="hlFld-ContribAuthor ">Nicola E. A.  Chessum</span>, <span class="hlFld-ContribAuthor ">Scott  Lamont</span>, <span class="hlFld-ContribAuthor ">Kurt G.  Pike</span>, <span class="hlFld-ContribAuthor ">Paul  Faulder</span>, <span class="hlFld-ContribAuthor ">Julie  Demeritt</span>, <span class="hlFld-ContribAuthor ">Paul  Kemmitt</span>, <span class="hlFld-ContribAuthor ">Julie  Tucker</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Zani</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Cheeseman</span>, <span class="hlFld-ContribAuthor ">Rosie  Isaac</span>, <span class="hlFld-ContribAuthor ">Louise  Goodwin</span>, <span class="hlFld-ContribAuthor ">Joanna  Boros</span>, <span class="hlFld-ContribAuthor ">Florence  Raynaud</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Alan T.  Henley</span>, <span class="hlFld-ContribAuthor ">Emmanuel  de Billy</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Lynch</span>, <span class="hlFld-ContribAuthor ">Swee Y.  Sharp</span>, <span class="hlFld-ContribAuthor ">Robert  te Poele</span>, <span class="hlFld-ContribAuthor ">Lisa O’  Fee</span>, <span class="hlFld-ContribAuthor ">Kevin M.  Foote</span>, <span class="hlFld-ContribAuthor ">Stephen  Green</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>, <span class="hlFld-ContribAuthor ">Keith  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4,6-disubstituted pyrimidines as potent inhibitors of the heat shock factor 1 (HSF1) stress pathway and CDK9. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (8)
                                     , 1580-1586. <a href="https://doi.org/10.1039/C6MD00159A" title="DOI URL">https://doi.org/10.1039/C6MD00159A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00159A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00159A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDiscovery%252Bof%252B4%25252C6-disubstituted%252Bpyrimidines%252Bas%252Bpotent%252Binhibitors%252Bof%252Bthe%252Bheat%252Bshock%252Bfactor%252B1%252B%252528HSF1%252529%252Bstress%252Bpathway%252Band%252BCDK9%26aulast%3DRye%26aufirst%3DCarl%2BS.%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D8%26spage%3D1580%26epage%3D1586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asterios I.  Grigoroudis</span>, <span class="hlFld-ContribAuthor ">George  Kontopidis</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of CDK/Cyclin Inhibitor Complexes for Structural Determination. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 29-45. <a href="https://doi.org/10.1007/978-1-4939-2926-9_4" title="DOI URL">https://doi.org/10.1007/978-1-4939-2926-9_4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-2926-9_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-2926-9_4%26sid%3Dliteratum%253Aachs%26atitle%3DPreparation%252Bof%252BCDK%25252FCyclin%252BInhibitor%252BComplexes%252Bfor%252BStructural%252BDetermination%26aulast%3DGrigoroudis%26aufirst%3DAsterios%2BI.%26date%3D2016%26spage%3D29%26epage%3D45%26pub%3DSpringer%2520New%2520York%26atitle%3DCyclin-Dependent%252BKinase%252B%252528CDK%252529%252BInhibitors%26aulast%3DOrz%25C3%25A1ez%26aufirst%3DMar%26date%3D2016%26volume%3D1336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joanna  Wlochal</span>, <span class="hlFld-ContribAuthor ">Andrew  Bailey</span>. </span><span class="cited-content_cbyCitation_article-title">Facile synthesis of 4-aryl and alkyl substituted, N 6 -alkylated pyridazine-3,6-diamines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (48)
                                     , 6791-6794. <a href="https://doi.org/10.1016/j.tetlet.2015.10.075" title="DOI URL">https://doi.org/10.1016/j.tetlet.2015.10.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2015.10.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2015.10.075%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DFacile%252Bsynthesis%252Bof%252B4-aryl%252Band%252Balkyl%252Bsubstituted%25252C%252BN%252B6%252B-alkylated%252Bpyridazine-3%25252C6-diamines%26aulast%3DWlochal%26aufirst%3DJoanna%26date%3D2015%26volume%3D56%26issue%3D48%26spage%3D6791%26epage%3D6794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Solomon  Tadesse</span>, <span class="hlFld-ContribAuthor ">Mingfeng  Yu</span>, <span class="hlFld-ContribAuthor ">Malika  Kumarasiri</span>, <span class="hlFld-ContribAuthor ">Bich Thuy  Le</span>, <span class="hlFld-ContribAuthor ">Shudong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting CDK6 in cancer: State of the art and new insights. </span><span class="cited-content_cbyCitation_journal-name">Cell Cycle</span><span> <strong>2015,</strong> <em>14 </em>
                                    (20)
                                     , 3220-3230. <a href="https://doi.org/10.1080/15384101.2015.1084445" title="DOI URL">https://doi.org/10.1080/15384101.2015.1084445</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/15384101.2015.1084445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F15384101.2015.1084445%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Cycle%26atitle%3DTargeting%252BCDK6%252Bin%252Bcancer%25253A%252BState%252Bof%252Bthe%252Bart%252Band%252Bnew%252Binsights%26aulast%3DTadesse%26aufirst%3DSolomon%26date%3D2015%26date%3D2015%26volume%3D14%26issue%3D20%26spage%3D3220%26epage%3D3230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Xing</span>, <span class="hlFld-ContribAuthor ">Jacquelyn  Klug-Mcleod</span>, <span class="hlFld-ContribAuthor ">Brajesh  Rai</span>, <span class="hlFld-ContribAuthor ">Elizabeth A.  Lunney</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase hinge binding scaffolds and their hydrogen bond patterns. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (19)
                                     , 6520-6527. <a href="https://doi.org/10.1016/j.bmc.2015.08.006" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.08.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.08.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DKinase%252Bhinge%252Bbinding%252Bscaffolds%252Band%252Btheir%252Bhydrogen%252Bbond%252Bpatterns%26aulast%3DXing%26aufirst%3DLi%26date%3D2015%26volume%3D23%26issue%3D19%26spage%3D6520%26epage%3D6527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul A.  Bethel</span>, <span class="hlFld-ContribAuthor ">Bryan  Roberts</span>, <span class="hlFld-ContribAuthor ">Andrew  Bailey</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of differentially substituted 3,6-diaminopyridazines under mild conditions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (37)
                                     , 5186-5190. <a href="https://doi.org/10.1016/j.tetlet.2014.07.096" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.07.096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.07.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.07.096%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DPreparation%252Bof%252Bdifferentially%252Bsubstituted%252B3%25252C6-diaminopyridazines%252Bunder%252Bmild%252Bconditions%26aulast%3DBethel%26aufirst%3DPaul%2BA.%26date%3D2014%26volume%3D55%26issue%3D37%26spage%3D5186%26epage%3D5190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simpal  Kumari</span>, <span class="hlFld-ContribAuthor ">Sarvesh  Paliwal</span>, <span class="hlFld-ContribAuthor ">Rajani  Chauhan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Pyrazole Derivatives Possessing Anticancer Activity: Current Status. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2014,</strong> <em>44 </em>
                                    (11)
                                     , 1521-1578. <a href="https://doi.org/10.1080/00397911.2013.828757" title="DOI URL">https://doi.org/10.1080/00397911.2013.828757</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2013.828757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2013.828757%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DSynthesis%252Bof%252BPyrazole%252BDerivatives%252BPossessing%252BAnticancer%252BActivity%25253A%252BCurrent%252BStatus%26aulast%3DKumari%26aufirst%3DSimpal%26date%3D2014%26date%3D2014%26volume%3D44%26issue%3D11%26spage%3D1521%26epage%3D1578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kothanahally S.  Sharath Kumar</span>, <span class="hlFld-ContribAuthor ">Ananda  Hanumappa</span>, <span class="hlFld-ContribAuthor ">Mahesh  Hegde</span>, <span class="hlFld-ContribAuthor ">Kereyagalahally H.  Narasimhamurthy</span>, <span class="hlFld-ContribAuthor ">Sathees C.  Raghavan</span>, <span class="hlFld-ContribAuthor ">Kanchugarakoppal S.  Rangappa</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antiproliferative effect of novel 4-thiazolidinone-, pyridine- and piperazine-based conjugates on human leukemic cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>81 </em>, 341-349. <a href="https://doi.org/10.1016/j.ejmech.2014.05.009" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.05.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.05.009%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantiproliferative%252Beffect%252Bof%252Bnovel%252B4-thiazolidinone-%25252C%252Bpyridine-%252Band%252Bpiperazine-based%252Bconjugates%252Bon%252Bhuman%252Bleukemic%252Bcells%26aulast%3DSharath%2BKumar%26aufirst%3DKothanahally%2BS.%26date%3D2014%26volume%3D81%26spage%3D341%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simpal  Chauhan</span>, <span class="hlFld-ContribAuthor ">Sarvesh  Paliwal</span>, <span class="hlFld-ContribAuthor ">Rajani  Chauhan</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer Activity of Pyrazole via Different Biological Mechanisms. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2014,</strong> <em>44 </em>
                                    (10)
                                     , 1333-1374. <a href="https://doi.org/10.1080/00397911.2013.837186" title="DOI URL">https://doi.org/10.1080/00397911.2013.837186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2013.837186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2013.837186%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DAnticancer%252BActivity%252Bof%252BPyrazole%252Bvia%252BDifferent%252BBiological%252BMechanisms%26aulast%3DChauhan%26aufirst%3DSimpal%26date%3D2014%26date%3D2014%26volume%3D44%26issue%3D10%26spage%3D1333%26epage%3D1374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Terentjeva</span>, <span class="hlFld-ContribAuthor ">D.  Muceniece</span>, <span class="hlFld-ContribAuthor ">V.  Lusis</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of 6-Unsubstituted 3,4-Dihydropyrimidin-2(1H)-Ones and 2-(Arylamino)Pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2014,</strong> <em>49 </em>
                                    (12)
                                     , 1757-1769. <a href="https://doi.org/10.1007/s10593-014-1428-0" title="DOI URL">https://doi.org/10.1007/s10593-014-1428-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-014-1428-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-014-1428-0%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DPreparation%252Bof%252B6-Unsubstituted%252B3%25252C4-Dihydropyrimidin-2%2525281H%252529-Ones%252Band%252B2-%252528Arylamino%252529Pyrimidines%26aulast%3DTerentjeva%26aufirst%3DS.%26date%3D2014%26date%3D2014%26volume%3D49%26issue%3D12%26spage%3D1757%26epage%3D1769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Archana  Jayaraman</span>, <span class="hlFld-ContribAuthor ">Kaiser  Jamil</span>, . </span><span class="cited-content_cbyCitation_article-title">Drug Targets for Cell Cycle Dysregulators in Leukemogenesis: In Silico Docking Studies. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (1)
                                     , e86310. <a href="https://doi.org/10.1371/journal.pone.0086310" title="DOI URL">https://doi.org/10.1371/journal.pone.0086310</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0086310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0086310%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DDrug%252BTargets%252Bfor%252BCell%252BCycle%252BDysregulators%252Bin%252BLeukemogenesis%25253A%252BIn%252BSilico%252BDocking%252BStudies%26aulast%3DJayaraman%26aufirst%3DArchana%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D1%26spage%3De86310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Stella</span>, <span class="hlFld-ContribAuthor ">Kristien  Van Belle</span>, <span class="hlFld-ContribAuthor ">Steven  De Jonghe</span>, <span class="hlFld-ContribAuthor ">Thierry  Louat</span>, <span class="hlFld-ContribAuthor ">Jean  Herman</span>, <span class="hlFld-ContribAuthor ">Jef  Rozenski</span>, <span class="hlFld-ContribAuthor ">Mark  Waer</span>, <span class="hlFld-ContribAuthor ">Piet  Herdewijn</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a 2,4,6-trisubstituted 5-cyano-pyrimidine library and evaluation of its immunosuppressive activity in a Mixed Lymphocyte Reaction assay. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (5)
                                     , 1209-1218. <a href="https://doi.org/10.1016/j.bmc.2012.12.032" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.12.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.12.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Ba%252B2%25252C4%25252C6-trisubstituted%252B5-cyano-pyrimidine%252Blibrary%252Band%252Bevaluation%252Bof%252Bits%252Bimmunosuppressive%252Bactivity%252Bin%252Ba%252BMixed%252BLymphocyte%252BReaction%252Bassay%26aulast%3DStella%26aufirst%3DAlessandro%26date%3D2013%26volume%3D21%26issue%3D5%26spage%3D1209%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akrimah</span>, <span class="hlFld-ContribAuthor ">Daryono Hadi  Tjahyono</span>, <span class="hlFld-ContribAuthor ">Amir  Musadad</span>. </span><span class="cited-content_cbyCitation_article-title">Docking of Potent Anticancer Agents; 4-(Pyrazol-4yl)-Pyrimidine Derivatives as Selective Cyclin-Dependent Kinase 4/6 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Chemical Engineering and Applications</span><span> <strong>2013,</strong> <em> </em>, 419-422. <a href="https://doi.org/10.7763/IJCEA.2013.V4.338" title="DOI URL">https://doi.org/10.7763/IJCEA.2013.V4.338</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7763/IJCEA.2013.V4.338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7763%2FIJCEA.2013.V4.338%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Chemical%2520Engineering%2520and%2520Applications%26atitle%3DDocking%252Bof%252BPotent%252BAnticancer%252BAgents%25253B%252B4-%252528Pyrazol-4yl%252529-Pyrimidine%252BDerivatives%252Bas%252BSelective%252BCyclin-Dependent%252BKinase%252B4%25252F6%252BInhibitors%26aulast%3DAkrimah%26date%3D2013%26date%3D2013%26spage%3D419%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hans  Matter</span>, <span class="hlFld-ContribAuthor ">Marc  Nazaré</span>, <span class="hlFld-ContribAuthor ">Stefan  Güssregen</span>. </span><span class="cited-content_cbyCitation_article-title">Halogen…π Interactions as Important Contributors to Binding Affinity in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 187-232. <a href="https://doi.org/10.1002/9781119945888.ch8" title="DOI URL">https://doi.org/10.1002/9781119945888.ch8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119945888.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119945888.ch8%26sid%3Dliteratum%253Aachs%26atitle%3DHalogen%2525E2%252580%2525A6%2525CF%252580%252BInteractions%252Bas%252BImportant%252BContributors%252Bto%252BBinding%252BAffinity%252Bin%252BMedicinal%252BChemistry%26aulast%3DMatter%26aufirst%3DHans%26date%3D2012%26date%3D2012%26spage%3D187%26epage%3D232%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DThe%252BImportance%252Bof%252BPi-Interactions%252Bin%252BCrystal%252BEngineering%26aulast%3DTiekink%26aufirst%3DEdward%2BR.%2BT.%26date%3D2012%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mei-Chu  Lo</span>, <span class="hlFld-ContribAuthor ">Rachel  Ngo</span>, <span class="hlFld-ContribAuthor ">Kang  Dai</span>, <span class="hlFld-ContribAuthor ">Cong  Li</span>, <span class="hlFld-ContribAuthor ">Lingming  Liang</span>, <span class="hlFld-ContribAuthor ">Josie  Lee</span>, <span class="hlFld-ContribAuthor ">Renee  Emkey</span>, <span class="hlFld-ContribAuthor ">John  Eksterowicz</span>, <span class="hlFld-ContribAuthor ">Manuel  Ventura</span>, <span class="hlFld-ContribAuthor ">Stephen W.  Young</span>, <span class="hlFld-ContribAuthor ">Shou-Hua  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a time-resolved fluorescence resonance energy transfer assay for cyclin-dependent kinase 4 and identification of its ATP-noncompetitive inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Analytical Biochemistry</span><span> <strong>2012,</strong> <em>421 </em>
                                    (2)
                                     , 368-377. <a href="https://doi.org/10.1016/j.ab.2011.10.014" title="DOI URL">https://doi.org/10.1016/j.ab.2011.10.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ab.2011.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ab.2011.10.014%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Biochemistry%26atitle%3DDevelopment%252Bof%252Ba%252Btime-resolved%252Bfluorescence%252Bresonance%252Benergy%252Btransfer%252Bassay%252Bfor%252Bcyclin-dependent%252Bkinase%252B4%252Band%252Bidentification%252Bof%252Bits%252BATP-noncompetitive%252Binhibitors%26aulast%3DLo%26aufirst%3DMei-Chu%26date%3D2012%26volume%3D421%26issue%3D2%26spage%3D368%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sudipta  Roy</span>, <span class="hlFld-ContribAuthor ">Sujata  Roy</span>, <span class="hlFld-ContribAuthor ">Gordon W.  Gribble</span>. </span><span class="cited-content_cbyCitation_article-title">Metalation of Pyrazoles and Indazoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 155-260. <a href="https://doi.org/10.1007/7081_2012_82" title="DOI URL">https://doi.org/10.1007/7081_2012_82</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7081_2012_82&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7081_2012_82%26sid%3Dliteratum%253Aachs%26atitle%3DMetalation%252Bof%252BPyrazoles%252Band%252BIndazoles%26aulast%3DRoy%26aufirst%3DSudipta%26date%3D2012%26date%3D2012%26spage%3D155%26epage%3D260%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DMetalation%252Bof%252BAzoles%252Band%252BRelated%252BFive-Membered%252BRing%252BHeterocycles%26aulast%3DGribble%26aufirst%3DGordon%2BW.%26date%3D2012%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne  Ertan</span>, <span class="hlFld-ContribAuthor ">Parhalad  Sharma</span>, <span class="hlFld-ContribAuthor ">Dokka  Nagaraju</span>, <span class="hlFld-ContribAuthor ">K.  Deepthi</span>, <span class="hlFld-ContribAuthor ">Sulur G.  Manjunatha</span>. </span><span class="cited-content_cbyCitation_article-title">(2
              R
              )-4-[(9
              H
              -Fluoren-9-ylmethoxy)carbonyl]-2-methylpiperazin-1-ium chloride. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section E Structure Reports Online</span><span> <strong>2011,</strong> <em>67 </em>
                                    (12)
                                     , o3386-o3387. <a href="https://doi.org/10.1107/S1600536811048306" title="DOI URL">https://doi.org/10.1107/S1600536811048306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S1600536811048306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS1600536811048306%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520E%2520Structure%2520Reports%2520Online%26atitle%3D%2525282%252BR%252B%252529-4-%25255B%2525289%252BH%252B-Fluoren-9-ylmethoxy%252529carbonyl%25255D-2-methylpiperazin-1-ium%252Bchloride%26aulast%3DErtan%26aufirst%3DAnne%26date%3D2011%26date%3D2011%26volume%3D67%26issue%3D12%26spage%3Do3386%26epage%3Do3387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangfang  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi  Ma</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Shanna  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhengtao  Xiao</span>, <span class="hlFld-ContribAuthor ">Hong  Zhang</span>, <span class="hlFld-ContribAuthor ">Yonghua  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of in silico models for pyrazoles and pyrimidine derivatives as cyclin-dependent kinase 2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2011,</strong> <em>30 </em>, 67-81. <a href="https://doi.org/10.1016/j.jmgm.2011.06.006" title="DOI URL">https://doi.org/10.1016/j.jmgm.2011.06.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2011.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2011.06.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DDevelopment%252Bof%252Bin%252Bsilico%252Bmodels%252Bfor%252Bpyrazoles%252Band%252Bpyrimidine%252Bderivatives%252Bas%252Bcyclin-dependent%252Bkinase%252B2%252Binhibitors%26aulast%3DWang%26aufirst%3DFangfang%26date%3D2011%26volume%3D30%26spage%3D67%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jarosław  Sławiński</span>, <span class="hlFld-ContribAuthor ">Kamil  Brożewicz</span>, <span class="hlFld-ContribAuthor ">Andrzej  Fruziński</span>, <span class="hlFld-ContribAuthor ">Marek  L. Główka</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antitumor Activity of Novel N’-(2-Benzylthiobenzenesulfonyl)-1H-pyrazole-1-amidine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2011,</strong> <em>83 </em>
                                    (5)
                                     , 1093. <a href="https://doi.org/10.3987/COM-11-12164" title="DOI URL">https://doi.org/10.3987/COM-11-12164</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-11-12164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-11-12164%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DSynthesis%252Band%252BAntitumor%252BActivity%252Bof%252BNovel%252BN%2525E2%252580%252599-%2525282-Benzylthiobenzenesulfonyl%252529-1H-pyrazole-1-amidine%252BDerivatives%26aulast%3DS%25C5%2582awi%25C5%2584ski%26aufirst%3DJaros%25C5%2582aw%26date%3D2011%26volume%3D83%26issue%3D5%26spage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0014.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selective CDK4/6 inhibitor <b>1</b> and general structure of 4-(pyrazol-4-yl)-pyrimidines (<b>A</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0015.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (I) R<sub>1</sub>NH<sub>2</sub>, heating; (II) R<sub>1</sub>NH<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, BINAP or XANTPHOS, NaO<i>t</i>Bu or Cs<sub>2</sub>CO<sub>3</sub>, dioxane, heating.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0016.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LDA or LHMDS, THF, 0 °C; R<sub>1</sub>CO<sub>2</sub>Me, 0 °C to room temperature; (b) (i) dimethylformamide dimethyl acetal, (ii) H<sub>2</sub>NNH<sub>2</sub>·H<sub>2</sub>O, MeOH; (c) <i>m</i>CPBA, CH<sub>2</sub>Cl<sub>2</sub> or oxone, DMF, 90 °C; (d) SO<sub>2</sub>Cl<sub>2</sub>, AcOH, 60 °C, 43%; (e) (i) Cs<sub>2</sub>CO<sub>3</sub>, SEMCl, DMF, 73%, (ii) NCS, DMF, 40 °C, 62%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0017.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0018.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0019.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0020.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0021.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0001.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray structure of compound <b>37</b> bound to CDK6.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overlay of compounds <b>50</b> (carbon atoms, cyan; chlorine, green) and <b>37</b> (carbon atoms, purple) bound to the active site of CDK6 (carbon atoms, yellow).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/medium/jm-2010-00571n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0011.jpeg" id="rightTab-_i10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cell cycle flow cytometry analyses.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100571n/production/images/large/jm-2010-00571n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100571n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i88">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12388" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12388" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 29 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ortega, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cyclin D-dependent kinases, INK4 inhibitors and cancer</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1602</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1016%2FS0304-419X%2802%2900037-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=11960696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD38XktVKgu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1602&publication_year=2002&pages=73-87&author=S.+Ortegaauthor=M.+Malumbresauthor=M.+Barbacid&title=Cyclin+D-dependent+kinases%2C+INK4+inhibitors+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin D-dependent kinases, INK4 inhibitors and cancer</span></div><div class="casAuthors">Ortega, Sagrario; Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1602</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-87</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Cyclin D-Cdk4,6/INK4/Rb/E2F pathway plays a key role in controlling cell growth by integrating multiple mitogenic and antimitogenic stimuli.  The components of this pathway are gene families with a high level of structural and functional redundancy and are expressed in an overlapping fashion in most tissues and cell types.  Using classical transgenic technol. as well as gene-targeting in ES cells, a series of mouse models have been developed to study the in vivo function of individual components of this pathway in both normal homeostasis and tumor development.  These models have proven to be useful to define specific as well as redundant roles among members of these cell cycle regulatory gene families.  This pathway is deregulated in the vast majority of human tumors by genetic and epigenetic alterations that target at least some of its key members such as Cyclin D1, Cdk4, INK4a and INK4b, pRb etc.  As a consequence, some of these mols. are currently being considered as targets for cancer therapy, and several novel mols., such as Cdk inhibitors, are under development as potential anti-cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpizIeKkGlMJLVg90H21EOLACvtfcHk0liWkP8Vw6smvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktVKgu7o%253D&md5=8f5ab2839d58abcb3a7df53269af2913</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FS0304-419X%2802%2900037-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-419X%252802%252900037-9%26sid%3Dliteratum%253Aachs%26aulast%3DOrtega%26aufirst%3DS.%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCyclin%2520D-dependent%2520kinases%252C%2520INK4%2520inhibitors%2520and%2520cancer%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2002%26volume%3D1602%26spage%3D73%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sherr, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. M.</span><span> </span><span class="NLM_article-title">CDK inhibitors: positive and negative regulators of G1-phase progression</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1501</span><span class="NLM_x">–</span> <span class="NLM_lpage">1512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1101%2Fgad.13.12.1501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=10385618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADyaK1MXktlOhsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=1501-1512&author=C.+J.+Sherrauthor=J.+M.+Roberts&title=CDK+inhibitors%3A+positive+and+negative+regulators+of+G1-phase+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">CDK inhibitors: positive and negative regulators of G1-phase progression</span></div><div class="casAuthors">Sherr, Charles J.; Roberts, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1501-1512</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review with over 100 refs.  Topics include: collaboration between cyclin D- and E-dependent kinases during G1 phase, catalytically active cyclin D-dependent holoenzymes contain Cip/Kip subunits, cyclinD-CDK assembly requires CKIs, INK4 proteins depend on Cip/Kip proteins to induce G1-phase arrest, is cyclin D-dependent kinase activity essential for cell cycle, and role for Cip/Kip proteins in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwaa1ctpF0IrVg90H21EOLACvtfcHk0liWkP8Vw6smvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktlOhsLs%253D&md5=ea4e91c8d0e79a17148b4abec162c8cb</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1101%2Fgad.13.12.1501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.13.12.1501%26sid%3Dliteratum%253Aachs%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26atitle%3DCDK%2520inhibitors%253A%2520positive%2520and%2520negative%2520regulators%2520of%2520G1-phase%2520progression%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26spage%3D1501%26epage%3D1512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Benson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bono, J.</span><span> </span><span class="NLM_article-title">Clinical anticancer drug development: targeting the cyclin-dependent kinases</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1038%2Fsj.bjc.6602229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=15558073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2qu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2005&pages=7-12&author=C.+Bensonauthor=S.+Kayeauthor=P.+Workmanauthor=M.+Garrettauthor=M.+Waltonauthor=J.+de+Bono&title=Clinical+anticancer+drug+development%3A+targeting+the+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical anticancer drug development: targeting the cyclin-dependent kinases</span></div><div class="casAuthors">Benson, C.; Kaye, S.; Workman, P.; Garrett, M.; Walton, M.; de Bono, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-12</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cell division involves a cyclical biochem. process composed of several step-wise reactions that have to occur once per cell cycle.  Dysregulation of cell division is a hallmark of all cancers.  Genetic and epigenetic mechanisms frequently result in deranged expression and/or activity of cell-cycle proteins including the cyclins, cyclin-dependent kinases (Cdks), Cdk inhibitors and checkpoint control proteins.  The crit. nature of these proteins in cell cycling raises hope that targeting them may result in selective cytotoxicity and valuable anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQY1tBrrikrVg90H21EOLACvtfcHk0liWkP8Vw6smvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2qu7k%253D&md5=82191c598697434e2f8f80a5171f99dc</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6602229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6602229%26sid%3Dliteratum%253Aachs%26aulast%3DBenson%26aufirst%3DC.%26aulast%3DKaye%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DGarrett%26aufirst%3DM.%26aulast%3DWalton%26aufirst%3DM.%26aulast%3Dde%2BBono%26aufirst%3DJ.%26atitle%3DClinical%2520anticancer%2520drug%2520development%253A%2520targeting%2520the%2520cyclin-dependent%2520kinases%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2005%26volume%3D92%26spage%3D7%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Blagosklonny, M. V.</span><span> </span><span class="NLM_article-title">Flavopiridol, an inhibitor of transcription: implications, problems and solutions</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1537</span><span class="NLM_x">–</span> <span class="NLM_lpage">1542</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1537-1542&author=M.+V.+Blagosklonny&title=Flavopiridol%2C+an+inhibitor+of+transcription%3A+implications%2C+problems+and+solutions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlagosklonny%26aufirst%3DM.%2BV.%26atitle%3DFlavopiridol%252C%2520an%2520inhibitor%2520of%2520transcription%253A%2520implications%252C%2520problems%2520and%2520solutions%26jtitle%3DCell%2520Cycle%26date%3D2004%26volume%3D3%26spage%3D1537%26epage%3D1542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Deshpande, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinds, P. W.</span><span> </span><span class="NLM_article-title">Cyclins and cdks in development and cancer: a perspective</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2909</span><span class="NLM_x">–</span> <span class="NLM_lpage">2915</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=2909-2915&author=A.+Deshpandeauthor=P.+Sicinskiauthor=P.+W.+Hinds&title=Cyclins+and+cdks+in+development+and+cancer%3A+a+perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeshpande%26aufirst%3DA.%26aulast%3DSicinski%26aufirst%3DP.%26aulast%3DHinds%26aufirst%3DP.%2BW.%26atitle%3DCyclins%2520and%2520cdks%2520in%2520development%2520and%2520cancer%253A%2520a%2520perspective%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D2909%26epage%3D2915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span> </span><span class="NLM_article-title">Recent advances in the development of selective small molecule inhibitors for cyclin-dependent kinases</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.2174%2F1568026053507688" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=15853645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFyksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=167-179&author=H.+Hiraiauthor=N.+Kawanishiauthor=Y.+Iwasawa&title=Recent+advances+in+the+development+of+selective+small+molecule+inhibitors+for+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of selective small molecule inhibitors for Cyclin-dependent kinases</span></div><div class="casAuthors">Hirai, Hiroshi; Kawanishi, Nobuhiko; Iwasawa, Yoshikazu</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-179</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Loss of normal cell cycle regulation is the hallmark of human cancers, and alteration of the components involved in cell cycle regulation occurs in most human tumors.  This suggests that Cyclin dependent kinases (CDKs) are an attractive target for the development of pharmacol. agents for the treatment of cancer.  Recently, CDK family members that are not directly involved in cell cycle regulation were identified.  This includes CDK7, CDK8, and CDK9, which participate in transcription regulation, and CDK5, which plays a role in neuronal and secretory functions.  Given the involvement of CDKs in multiple cellular processes, development of selective small mol. inhibitors for specific CDKs is expected to help clarify whether improved specificity of cell cycle CDK inhibitors will enhance their therapeutic potential in cancer treatment.  Selective inhibitors are also needed as tools to explore the biol. of diseases in which CDKs may participate and to help develop therapeutics to treat them.  Intensive screening and drug design based on CDK/inhibitor co-crystal structure and SAR studies have led to the identification of a large variety of chem. inhibitors of CDKs.  Although they are competitive with ATP at the catalytic site, their kinase selectivity varies greatly, and inhibitors selective for certain CDKs have begun to be identified.  There are currently 2 categories of selective CDK inhibitors: those that are selective for CDK2 and CDK1 and those that are selective for CDK4/6.  These 2 types of inhibitors have different effects on tumor cells and are expected to be useful in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooiAF6UAza_7Vg90H21EOLACvtfcHk0lhKzFSqQ3bQLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFyksbw%253D&md5=2fceab02ebbaaca45061a80884571ef7</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.2174%2F1568026053507688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053507688%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DKawanishi%26aufirst%3DN.%26aulast%3DIwasawa%26aufirst%3DY.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520selective%2520small%2520molecule%2520inhibitors%2520for%2520cyclin-dependent%2520kinases%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D167%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kamb, A.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase inhibitors and human cancer</span> <span class="citation_source-journal">Curr. Top. Microbiol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">227</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=1998&pages=139-148&author=A.+Kamb&title=Cyclin-dependent+kinase+inhibitors+and+human+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKamb%26aufirst%3DA.%26atitle%3DCyclin-dependent%2520kinase%2520inhibitors%2520and%2520human%2520cancer%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D1998%26volume%3D227%26spage%3D139%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Malumbres, M.</span><span> </span><span class="NLM_article-title">Revisiting the “Cdk-centric” view of the mammalian cell cycle</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">206</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=206-210&author=M.+Malumbres&title=Revisiting+the+%E2%80%9CCdk-centric%E2%80%9D+view+of+the+mammalian+cell+cycle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26atitle%3DRevisiting%2520the%2520%25E2%2580%259CCdk-centric%25E2%2580%259D%2520view%2520of%2520the%2520mammalian%2520cell%2520cycle%26jtitle%3DCell%2520Cycle%26date%3D2005%26volume%3D4%26spage%3D206%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Murray, A. W.; Hunt, T.</span> <span class="citation_source-book">The Cell Cycle</span><span> </span><span class="NLM_article-title"></span>; <span class="NLM_publisher-name">Oxford Univeristy Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1993</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&author=A.+W.+Murray&author=T.+Hunt&title=The+Cell+Cycle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DA.%2BW.%26btitle%3DThe%2520Cell%2520Cycle%26pub%3DOxford%2520Univeristy%2520Press%26date%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaharevitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gussio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louarn-Leost, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunick, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahusen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headlee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbuck, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senderowicz, A.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinases: initial approaches to exploit a novel therapeutic target</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2h&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1016%2FS0163-7258%2898%2900062-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2h&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=10454206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2h&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFOhtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1999&pages=285-292&author=E.+A.+Sausvilleauthor=D.+Zaharevitzauthor=R.+Gussioauthor=L.+Meijerauthor=M.+Louarn-Leostauthor=C.+Kunickauthor=R.+Schultzauthor=T.+Lahusenauthor=D.+Headleeauthor=S.+Stinsonauthor=S.+G.+Arbuckauthor=A.+Senderowicz&title=Cyclin-dependent+kinases%3A+initial+approaches+to+exploit+a+novel+therapeutic+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2hR"><div class="casContent"><span class="casTitleNuber">2h</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinases: initial approaches to exploit a novel therapeutic target</span></div><div class="casAuthors">Sausville, Edward A.; Zaharevitz, Daniel; Gussio, Robert; Meijer, Laurent; Louarn-Leost, Maryse; Kunick, Conrad; Schultz, Robert; Lahusen, Tyler; Headlee, Donna; Stinson, Sherman; Arbuck, Susan G.; Senderowicz, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">285-292</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (CDKs) have been recognized as key regulators of cell cycle progression.  Alteration and deregulation of CDK activity are pathogenic hallmarks of neoplasia.  Therefore, inhibitors or modulators would be of interest to explore as novel therapeutic agents in cancer, as well as other hyperproliferative disorders.  Flavopiridol is a semisynthetic flavonoid that emerged from an empirical screening program as a potent antiproliferative agent that mechanistic studies demonstrated to directly inhibit CDKs 1, 2, and 4 as a competitive ATP site antagonist.  Initial clin. trials have shown that concns. that inhibit cell proliferation and CDK activity in vitro can be safely achieved in humans, and addnl. clin. trials will establish its clin. potential.  To address the need for addnl. chemotypes that may serve as lead structures for drugs that would not have the toxicities assocd. with flavopiridol, compds. with a similar pattern of cell growth inhibitory activity in the National Cancer Institute's in vitro anticancer drug screen have been recognized by the computer-assisted pattern recognition algorithm COMPARE and then screened for anti-CDK activity in a biochem. screen.  The benzodiazepine deriv. NSC 664704 (7,12-dihydro-indolo[3,2-d][1]benzazepin-6(5H)-one) was revealed by that approach as a moderately potent (IC50 0.4 μM) inhibitor of CDK2, which in initial expts. shows evidence of causing cell cycle redistribution in living cells.  NSC 664704 is, therefore, a candidate for further structural optimization, guided in part by understanding of the ATP-binding site in CDK2.  This approach represents one way of combining empirical screening information with structure-based design to derive novel candidate therapeutic agents directed against an important cellular target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlhbRCp8hA6rVg90H21EOLACvtfcHk0lgCoBT9FeZY9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFOhtLk%253D&md5=de21027b523d6fad892d4afd19fa6514</span></div><a href="/servlet/linkout?suffix=cit2h&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2898%2900062-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252898%252900062-X%26sid%3Dliteratum%253Aachs%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DZaharevitz%26aufirst%3DD.%26aulast%3DGussio%26aufirst%3DR.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DLouarn-Leost%26aufirst%3DM.%26aulast%3DKunick%26aufirst%3DC.%26aulast%3DSchultz%26aufirst%3DR.%26aulast%3DLahusen%26aufirst%3DT.%26aulast%3DHeadlee%26aufirst%3DD.%26aulast%3DStinson%26aufirst%3DS.%26aulast%3DArbuck%26aufirst%3DS.%2BG.%26aulast%3DSenderowicz%26aufirst%3DA.%26atitle%3DCyclin-dependent%2520kinases%253A%2520initial%2520approaches%2520to%2520exploit%2520a%2520novel%2520therapeutic%2520target%26jtitle%3DPharmacol.%2520Ther.%26date%3D1999%26volume%3D82%26spage%3D285%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ely, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Liberto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niesvizky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baughn, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatada, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knowles, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen-Kiang, S.</span><span> </span><span class="NLM_article-title">Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">11345</span><span class="NLM_x">–</span> <span class="NLM_lpage">11353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=11345-11353&author=S.+Elyauthor=M.+Di+Libertoauthor=R.+Niesvizkyauthor=L.+B.+Baughnauthor=H.+J.+Choauthor=E.+N.+Hatadaauthor=D.+M.+Knowlesauthor=J.+Laneauthor=S.+Chen-Kiang&title=Mutually+exclusive+cyclin-dependent+kinase+4%2Fcyclin+D1+and+cyclin-dependent+kinase+6%2Fcyclin+D2+pairing+inactivates+retinoblastoma+protein+and+promotes+cell+cycle+dysregulation+in+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEly%26aufirst%3DS.%26aulast%3DDi%2BLiberto%26aufirst%3DM.%26aulast%3DNiesvizky%26aufirst%3DR.%26aulast%3DBaughn%26aufirst%3DL.%2BB.%26aulast%3DCho%26aufirst%3DH.%2BJ.%26aulast%3DHatada%26aufirst%3DE.%2BN.%26aulast%3DKnowles%26aufirst%3DD.%2BM.%26aulast%3DLane%26aufirst%3DJ.%26aulast%3DChen-Kiang%26aufirst%3DS.%26atitle%3DMutually%2520exclusive%2520cyclin-dependent%2520kinase%25204%252Fcyclin%2520D1%2520and%2520cyclin-dependent%2520kinase%25206%252Fcyclin%2520D2%2520pairing%2520inactivates%2520retinoblastoma%2520protein%2520and%2520promotes%2520cell%2520cycle%2520dysregulation%2520in%2520multiple%2520myeloma%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D11345%26epage%3D11353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kitagawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">SuzukiTakahashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taya, Y.</span><span> </span><span class="NLM_article-title">The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">7060</span><span class="NLM_x">–</span> <span class="NLM_lpage">7069</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1002%2Fj.1460-2075.1996.tb01097.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=9003781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADyaK2sXosFKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1996&pages=7060-7069&author=M.+Kitagawaauthor=H.+Higashiauthor=H.+K.+Jungauthor=I.+SuzukiTakahashiauthor=M.+Ikedaauthor=K.+Tamaiauthor=J.+Katoauthor=K.+Segawaauthor=E.+Yoshidaauthor=S.+Nishimuraauthor=Y.+Taya&title=The+consensus+motif+for+phosphorylation+by+cyclin+D1-Cdk4+is+different+from+that+for+phosphorylation+by+cyclin+A%2FE-Cdk2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2</span></div><div class="casAuthors">Kitagawa, Masatoshi; Higashi, Hideaki; Jung, Hai-Kwan; Suzuki-Takahashi, Ikuko; Ikeda, Masako; Tamai, Katsuyuki; Kato, Jun-ya; Segawa, Kaoru; Yoshida, Eisaku; Nishimura, Susumu; Taya, Yoichi</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7060-7069</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Cyclin D-Cdk4/6 and cyclin A/E-Cdk2 are suggested to be involved in phosphorylation of the retinoblastoma protein (pRB) during the G1/S transition of the cell cycle.  However, it is unclear why several Cdks are needed and how they are different from one another.  We found that the consensus amino acid sequence for phosphorylation by cyclin D1-Cdk4 is different from S/T-P-X-K/R, which is the consensus sequence for phosphorylation by cyclin A/E-Cdk2 using various synthetic peptides as substrates.  Cyclin D1-Cdk4 efficiently phosphorylated the G1 peptide, RPPTLS780PIPhipr that contained a part of the sequence of pRB, while cyclins E-Cdk2 and A-Cdk2 did not.  To det. the phosphorylation state of pRB in vitro and in vivo, we raised the specific antibody against phospho-Ser780 in pRB.  We confirmed that cyclin D1-Cdk4, but not cyclin E-Cdk2, phosphorylated Ser780 in recombinant pRB.  The Ser780 in pRB was phosphorylated in the G1 phase in a cell cycle-dependent manner.  Furthermore, we found that pRB phosphorylated at Ser780 cannot bind to E2F-1 in vivo.  Our data show that cyclin D1-Cdk4 and cyclin A/E Cdk2 phosphorylate different sites of pRB in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogbhxXMzHcPrVg90H21EOLACvtfcHk0ljl73DretrDyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXosFKlsQ%253D%253D&md5=a0bb66af6ded3baa26d56771f0fd5d67</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1002%2Fj.1460-2075.1996.tb01097.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fj.1460-2075.1996.tb01097.x%26sid%3Dliteratum%253Aachs%26aulast%3DKitagawa%26aufirst%3DM.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DJung%26aufirst%3DH.%2BK.%26aulast%3DSuzukiTakahashi%26aufirst%3DI.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DTamai%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DJ.%26aulast%3DSegawa%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DE.%26aulast%3DNishimura%26aufirst%3DS.%26aulast%3DTaya%26aufirst%3DY.%26atitle%3DThe%2520consensus%2520motif%2520for%2520phosphorylation%2520by%2520cyclin%2520D1-Cdk4%2520is%2520different%2520from%2520that%2520for%2520phosphorylation%2520by%2520cyclin%2520A%252FE-Cdk2%26jtitle%3DEMBO%2520J.%26date%3D1996%26volume%3D15%26spage%3D7060%26epage%3D7069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Amin, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medeiros, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassidakis, G. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leventaki, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, R.</span><span> </span><span class="NLM_article-title">Characterization of 4 mantle cell lymphoma cell lines: Establishment of an in vitro study model</span> <span class="citation_source-journal">Arch. Pathol. Lab. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">424</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=12683869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A280%3ADC%252BD3s7ms1Cjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2003&pages=424-431&author=H.+M.+Aminauthor=T.+J.+McDonnellauthor=L.+J.+Medeirosauthor=G.+Z.+Rassidakisauthor=V.+Leventakiauthor=S.+L.+O%E2%80%99Connorauthor=M.+J.+Keatingauthor=R.+Lai&title=Characterization+of+4+mantle+cell+lymphoma+cell+lines%3A+Establishment+of+an+in+vitro+study+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of 4 mantle cell lymphoma cell lines</span></div><div class="casAuthors">Amin Hesham M; McDonnell Timothy J; Medeiros L Jeffrey; Rassidakis Georgios Z; Leventaki Vasiliki; O'Connor Sean L; Keating Michael J; Lai Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Archives of pathology & laboratory medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">424-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">CONTEXT:  Mantle cell lymphoma (MCL) is a distinct type of B-cell non-Hodgkin lymphoma characterized by t(11;14)(q13;q32) and cyclin D1 overexpression.  The pathogenesis of MCL has not been comprehensively studied, which can be attributed in part to the paucity of well-characterized MCL cell lines.  OBJECTIVES:  We collected 4 previously developed MCL cell lines and performed extensive characterization, including the susceptibly of these cell lines to transduction by adenovirus vectors.  Our aim was to facilitate the establishment of an in vitro model that can be reliably used to study the pathogenesis of MCL.  METHODS:  Standard techniques were used to compare the morphologic, immunophenotypic, and cytogenetic features of the 4 cell lines.  In addition, Western blotting was used to investigate the presence of several cell cycle- and apoptosis-related proteins.  TP53 DNA sequencing was also performed on the cell lines.  The adenoviral transduction efficiency was assessed using an adenoviral vector carrying the gene encoding for the green fluorescence protein (Ad-GFP).  RESULTS:  All cell lines demonstrated evidence of t(11;14)(q13;q32) and overexpression of cyclin D1.  Cyclin D2 was not detectable in all cell lines, whereas cyclin D3 was weakly expressed in JeKo-1 and SP-53.  Other abnormalities of the cell cycle G1 phase regulatory pathway were detected, including loss of expression of p53 (JeKo-1) and p16(INK4a) (SP-53 and Granta 519), as well as TP53 mutation (Mino).  All cell lines express high levels of cyclin E, c-Myc, Bcl-2, Bax, Bcl-x(L), and Mcl-1.  Retinoblastoma protein is hyperphosphorylated in all cell lines.  With the exception of Mino, MCL cell lines are highly transducible with adenoviral vectors.  CONCLUSION:  These cell lines are representative of MCL and can be used as an in vitro model to further explore the pathogenesis of this disease.  The susceptibility of these cell lines to gene transfer provides opportunities to evaluate the importance of various oncogenes and tumor suppressor genes that may have an impact on developing effective therapeutic regimens for MCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRZqla8AANb9RBrI9DTGjC0fW6udTcc2ebTYPbpNXb6Y7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7ms1Cjsg%253D%253D&md5=2f8cea1c7a9eaca2e40dbbd4f9e2be62</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmin%26aufirst%3DH.%2BM.%26aulast%3DMcDonnell%26aufirst%3DT.%2BJ.%26aulast%3DMedeiros%26aufirst%3DL.%2BJ.%26aulast%3DRassidakis%26aufirst%3DG.%2BZ.%26aulast%3DLeventaki%26aufirst%3DV.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DS.%2BL.%26aulast%3DKeating%26aufirst%3DM.%2BJ.%26aulast%3DLai%26aufirst%3DR.%26atitle%3DCharacterization%2520of%25204%2520mantle%2520cell%2520lymphoma%2520cell%2520lines%253A%2520Establishment%2520of%2520an%2520in%2520vitro%2520study%2520model%26jtitle%3DArch.%2520Pathol.%2520Lab.%2520Med.%26date%3D2003%26volume%3D127%26spage%3D424%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bergsagel, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehl, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlogie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaughnessy, J.</span><span> </span><span class="NLM_article-title">Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">296</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=296-303&author=P.+L.+Bergsagelauthor=W.+M.+Kuehlauthor=F.+H.+Zhanauthor=J.+Sawyerauthor=B.+Barlogieauthor=J.+Shaughnessy&title=Cyclin+D+dysregulation%3A+an+early+and+unifying+pathogenic+event+in+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26aulast%3DKuehl%26aufirst%3DW.%2BM.%26aulast%3DZhan%26aufirst%3DF.%2BH.%26aulast%3DSawyer%26aufirst%3DJ.%26aulast%3DBarlogie%26aufirst%3DB.%26aulast%3DShaughnessy%26aufirst%3DJ.%26atitle%3DCyclin%2520D%2520dysregulation%253A%2520an%2520early%2520and%2520unifying%2520pathogenic%2520event%2520in%2520multiple%2520myeloma%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D296%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bergsagel, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehl, W. M.</span><span> </span><span class="NLM_article-title">Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">194</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1034%2Fj.1600-065X.2003.00052.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=12846810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsV2ms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2003&pages=96-104&author=P.+L.+Bergsagelauthor=W.+M.+Kuehl&title=Critical+roles+for+immunoglobulin+translocations+and+cyclin+D+dysregulation+in+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma</span></div><div class="casAuthors">Bergsagel, P. Leif; Kuehl, W. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">194</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">96-104</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">A review.  Multiple myeloma (MM) is a tumor of long-lived bone marrow plasma cells (PCs).  Nearly 40% of MM tumors have Ig H (IgH) translocations involving four recurrent chromosomal loci (oncogenes): 11q13 (cyclin D1), 6p21 (cyclin D3), 4p16 (MMSET and FGFR3), and 16q23 (c-maf).  Other MM tumors have Ig translocations involving different loci, none of which is involved in more than 1% of tumors.  At least 25% of MM tumors have no Ig translocation.  Unlike normal PCs, MM tumors usually express one of the three cyclin D genes at a high level.  Translocations involving 4p16 and 16q23 do not directly target a cyclin D gene, but they are assocd. with a high level of cyclin D2 expression.  Although cyclin D1 is not expressed in normal hematopoietic cells, one-third of MM tumors ectopically express cyclin D1 in the absence of t(11;14).  Despite a low proliferation index in MM dysregulation of a cyclin D gene seems to be a unifying oncogenic event.  Anal. of 34 MM cell lines indicates that tumors having an IgH translocation are significantly over-represented, whereas tumors that ectopically express cyclin D1 are not represented.  We speculate that ectopic cyclin D1 expression without t(11;14) is dependent on tumor-specific interaction with bone marrow stromal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYEua-3MWjkbVg90H21EOLACvtfcHk0lirOdYQbakv1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsV2ms7w%253D&md5=904c6abc53606495daa7a9b748248096</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1034%2Fj.1600-065X.2003.00052.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1600-065X.2003.00052.x%26sid%3Dliteratum%253Aachs%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26aulast%3DKuehl%26aufirst%3DW.%2BM.%26atitle%3DCritical%2520roles%2520for%2520immunoglobulin%2520translocations%2520and%2520cyclin%2520D%2520dysregulation%2520in%2520multiple%2520myeloma%26jtitle%3DImmunol.%2520Rev.%26date%3D2003%26volume%3D194%26spage%3D96%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, T. S.</span><span> </span><span class="NLM_article-title">Detection of CCND1 amplification using laser capture microdissection coupled with real-time polymerase chain reaction in human esophageal squamous cell carcinoma</span> <span class="citation_source-journal">Cancer Genet. Cytogenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">175</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1016%2Fj.cancergencyto.2007.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=17498553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A280%3ADC%252BD2szksVOgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2007&pages=19-25&author=C.+Huangauthor=L.+Yangauthor=Z.+F.+Liauthor=J.+Yangauthor=J.+J.+Zhaoauthor=D.+H.+Xuauthor=L.+Y.+Liuauthor=Q.+L.+Wangauthor=T.+S.+Song&title=Detection+of+CCND1+amplification+using+laser+capture+microdissection+coupled+with+real-time+polymerase+chain+reaction+in+human+esophageal+squamous+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4d</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of CCND1 amplification using laser capture microdissection coupled with real-time polymerase chain reaction in human esophageal squamous cell carcinoma</span></div><div class="casAuthors">Huang Chen; Yang Lin; Li Zhongfang; Yang Jun; Zhao Junjie; Dehui Xu; Liu Liying; Wang Quanli; Song Tusheng</div><div class="citationInfo"><span class="NLM_cas:title">Cancer genetics and cytogenetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-25</span>
        ISSN:<span class="NLM_cas:issn">0165-4608</span>.
    </div><div class="casAbstract">Several methods have been used to detect CCND1 amplification or overexpression in esophageal squamous cell carcinoma (ESCC), but problems remain, associated with heterogeneity of tumor tissue and quantification of gene copies.  Laser capture microdissection coupled with real-time polymerase chain reaction (PCR) is a reliable method for the molecular analysis of gene profiles in specific tissues.  All 35 specimens of ESCC studied were paraffin-embedded, cut into tissue slides, and stained by hematoxylin-eosin.  The pure ESCC cell and normal squamous epithelia populations were separated by LCM and then genomic DNA was extracted from the dissected cells.  CCND1 amplification was detected with real-time FQ-PCR and with PCR.  Amplification was calculated by the formula X = 2(-DeltaDeltaCt) and R = (CCND1/ACTB) CANCER/(CCND1/ACTB) NORMAL.  Twenty (57%) of primary ESCC cancer cell groups had a detectable CCND1 amplification (range, 2.06-fold to 25.9-fold) with real-time FQ-PCR, but only 2 of 15 primary ESCC cancer cell groups had detectable CCND1 amplification by PCR.  CCND1 amplification was not correlated with age, sex, size of tumor, histological grade, and lymph node metastasis.  In conclusion, LCM coupled with real-time fluorescence quantitative-PCR technique is more precise than PCR for the identifying amplified oncogenes; The role of CCND1 amplification in ESCC development and progression needs more extensive study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRI_he2LCM0b1f1XRtfYM0dfW6udTcc2eaN9tFW1vnGl7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szksVOgsw%253D%253D&md5=b392255cb6de61cccacd50f8ce1cd4f4</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1016%2Fj.cancergencyto.2007.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cancergencyto.2007.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DZ.%2BF.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26aulast%3DXu%26aufirst%3DD.%2BH.%26aulast%3DLiu%26aufirst%3DL.%2BY.%26aulast%3DWang%26aufirst%3DQ.%2BL.%26aulast%3DSong%26aufirst%3DT.%2BS.%26atitle%3DDetection%2520of%2520CCND1%2520amplification%2520using%2520laser%2520capture%2520microdissection%2520coupled%2520with%2520real-time%2520polymerase%2520chain%2520reaction%2520in%2520human%2520esophageal%2520squamous%2520cell%2520carcinoma%26jtitle%3DCancer%2520Genet.%2520Cytogenet.%26date%3D2007%26volume%3D175%26spage%3D19%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, I. B.</span><span> </span><span class="NLM_article-title">Amplification and Expression of the Human Cyclin-D Gene in Esophageal Cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2980</span><span class="NLM_x">–</span> <span class="NLM_lpage">2983</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1992&pages=2980-2983&author=W.+Jiangauthor=S.+M.+Kahnauthor=N.+Tomitaauthor=Y.+J.+Zhangauthor=S.+H.+Luauthor=I.+B.+Weinstein&title=Amplification+and+Expression+of+the+Human+Cyclin-D+Gene+in+Esophageal+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DKahn%26aufirst%3DS.%2BM.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DY.%2BJ.%26aulast%3DLu%26aufirst%3DS.%2BH.%26aulast%3DWeinstein%26aufirst%3DI.%2BB.%26atitle%3DAmplification%2520and%2520Expression%2520of%2520the%2520Human%2520Cyclin-D%2520Gene%2520in%2520Esophageal%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D1992%26volume%3D52%26spage%3D2980%26epage%3D2983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Steeg, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span> </span><span class="NLM_article-title">Cyclins and breast cancer</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1023%2FA%3A1006102916060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=10066069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A280%3ADyaK1M7mtl2msA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1998&pages=17-28&author=P.+S.+Steegauthor=Q.+Zhou&title=Cyclins+and+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4fR"><div class="casContent"><span class="casTitleNuber">4f</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclins and breast cancer</span></div><div class="casAuthors">Steeg P S; Zhou Q</div><div class="citationInfo"><span class="NLM_cas:title">Breast cancer research and treatment</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">17-28</span>
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    </div><div class="casAbstract">Cyclins are regulatory subunits for cyclin dependent kinases in the coordination of the cell cycle.  Cyclins can also serve non-cell cycle functions, such as the transactivation of estrogen receptor by cyclin D.  Evidence for the participation of the G1 cyclins D and E in breast cancer is summarized, including transgenic and knockout mice, transfections, and expression patterns in cohort studies.  Overexpression of cyclin D has been reported in ductal carcinoma in situ (DCIS), and similar overexpression of cyclin E is suggested.  Strategies to reduce cyclin expression are discussed as potential prevention efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkUNrTIA9hgmx8TEN9K18QfW6udTcc2eY8LrOHmDaivbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7mtl2msA%253D%253D&md5=dd96bd4b146d25341030f011417f23ff</span></div><a href="/servlet/linkout?suffix=cit4f&amp;dbid=16384&amp;doi=10.1023%2FA%3A1006102916060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1006102916060%26sid%3Dliteratum%253Aachs%26aulast%3DSteeg%26aufirst%3DP.%2BS.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DCyclins%2520and%2520breast%2520cancer%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D1998%26volume%3D52%26spage%3D17%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase pathways as targets for cancer treatment</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1770</span><span class="NLM_x">–</span> <span class="NLM_lpage">1783</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4g&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1200%2FJCO.2005.03.7689" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=1770-1783&author=G.+I.+Shapiro&title=Cyclin-dependent+kinase+pathways+as+targets+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4g&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.03.7689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.03.7689%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DCyclin-dependent%2520kinase%2520pathways%2520as%2520targets%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D24%26spage%3D1770%26epage%3D1783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dailey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrosetti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansukhani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basilico, C.</span><span> </span><span class="NLM_article-title">Mechanisms underlying differential responses to FGF signaling</span> <span class="citation_source-journal">Cytokine Growth Factor Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1016%2Fj.cytogfr.2005.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=15863038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=233-247&author=L.+Daileyauthor=D.+Ambrosettiauthor=A.+Mansukhaniauthor=C.+Basilico&title=Mechanisms+underlying+differential+responses+to+FGF+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms underlying differential responses to FGF signaling</span></div><div class="casAuthors">Dailey, Lisa; Ambrosetti, Davide; Mansukhani, Alka; Basilico, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine & Growth Factor Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-247</span>CODEN:
                <span class="NLM_cas:coden">CGFRFB</span>;
        ISSN:<span class="NLM_cas:issn">1359-6101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Fibroblast growth factors (FGFs) are key regulators of several developmental processes in which cell fate and differentiation to various tissue lineages are detd.  The importance of the proper spatial and temporal regulation of FGF signals is evident from human and mouse genetic studies which show that mutations leading to the dysregulation of FGF signals cause a variety of developmental disorders including dominant skeletal diseases and cancer.  The FGF ligands signal via a family of receptor tyrosine kinases and, depending on the cell type or stage of maturation, produce diverse biol. responses that include proliferation, growth arrest, differentiation or apoptosis.  A central issue in FGF biol. is to understand how these diverse cellular responses are detd. and how similar signaling inputs can generate distinct patterns of gene expression that govern the specificity of the cellular response.  In this review the authors draw upon studies from the past fifteen years and attempt to construct a mol. picture of the different levels of regulation by which such specific cellular responses could be achieved by FGF signals.  The authors discuss whether specificity could lie in the nature of the ligand, the particular receptor, the signal transduction pathways utilized, or the transcriptional regulation of specific genes.  Finally, the authors also discuss how the interplay of FGF signals with other signaling systems could contribute to the cellular response.  In particular the authors focus on the interaction with the Wnt pathway since FGF/Wnt cross-talk is emerging as an important nexus in regulating a variety of biol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOsKybSoaLlLVg90H21EOLACvtfcHk0li0B2UPTRmvXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOnsLs%253D&md5=d58f7df4baa2ab2fa348a9b443e95782</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2Fj.cytogfr.2005.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cytogfr.2005.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DDailey%26aufirst%3DL.%26aulast%3DAmbrosetti%26aufirst%3DD.%26aulast%3DMansukhani%26aufirst%3DA.%26aulast%3DBasilico%26aufirst%3DC.%26atitle%3DMechanisms%2520underlying%2520differential%2520responses%2520to%2520FGF%2520signaling%26jtitle%3DCytokine%2520Growth%2520Factor%2520Rev.%26date%3D2005%26volume%3D16%26spage%3D233%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Protein and lipid kinase inhibitors as targeted anticancer agents of the Ras/Raf/MEK and PI3K/PKB pathways</span> <span class="citation_source-journal">Purinergic Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=117-125&author=C.+Garcia-Echeverria&title=Protein+and+lipid+kinase+inhibitors+as+targeted+anticancer+agents+of+the+Ras%2FRaf%2FMEK+and+PI3K%2FPKB+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DProtein%2520and%2520lipid%2520kinase%2520inhibitors%2520as%2520targeted%2520anticancer%2520agents%2520of%2520the%2520Ras%252FRaf%252FMEK%2520and%2520PI3K%252FPKB%2520pathways%26jtitle%3DPurinergic%2520Signalling%26date%3D2009%26volume%3D5%26spage%3D117%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">John, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, M. S.</span><span> </span><span class="NLM_article-title">Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">S14</span><span class="NLM_x">–</span> <span class="NLM_lpage">S23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=S14-S23&author=T.+Johnauthor=G.+Liuauthor=M.+S.+Tsao&title=Overview+of+molecular+testing+in+non-small-cell+lung+cancer%3A+mutational+analysis%2C+gene+copy+number%2C+protein+expression+and+other+biomarkers+of+EGFR+for+the+prediction+of+response+to+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohn%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DTsao%26aufirst%3DM.%2BS.%26atitle%3DOverview%2520of%2520molecular%2520testing%2520in%2520non-small-cell%2520lung%2520cancer%253A%2520mutational%2520analysis%252C%2520gene%2520copy%2520number%252C%2520protein%2520expression%2520and%2520other%2520biomarkers%2520of%2520EGFR%2520for%2520the%2520prediction%2520of%2520response%2520to%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DOncogene%26date%3D2009%26volume%3D28%26spage%3DS14%26epage%3DS23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Landis, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlyk, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinds, P. W.</span><span> </span><span class="NLM_article-title">Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=13-22&author=M.+W.+Landisauthor=B.+S.+Pawlykauthor=T.+Liauthor=P.+Sicinskiauthor=P.+W.+Hinds&title=Cyclin+D1-dependent+kinase+activity+in+murine+development+and+mammary+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLandis%26aufirst%3DM.%2BW.%26aulast%3DPawlyk%26aufirst%3DB.%2BS.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DSicinski%26aufirst%3DP.%26aulast%3DHinds%26aufirst%3DP.%2BW.%26atitle%3DCyclin%2520D1-dependent%2520kinase%2520activity%2520in%2520murine%2520development%2520and%2520mammary%2520tumorigenesis%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D13%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yu, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span> </span><span class="NLM_article-title">Specific protection against breast cancers by cyclin D1 ablation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">411</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1021</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=1017-1021&author=Q.+Y.+Yuauthor=Y.+Gengauthor=P.+Sicinski&title=Specific+protection+against+breast+cancers+by+cyclin+D1+ablation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DQ.%2BY.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DSicinski%26aufirst%3DP.%26atitle%3DSpecific%2520protection%2520against%2520breast%2520cancers%2520by%2520cyclin%2520D1%2520ablation%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D1017%26epage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yu, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagozdzon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stal, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span> </span><span class="NLM_article-title">Requirement for CDK4 kinase function in breast cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1016%2Fj.ccr.2005.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=16413469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD28XosFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=23-32&author=Q.+Y.+Yuauthor=E.+Sicinskaauthor=Y.+Gengauthor=M.+Ahnstromauthor=A.+Zagozdzonauthor=Y.+Kongauthor=H.+Gardnerauthor=H.+Kiyokawaauthor=L.+N.+Harrisauthor=Q.+Stalauthor=P.+Sicinski&title=Requirement+for+CDK4+kinase+function+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement for CDK4 kinase function in breast cancer</span></div><div class="casAuthors">Yu, Qunyan; Sicinska, Ewa; Geng, Yan; Ahnstrom, Marie; Zagozdzon, Agnieszka; Kong, Yinxin; Gardner, Humphrey; Kiyokawa, Hiroaki; Harris, Lyndsay N.; Stal, Olle; Sicinski, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-32</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cyclin D1 is overexpressed in the majority of human breast cancers.  The authors previously found that mice lacking cyclin D1 are resistant to mammary carcinomas triggered by the ErbB-2 oncogene.  In this study, the authors investigated which function of cyclin D1 is required for ErbB-2-driven mammary oncogenesis.  The authors report that the ability of cyclin D1 to activate cyclin-dependent kinase CDK4 underlies the crit. role for cyclin D1 in breast cancer formation.  The authors also found that the continued presence of CDK4-assocd. kinase activity is required to maintain breast tumorigenesis.  The authors analyzed primary human breast cancers and found high cyclin D1 levels in a subset (∼25%) of ErbB-2-overexpressing tumors.  The authors propose that this subset of breast cancer patients might benefit from inhibiting CDK4 kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7XtIoi9OqULVg90H21EOLACvtfcHk0lhK7bx0VaMK7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosFersw%253D%253D&md5=de0dbbf7f2463d60b126c201ac6bb7f6</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2005.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2005.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DQ.%2BY.%26aulast%3DSicinska%26aufirst%3DE.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DAhnstrom%26aufirst%3DM.%26aulast%3DZagozdzon%26aufirst%3DA.%26aulast%3DKong%26aufirst%3DY.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DKiyokawa%26aufirst%3DH.%26aulast%3DHarris%26aufirst%3DL.%2BN.%26aulast%3DStal%26aufirst%3DQ.%26aulast%3DSicinski%26aufirst%3DP.%26atitle%3DRequirement%2520for%2520CDK4%2520kinase%2520function%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D23%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamaria, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerezo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Mammalian cells cycle without the D-type cyclin-elependent kinases Cdk4 and Cdk6</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2004&pages=493-504&author=M.+Malumbresauthor=R.+Sotilloauthor=D.+Santamariaauthor=J.+Galanauthor=A.+Cerezoauthor=S.+Ortegaauthor=P.+Dubusauthor=M.+Barbacid&title=Mammalian+cells+cycle+without+the+D-type+cyclin-elependent+kinases+Cdk4+and+Cdk6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DSotillo%26aufirst%3DR.%26aulast%3DSantamaria%26aufirst%3DD.%26aulast%3DGalan%26aufirst%3DJ.%26aulast%3DCerezo%26aufirst%3DA.%26aulast%3DOrtega%26aufirst%3DS.%26aulast%3DDubus%26aufirst%3DP.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DMammalian%2520cells%2520cycle%2520without%2520the%2520D-type%2520cyclin-elependent%2520kinases%2520Cdk4%2520and%2520Cdk6%26jtitle%3DCell%26date%3D2004%26volume%3D118%26spage%3D493%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rane, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boden, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mettus, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Loss of cyclin-dependent kinase 4 (Cdk4) causes insulin-deficient diabetes while its activation results in pancreatic islet hyperplasia</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">A34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1999&pages=A34&author=S.+G.+Raneauthor=G.+Bodenauthor=R.+V.+Mettusauthor=E.+P.+Reddyauthor=M.+Barbacid&title=Loss+of+cyclin-dependent+kinase+4+%28Cdk4%29+causes+insulin-deficient+diabetes+while+its+activation+results+in+pancreatic+islet+hyperplasia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRane%26aufirst%3DS.%2BG.%26aulast%3DBoden%26aufirst%3DG.%26aulast%3DMettus%26aufirst%3DR.%2BV.%26aulast%3DReddy%26aufirst%3DE.%2BP.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DLoss%2520of%2520cyclin-dependent%2520kinase%25204%2520%2528Cdk4%2529%2520causes%2520insulin-deficient%2520diabetes%2520while%2520its%2520activation%2520results%2520in%2520pancreatic%2520islet%2520hyperplasia%26jtitle%3DDiabetes%26date%3D1999%26volume%3D48%26spage%3DA34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Santamaria, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barriere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerqueira, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caceres, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cdk1 is sufficient to drive the mammalian cell cycle</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">448</span><span class="NLM_x">, </span> <span class="NLM_fpage">811</span><span class="NLM_x">–</span> <span class="NLM_lpage">U8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2007&pages=811-U8&author=D.+Santamariaauthor=C.+Barriereauthor=A.+Cerqueiraauthor=S.+Huntauthor=C.+Tardyauthor=K.+Newtonauthor=J.+F.+Caceresauthor=P.+Dubusauthor=M.+Malumbresauthor=M.+Barbacid&title=Cdk1+is+sufficient+to+drive+the+mammalian+cell+cycle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSantamaria%26aufirst%3DD.%26aulast%3DBarriere%26aufirst%3DC.%26aulast%3DCerqueira%26aufirst%3DA.%26aulast%3DHunt%26aufirst%3DS.%26aulast%3DTardy%26aufirst%3DC.%26aulast%3DNewton%26aufirst%3DK.%26aulast%3DCaceres%26aufirst%3DJ.%2BF.%26aulast%3DDubus%26aufirst%3DP.%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCdk1%2520is%2520sufficient%2520to%2520drive%2520the%2520mammalian%2520cell%2520cycle%26jtitle%3DNature%26date%3D2007%26volume%3D448%26spage%3D811%26epage%3DU8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sherr, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. M.</span><span> </span><span class="NLM_article-title">Living with or without cyclins and cyclin-dependent kinases</span> <span class="citation_source-journal">Gene. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2699</span><span class="NLM_x">–</span> <span class="NLM_lpage">2711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=2699-2711&author=C.+J.+Sherrauthor=J.+M.+Roberts&title=Living+with+or+without+cyclins+and+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26atitle%3DLiving%2520with%2520or%2520without%2520cyclins%2520and%2520cyclin-dependent%2520kinases%26jtitle%3DGene.%2520Dev.%26date%3D2004%26volume%3D18%26spage%3D2699%26epage%3D2711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cell cycle, CDKs and cancer: a changing paradigm</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1038%2Fnrc2602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=19238148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=153-166&author=M.+Malumbresauthor=M.+Barbacid&title=Cell+cycle%2C+CDKs+and+cancer%3A+a+changing+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle, CDKs and cancer: a changing paradigm</span></div><div class="casAuthors">Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-166</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. cell cycle defects are often mediated by alterations in cyclin-dependent kinase (CDK) activity.  Misregulated CDKs induce unscheduled proliferation as well as genomic and chromosomal instability.  According to current models, mammalian CDKs are essential for driving each cell cycle phase, so therapeutic strategies that block CDK activity are unlikely to selectively target tumor cells.  However, recent genetic evidence has revealed that, whereas CDK1 is required for the cell cycle, interphase CDKs are only essential for proliferation of specialized cells.  Emerging evidence suggests that tumor cells may also require specific interphase CDKs for proliferation.  Thus, selective CDK inhibition may provide therapeutic benefit against certain human neoplasias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzlIKlbCPWnLVg90H21EOLACvtfcHk0lg-r_IiU-cu2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D&md5=2a7eb34b2381e288b3f43ec1bffc0aec</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1038%2Fnrc2602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2602%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCell%2520cycle%252C%2520CDKs%2520and%2520cancer%253A%2520a%2520changing%2520paradigm%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D153%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, J. R.</span><span> </span><span class="NLM_article-title">CDK inhibitors in cancer therapy: what is next?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2007&pages=16-21&author=M.+Malumbresauthor=P.+Pevarelloauthor=M.+Barbacidauthor=J.+R.+Bischoff&title=CDK+inhibitors+in+cancer+therapy%3A+what+is+next%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DBarbacid%26aufirst%3DM.%26aulast%3DBischoff%26aufirst%3DJ.%2BR.%26atitle%3DCDK%2520inhibitors%2520in%2520cancer%2520therapy%253A%2520what%2520is%2520next%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D29%26spage%3D16%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Horiuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahane, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uoto, K.</span><span> </span><span class="NLM_article-title">Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: Synthesis, biological evaluation and structure−activity relationships. Part 2</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">7850</span><span class="NLM_x">–</span> <span class="NLM_lpage">7860</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=7850-7860&author=T.+Horiuchiauthor=M.+Nagataauthor=M.+Kitagawaauthor=K.+Akahaneauthor=K.+Uoto&title=Discovery+of+novel+thieno%5B2%2C3-d%5Dpyrimidin-4-yl+hydrazone-based+inhibitors+of+Cyclin+D1-CDK4%3A+Synthesis%2C+biological+evaluation+and+structure%E2%88%92activity+relationships.+Part+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoriuchi%26aufirst%3DT.%26aulast%3DNagata%26aufirst%3DM.%26aulast%3DKitagawa%26aufirst%3DM.%26aulast%3DAkahane%26aufirst%3DK.%26aulast%3DUoto%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520novel%2520thieno%255B2%252C3-d%255Dpyrimidin-4-yl%2520hydrazone-based%2520inhibitors%2520of%2520Cyclin%2520D1-CDK4%253A%2520Synthesis%252C%2520biological%2520evaluation%2520and%2520structure%25E2%2588%2592activity%2520relationships.%2520Part%25202%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D7850%26epage%3D7860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Aubry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmerson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickens, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span> </span><span class="NLM_article-title">Fascaplysin-inspired diindolyls as selective inhibitors of CDK4 /cyclin D1</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6073</span><span class="NLM_x">–</span> <span class="NLM_lpage">6084</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6073-6084&author=C.+Aubryauthor=A.+J.+Wilsonauthor=D.+Emmersonauthor=E.+Murphyauthor=Y.+Y.+Chanauthor=M.+P.+Dickensauthor=M.+D.+Garciaauthor=P.+R.+Jenkinsauthor=S.+Mahaleauthor=B.+Chaudhuri&title=Fascaplysin-inspired+diindolyls+as+selective+inhibitors+of+CDK4+%2Fcyclin+D1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAubry%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26aulast%3DEmmerson%26aufirst%3DD.%26aulast%3DMurphy%26aufirst%3DE.%26aulast%3DChan%26aufirst%3DY.%2BY.%26aulast%3DDickens%26aufirst%3DM.%2BP.%26aulast%3DGarcia%26aufirst%3DM.%2BD.%26aulast%3DJenkins%26aufirst%3DP.%2BR.%26aulast%3DMahale%26aufirst%3DS.%26aulast%3DChaudhuri%26aufirst%3DB.%26atitle%3DFascaplysin-inspired%2520diindolyls%2520as%2520selective%2520inhibitors%2520of%2520CDK4%2520%252Fcyclin%2520D1%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D6073%26epage%3D6084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Tsou, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otteng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutterer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suayan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnis, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-diones and 4-[(pyridylmethyl)aminomethylene]-isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2289</span><span class="NLM_x">–</span> <span class="NLM_lpage">2310</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801026e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2289-2310&author=H.-R.+Tsouauthor=X.+Liuauthor=G.+Birnbergauthor=J.+Kaplanauthor=M.+Ottengauthor=T.+Tranauthor=K.+Kuttererauthor=Z.+Tangauthor=R.+Suayanauthor=A.+Zaskauthor=M.+Raviauthor=A.+Bretzauthor=M.+Grilloauthor=J.+P.+McGinnisauthor=S.+K.+Rabindranauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansour&title=Discovery+of+4-%28benzylaminomethylene%29isoquinoline-1%2C3-%282H%2C4H%29-diones+and+4-%5B%28pyridylmethyl%29aminomethylene%5D-isoquinoline-1%2C3-%282H%2C4H%29-diones+as+potent+and+selective+inhibitors+of+the+cyclin-dependent+kinase+4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1021%2Fjm801026e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801026e%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.-R.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBirnberg%26aufirst%3DG.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DOtteng%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DKutterer%26aufirst%3DK.%26aulast%3DTang%26aufirst%3DZ.%26aulast%3DSuayan%26aufirst%3DR.%26aulast%3DZask%26aufirst%3DA.%26aulast%3DRavi%26aufirst%3DM.%26aulast%3DBretz%26aufirst%3DA.%26aulast%3DGrillo%26aufirst%3DM.%26aulast%3DMcGinnis%26aufirst%3DJ.%2BP.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DDiscovery%2520of%25204-%2528benzylaminomethylene%2529isoquinoline-1%252C3-%25282H%252C4H%2529-diones%2520and%25204-%255B%2528pyridylmethyl%2529aminomethylene%255D-isoquinoline-1%252C3-%25282H%252C4H%2529-diones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520cyclin-dependent%2520kinase%25204%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2289%26epage%3D2310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Liu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span> </span><span class="NLM_article-title">Recent research in selective cyclin-dependent kinase 4 inhibitors for anti-cancer treatment</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4869</span><span class="NLM_x">–</span> <span class="NLM_lpage">4888</span><div class="note"><p class="first last">and references therein.</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.2174%2F092986709789909611" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=19929781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=4869-4888&author=N.+Liuauthor=H.+Fangauthor=Y.+Liauthor=W.+Xu&title=Recent+research+in+selective+cyclin-dependent+kinase+4+inhibitors+for+anti-cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">Recent research in selective cyclin-dependent kinase 4 inhibitors for anti-cancer treatment</span></div><div class="casAuthors">Liu, Ning; Fang, Hao; Li, Yanling; Xu, Wenfang</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">4869-4888</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  It is well known that cyclins and cyclin-dependent kinases (CDKs) play essential roles in regulation of the cell cycle.  In past two decades, the scientific researches suggest that the cyclin D1/ CDK4 complex is a key regulator of the transition through the G1 phase of the cell cycle.  Moreover, deregulation of the cyclin D /CDK4 pathway has been identified in multiple tumor types.  Thus, CDK4 is a genetically validated therapeutic target; hence, there has been a surge of interests in finding selective CDK4 inhibitors as anti-cancer agents.  This review will give the recent progress in the studies of structure, functions of CDK4 and highly selective and potent CDK4 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXMr9IPS1YKLVg90H21EOLACvtfcHk0liARn3MGc6mZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSmtro%253D&md5=b56fa129cbd008b0a9c8d043ff81e2b4</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.2174%2F092986709789909611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986709789909611%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DW.%26atitle%3DRecent%2520research%2520in%2520selective%2520cyclin-dependent%2520kinase%25204%2520inhibitors%2520for%2520anti-cancer%2520treatment%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2009%26volume%3D16%26spage%3D4869%26epage%3D4888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Jenkins, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmerson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britton, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of new tryptamine and tetrahydro-β-carboline-based selective inhibitors of CDK4</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">7728</span><span class="NLM_x">–</span> <span class="NLM_lpage">7739</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=7728-7739&author=P.+R.+Jenkinsauthor=J.+Wilsonauthor=D.+Emmersonauthor=M.+D.+Garciaauthor=M.+R.+Smithauthor=S.+J.+Grayauthor=R.+G.+Brittonauthor=S.+Mahaleauthor=B.+Chaudhuri&title=Design%2C+synthesis+and+biological+evaluation+of+new+tryptamine+and+tetrahydro-%CE%B2-carboline-based+selective+inhibitors+of+CDK4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJenkins%26aufirst%3DP.%2BR.%26aulast%3DWilson%26aufirst%3DJ.%26aulast%3DEmmerson%26aufirst%3DD.%26aulast%3DGarcia%26aufirst%3DM.%2BD.%26aulast%3DSmith%26aufirst%3DM.%2BR.%26aulast%3DGray%26aufirst%3DS.%2BJ.%26aulast%3DBritton%26aufirst%3DR.%2BG.%26aulast%3DMahale%26aufirst%3DS.%26aulast%3DChaudhuri%26aufirst%3DB.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520new%2520tryptamine%2520and%2520tetrahydro-%25CE%25B2-carboline-based%2520selective%2520inhibitors%2520of%2520CDK4%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D7728%26epage%3D7739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">VanderWel, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repine, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quin, J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrusin, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toogood, P. L.</span><span> </span><span class="NLM_article-title">Pyrido[2,3-<i>d</i>]pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2371</span><span class="NLM_x">–</span> <span class="NLM_lpage">2387</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049355%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2371-2387&author=S.+N.+VanderWelauthor=P.+J.+Harveyauthor=D.+J.+McNamaraauthor=J.+T.+Repineauthor=P.+R.+Kellerauthor=J.+Quinauthor=R.+J.+Boothauthor=W.+L.+Elliottauthor=E.+M.+Dobrusinauthor=D.+W.+Fryauthor=P.+L.+Toogood&title=Pyrido%5B2%2C3-d%5Dpyrimidin-7-ones+as+specific+inhibitors+of+cyclin-dependent+kinase+4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9f&amp;dbid=16384&amp;doi=10.1021%2Fjm049355%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049355%252B%26sid%3Dliteratum%253Aachs%26aulast%3DVanderWel%26aufirst%3DS.%2BN.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26aulast%3DRepine%26aufirst%3DJ.%2BT.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DQuin%26aufirst%3DJ.%26aulast%3DBooth%26aufirst%3DR.%2BJ.%26aulast%3DElliott%26aufirst%3DW.%2BL.%26aulast%3DDobrusin%26aufirst%3DE.%2BM.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DToogood%26aufirst%3DP.%2BL.%26atitle%3DPyrido%255B2%252C3-d%255Dpyrimidin-7-ones%2520as%2520specific%2520inhibitors%2520of%2520cyclin-dependent%2520kinase%25204%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2371%26epage%3D2387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Toogood, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repine, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanderWel, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodfuehrer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barvian, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span> </span><span class="NLM_article-title">Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2388</span><span class="NLM_x">–</span> <span class="NLM_lpage">2406</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049354h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2388-2406&author=P.+L.+Toogoodauthor=P.+J.+Harveyauthor=J.+T.+Repineauthor=D.+J.+Sheehanauthor=S.+N.+VanderWelauthor=H.+Zhouauthor=P.+R.+Kellerauthor=D.+J.+McNamaraauthor=D.+Sherryauthor=T.+Zhuauthor=J.+Brodfuehrerauthor=C.+Choiauthor=M.+R.+Barvianauthor=D.+W.+Fry&title=Discovery+of+a+potent+and+selective+inhibitor+of+cyclin-dependent+kinase+4%2F6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6</span></div><div class="casAuthors">Toogood, Peter L.; Harvey, Patricia J.; Repine, Joseph T.; Sheehan, Derek J.; VanderWel, Scott N.; Zhou, Hairong; Keller, Paul R.; McNamara, Dennis J.; Sherry, Debra; Zhu, Tong; Brodfuehrer, Joanne; Choi, Chung; Barvian, Mark R.; Fry, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2388-2406</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A pharmacol. approach to inhibition of cyclin-dependent kinases 4 and 6 (Cdk4/6) using highly selective small mol. inhibitors has the potential to provide novel cancer therapies for clin. use.  Achieving high levels of selectivity for Cdk4/6, vs. other ATP-dependent kinases, presents a significant challenge.  The pyrido[2,3-d]pyrimidin-7-one template provides an effective platform for the inhibition of a broad cross-section of kinases, including Cdks.  It is now demonstrated that the modification of pyrido[2,3-d]pyrimidin-7-ones to include a 2-aminopyridine side chain at the C2-position provides inhibitors with exquisite selectivity for Cdk4/6 in vitro.  This selectivity profile is recapitulated in cells where the most selective inhibitors create a G1 block at concns. up to 100-fold the IC50 for cell proliferation.  On the basis of its selectivity profile and pharmacokinetic profile, compd. I (PD 0332991) was identified as a drug candidate for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX577J5U0r97Vg90H21EOLACvtfcHk0ljg2oIaAMRM_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D&md5=23cbe58426ff1975695712db7c1b128a</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Fjm049354h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049354h%26sid%3Dliteratum%253Aachs%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DRepine%26aufirst%3DJ.%2BT.%26aulast%3DSheehan%26aufirst%3DD.%2BJ.%26aulast%3DVanderWel%26aufirst%3DS.%2BN.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26aulast%3DSherry%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DBarvian%26aufirst%3DM.%2BR.%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520cyclin-dependent%2520kinase%25204%252F6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2388%26epage%3D2406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trachet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albassam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopold, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryer, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toogood, P. L.</span><span> </span><span class="NLM_article-title">Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1427</span><span class="NLM_x">–</span> <span class="NLM_lpage">1438</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=15542782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpslCkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1427-1438&author=D.+W.+Fryauthor=P.+J.+Harveyauthor=P.+R.+Kellerauthor=W.+L.+Elliottauthor=M.+Meadeauthor=E.+Trachetauthor=M.+Albassamauthor=X.+Zhengauthor=W.+R.+Leopoldauthor=N.+K.+Pryerauthor=P.+L.+Toogood&title=Specific+inhibition+of+cyclin-dependent+kinase+4%2F6+by+PD+0332991+and+associated+antitumor+activity+in+human+tumor+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts</span></div><div class="casAuthors">Fry, David W.; Harvey, Patricia J.; Keller, Paul R.; Elliott, William L.; Meade, MaryAnne; Trachet, Erin; Albassam, Mudher; Zheng, XianXian; Leopold, Wilbur R.; Pryer, Nancy K.; Toogood, Peter L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1427-1438</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PD 0332991 is a highly specific inhibitor of cyclin-dependent kinase 4 (Cdk4) (IC50, 0.011 μmol/L) and Cdk6 (IC50, 0.016 μmol/L), having no activity against a panel of 36 addnl. protein kinases.  It is a potent antiproliferative agent against retinoblastoma (Rb)-pos. tumor cells in vitro, inducing an exclusive G1 arrest, with a concomitant redn. of phospho-Ser780/Ser795 on the Rb protein.  Oral administration of PD 0332991 to mice bearing the Colo-205 human colon carcinoma produces marked tumor regression.  Therapeutic doses of PD 0332991 cause elimination of phospho-Rb and the proliferative marker Ki-67 in tumor tissue and down-regulation of genes under the transcriptional control of E2F.  The results indicate that inhibition of Cdk4/6 alone is sufficient to cause tumor regression and a net redn. in tumor burden in some tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9TOgbe4wrBLVg90H21EOLACvtfcHk0ljg2oIaAMRM_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpslCkt7c%253D&md5=70931ebc6abd1c59bf1cc29748b7945f</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DElliott%26aufirst%3DW.%2BL.%26aulast%3DMeade%26aufirst%3DM.%26aulast%3DTrachet%26aufirst%3DE.%26aulast%3DAlbassam%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DLeopold%26aufirst%3DW.%2BR.%26aulast%3DPryer%26aufirst%3DN.%2BK.%26aulast%3DToogood%26aufirst%3DP.%2BL.%26atitle%3DSpecific%2520inhibition%2520of%2520cyclin-dependent%2520kinase%25204%252F6%2520by%2520PD%25200332991%2520and%2520associated%2520antitumor%2520activity%2520in%2520human%2520tumor%2520xenografts%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D1427%26epage%3D1438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">McInnes, C.</span><span> </span><span class="NLM_article-title">Progress in the evaluation of CDK inhibitors as anti-tumor agents</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">875</span><span class="NLM_x">–</span> <span class="NLM_lpage">881</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=875-881&author=C.+McInnes&title=Progress+in+the+evaluation+of+CDK+inhibitors+as+anti-tumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcInnes%26aufirst%3DC.%26atitle%3DProgress%2520in%2520the%2520evaluation%2520of%2520CDK%2520inhibitors%2520as%2520anti-tumor%2520agents%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D13%26spage%3D875%26epage%3D881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="note"><p class="first last">4-(Pyrazol-4-yl)-pyrimidines have been applied as a platform to generate inhibitors of various kinases. For example,</p></div><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Humphries, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafontaine, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agree, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, Q.-Q. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunney, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajapakse, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhite, D. M.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of 4-substituted-2-aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2099</span><span class="NLM_x">–</span> <span class="NLM_lpage">2102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2099-2102&author=P.+S.+Humphriesauthor=J.+A.+Lafontaineauthor=C.+S.+Agreeauthor=D.+Alexanderauthor=P.+Chenauthor=Q.-Q.+T.+Doauthor=L.+Y.+Liauthor=E.+A.+Lunneyauthor=R.+J.+Rajapakseauthor=K.+Siegelauthor=S.+L.+Timofeevskiauthor=T.+Wangauthor=D.+M.+Wilhite&title=Synthesis+and+SAR+of+4-substituted-2-aminopyrimidines+as+novel+c-Jun+N-terminal+kinase+%28JNK%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHumphries%26aufirst%3DP.%2BS.%26aulast%3DLafontaine%26aufirst%3DJ.%2BA.%26aulast%3DAgree%26aufirst%3DC.%2BS.%26aulast%3DAlexander%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DDo%26aufirst%3DQ.-Q.%2BT.%26aulast%3DLi%26aufirst%3DL.%2BY.%26aulast%3DLunney%26aufirst%3DE.%2BA.%26aulast%3DRajapakse%26aufirst%3DR.%2BJ.%26aulast%3DSiegel%26aufirst%3DK.%26aulast%3DTimofeevski%26aufirst%3DS.%2BL.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWilhite%26aufirst%3DD.%2BM.%26atitle%3DSynthesis%2520and%2520SAR%2520of%25204-substituted-2-aminopyrimidines%2520as%2520novel%2520c-Jun%2520N-terminal%2520kinase%2520%2528JNK%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2099%26epage%3D2102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ioannidis, S.; Lamb, M.</span><span> </span><span class="NLM_article-title">Preparation of <i>N</i>-(pyrazol-3-yl)-<i>N</i>′-(1-pyridin-2-ylethyl)pyrimidine-2,4-diamine derivatives as JAK inhibitors for the treatment of cancer</span>. Int. Patent WO 2009027736,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Ioannidis&author=M.+Lamb&title=Preparation+of+N-%28pyrazol-3-yl%29-N%E2%80%B2-%281-pyridin-2-ylethyl%29pyrimidine-2%2C4-diamine+derivatives+as+JAK+inhibitors+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DIoannidis%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520N-%2528pyrazol-3-yl%2529-N%25E2%2580%25B2-%25281-pyridin-2-ylethyl%2529pyrimidine-2%252C4-diamine%2520derivatives%2520as%2520JAK%2520inhibitors%2520for%2520the%2520treatment%2520of%2520cancer%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cui, J. J.; Deal, J. G.; Gu, D.; Guo, C.; Johnson, M. C.; Kania, R. S.; Kephart, S. E.; Linton, M. A.; McApline, I. J.; Pairish, M. A.; Palmer, C. L.</span><span> </span><span class="NLM_article-title">Preparation of pyrazole compounds as Raf inhibitors</span>. Int. Patent WO 2009016460,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+J.+Cui&author=J.+G.+Deal&author=D.+Gu&author=C.+Guo&author=M.+C.+Johnson&author=R.+S.+Kania&author=S.+E.+Kephart&author=M.+A.+Linton&author=I.+J.+McApline&author=M.+A.+Pairish&author=C.+L.+Palmer&title=Preparation+of+pyrazole+compounds+as+Raf+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26atitle%3DPreparation%2520of%2520pyrazole%2520compounds%2520as%2520Raf%2520inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Fu, H.; Liotta, D. C.; Thomas, S. L.; Snyder, J. P.</span><span> </span><span class="NLM_article-title">NF-κB inhibitor-p38 MAP kinase inhibitor combination for the treatment of cancer and inflammatory diseases</span>. Int. Patent WO 2008150899,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=H.+Fu&author=D.+C.+Liotta&author=S.+L.+Thomas&author=J.+P.+Snyder&title=NF-%CE%BAB+inhibitor-p38+MAP+kinase+inhibitor+combination+for+the+treatment+of+cancer+and+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DH.%26atitle%3DNF-%25CE%25BAB%2520inhibitor-p38%2520MAP%2520kinase%2520inhibitor%2520combination%2520for%2520the%2520treatment%2520of%2520cancer%2520and%2520inflammatory%2520diseases%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Chen, P.; Hong, Y.; Humphries, P. S.; Johnson, T. O.,  Jr.; Lafontaine, J. A.; Liu, S.; Lunney, E. A.</span><span> </span><span class="NLM_article-title">4-Pyrimidine-5-aminopyrazole compounds as JNK modulators and their preparation, pharmaceutical compositions and use in the treatment of diseases</span>. Int. Patent WO 2007129195,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=P.+Chen&author=Y.+Hong&author=P.+S.+Humphries&author=T.+O.+Johnson&author=J.+A.+Lafontaine&author=S.+Liu&author=E.+A.+Lunney&title=4-Pyrimidine-5-aminopyrazole+compounds+as+JNK+modulators+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26atitle%3D4-Pyrimidine-5-aminopyrazole%2520compounds%2520as%2520JNK%2520modulators%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Bennett, M. J.; Cho-Schultz, S.; Deal, J. G.; King, S. J.; Marrone, T. J.; Palmer, C. L.; Romines, W. H.,  III; Rui, E. Y.; Sutton, S. C.; Zhender, L. R.</span><span> </span><span class="NLM_article-title">Pyrazole compounds as Raf inhibitors and their preparation, pharmaceutical compositions and use in the treatment of abnormal cell growth</span>. Int. Patent WO 2007105058,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+J.+Bennett&author=S.+Cho-Schultz&author=J.+G.+Deal&author=S.+J.+King&author=T.+J.+Marrone&author=C.+L.+Palmer&author=W.+H.+Romines&author=E.+Y.+Rui&author=S.+C.+Sutton&author=L.+R.+Zhender&title=Pyrazole+compounds+as+Raf+inhibitors+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+abnormal+cell+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DM.%2BJ.%26atitle%3DPyrazole%2520compounds%2520as%2520Raf%2520inhibitors%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520abnormal%2520cell%2520growth%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Adams, J. L.; Faitg, T. H.; Ralph, J. M.; Silva, D. J.</span><span> </span><span class="NLM_article-title">Pyrimidinyl-pyrazole inhibitors of Aurora kinases and their preparation, pharmaceutical compositions and use in the treatment of cell proliferative diseases</span>. Int. Patent WO 2007024843,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+L.+Adams&author=T.+H.+Faitg&author=J.+M.+Ralph&author=D.+J.+Silva&title=Pyrimidinyl-pyrazole+inhibitors+of+Aurora+kinases+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+cell+proliferative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26atitle%3DPyrimidinyl-pyrazole%2520inhibitors%2520of%2520Aurora%2520kinases%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520cell%2520proliferative%2520diseases%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Garcia-Echeverria, G.</span><span> </span><span class="NLM_article-title">Preparation of pyrazolyl-pyrimidinyl-amine derivatives as IGF-1R inhibitors</span>. Int. Patent WO 2005068452,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=G.+Garcia-Echeverria&title=Preparation+of+pyrazolyl-pyrimidinyl-amine+derivatives+as+IGF-1R+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Echeverria%26aufirst%3DG.%26atitle%3DPreparation%2520of%2520pyrazolyl-pyrimidinyl-amine%2520derivatives%2520as%2520IGF-1R%2520inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Moon, Y.-C.</span><span> </span><span class="NLM_article-title">Preparation of pyrazolyl pyridinamines and pyrimidinamines as inhibitors of Src and other protein kinases</span>. Int. Patent WO 02092573,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=Y.-C.+Moon&title=Preparation+of+pyrazolyl+pyridinamines+and+pyrimidinamines+as+inhibitors+of+Src+and+other+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DY.-C.%26atitle%3DPreparation%2520of%2520pyrazolyl%2520pyridinamines%2520and%2520pyrimidinamines%2520as%2520inhibitors%2520of%2520Src%2520and%2520other%2520protein%2520kinases%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Cho, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, M. J.</span><span> </span><span class="NLM_article-title">Chemo- and regioselective halogenation of 4-(pyrazol-4-yl)-pyrimidines</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5762</span><span class="NLM_x">–</span> <span class="NLM_lpage">5764</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=5762-5764&author=Y.+S.+Choauthor=Y.+Houauthor=C.+H.-T.+Chenauthor=M.+J.+Sung&title=Chemo-+and+regioselective+halogenation+of+4-%28pyrazol-4-yl%29-pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DC.%2BH.-T.%26aulast%3DSung%26aufirst%3DM.%2BJ.%26atitle%3DChemo-%2520and%2520regioselective%2520halogenation%2520of%25204-%2528pyrazol-4-yl%2529-pyrimidines%26jtitle%3DTetrahedron%2520Lett.%26date%3D2009%26volume%3D50%26spage%3D5762%26epage%3D5764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Jeon, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, I. H.</span><span> </span><span class="NLM_article-title">Synthesis of novel 1,4,5-trisubstituted 3-trifluoromethylpyrazoles via microwave-assisted Stille coupling reactions</span> <span class="citation_source-journal">J. Fluorine Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">1191</span><span class="NLM_x">–</span> <span class="NLM_lpage">1197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1016%2Fj.jfluchem.2007.04.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFShs73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2007&pages=1191-1197&author=S.+L.+Jeonauthor=J.+H.+Choiauthor=B.+T.+Kimauthor=I.+H.+Jeong&title=Synthesis+of+novel+1%2C4%2C5-trisubstituted+3-trifluoromethylpyrazoles+via+microwave-assisted+Stille+coupling+reactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of novel 1,4,5-trisubstituted 3-trifluoromethylpyrazoles via microwave-assisted Stille coupling reactions</span></div><div class="casAuthors">Jeon, Sung Lan; Choi, Ji Hoon; Kim, Bum Tae; Jeong, In Howa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1191-1197</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">1,5-Disubstituted 3-trifluoromethylpyrazoles were reacted with N-bromosuccinimide in DMF at room temp. or 70-80° for 1-2 h to afford the corresponding 4-bromopyrazoles in 95-99% yields.  Subsequent microwave-assisted Stille coupling reactions with arylstannanes having a substituent on the benzene ring and allylstannane in refluxing MeCN in the presence of Pd(PPh3)4 provided the corresponding 1,4,5-trisubstituted 3-(trifluoromethyl)pyrazoles in 75-98% yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-410FPMlccrVg90H21EOLACvtfcHk0lh62eieHyn8cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFShs73J&md5=6bb9460dca9917ba5777970d12dc0127</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.jfluchem.2007.04.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jfluchem.2007.04.029%26sid%3Dliteratum%253Aachs%26aulast%3DJeon%26aufirst%3DS.%2BL.%26aulast%3DChoi%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DB.%2BT.%26aulast%3DJeong%26aufirst%3DI.%2BH.%26atitle%3DSynthesis%2520of%2520novel%25201%252C4%252C5-trisubstituted%25203-trifluoromethylpyrazoles%2520via%2520microwave-assisted%2520Stille%2520coupling%2520reactions%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D2007%26volume%3D128%26spage%3D1191%26epage%3D1197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Harden, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokrosz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strekowski, L.</span><span> </span><span class="NLM_article-title">Addition and substitution reactions of chloropyrimidines with lithium reagents</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4137</span><span class="NLM_x">–</span> <span class="NLM_lpage">4140</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00252a057" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=4137-4140&author=D.+B.+Hardenauthor=M.+J.+Mokroszauthor=L.+Strekowski&title=Addition+and+substitution+reactions+of+chloropyrimidines+with+lithium+reagents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjo00252a057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00252a057%26sid%3Dliteratum%253Aachs%26aulast%3DHarden%26aufirst%3DD.%2BB.%26aulast%3DMokrosz%26aufirst%3DM.%2BJ.%26aulast%3DStrekowski%26aufirst%3DL.%26atitle%3DAddition%2520and%2520substitution%2520reactions%2520of%2520chloropyrimidines%2520with%2520lithium%2520reagents%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1988%26volume%3D53%26spage%3D4137%26epage%3D4140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Brain, C. T.; Thoma, G.; Sung, M. J.</span><span> </span><span class="NLM_article-title">Preparation of pyrrolopyrimidine compounds as protein kinase inhibitors</span>. PCT Int. Appl. WO 2007140222 A2 20071206,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=C.+T.+Brain&author=G.+Thoma&author=M.+J.+Sung&title=Preparation+of+pyrrolopyrimidine+compounds+as+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrain%26aufirst%3DC.%2BT.%26atitle%3DPreparation%2520of%2520pyrrolopyrimidine%2520compounds%2520as%2520protein%2520kinase%2520inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Santora, V.; Askew, B.; Ghose, A.; Hague, A.; Kim, T. S.; Laber, E.; Li, A.; Lian, B.; Liu, G.; Norman, M. H.; Smith, L.; Tasker, A.; Tegley, C.; Yang, K.</span><span> </span><span class="NLM_article-title">Preparation of diheteroaryl ureas as antitumor agents</span>. PCT Int. Appl. WO 2002014311 A2 20020221,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=V.+Santora&author=B.+Askew&author=A.+Ghose&author=A.+Hague&author=T.+S.+Kim&author=E.+Laber&author=A.+Li&author=B.+Lian&author=G.+Liu&author=M.+H.+Norman&author=L.+Smith&author=A.+Tasker&author=C.+Tegley&author=K.+Yang&title=Preparation+of+diheteroaryl+ureas+as+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSantora%26aufirst%3DV.%26atitle%3DPreparation%2520of%2520diheteroaryl%2520ureas%2520as%2520antitumor%2520agents%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Kim, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, B.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. H.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of novel aryl-tetrahydropyridine PPARα/γ dual agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4993</span><span class="NLM_x">–</span> <span class="NLM_lpage">4996</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4993-4996&author=E.+Kimauthor=C.+S.+Parkauthor=T.+Hanauthor=M.-H.+Baeauthor=W.+Chongauthor=C.+H.+Leeauthor=Y.+A.+Shinauthor=B.-N.+Ahnauthor=M.+K.+Kimauthor=C.+Y.+Shinauthor=M.+Sonauthor=J.+K.+Kimauthor=H.+S.+Moonauthor=H.+J.+Shimauthor=E.+J.+Kimauthor=S.+H.+Kimauthor=J.+I.+Limauthor=C.+H.+Lee&title=Design%2C+synthesis%2C+and+evaluation+of+novel+aryl-tetrahydropyridine+PPAR%CE%B1%2F%CE%B3+dual+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DE.%26aulast%3DPark%26aufirst%3DC.%2BS.%26aulast%3DHan%26aufirst%3DT.%26aulast%3DBae%26aufirst%3DM.-H.%26aulast%3DChong%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DShin%26aufirst%3DY.%2BA.%26aulast%3DAhn%26aufirst%3DB.-N.%26aulast%3DKim%26aufirst%3DM.%2BK.%26aulast%3DShin%26aufirst%3DC.%2BY.%26aulast%3DSon%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%2BK.%26aulast%3DMoon%26aufirst%3DH.%2BS.%26aulast%3DShim%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DE.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DLim%26aufirst%3DJ.%2BI.%26aulast%3DLee%26aufirst%3DC.%2BH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520novel%2520aryl-tetrahydropyridine%2520PPAR%25CE%25B1%252F%25CE%25B3%2520dual%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4993%26epage%3D4996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Allerton, C. M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, K. K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMurray, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, L.</span><span> </span><span class="NLM_article-title">Design and synthesis of pyridazinone-based 5-HT2C agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5791</span><span class="NLM_x">–</span> <span class="NLM_lpage">5795</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5791-5795&author=C.+M.+N.+Allertonauthor=M.+D.+Andrewsauthor=J.+Blaggauthor=D.+Ellisauthor=E.+Evrardauthor=M.+P.+Greenauthor=K.+K.-C.+Liuauthor=G.+McMurrayauthor=M.+Ralphauthor=V.+Sandersonauthor=R.+Wardauthor=L.+Watson&title=Design+and+synthesis+of+pyridazinone-based+5-HT2C+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllerton%26aufirst%3DC.%2BM.%2BN.%26aulast%3DAndrews%26aufirst%3DM.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DEvrard%26aufirst%3DE.%26aulast%3DGreen%26aufirst%3DM.%2BP.%26aulast%3DLiu%26aufirst%3DK.%2BK.-C.%26aulast%3DMcMurray%26aufirst%3DG.%26aulast%3DRalph%26aufirst%3DM.%26aulast%3DSanderson%26aufirst%3DV.%26aulast%3DWard%26aufirst%3DR.%26aulast%3DWatson%26aufirst%3DL.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520pyridazinone-based%25205-HT2C%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5791%26epage%3D5795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Brown, D. L.; Grapperhaus, M. L.; Kassab, D. J.; Massa, M. A.; Mcdonald, J. J.; Mullins, P. B.; Rico, J. G.; Schmidt, M. A.</span><span> </span><span class="NLM_article-title">Preparation of piperidinyl- and piperazinylsulfonylmethyl hydroxamic acids and their use as protease inhibitors</span>. PCT Int. Appl. WO 2005042521 A2 20050512,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=D.+L.+Brown&author=M.+L.+Grapperhaus&author=D.+J.+Kassab&author=M.+A.+Massa&author=J.+J.+Mcdonald&author=P.+B.+Mullins&author=J.+G.+Rico&author=M.+A.+Schmidt&title=Preparation+of+piperidinyl-+and+piperazinylsulfonylmethyl+hydroxamic+acids+and+their+use+as+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BL.%26atitle%3DPreparation%2520of%2520piperidinyl-%2520and%2520piperazinylsulfonylmethyl%2520hydroxamic%2520acids%2520and%2520their%2520use%2520as%2520protease%2520inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Cioffi, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlin, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, R. J.</span><span> </span><span class="NLM_article-title">Convenient palladium-catalyzed preparation of primary anilines using a fluorous benzophenone imine reagent</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">845</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=841-845&author=C.+L.+Cioffiauthor=M.+L.+Berlinauthor=R.+J.+Herr&title=Convenient+palladium-catalyzed+preparation+of+primary+anilines+using+a+fluorous+benzophenone+imine+reagent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCioffi%26aufirst%3DC.%2BL.%26aulast%3DBerlin%26aufirst%3DM.%2BL.%26aulast%3DHerr%26aufirst%3DR.%2BJ.%26atitle%3DConvenient%2520palladium-catalyzed%2520preparation%2520of%2520primary%2520anilines%2520using%2520a%2520fluorous%2520benzophenone%2520imine%2520reagent%26jtitle%3DSynlett%26date%3D2004%26spage%3D841%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="note"><p class="first last">See <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for a detailed description of the cellular assay.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Day, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tickle, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holding, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhoti, H.</span><span> </span><span class="NLM_article-title">Crystal structure of human CDK4 in complex with a D-type cyclin</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">4166</span><span class="NLM_x">–</span> <span class="NLM_lpage">4170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=4166-4170&author=P.+J.+Dayauthor=A.+Cleasbyauthor=I.+J.+Tickleauthor=M.+O%E2%80%99Reillyauthor=J.+E.+Coyleauthor=F.+P.+Holdingauthor=R.+L.+McMenaminauthor=J.+Yonauthor=R.+Chopraauthor=C.+Lengauerauthor=H.+Jhoti&title=Crystal+structure+of+human+CDK4+in+complex+with+a+D-type+cyclin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DTickle%26aufirst%3DI.%2BJ.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DHolding%26aufirst%3DF.%2BP.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DYon%26aufirst%3DJ.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DCrystal%2520structure%2520of%2520human%2520CDK4%2520in%2520complex%2520with%2520a%2520D-type%2520cyclin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D4166%26epage%3D4170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Gahmen, U.</span><span> </span><span class="NLM_article-title">Toward understanding the structural basis of cyclin-dependent kinase 6 specific inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3826</span><span class="NLM_x">–</span> <span class="NLM_lpage">3831</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0600388" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVKgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3826-3831&author=H.+Luauthor=U.+Schulze-Gahmen&title=Toward+understanding+the+structural+basis+of+cyclin-dependent+kinase+6+specific+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">Toward Understanding the Structural Basis of Cyclin-Dependent Kinase 6 Specific Inhibition</span></div><div class="casAuthors">Lu, Heshu; Schulze-Gahmen, Ursula</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3826-3831</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (CDKs) are key players in cell cycle control, and genetic alterations of CDKs and their regulators have been linked to a variety of cancers.  Hence, CDKs are obvious targets for therapeutic intervention in various proliferative diseases, including cancer.  To date, drug design efforts have mostly focused on CDK2 because methods for crystn. of its inhibitor complexes have been well established.  CDK4 and CDK6, however, may be at least as important as enzymes for cell cycle regulation and could provide alternative treatment options.  We describe here two complex structures of human CDK6 with a very specific kinase inhibitor, PD0332991, which is based on a pyrido[2,3-d]pyrimidin-7-one scaffold, and with the less specific aminopurvalanol inhibitor.  Anal. of the structures suggests that relatively small conformational differences between CDK2 and CDK6 in the hinge region are contributing to the inhibitor specificity by inducing changes in the inhibitor orientation that lead to sterical clashes in CDK2 but not CDK6.  These complex structures provide valuable insights for the future development of CDK-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt5qOCDA_blLVg90H21EOLACvtfcHk0ligkoI6s0dr0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVKgtbk%253D&md5=218bcdfeac3e7371e3ae16ab0a5799db</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1021%2Fjm0600388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0600388%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DH.%26aulast%3DSchulze-Gahmen%26aufirst%3DU.%26atitle%3DToward%2520understanding%2520the%2520structural%2520basis%2520of%2520cyclin-dependent%2520kinase%25206%2520specific%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3826%26epage%3D3831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baratte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Gahmen, U.</span><span> </span><span class="NLM_article-title">Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">743</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049353p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFSqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=737-743&author=H.+Luauthor=D.+J.+Changauthor=B.+Baratteauthor=L.+Meijerauthor=U.+Schulze-Gahmen&title=Crystal+structure+of+a+human+cyclin-dependent+kinase+6+complex+with+a+flavonol+inhibitor%2C+fisetin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23cR"><div class="casContent"><span class="casTitleNuber">23c</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of a Human Cyclin-Dependent Kinase 6 Complex with a Flavonol Inhibitor, Fisetin</span></div><div class="casAuthors">Lu, Heshu; Chang, Debbie J.; Baratte, Blandine; Meijer, Laurent; Schulze-Gahmen, Ursula</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">737-743</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (CDKs) play a central role in cell cycle control, apoptosis, transcription, and neuronal functions.  They are important targets for the design of drugs with antimitotic or antineurodegenerative effects.  CDK4 and CDK6 form a subfamily among the CDKs in mammalian cells, as defined by sequence similarities.  Compared to CDK2 and CDK5, structural information on CDK4 and CDK6 is sparse.  We describe here the crystal structure of human CDK6 in complex with a viral cyclin and a flavonol inhibitor, fisetin.  Fisetin binds to the active form of CDK6, forming hydrogen bonds with the side chains of residues in the binding pocket that undergo large conformational changes during CDK activation by cyclin binding.  The 4-keto group and the 3-hydroxyl group of fisetin are hydrogen bonded with the backbone in the hinge region between the N-terminal and C-terminal kinase domain, as has been obsd. for many CDK inhibitors.  However, CDK2 and HCK kinase in complex with other flavone inhibitors such as quercetin and flavopiridol showed a different binding mode with the inhibitor rotated by about 180°.  The structural information of the CDK6-fisetin complex is correlated with the binding affinities of different flavone inhibitors for CDK6.  This complex structure is the first description of an inhibitor complex with a kinase from the CDK4/6 subfamily and can provide a basis for selecting and designing inhibitor compds. with higher affinities and specificities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeJrMaE-wOqrVg90H21EOLACvtfcHk0ligkoI6s0dr0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFSqsQ%253D%253D&md5=0c3910ed0310038be241230a633ba840</span></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.1021%2Fjm049353p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049353p%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DD.%2BJ.%26aulast%3DBaratte%26aufirst%3DB.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DSchulze-Gahmen%26aufirst%3DU.%26atitle%3DCrystal%2520structure%2520of%2520a%2520human%2520cyclin-dependent%2520kinase%25206%2520complex%2520with%2520a%2520flavonol%2520inhibitor%252C%2520fisetin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D737%26epage%3D743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Honma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukasawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeura, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikuta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki-Takahashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima, H.</span><span> </span><span class="NLM_article-title">A novel approach for the development of selective Cdk4 inhibitors: library design based on locations of Cdk4 specific amino acid residues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4628</span><span class="NLM_x">–</span> <span class="NLM_lpage">4640</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010326y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4628-4640&author=T.+Honmaauthor=T.+Yoshizumiauthor=N.+Hashimotoauthor=K.+Hayashiauthor=N.+Kawanishiauthor=K.+Fukasawaauthor=T.+Takakiauthor=C.+Ikeuraauthor=M.+Ikutaauthor=I.+Suzuki-Takahashiauthor=T.+Hayamaauthor=S.+Nishimuraauthor=H.+Morishima&title=A+novel+approach+for+the+development+of+selective+Cdk4+inhibitors%3A+library+design+based+on+locations+of+Cdk4+specific+amino+acid+residues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Fjm010326y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010326y%26sid%3Dliteratum%253Aachs%26aulast%3DHonma%26aufirst%3DT.%26aulast%3DYoshizumi%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DN.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DKawanishi%26aufirst%3DN.%26aulast%3DFukasawa%26aufirst%3DK.%26aulast%3DTakaki%26aufirst%3DT.%26aulast%3DIkeura%26aufirst%3DC.%26aulast%3DIkuta%26aufirst%3DM.%26aulast%3DSuzuki-Takahashi%26aufirst%3DI.%26aulast%3DHayama%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DS.%26aulast%3DMorishima%26aufirst%3DH.%26atitle%3DA%2520novel%2520approach%2520for%2520the%2520development%2520of%2520selective%2520Cdk4%2520inhibitors%253A%2520library%2520design%2520based%2520on%2520locations%2520of%2520Cdk4%2520specific%2520amino%2520acid%2520residues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D4628%26epage%3D4640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pratt, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E. M.</span><span> </span><span class="NLM_article-title">Dissecting the determinants of cyclin-dependent kinase 2 and dyclin-cependent kinase 4 inhibitor selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5470</span><span class="NLM_x">–</span> <span class="NLM_lpage">5477</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060216x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5470-5477&author=D.+J.+Prattauthor=J.+Bentleyauthor=P.+Jewsburyauthor=F.+T.+Boyleauthor=J.+A.+Endicottauthor=M.+E.+M.+Noble&title=Dissecting+the+determinants+of+cyclin-dependent+kinase+2+and+dyclin-cependent+kinase+4+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1021%2Fjm060216x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060216x%26sid%3Dliteratum%253Aachs%26aulast%3DPratt%26aufirst%3DD.%2BJ.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DNoble%26aufirst%3DM.%2BE.%2BM.%26atitle%3DDissecting%2520the%2520determinants%2520of%2520cyclin-dependent%2520kinase%25202%2520and%2520dyclin-cependent%2520kinase%25204%2520inhibitor%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5470%26epage%3D5477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jones, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blades, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byth, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, M. R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, H. M.</span><span> </span><span class="NLM_article-title">Imidazole pyrimidine amides as potent, orally bioavailable cyclin-dependent kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6486</span><span class="NLM_x">–</span> <span class="NLM_lpage">6489</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6486-6489&author=C.+D.+Jonesauthor=D.+M.+Andrewsauthor=A.+J.+Barkerauthor=K.+Bladesauthor=K.+F.+Bythauthor=M.+R.+V.+Finlayauthor=C.+Gehauthor=C.+P.+Greenauthor=M.+Johannsenauthor=M.+Walkerauthor=H.+M.+Weir&title=Imidazole+pyrimidine+amides+as+potent%2C+orally+bioavailable+cyclin-dependent+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BD.%26aulast%3DAndrews%26aufirst%3DD.%2BM.%26aulast%3DBarker%26aufirst%3DA.%2BJ.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DByth%26aufirst%3DK.%2BF.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%2BV.%26aulast%3DGeh%26aufirst%3DC.%26aulast%3DGreen%26aufirst%3DC.%2BP.%26aulast%3DJohannsen%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DM.%26aulast%3DWeir%26aufirst%3DH.%2BM.%26atitle%3DImidazole%2520pyrimidine%2520amides%2520as%2520potent%252C%2520orally%2520bioavailable%2520cyclin-dependent%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6486%26epage%3D6489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jones, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blades, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daunt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">East, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loddick, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarland, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGregor, A.a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudge, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swain, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M.</span><span> </span><span class="NLM_article-title">The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosing</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6369</span><span class="NLM_x">–</span> <span class="NLM_lpage">6373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1016%2Fj.bmcl.2008.10.102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=18996007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWjs7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6369-6373&author=C.+D.+Jonesauthor=D.+M.+Andrewsauthor=A.+J.+Barkerauthor=K.+Bladesauthor=P.+Dauntauthor=S.+Eastauthor=C.+Gehauthor=M.+A.+Grahamauthor=K.+M.+Johnsonauthor=S.+A.+Loddickauthor=H.+M.+McFarlandauthor=A.a+McGregorauthor=L.+Mossauthor=D.+A.+Rudgeauthor=P.+B.+Simpsonauthor=M.+L.+Swainauthor=K.+Y.+Tamauthor=J.+A.+Tuckerauthor=M.+Walker&title=The+discovery+of+AZD5597%2C+a+potent+imidazole+pyrimidine+amide+CDK+inhibitor+suitable+for+intravenous+dosing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosing</span></div><div class="casAuthors">Jones, Clifford D.; Andrews, David M.; Barker, Andrew J.; Blades, Kevin; Daunt, Paula; East, Simon; Geh, Catherine; Graham, Mark A.; Johnson, Keith M.; Loddick, Sarah A.; McFarland, Heather M.; McGregor, Alexandra; Moss, Louise; Rudge, David A.; Simpson, Peter B.; Swain, Michael L.; Tam, Kin Y.; Tucker, Julie A.; Walker, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6369-6373</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The development of a novel series of imidazole pyrimidine amides as cyclin-dependent kinase (CDK) inhibitors is described.  Optimization of inhibitory potency against multiple CDK's (1, 2 and 9) resulted in imidazole pyrimidine amides with potent in vitro anti-proliferative effects against a range of cancer cell lines.  Excellent physiochem. properties and large margins against inhibition of CYP isoforms and the hERG ion channel were achieved by modification of lipophilicity and amine basicity.  A candidate with disease model activity in human cancer cell line xenografts and with suitable physiochem. and pharmacokinetic profiles for i.v. (iv) dosing was selected for further development as AZD5597 (I).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnX9-GP03dzbVg90H21EOLACvtfcHk0lhEGbhYXoYj-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWjs7bP&md5=084ed54076134c7173953ebbdb23fd86</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.10.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.10.102%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BD.%26aulast%3DAndrews%26aufirst%3DD.%2BM.%26aulast%3DBarker%26aufirst%3DA.%2BJ.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DDaunt%26aufirst%3DP.%26aulast%3DEast%26aufirst%3DS.%26aulast%3DGeh%26aufirst%3DC.%26aulast%3DGraham%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DK.%2BM.%26aulast%3DLoddick%26aufirst%3DS.%2BA.%26aulast%3DMcFarland%26aufirst%3DH.%2BM.%26aulast%3DMcGregor%26aufirst%3DA.a%26aulast%3DMoss%26aufirst%3DL.%26aulast%3DRudge%26aufirst%3DD.%2BA.%26aulast%3DSimpson%26aufirst%3DP.%2BB.%26aulast%3DSwain%26aufirst%3DM.%2BL.%26aulast%3DTam%26aufirst%3DK.%2BY.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DWalker%26aufirst%3DM.%26atitle%3DThe%2520discovery%2520of%2520AZD5597%252C%2520a%2520potent%2520imidazole%2520pyrimidine%2520amide%2520CDK%2520inhibitor%2520suitable%2520for%2520intravenous%2520dosing%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6369%26epage%3D6373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Anderson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brassington, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byth, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culshaw, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, M. R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMiken, H. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcombe, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakes, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauptit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanway, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, H. M.</span><span> </span><span class="NLM_article-title">Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5487</span><span class="NLM_x">–</span> <span class="NLM_lpage">5492</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5487-5492&author=M.+Andersonauthor=D.+M.+Andrewsauthor=A.+J.+Barkerauthor=C.+A.+Brassingtonauthor=J.+Breedauthor=K.+F.+Bythauthor=J.+D.+Culshawauthor=M.+R.+V.+Finlayauthor=E.+Fisherauthor=H.+H.+J.+McMikenauthor=C.+P.+Greenauthor=D.+W.+Heatonauthor=I.+A.+Nashauthor=N.+J.+Newcombeauthor=S.+E.+Oakesauthor=R.+A.+Pauptitauthor=A.+Robertsauthor=J.+J.+Stanwayauthor=A.+P.+Thomasauthor=J.+A.+Tuckerauthor=M.+Walkerauthor=H.+M.+Weir&title=Imidazoles%3A+SAR+and+development+of+a+potent+class+of+cyclin-dependent+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DAndrews%26aufirst%3DD.%2BM.%26aulast%3DBarker%26aufirst%3DA.%2BJ.%26aulast%3DBrassington%26aufirst%3DC.%2BA.%26aulast%3DBreed%26aufirst%3DJ.%26aulast%3DByth%26aufirst%3DK.%2BF.%26aulast%3DCulshaw%26aufirst%3DJ.%2BD.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%2BV.%26aulast%3DFisher%26aufirst%3DE.%26aulast%3DMcMiken%26aufirst%3DH.%2BH.%2BJ.%26aulast%3DGreen%26aufirst%3DC.%2BP.%26aulast%3DHeaton%26aufirst%3DD.%2BW.%26aulast%3DNash%26aufirst%3DI.%2BA.%26aulast%3DNewcombe%26aufirst%3DN.%2BJ.%26aulast%3DOakes%26aufirst%3DS.%2BE.%26aulast%3DPauptit%26aufirst%3DR.%2BA.%26aulast%3DRoberts%26aufirst%3DA.%26aulast%3DStanway%26aufirst%3DJ.%2BJ.%26aulast%3DThomas%26aufirst%3DA.%2BP.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DWalker%26aufirst%3DM.%26aulast%3DWeir%26aufirst%3DH.%2BM.%26atitle%3DImidazoles%253A%2520SAR%2520and%2520development%2520of%2520a%2520potent%2520class%2520of%2520cyclin-dependent%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5487%26epage%3D5492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Matter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazare, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guessregen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreuder, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehner, V.</span><span> </span><span class="NLM_article-title">Evidence for C-Cl/C-Br···π interactions as an important contribution to protein−ligand binding affinity</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2911</span><span class="NLM_x">–</span> <span class="NLM_lpage">2916</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=2911-2916&author=H.+Matterauthor=M.+Nazareauthor=S.+Guessregenauthor=D.+W.+Willauthor=H.+Schreuderauthor=A.+Bauerauthor=M.+Urmannauthor=K.+Ritterauthor=M.+Wagnerauthor=V.+Wehner&title=Evidence+for+C-Cl%2FC-Br%C2%B7%C2%B7%C2%B7%CF%80+interactions+as+an+important+contribution+to+protein%E2%88%92ligand+binding+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatter%26aufirst%3DH.%26aulast%3DNazare%26aufirst%3DM.%26aulast%3DGuessregen%26aufirst%3DS.%26aulast%3DWill%26aufirst%3DD.%2BW.%26aulast%3DSchreuder%26aufirst%3DH.%26aulast%3DBauer%26aufirst%3DA.%26aulast%3DUrmann%26aufirst%3DM.%26aulast%3DRitter%26aufirst%3DK.%26aulast%3DWagner%26aufirst%3DM.%26aulast%3DWehner%26aufirst%3DV.%26atitle%3DEvidence%2520for%2520C-Cl%252FC-Br%25C2%25B7%25C2%25B7%25C2%25B7%25CF%2580%2520interactions%2520as%2520an%2520important%2520contribution%2520to%2520protein%25E2%2588%2592ligand%2520binding%2520affinity%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2009%26volume%3D48%26spage%3D2911%26epage%3D2916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Otwinowski, Z; Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray diffraction data collected in oscillation mode</span>.  <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span>− <span class="NLM_lpage">326</span> (Macromolecular Crystallography, Part A).</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z+Otwinowski&author=W.+Minor&title=Processing+of+X-ray+diffraction+data+collected+in+oscillation+mode"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0liIjpRsFYqQdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ%26atitle%3DProcessing%2520of%2520X-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Bailey, S.</span><span> </span><span class="NLM_article-title">The CCP4 suite: programs for protein crystallography</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=15299374" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=760-763&author=S.+Bailey&title=The+CCP4+suite%3A+programs+for+protein+crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DS.%26atitle%3DThe%2520CCP4%2520suite%253A%2520programs%2520for%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3D50%26spage%3D760%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Brunger, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clore, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLano, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gros, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuszewski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilges, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, G. L.</span><span> </span><span class="NLM_article-title">Crystallography & NMR system: a new software suite for macromolecular structure determination</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">921</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm100571n&amp;key=10.1107%2FS0907444998003254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm100571n&amp;key=9757107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm100571n&amp;key=1%3ACAS%3A528%3ADyaK1cXmsVKgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=905-921&author=A.+T.+Brungerauthor=P.+D.+Adamsauthor=G.+M.+Cloreauthor=W.+L.+DeLanoauthor=P.+Grosauthor=R.+W.+Grosse-Kunstleveauthor=J.+S.+Jiangauthor=J.+Kuszewskiauthor=M.+Nilgesauthor=N.+S.+Pannuauthor=R.+J.+Readauthor=L.+M.+Riceauthor=T.+Simonsonauthor=G.+L.+Warren&title=Crystallography+%26+NMR+system%3A+a+new+software+suite+for+macromolecular+structure+determination"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallography & NMR System: a new software suite for macromolecular structure determination</span></div><div class="casAuthors">Brunger, Axel T.; Adams, Paul D.; Clore, G. Marius; DeLano, Warren L.; Gros, Piet; Grosse-Kunstleve, Ralf W.; Jiang, Jian-Sheng; Kuszewski, John; Nilges, Michael; Pannu, Navraj S.; Read, Randy J.; Rice, Luke M.; Simonson, Thomas; Warren, Gregory L.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">D54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">905-921</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">A new software suite, called Crystallog. & NMR System (CNS), has been developed for macromol. structure detn. by x-ray crystallog. or soln. NMR (NMR) spectroscopy.  In contrast to existing structure-detn. programs the architecture of CNS is highly flexible, allowing for extension to other structure-detn. methods, such as electron microscopy and solid-state NMR spectroscopy.  CNS has a hierarchical structure: a high-level hypertext markup language (HTML) user interface, task-oriented user input files, module files, a symbolic structure-detn. language (CNS language), and low-level source code.  Each layer is accessible to the user.  The novice user may just use the HTML interface, while the more advanced user may use any of the other layers.  The source code will be distributed, thus source-code modification is possible.  The CNS language is sufficiently powerful and flexible that many new algorithms can be easily implemented in the CNS language without changes to the source code.  The CNS language allows the user to perform operations on data structures, such as structure factors, electron-d. maps, and at. properties.  The power of the CNS language has been demonstrated by the implementation of a comprehensive set of crystallog. procedures for phasing, d. modification and refinement.  User-friendly task-oriented input files are available for nearly all aspects of macromol. structure detn. by x-ray crystallog. and soln. NMR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrffnnqTlxIurVg90H21EOLACvtfcHk0ljCGNAWEHyWhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsVKgsbo%253D&md5=1ff3025ab69077f4086a6e3d8ef99bf8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0907444998003254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444998003254%26sid%3Dliteratum%253Aachs%26aulast%3DBrunger%26aufirst%3DA.%2BT.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DClore%26aufirst%3DG.%2BM.%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26aulast%3DGros%26aufirst%3DP.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DJiang%26aufirst%3DJ.%2BS.%26aulast%3DKuszewski%26aufirst%3DJ.%26aulast%3DNilges%26aufirst%3DM.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRice%26aufirst%3DL.%2BM.%26aulast%3DSimonson%26aufirst%3DT.%26aulast%3DWarren%26aufirst%3DG.%2BL.%26atitle%3DCrystallography%2520%2526%2520NMR%2520system%253A%2520a%2520new%2520software%2520suite%2520for%2520macromolecular%2520structure%2520determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1998%26volume%3D54%26spage%3D905%26epage%3D921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NUP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NUP','PDB','3NUP'); return false;">PDB: 3NUP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NUX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NUX','PDB','3NUX'); return false;">PDB: 3NUX</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100571n&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-22%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm100571n%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100571n" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c7c87eb83cb8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
